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Abstract 
 
Fumonisins B1 6 and B3 8 are toxic secondary metabolites of the fungus Fusarium 
moniliforme that inhibit enzymes of sphingolipid biosynthesis. This dissertation describes 
work towards the stereocontrolled total synthesis of the fumonisin natural products.  
The proposed highly convergent strategy allows for the late stage stereocontrolled 
coupling of the two fragments C1-C10 58 and C11-C20 57 with concomitant installation of 
the C10 hydroxyl using key boron aldol methodology. A directed hydrogenation installs the 
final methyl-bearing stereocentre at C12. Syntheses of the left- and right-hand fragments 57 
and 58 by means of substrate-based stereocontrol and asymmetric catalytic methods is 
reported.  
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A completed synthesis of the protected FB3 carbon backbone 59 is achieved in a 
linear reaction sequence of 14 steps. Tentative assignment of stereogenic centres within 59 
was made by analogy to the C4-C20 fragment 190 of fumonisin B3. Synthesis of C4-C20 190 
by the coupling of C11-C20 57 with heptaldehyde is also described.  
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Nomenclature 
 
A. Compound Numbering and Naming 
The numbering system for intermediates is based on the numbering within the 
fumonisin B3 carbon backbone.  
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The naming of intermediates follows the naming features provided by AutoNom 
Version 2.1. 
 
B. Syn and Anti Isomers 
The syn and anti descriptors were first used by Masamune1 in the designation of 
relative configuration in stereoisomers. When the carbon chain of a molecule is drawn in 
a zigzag manner in the plane of the page, then non-hydrogen substituents on the same 
side of the plane are designated syn 1, and substituents on opposite sides of the plane are 
designated anti 2. 
R1
R2
R1
R2
1   syn 2   anti  
 
C. A wavy line 3A indicates that the configuration at a carbon centre in a 
stereoisomer is unknown, and in the case of an alkene 3B E and Z isomers exist. 
 
 
 
 
D. R* and S* represent the configuration at racemic carbon centres in a molecule.
R
3
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1 Introduction 
 
 
1.1 Fumonisins: Isolation, Structure and Biology. 
  
Fumonisins are a class of structurally-related mycotoxins first isolated from 
Fusarium moniliforme (Sheldon) and related fungi by a South African research group in 
1988.2 The worldwide contamination of corn and other grains by Fusarium moniliforme, and 
its implications in animal and human diseases has made the fumonisins and related 
compounds a concern for scientists, corn growers, food industry groups and regulatory 
agencies alike. The toxic, carcinogenic and phytotoxic properties exhibited by this fungus 
have been traced to the presence of the fumonisins.  
The characteristic toxicological effects of fumonisins differ between species and 
include leukoencephalomalacia (LEM) or ‘mouldy corn poisoning’ in horses,3,4 pulmonary 
edema syndrome (PES) in pigs,5 hepatotoxicity6 and hepatocarcinogenicity7 in rats, 
cytotoxicity8,9 to mammalian cells, and phytotoxicity.10,11 Fumonisins inhibit sphingolipid 
biosynthesis,12,13 and have been correlated with oesophageal cancer in humans.14 The 
International Agency For Research on Cancer (IARC) evaluated the “toxins derived from 
Fusarium moniliforme” as Group 2B carcinogens (i.e. possibly carcinogenic to humans).15,16   
The first fumonisins to be structurally elucidated were fumonisins A1 (FA1 4), A2 
(FA2 5), B1 (FB1 6) and B2 (FB2 7) (Figure 1).17 Since then, structures for fumonisins B3 
(FB3 8) and B4 (FB4 9),18,19 iso-fumonisin B1 (iso-FB1 10),20 fumonisin AK1 (FAK1 11),21 
fumonisins C1 (FC1 12) and C4 (FC4 13),22,23 hydroxylated C1 14, fumonisin C3 (FC3 15)24 
(Figure 1) and fumonisins P1 (FP1 16), P2 (FP2 17) and P3 (FP3 18)25 (Figure 2) have been 
identified.  
Fumonisins are water soluble diesters characterised by having a 20-carbon (or 19-
carbon for FC series) polyhydroxylated amine backbone and two propane-1,2,3-tricarboxylic 
acid (PTCA) ester side chains. The common sites of substitution between the fumonisins are 
the amino group at C2, the hydroxy groups at C3, C14 and C15, and the methyl groups at 
C12 and C16 (and equivalent positions in the FC series). The hydroxy substitutions at C4, 
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C5 and C10 are more random. The hydroxy groups at C14 and C15 in all fumonisins (except 
FAK1 11) are esterified with the PTCA moieties. The FB series contain the major 
fumonisins, FB1 6, FB2 7, and FB3 8 found in naturally contaminated corn. Although FB1 is 
the major mammalian and plant toxin, FB2 and FB3 appear to be as active. FB1 contains 
hydroxy groups at C5 and C10, while FB2 and FB3 lack hydroxy groups at C10 and C5 
respectively, and FB4 9 lacks hydroxy groups at both sites. Hydrolytic removal (usually by 
food processing steps such as in the preparation of tortillas from maize) of the PTCA ester 
groups from FB1, FB2 and FB3 yields hydrolysed FB1 (HFB1), HFB2 and HFB3 19, 
respectively and reduces their potency 10-fold. Iso-FB1 10, the fourth most abundant 
fumonisin in F. moniliforme cultures, is a structural isomer of FB1. It contains hydroxy 
functions on C4 and C10 rather than on C5 and C10. 
The FA series (Figure 1) are the naturally occurring21 N-acetylated forms of the FB 
series, and are essentially inactive. Thus FA1 4 and FA2 5 are the N-acetyl derivatives of FB1 
6 and FB2 7, respectively. It has been suggested however that the N-acetylated fumonisins 
are possible artifacts of the isolation procedure which uses acetic acid.23,26 The keto amide 
FAK1 11 contains a ketone group at C15 instead of the PTCA chain.  
The FC series (Figure 1) lacks the 1-methyl group characteristic of other fumonisins 
and resembles another family of mycotoxins called the AAL toxins (see Section 1.2). 
Members of this group include FC1 12, FC3 15, FC4 13 and hydroxylated-FC1 14, which 
contains an additional hydroxy group at C3. Once again, the number and location of the 
hydroxy groups in FC1, FC2 and FC3 correspond to the pattern found in FB1, FB2 and FB3 
respectively. 
The FP series (Figure 2) consisting of FP1 16, FP2 17 and FP3 18 have a characteristic 
N-linked 3-hydroxypyridinium moiety at C2, and can occur at levels up to 30% of FB1 when 
grown on solid corn cultures. This group is of interest because of the known toxic effects of 
long alkyl-chain pyridinium compounds.25,27 
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Gelderblom et al.9,28 observed that only the fumonisins of the B series (FB1, FB2, 
FB3) initiated cancer in rat liver whereas the N-acetylated analogues FA1 and FA2, and the 
PTCA hydrolysis product did not. Furthermore, Merrill et al.29 found that removal of the 
PTCA groups from FB1 gave HFB1 that inhibits sphingolipid metabolism with an IC50 only 
about 10-fold higher (1 µM). These studies lend some insight into the structure-activity 
dependence of the fumonisins. They show that the free amino group and, to a smaller extent, 
the intact molecule are required for cancer promotion. Likewise, the high level of herbicidal 
activity of FB1 and AAL-toxins was attributed to the free amine group.11,30 The C5 hydroxy 
group is not critical for bioactivity because FB3 which is structurally similar to FB1 but lacks 
the hydroxy group at C5 has an IC50 of approximately 1 µM in rat hepatocytes,29 comparable 
to inhibition by FB1. Furthermore, the C10 hydroxy group does not appear critical either 
because FB2 which lacks the C10 hydroxy group present in FB1 shows a similar degree of 
inhibition of sphingosine 20 biosynthesis in rat hepatocytes to FB1.13,29 
Merrill et al.13,31,32 have shown that fumonisin B1 interferes with the biosynthesis of 
sphingolipids (which takes place at the intracellular membranes of the endoplasmic 
reticulum and Golgi apparatus in eukaryotic cells) by inhibiting the enzymes sphinganine 
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and sphingosine N-acyltransferase (ceramide synthases) which are responsible for catalysing 
the conversion of sphinganine 21 to dihydroceramide 22 as well as sphingosine 20 to 
ceramide 23 in the metabolic pathway to sphingolipids (Scheme 1). This inhibition by FB1 
occurred with an IC50 of 0.1 µM in primary rat hepatocytes,13,33 a concentration that could 
easily be reached by the consumption of naturally contaminated corn. The biosynthetic 
interruption leads to a reduction of intracellular complex sphingolipids and an accumulation 
of sphinganine and sometimes sphingosine, owing to inhibition of the reacylation of 
sphingosine produced by sphingolipid turnover. The carcinogenicity of FB1 is related to the 
increase in concentration of the sphingoid bases which have been shown by Schroeder et 
al.34 to stimulate DNA synthesis in the presence of insulin and to act as inhibitors of protein 
kinase C.35-37 
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Scheme 1. Sphingolipid biosynthesis showing sphingolipid turnover and intracellular metabolic flux. 
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The effects of fumonisins are numerous because sphingolipids and their intermediates 
are involved in diverse and complex ways in the regulation of cell behaviour.38 Long chain 
sphingoid bases have other cellular targets leading to cell death. They have been shown to 
activate phospholipase D, to activate or inhibit enzymes of lipid signaling pathways (e.g. 
phosphatidic acid phosphatase), to inhibit the Na+/K+ ATPase, to induce dephosphorylation 
of the retinoblastoma protein (a key regulator of the G to S transition of the cell cycle), and 
to induce the release of Ca2+ from intracellular stores.38  
The ability of fumonisins to interfere with sphingolipid metabolism is related to the 
fact that they are structurally similar to the sphingoid bases, sphinganine 21 and sphingosine 
20 (Figure 3). FB1 6 has been shown to bind more tightly to ceramide synthase than 
sphinganine and it has been suggested that the reason for this could be related to the fact that 
FB1 has the opposite absolute configuration at the C3 position to sphinganine and 
sphingosine.39 The lack of a hydroxy group on C1 of FB1 may prevent it from being 
metabolised in a similar manner to the sphingolipids39 which proceeds via either 
phosphorylation on the terminal hydroxy to form sphingomyelin 24 or glycosylation to form 
such glycosphingolipids as galactosylceramide and glucosylceramide. This results in the 
metabolic stability of fumonisins which is evidenced by their presence in serum.12  
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Since the recognition of the role of sphingolipids and their intermediates in cellular 
signal transduction and as hormones that modulate physiological activities, interest has 
recently focused on the synthesis of related compounds. A combinatorial library of 528 
ceramide analogues was generated and their biological activities were screened for cell-
based apoptosis (cell death) and signal transduction.40 It was found that several structural 
elements were required for bioactivity. The induction of apoptosis by DNA fragmentation 
was a function of the C4-C5 double bond and bulky and/or long carbon hydrophobic N-acyl 
tail. The stereochemistry (syn vs anti) was found not to be critical as 2,3-syn and 2,3-anti 
dihydroceramide isomers tested were inactive. This contrasts with a previous study by 
Bielawska et al.41 which indicated that only the 2,3-syn-dihydroceramides were active 
inducers of apoptosis whereas the anti isomers were not (Figure 4). This finding was 
consistent with the role of 2S,3R-anti-dihydroceramide 22 in the biosynthesis of 
sphingolipids; the biological processes of 2S,3R-anti-ceramide 23 are regulated by the 
controlled conversion of 2S,3R-anti-dihydroceramide to its bioactive successor by the 
dihydroceramide desaturase-catalysed introduction of the C4-C5 double bond (Scheme 1).41 
The mechanism of action of apoptosis is speculated to arise via a signaling pathway 
involving ceramide-activated protein phosphatase (CAPP), however its exact nature is 
unclear.41 
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Figure 4. Dihydroceramides 
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Structural resemblances between the sphingoid bases (sphingosine and sphinganine) 
and fumonisins prompted the idea that both series of compounds arise from similar 
biosynthetic pathways, and experimental evidence thus far points in this direction.42 
Although sphinganine 21 has the anti relative configuration about the 2-amino-3-hydroxy 
groups and fumonisin B1 6 is syn, both retain the 2S-configuration of their S-amino acid 
precursor. The biosynthesis of sphingolipids has been studied in mammals43 as well as 
yeast.44 The biosynthesis of FB1 is likely to proceed in a similar polyketide-like fashion via 
the condensation of alanine45 (incorporates C1 and C2), with an 18-carbon CoA polyketide 
ester (C3-C20) with concomitant decarboxylation of the amino acid carbonyl group to give 
1-deoxy-3-ketosphinganine. The ketone group of the ketosphinganine is reduced and a series 
of hydroxylation and methylation steps followed by esterification at the C14 and C15 
hydroxy groups furnish fumonisin B1.30 The incorporation of a hydroxy group at C3 is 
suggestive of polyketide synthesis as it is in the correct position for oxidation from a 
polyketide carbonyl group (Figure 5). Also indicative of polyketide synthesis is the 
incorporation pattern of labelled acetate into the 18-carbon CoA precursor which is 
consistent with the head-to-tail condensation of acetyl CoA units.39,46,47 However, 
incorporation of the methyl group of methionine42,48 by methyl transferase into the 2 methyl 
groups at C12 and C16,39 and the presence  of hydroxy groups at C5, C10, C14 and C15 
show an array of functionality not expected with polyketide synthesis. The order in which 
the methyl and hydroxy groups are incorporated into the backbone has not been determined. 
Esterification at C14 and C15 by an undefined PTCA precursor occurs after the 14- and 15-
hydroxy groups are formed. This undefined precursor is not likely to form at the same time 
as the backbone because labelling experiments show that it does not incorporate acetate 
groups to the same extent.39 These experiments may also suggest that the PTCA precursor is 
not polyketide-derived. Studies using 13C-enriched glutamic acid have shown that the 
secondary carboxyl function is derived from C5 of L-glutamic acid.  
In summary, FB1 is synthesised by a pathway involving 4 separate pools of 
metabolites which are acetate (C3 to C20), alanine (C1 and C2), methionine (Me-12 and Me-
16), and glutamic acid (PTCA). It is likely that the different FB analogues are derived from 
enzymatically different pathways relatively early in the biosynthesis due to the inability of F. 
moniliforme to process added FB2 7 or FB3 8 into FB1 6.26 
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1.2 Related Compounds. 
 
 AAL-toxins 
Fumonisins and AAL-toxins are structurally related natural products produced by 
fungi and are believed to follow similar biosynthetic pathways. AAL-toxins TA1, TA2, TB1 
and TB2 (Figure 6) were isolated in 1981 from A. alternata f. sp. Lycopersici, and were 
found to be the active phytotoxins responsible for stem canker disease in susceptible 
tomatoes,49-51 as well as inhibitors of sphingolipid biosynthesis.29 Since then TC, TD and TE, 
each with two isomers, have been discovered (Figure 6).52 The AAL-toxins are 
hydroxylated, 17-carbon chain alkylamines with only one propane-1,2,3-tricarboxylic acid 
side chain. AAL toxins lack a methyl group at the amino terminus, like the FC series, and are 
2 methylene units shorter at the alkyl terminus. The stereochemistry of the AAL-toxin TA 
backbone and the PTCA side chain have been established (see Section 1.3 below) and were 
identified as the same as for FB1. 
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* The stereochemistry has only been determined for AAL-TA1  
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Sphingofungins 
Sphingofungins A-D (25-28) are antifungal agents isolated a decade ago (Figure 
7).53,54 They contain a 20-carbon long chain, five chiral centres and a trans olefin. They 
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possess a carboxyl group at C1 instead of the methyl found in the fumonisins. The absolute 
stereochemistry has been determined as 2S, 3R, 4R, 5S and thus possess the same 2,3-anti 
configuration as sphinganine.54 Sphingofungin B 26 inhibits serine palmitoyltransferase,53,54 
which catalyses the first condensation step of palmitoyl-CoenzymeA with serine (Scheme 1) 
in the biosynthesis of sphingolipids.  Sphingofungins E and F (29 and 30) have also been 
isolated.55 They contain a chiral quaternary carbon at the C2 position and a carbonyl group at 
C14.  
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Figure 7. 
 
(-)-Rhizochalin and Oceanapiside 
(-)-Rhizochalin 31 is an antimicrobial galactopyranosyl pseudodimeric amino alcohol 
lipid isolated from the calcareous sponge Rhizochalina incrustata collected near 
Madagascar.56 It possesses a backbone that is 28-carbons long with a keto group at C11 
(Figure 8). The 3-hydroxy is protected with a β-D-galactopyranosyl group. Both termini 
possess 2-amino-3-hydroxy groups that are disposed in a syn configuration, as well as a 1-
methyl group. The complete absolute configuration was shown to be 2R, 3R, 26R, 27R as 
determined by the exciton-coupling CD superposition method.57 Thus, (-)-rhizochalin is of 
opposite absolute configuration to the fumonisins about the amino termini. 
 Oceanapiside 32 is a structurally related antifungal agent isolated from a temperate-
water marine sponge, Oceanapia phillipensis Dendy 1895 (Haplosclerida, 
Phloeodictyidae).58 It is a bipolar keto-sphingolipid which is functionalised at both ends of 
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the long 28-carbon chain with 2-amino-3-hydroxy groups (Figure 8). It possesses a ketone at 
C11 and a β-D-glucopyranosyl group on the 3-hydroxy. In comparison to (-)-rhizochalin 31, 
oceanapiside is less symmetrical. The C1 terminus is substituted with a primary hydroxy 
group, analogous to sphinganine, and the C28 terminus is a methyl group. The termini differ 
in their stereochemistry as well; the C2,3 end is anti (2S, 3R) and compares to sphinganine, 
while the C26,27 terminus is syn (26R, 27R) and identical to (-)-rhizochalin.59  
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1.3 Determination of the Relative and Absolute Stereochemistry of 
Fumonisins and AAL-Toxins. 
 
Knowledge of the stereochemical information in fumonisins has helped to better 
understand the mechanistic implications of fumonisin biosynthesis and its mode of action in 
the inhibition of sphingolipid biosynthesis. The configuration at C3 of fumonisin was found 
to be the opposite to that of the C3 in sphingolipids and the implications of this difference 
have already been discussed in Section 1.1.   
Because fumonisin does not crystallise for X-ray analysis, various research groups 
have contributed to the understanding of fumonisin stereochemistry by a variety of 
approaches involving degradation, derivatisation, NMR analysis, Mosher ester analysis, 
chiral and achiral shift reagents, chiral column chromatography and the circular dichroism 
(CD) exciton chirality method. Complete stereochemical information on the fumonisin 
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backbones of FB1 and FB2, and AAL-toxin TA1 exists and was obtained by 5 independent 
studies over a short period spanning only two years. Only one reference is made to the 
determination of stereochemistry within the FB3 backbone. The absolute stereochemistry of 
the propane-1,2,3-tricarboxylic acid side chain, common to all fumonisins and AAL-toxins, 
has been unambiguously assigned as R by 3 independent groups despite some original 
disagreement. 
Hoye et al.60 have provided a complete understanding of the stereochemistry in the 
backbone of FB1 (HFB1) (Scheme 2). They commenced with the establishment of the R 
absolute configuration at C10 by Mosher ester analysis of acetonide 33 which was arrived at 
by a series of derivatisation steps on a sample of HFB1. The relative configuration between 
C2 and C3, and C3 and C5 was assigned as 2,3-syn and 3,5-anti respectively on the basis of 
spectroscopic analysis and comparison of the J2,3 coupling constant with values obtained 
from a Monte Carlo conformational analysis of appropriate model compounds. The C2,3 syn 
configuration is supported by Poch et al.61 who based their finding on the NMR analysis of 
oxazolidine derivatives. The absolute configuration at C2 was assigned as S using Mosher’s 
amide derivative 34, and the absolute configuration at the methyl bearing C16 was achieved 
by comparative analysis of fragment 35 (obtained through periodate cleavage of HFB1) with 
synthetic 35 by chiral gas chromatography. The absolute configurations of C12, C14 and 
C15 were established from pyran 36 and its R and S tris-Mosher ester derivatives using 
spectral data which was supported by a multiconformational search of an appropriate model 
compound. Pyran 36 was obtained by further transformations on acetonide 33. In light of the 
work undertaken above the configurations of the 8 stereogenic centres in the backbone of 
FB1 were assigned as 2S, 3S, 5R, 10R, 12S, 14S, 15R, 16R. Further support for the 
configurations determined by Hoye et al. come from studies conducted by Blackwell et 
al.39,62 and ApSimon et al.63 The relative configurations within the C1-C5 fragment were 
established based on NMR analysis of 2,3-carbamate and 3,5-carbonate derivatives, while 
the stereochemistry in the C10-C16 fragment was obtained using NMR analysis of a 10,14-
pyran derivative.   
Studies on the configuration of FB1 agree with those of Harmange et al.64 on FB2 7, 
and Boyle et al.65 and Oikawa et al.66 on AAL-toxin A1. Their approach involved the 
independent synthesis of all the possible diastereomers for the separate halves of 7 and the 
AAL-toxin, and then comparison of the spectroscopic data for each of the diastereomers with 
that of the intact authentic sample on the basis that the two halves are remote enough not to 
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interfere with each other. These studies convincingly showed that fumonisin analogues and 
AAL-toxin A1 have common stereoconfigurations to FB1.  
Hartl and Humpf67 confirmed the configuration at the amino terminus of FB3 8 as 
2,3-syn using the circular dichroism exciton chirality method. This method can be conducted 
on the microscale. It is based on the through-space coupling of two or more chromophores in 
the molecule to give characteristic CD curves, the signs of which are defined by the absolute 
sense of twist between the coupled chromophoric electric transition moments which reflects 
the spatial arrangement of the functional groups bearing the chromophores.68 Thus the 
absolute stereochemistry of the amino-bearing terminus of fumonisin B3 was shown to be the 
same (2S, 3S) as for fumonisin B1.  
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The stereochemistry at the chiral centre of the PTCA side chain was postulated69,70 as 
both R and S via NMR studies and chiral gas chromatography of the methyl ester derivatives, 
respectively. Subsequent work by Edwards et al.71 and Hartl and Humpf72 provided evidence 
that supports the R configuration in agreement with Boyle et al.69 Edward’s approach was to 
compare the spectroscopic data of a benzoyloxy γ-lactone 37 derived from the FB1 natural 
product with that of the synthetic enantiomerically enriched compound. Hartl and Humpf 
compared the CD curve of a chromophoric derivative 38 of the PTCA side chain derived 
from the natural product with a synthetically derived S-configured one 39, and found that 
they were enantiomeric (Figure 9). 
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1.4 Synthetic Approaches Towards FB1, FB2 and AAL-Toxin A1. 
 
The first total synthesis of a fumonisin, namely fumonisin B2, was reported by Shi et 
al.73 in 1997. Their retrosynthetic analysis of FB2 divided the compound into three fragments 
to give aldehyde 40, phosphonium iodide salt 41 and the PTCA segment 42 (Scheme 3). The 
synthesis of the C1-C10 aldehyde fragment 40 started with a chiral alkyne 43 and triflate 44 
both of which possessed the methyl bearing C16 and C12 stereocentres, respectively, in the 
required configuration. The chiral alkyne 43 was synthesised in 3 steps from (R)-2-methyl-1-
hexanol and triflate 44 was formed in 3 steps from 1-bromo-3-methyl-2-butene using a 
(R,R)-(-)-pseudoephedrine amide as chiral auxiliary. Installation of the vicinal hydroxy 
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groups at C14 and C15 was achieved in a four step process utilising an iodolactonisation 
reaction to install the 14,15-anti configuration in 50 with a diastereomeric ratio of 20:1. The 
synthetic strategy for the formation of the phosphonium iodide segment 41 began with α-
amino aldehyde 45, derived from alanine in 3 steps, bearing the 2S-amino group in the 
correct stereoconfiguration. The 2,3-syn and 3,5-anti aminoalcohol moieties in olefin 46 
were installed by use of Brown’s allylation reaction with a high level of stereocontrol (94% 
and 82% de respectively) in 4 steps from 45. Elaboration of alkene 46 in 10 steps furnished 
the required fragment 41. Segment 42 was synthesised using an asymmetric Michael 
addition of the chiral allyl phosphonamide 47 with ester 48 to give 49 which was elaborated 
to 42 in 3 steps. To complete the synthesis, the two segments 40 and 41 were coupled via a 
Wittig reaction, then after acetonide deprotection at C14 and C15, the resulting hydroxy 
groups were esterified with the PTCA group 42. The final target molecule was obtained after 
a global deprotection with simultaneous reduction of the double bond. Conclusively, the total 
synthesis of FB2 was obtained in 1.7% overall yield in 44 steps. The approach was highly 
convergent with the longest linear sequence consisting of 23 steps. Stereocentres were 
installed with excellent stereoselectivity, however their approach to this was mainly by chiral 
reagents and auxillary control, for example the use of chiral diisopinocampheyl ligands in 
Brown’s allylborane reagent and the chiral phosphonamide.74 
 Synthetic studies directed towards FB1 by Gurjar et al.75 culminated in the formation 
of a hexaacetate derivative of the fumonisin B1 backbone. Retrosynthetic analysis of their 
approach divided the FB1 backbone into two fragments, 51 and 52 (Scheme 4). Alkyne 
fragment 51 was made in 25 steps from D-glucose and epoxide 52 was synthesised in 
approximately 16 steps starting from D-glucosamine. The C-C bond coupling of the C1-C6 
epoxide 52 and C7-C20 alkyne 51 fragments was accomplished by nucleophilic attack of the 
alkynide corresponding to 51, to C6 of 52. Following protecting group manipulations the 
hexaacetate derivative of HFB1 was obtained in a maximum overall yield of 0.9%, with the 
longest linear sequence requiring 30 steps. Although the inherent chirality of the 
carbohydrate starting materials overcame the major challenge of having to install the 
stereocentres of FB1, the reaction sequence was lengthened by such steps as inverting the 
stereocentre in the intermediate corresponding to C14 of HFB1 and removing functionalities 
present in the sugar not required in the FB1 backbone, for example deoxygenation at C4 of 
the glucosamine derivative corresponding to C4 of the fumonisin backbone. Furthermore, the 
approach lacked stereoselectivity, for example in the Wittig olefination/hydrogenation 
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sequence and nucleophilic addition reaction which installed the 16-methyl and 10-hydroxy 
groups respectively with 50:50 diastereoselectivities.  
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Scheme 4. 
 
Oikawa et al.’s approach76 toward the total synthesis of AAL-toxin A1 
retrosynthetically broke the C9-C10 bond of the molecule into left fragment 53 and right 
fragment 54 (Scheme 5). Lactone 53 was synthesised in 14 steps starting from (R)-methyl 3-
hydroxy-2-methylpropionate. Alkyne 54 was prepared in 7 steps from silyl protected 4-
pentyn-1-ol. A Grignard reaction installed the C14 hydroxy albeit with no selectivity. The 
lactone moiety of 53 served a dual role; it protected the C13 hydroxy group and hindered the 
bottom face of the rigid cycle from methylation at C11 in a subsequent step. However a three 
step deoxygenation of the carbonyl at C10 of the lactone was required at a later stage. 
Attempts to couple fragments 53 and 54 via either a Wittig or Julia olefination approach 
resulted in poor yields, thus the two fragments were coupled using alkyne chemistry, an 
approach similar to that used by Gurjar et al.75 Introduction of the azide group (a protected 
amine) was accomplished after the key coupling step under Mitsunobu conditions. 
Esterification with PTCA derivative 55 and a final global benzyl deprotection with 
simultaneous reductions of the azide and the triple bond in 56 furnished the final product.  
The longest linear sequence in Oikawa et al.’s approach was 25 steps long.  
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1.5 Our Retrosynthetic Approach to FB1 and FB3. 
 
Our approach to the synthesis of the fumonisin B3 backbone adopts a highly 
convergent strategy that is flexible enough to allow easy access to the fumonisin B1 
analogue. Our goal is to improve on Shi et al.’s protocol73 by firstly reducing the number of 
steps in the synthesis and second, by installing all the seven chiral centres in the FB3 
backbone under conditions of internal asymmetric induction utilising substrate-based 
diastereomeric relay. Idealistically, all the chiral centres would be formed from a single 
stereogenic point without any additional external chirality being used. 
 Based on the retrosynthetic analysis depicted in Scheme 6, FB3 8 is divided into three 
major fragments to give methyl ketone 57, aldehyde 58 and PTCA derivative 42. Removal of 
the PTCA side chains from 8 leads back to the fumonisin B3 backbone 59 after protecting 
group manipulations. The presence of the 10-hydroxy is critical to the stereoselective 
formation of the methyl at C12. With literature77-79 precedent in hand it was hoped that the 
Chapter 1 
 18 
10-hydroxy would induce the stereoselective hydrogenation of the C12 homoallylic double 
bond, which in turn would be formed from a methylenation reaction of the C12 carbonyl in 
60. Installation of the 10-hydroxy in the correct configuration will arise from the key 
coupling of the two major fragments 57 and 58 by an asymmetric aldol reaction. Methyl 
ketone 57, common to both FB1 and FB3, will come from epoxide 61, which will be formed 
by an asymmetric epoxidation reaction on the corresponding allylic alcohol. Aminoaldehyde 
58 was envisioned to arise from one of the alkenes 62 and 63, which are also common 
intermediates to the FB1 aminoaldehyde fragment 64. Alkenes 62 and 63 in turn would arise 
from the coupling of aldehyde 65 with fragments 66 and 67 respectively using either the 
modified Julia olefination protocol or Wittig methodology. En route to the fumonisin B1 
backbone, it was envisaged that aldehyde 64 will arise from alkene 63 using an asymmetric 
epoxidation reaction via compound 68.  
The remaining fragment 42 could be approached using a catalytic asymmetric variant 
of the Mukaiyama-Michael reaction of thioester derived silylketene acetal 71 to alkylidene 
malonate 72 developed by Evans et al. (Scheme 7).80 Intermediate 73 will be converted to 
the diacid 74 in three steps, beginning with the hydrolysis of the thioester followed by 
protection of the resulting carboxyl group as the trichloroethyl ester. Removal of the benzyl 
groups by hydrogenolysis will lead to an intermediate which is expected to readily undergo 
decarboxylation, and then oxidation of the phenyl ring81 will give diacid 74. Benzyl 
protection of the carboxyl groups in 74 followed by hydrolysis of the trichloroethyl ester will 
finally furnish acid 42.  
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In comparison to Shi et al.’s synthesis of FB2,73 the longest linear sequence required 
for the synthesis of FB3 will be 18 steps long. An effective way of simplifying the number of 
steps in a synthesis is to reduce protecting group manipulation. Thus the choice of a 
protecting group capable of masking more than one functional group at a time, as well as 
having the ability to enhance asymmetric induction in a reaction was critical to our strategy. 
Thus with this in mind, execution of our plan towards the synthesis of the FB3 backbone 
began with the synthesis of the methyl ketone fragment 57 , the details of which are outlined 
in the next chapter. 
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             Synthesis of the 
                   C11-C20 Fragment 
 
 
Disconnection of the C10-C11 bond within the fumonisin B3 backbone 60 leads to 
the two fragments C11-C20 57 and C1-C10 58 (Chapter 1, Scheme 6). It was envisaged that 
methyl ketone fragment 57 will be formed by a Felkin-Anh controlled aldol addition reaction 
of aldehyde 75 with an acetone derived enol ether (Scheme 1). Aldehyde 75 will arise in 
three steps from 14,15-diol 76 which in turn will be generated from epoxide 61. Construction 
of 61 will be accomplished in three steps from commercially available n-butyl bromide and 
propargyl alcohol. The three stereogenic centres within methyl ketone 57 will be generated 
stereoselectively via acyclic stereocontrol with relay from a single stereogenic point. 
Installation of the first stereogenic centres will be achieved using an asymmetric epoxidation 
reaction.  
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Construction of methyl ketone 57 began with the synthesis of hept-2-yn-1-ol by the 
method of Brandsma82,83 (Scheme 2). Propargyl alcohol was doubly deprotonated with 
lithium amide and alkylated at the triple bond by adding 1.0 equivalent of n-butyl bromide. 
The reaction proceeded cleanly on large scale in 74% yield. Ferric nitrate hydrate was used 
to promote the formation of lithium amide from lithium metal in liquid ammonia, whilst a 
longer reaction time was required when anhydrous ferric chloride was used.  
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Reduction of hept-2-yn-1-ol was done according to the procedure of Chanley84 using 
at least 2.0 equivalents of LiAlH4 to give trans-hept-2-en-1-ol 77 as the exclusive product in 
80% yield. The reaction is thought to proceed via a chelated intermediate 78 (Figure 1) 
through the σ-bonding of the oxygen to the aluminium Lewis acid, and π-coordination of the 
triple bond to the metal. The hydride source adds to intermediate 78 from the less hindered 
side opposite to the coordinated metal and this is followed by hydrolysis of the resulting 
organometallic species 79 in the aqueous workup to give the trans alkene.  
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Installation of stereochemistry in the synthesis was achieved using the Sharpless-
Katsuki asymmetric epoxidation85 of allylic alcohol 77. The reaction utilises a chiral ligand 
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derived from Ti(OiPr)4 and dialkyl tartrate, and tert-butylhydroperoxide (TBHP) as the 
oxidant. Use of (R,R)-(+)-diisopropyl tartrate was predicted to give the required S,S 
stereochemical outcome in accordance with the empirical rule shown in Figure 2. The 
epoxidation proceeded cleanly in 86% yield. The absolute configuration of epoxide 61 was 
assigned based on its known optical rotation and comparison of the optical rotation of 
epoxide 61 ([α]D -29.2) with that previously prepared ([α]D -29.7, 95% ee)86 indicated that it 
had been obtained in approximately 93% ee.  
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Figure 2. 
 
Treatment of (S,S)-epoxide 61 with 3.0 equivalents of trimethylaluminium afforded 
14,15-diol 76 in 71% yield (Scheme 2). Formation and isolation of a byproduct in trace 
quantity (1:14 with respect to product) whose identity was suspected of being that of heptan-
1,2,3-triol87 80 based on spectral data was achieved. The 100.6 MHz 13C NMR spectrum 
exhibited seven signals, four of which were confirmed as methylenes by DEPT analysis, 
while resonance signals at δ 74.6, 63.9 and 63.4 ppm suggested the presence of 3 carbons 
attached to oxygen. Furthermore the low resolution mass spectrum (CI+) showed a 
protonated molecular ion peak at m/z 149 corresponding to M+H and a base peak at m/z 113 
corresponding to loss of a hydroxy group and H2O from the molecular ion.  
Nucleophilic substitution on activated E-epoxide 61 (Figure 3) occurred with 
inversion at the position furthest removed from the hydroxy substituent (β-carbon). This 
regioselectivity is attributed to the presence of the electronegative hydroxy group at C1 
which inductively retards SN2 substitution at the vicinal carbon. Selectivity for nucleophilic 
opening at the β-carbon of epoxyalcohols is dictated by the use of appropriate 
organometallic reagents. Roush et al.88 found that complementary regioselectivity (i.e. attack 
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at the α position) is realised by the use of organocuprates. Since conducting this work, the 
alkylation of epoxides was reported to progress more efficiently with the use of a 
trialkylaluminium/water system.89 Such a system enhances the electrophilic activation of the 
epoxy α-carbons via its double coordination behaviour (Figure 3, structure 81). 
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With 14,15-diol 76 in hand, attention then focused on differentiating the diol by 
selective protection. One way of doing this is to reductively open a PMB acetal resulting in 
the formation of the p-methoxybenzyl ether protected secondary alcohol. It was envisaged 
that an oxidative cyclisation of the PMB ether onto the proximate hydroxy group in the 
subsequent acetone aldol product 82 will circumvent the need for introducing a second 
protecting group. Based on literature precedent90,91 it was also anticipated that the resulting 
PMB acetal will control the stereochemical outcome of the impending key boron aldol 
coupling of methyl ketone 57 and aldehyde 58, the details of which are discussed in Chapter 
4. Finally the PMB acetal can be removed selectively towards the end of the synthesis 
allowing for the introduction of the propane-1,2,3-tricarboxylic acid side chains. The PMB 
acetal is more labile than its benzylidene parent by virtue of the methoxy group on the 
benzene ring, and undergoes easier reductive ring cleavage in aqueous conditions on 
treatment with a Lewis acidic hydride source. 
The sequential conversion of 14,15-diol 76 to the p-methoxybenzylidene acetal 
followed by regioselective reductive cleavage of the acetal differentially protected the 14,15-
diol as a p-methoxybenzyl ether (Scheme 3).92 Protection of 14,15-diol 76 as the p-
methoxybenzylidene acetal was accomplished in 92% yield using catalytic p-toluenesulfonic 
acid in DMF and 4-methoxybenzaldehyde dimethyl acetal (PMBDMA) 83 prepared 
according to the known literature method.93 The reaction did not go to completion when 
conducted at room temperature under standard conditions, thus to aid conversion the reaction 
was conducted under reduced pressure94 at 76oC. The instantaneous removal of methanol 
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under reduced pressure from the reaction mixture upon formation helped push the 
equilibrium toward completion. A mixture of two diastereomers with respect to the benzylic 
position, 84 and 85, were obtained in a ratio of 38:62 as determined by 1H NMR after flash 
chromatographic purification of the crude mixture. However this did not pose a problem as 
the newly created stereogenic centre would be destroyed in the subsequent reductive ring 
opening reaction.  
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Scheme 3. 
 
The regiochemistry of reductive cleavage of p-methoxybenzylidene acetals 84 and 85 
depends on the reaction conditions and by a suitable choice of solvent and Lewis acid.95 
Thus cleavage resulting in the PMB ether of the more hindered hydroxy was accomplished 
cleanly with DIBALH in dichloromethane at 0oC to afford 86 in 83% yield. Coordination of 
the aluminium Lewis acid to the less hindered oxygen led to ring cleavage to give oxonium 
intermediate 87 followed by hydride transfer (Figure 4). Regioisomer 88 was isolated in only 
trace quantity. Oxidation of primary alcohol 86 under Swern conditions afforded α,β-
substituted aldehyde 75 in 91% yield.  
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Having effected the installation of the C16 methyl and C15 hydroxy centres with a 
high level of stereocontrol, attention then focused on setting up the C14 hydroxy substituent 
in methyl ketone 57. It was envisaged that the C14 hydroxy could be installed with a high 
level of 1,2-induction using aldol chemistry (Scheme 4). Since stereochemical control from a 
chiral aldehyde was required, the Mukaiyama aldol reaction was the method of choice.96 
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The diastereofacial bias in the Lewis acid catalysed addition of enolates to chiral 
aldehydes bearing α-methyl and β-alkoxy groups, is well documented in the literature.97-100  
Cooperative steric and electrostatic effects of the α and β substituents combine to influence 
the stereofacial bias of the carbonyl moiety. However no literature precedent for the 
diastereofacial bias of chiral aldehydes containing α-alkoxy and β-methyl groups exists. The 
extent to which each substituent confers its stereofacial bias on the carbonyl was inferred 
from the work of Evans et al.100 They established that π-facial selectivity in 1,3-asymmetric 
induction was largely a result of the polar nature of the β-substituent (Scheme 5, Equation 1) 
and that the steric contribution of a β-substituent did not appear to strongly influence the π-
facial bias of the carbonyl (Scheme 5, Equation 2). Thus, one can deduce that the 
stereochemical outcome of the chiral aldehyde in question would be largely due to the α-
alkoxy group with little steric influence from the β-methyl.  
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The polar Felkin-Anh model is invoked to explain the stereofacial bias conferred on 
the carbonyl by the α-alkoxide. The Felkin-Anh model is based on ab initio calculations of 
the proposed transition states resulting from hydride attack to a chiral α-substituted 
aldehyde,101 and was built by experiment and theory on the proposed models of Cram,102 
Karabatsos103 and Felkin.104 The model was based on the Felkin conformer (which orients 
the large ligand perpendicular to the face of the carbonyl) which was found to possess the 
lowest energy. Lodge and Heathcock105 studied the effects of α-methoxy groups in 
aldehydes, and concluded that except in the case of extremely bulky substituents, the 
electrostatic effects of the heteroatom group dominate to control the stereochemical outcome 
of the aldol reaction. Thus, the major diastereomer formed is that predicted by the Felkin-
Anh model when the α-alkoxy moiety is perpendicular to the carbonyl in accord with the 
Anh-Eisenstein postulate (Figure 5).101 The proposal by Anh and Eisenstein puts the ligand 
with the energetically lower lying σ* orbital, rather than the sterically most demanding group 
proposed by Cherest, Felkin and Prudent,104 perpendicular to the carbonyl plane. The 
nucleophile attacks opposite to the large group at an angled trajectory106-108 from the side that 
minimises nonbonded interactions between the nucleophile and substituents α to the 
carbonyl centre. Early calculations by Burgi, Dunitz and coworkers106-108 carried out on 
formaldehyde showed that the trajectory of a nucleophile occurs on a plane perpendicular to 
the plane of the carbonyl and at an angle of approximately 107o (known as the Burgi-Dunitz 
angle). 
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Enolisation of acetone using the trimethylchlorosilane-sodium iodide-tertiary amine 
reagent in acetonitrile as described by Cazeau et al.,109 was achieved in 48% yield (Scheme 
6). They report this method to be mild and more versatile than the methods of House et al.110  
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Scheme 6. 
 
Addition of enolsilane 90 to α-OPMB-β-methyl aldehyde 75 under Lewis acid 
promoted conditions was next investigated (Scheme 7, Table 1). Higher levels of 1,2-
asymmetric induction in favour of the anti diastereomer 82 was observed for the BF3.OEt2 
catalysed enolsilane aldol reaction (Table 1, entry 1). This reaction proceeds through an open 
transition state governed by the Felkin-Anh model rather than through the chelation model100 
due to the monodentate nature of the boron Lewis acid. The ability of a metal to partake in 
chelate organisation and lock a substrate into a predefined transition state for attack by a 
nucleophile from the less hindered face is dependent on the availability of two or more open 
coordination sites on the metal.  
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P' Lewis acid
anti : syn
82 : 89
SiMe3
SiMe3
SiMe3
SiMe2
tBu
Me2AlCl
Et2AlCl
72 : 28
58 : 42
34 : 66
45 : 55
BF3.OEt2
BF3.OEt2
yield
82%
not isolated
28%
17%
Entry
1
2
3
4
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The relative stereochemistry about the C14 and C15 centres in the aldol products 82 
and 89 was assigned by subsequent conversion to the PMB acetals (see Schemes 13 and 14). 
In the hope of improving the stereoselectivity of the BF3.OEt2 mediated Mukaiyama 
aldol reaction, the steric bulk of the silyl group on the enol ether was increased (Table 1, 
entry 4). Heathcock et al.111-115 proposed that diastereofacial selectivity in nucleophilic 
additions to chiral aldehydes is related to the trajectory of a nucleophile in its attack on the 
carbonyl. Heathcock speculated that steric effects exerted by the coordination of a bulky 
Lewis acid to the carbonyl diverts the path of an approaching nucleophile away from the 
bulky Lewis acid with respect to the normal plane (the plane containing the C=O and 
perpendicular to the R-C-H plane). This results in an increase in the interaction between the 
nucleophile and chiral centre in R, and thus increases the diastereoselectivity of the reaction 
(Figure 6).114 An increase in the steric bulk of the enol ether is expected to enhance the 
diversion in the trajectory of the nucleophile.  
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Figure 6. 
 
Use of the sterically more encumbered TBS enolsilane,116 prepared in 33% yield, 
unexpectedly failed to improve diastereoselectivity (Table 1, entry 4). The observed 
sluggishness of the reaction was suspected to be the result of water-promoted hydrolysis of 
the enolsilane, so it was hoped that addition of a few grains of CaH2 would prevent this from 
occurring. Disappointingly only a slight improvement in conversion was observed.  
The use of bulky Lewis acids was next investigated. Mikami et al.117 provide 
examples on the use of aluminium Lewis acids to promote ene reactions with α-amino 
aldehydes while Heathcock and Walker118 use Et2AlCl in the Evan’s asymmetric aldol 
reaction to promote anti selectivity. Addition of TMS enolsilane 90 to Me2AlCl-activated 
aldehyde 75 (Table 1, entry 2) gave no selectivity while use of the still bulkier Et2AlCl (entry 
3) afforded preponderance for the syn isomer. The cause for the reversal in selectivity is at 
present unknown, however it is speculated that the metal might be involved in chelation-
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control (Figure 7). The ability of aluminium Lewis acids to form pentacoordinate chelate-
type complexes has recently been demonstrated by Maruoka and Ooi,119 in contrast to the 
general belief that aluminium compounds exist only as tricoordinate/tetracoordinate species. 
Also the dialkylaluminium chloride reagents were added as solutions in hexanes and since 
the Mukaiyama aldol is sensitive to solvent effects, this may have affected the 
diastereoselectivity to some extent.  
The recent discovery of a new catalytic silyl Lewis acid, one of a few known 
supersilylating agents for the Mukaiyama aldol reaction, has sparked interest since an earlier 
reported supersilylating reagent was shown to have produced the highest selectivities upon 
catalysing the addition of an enol ether to an α-substituted aldehyde.120,121 However, the 
process suffers in that silyl protected alcohols are produced. 
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 Addition of α-substituted chiral aldehyde 75 to a boron enolate was next investigated 
in an attempt to improve on the diastereoselectivity and yields of the aldol reaction (Scheme 
8). Stereoselective aldol reactions via boron enolates122 were simultaneously developed by 
Evans123 and Masamune and coworkers.124,125 Aldols with boron enolates owe their high 
stereoselectivity to their cyclic transition states, and to the short B-O and B-C bonds which 
lead to tight transition states. In this reaction the boron enolate adds to the aldehyde to 
generate an ate complex which then rearranges to form a new C-C bond, via a cyclic 
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transition state. Control of the si vs re face selectivity of nucleophilic attack on the aldehyde 
gives rise to the anti / Felkin-Anh vs syn / anti-Felkin-Anh isomers, respectively. Boron 
enolate 91 was prepared by enolisation of acetone with 2.2 equivalents of c-hexyl2BCl (Et3N, 
Et2O, -78oC)126-129 followed by addition of aldehyde 75 at -78oC. This reaction proceeded to 
give preponderance for the Felkin-Anh isomer 82 (88:12) in 77% yield. The use of 11.6 
equivalents of c-hexyl2BCl did not affect the yield or diastereoselectivity of the reaction 
(82:89 = 84:16; 74% yield). By comparison, the effect of using a vast excess of the 
dialkylboron reagent on the outcome of the methyl ketone aldol reaction of 57 will be 
discussed in Chapter 4. The stereochemical outcome can be simply rationalised in terms of 
the Felkin-Anh model for nucleophilic attack on α-chiral aldehydes as discussed previously. 
However boron-mediated aldol reactions are known to proceed through cyclic transition 
states and other factors controlling the π-facial bias of the aldehyde come into play. 
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L anti:syn
c-hexyl 91
(+)-Ipc
(-)-Ipc
88:12
>95:5
63:37
yield
77%
11%
74%
Entry
1
2
3
B
B
(+)-Ipc2B
(-)-Ipc2B
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 By modelling the reaction of the dihydroboron enolate of acetaldehyde with 
formaldehyde using a force field approach, Houk130 reported the involvement of a chair 
transition state 92 corresponding to the Zimmerman-Traxler131 transition state, and a twist 
boat transition state corresponding to boat A 93 which was favoured by 1.4 kcal mol-1 
(Figure 8). Goodman et al.132 and Bernardi et al.133 located a second boat (boat B 94) from 
the modelled reaction of the dihydroboron enolate of acetaldehyde and formaldehyde that 
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was only 0.4 kcal mol-1 higher in energy than the chair transition structure. In an extension of 
Houk’s work,130 Evans and coworkers,90 have demonstrated using ab initio calculations on 
the more relevant aldol addition of unsubstituted acetone dimethylboron enolate to ethanal 
that while Houk’s twist-boat transition state is still favoured over the chair geometry, their 
energies differ by only 0.4 kcal mol-1. 
 It has been concluded from the body of work conducted above that methyl ketone 
boron enolates may proceed through three competing transition structures all possessing 
similar energies; a chair transition state and two boats (A and B). The lower selectivity 
observed for methyl ketone aldol reactions when compared to substituted ketones, may be 
attributed to the competing reaction pathways. Support for this comes from the work of 
Bernardi et al.133 who demonstrated using an MM2 force field, ab initio calculations and 
conformational space searching that a large number of chair and boat transition structures all 
within 2.5 kcal mol-1 are responsible for the moderate selectivities observed by Paterson et 
al.134 in the aldols of methyl ketone derived boron enolates. 
Since the moderate diastereoselectivity of our aldol system is comparable to the 
selectivities obtained by Paterson it is reasonable to conclude that the reaction proceeds 
through competing boat and chair transition states (Figure 8). Formation of the major Felkin-
Anh isomer 82 may be rationalised in terms of the twist boat transition structure 95 leading 
to si face attack. The substituents on aldehyde 75 are oriented as dictated by the polar Felkin-
Anh model. This orientation also minimises steric interactions between the alkyl chain and 
the bulky cyclohexyl ligand on boron. 
 The involvement of other cyclic transition state conformers not presented here should 
not be precluded since rationalisation of aldol stereochemistry, particularly that involving 
unsubstituted methyl ketone derived enolates, is complex. Evans et al.135 illustrates this in a 
recent paper reporting the possibility of operative modified Cornforth transition states in 
nucleophilic additions of ethyl ketone derived enolates to α-oxygen-substituted carbonyl 
compounds.  
 The level of induction imparted by the chiral aldehyde 75 with an achiral 
dicyclohexylboron enolate was moderate. We sought to introduce stereocontrol from a chiral 
enolate in an effort to improve on the selectivity in Table 2, entry 1. The use of chiral ligands 
on boron sets the aldol reaction up for double stereodifferentiation with aldehyde 75. When 
the facial bias of the aldehyde matches the induction from the chiral ligands, the reaction 
should proceed with enhanced diastereoselectivity. In the mismatched case one would expect 
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diminished selectivity or in the extreme case an overturn in selectivity. Paterson et 
al.134,136,137 reported the use of (+)- and (-)-diisopinocampheylboron chloride (Ipc2BCl) for 
asymmetric aldol reactions of methyl ketones with various aldehydes. The enolisation of 
acetone with (+)-Ipc2BCl (Et3N, Et2O, 0oC) was followed by addition to aldehyde 75 at 
-78oC. This matched reaction proceeded in 11% yield to give predominantly the 14,15-anti 
isomer 82 in a ratio of >95:5 via si-face attack (Table 2, entry 2). The disappointing yield is 
attributed to the poor quality of the commercially available moisture-sensitive (+)-Ipc2BCl. 
For the mismatched case in comparison, the (-)-Ipc2B enolate produced 82 with a selectivity 
of 63:37 in 74% yield, indicating that 1,2-anti induction from the aldehyde though reduced, 
could not be overturned by reagent control. 
 The aldol reactions investigated thus far have required preformation of the acetone-
derived enolate, use of metals, inert and anhydrous conditions, low temperatures as well as 
the protection of hydroxy groups. A more direct approach to the aldol that would simplify 
manipulations was sought. Few reports for a direct aldol reaction between an unmodified 
acetone and aldehyde mediated by small-molecules exist. The majority of small-molecules 
reported are zinc, lanthanum and barium-containing complexes such as those of Shibasaki, 
Trost, and Noyori, and are regarded as Type II aldolase (contain a zinc cofactor) 
mimics.138,139 Organocatalysis which uses either amino acids or peptides as asymmetric 
catalysts is a new development in asymmetric catalysis.140 List et al.141,142 reported the first 
use of proline as a catalyst for the direct intermolecular aldol based on studies of catalytic 
antibodies that mediate asymmetric aldol reactions via an enamine mechanism in a fashion 
similar to Type I aldolases which do not require a metal cofactor. Structure-based catalyst 
screening141,143 showed that both the secondary 5-membered ring and the carboxylate are 
essential to maintain good enantioselectivities and yields. Aldehydes possessing α-
substitution yielded aldol products with high selectivities and yields (representative example 
in Scheme 9) since they did not suffer from self-aldolisation. Reactions were conducted in 
DMSO at room temperature and utilised a large excess of the acetone to prevent competing 
side reactions of proline with the aldehyde. 
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The mechanism (Scheme 10) of the direct aldol mediated by S-proline closely 
resembles the aldolase Type I mechanism and starts with the nucleophilic attack of the amino 
group to the acetone carbonyl (PATH A) followed by dehydration of intermediate 96 and 
deprotonation of iminium 97, with the carboxylate behaving as the acid-base cocatalyst. 
Aldol addition via a tricyclic Zimmerman-Traxler-like transition state131 98 involves a 6-
membered ring which is organised with hydrogen bonds involving the carboxylic acid, 
enamine and aldehyde. The enamine and carbonyl double bond are in a gauche arrangement 
and the forming C-C bond is staggered. Facial selectivity of the aldehyde is determined by 
the adoption of the bulky R group in the equatorial position so that steric interactions are 
minimised, and the configuration of the carboxylate is equatorial-like. Finally hydrolysis of 
imine 99 affords the aldol product 100 and regenerates proline. 
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Scheme 10. 
 
Using optimum conditions141 aldehyde 75 was added to a suspension of natural S-
proline (40 mol%) in DMSO with acetone as cosolvent and stirred at room temperature. The 
mixture became homogeneous immediately after the addition of the aldehyde. After an 
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aqueous workup to remove the catalyst, isomers 82 and 89 were obtained in a ratio of 25:75 
respectively by 1H NMR in a combined yield of 18% (Scheme 11). Re facial selectivity of 
the aldehyde was predicted based on the tricyclic transition structure 98 discussed above. 
Diastereofacial selectivity conferred to the addition by the chiral proline mismatches the 
Felkin-Anh selectivity of the aldehyde. The low isolated yield was due to the formation of 
the α,β-unsaturated byproduct 101. The α,β-unsaturated ketone is speculated to arise by a 
different mechanism (Scheme 10, PATH B) involving species 99 which undergoes 
deprotonation to enamine 102 followed by dehydration, with the carboxylate acting as acid-
base cocatalyst once again. Hydrolysis of the resulting intermediate 103 gives α,β-
unsaturated byproduct 104. List144 and Yamamoto145 have proposed an alternate mechanism 
for the formation of 104 involving a Mannich-reaction-elimination sequence as outlined in 
Scheme 12. Although the high concentration of acetone in the reaction is reported to 
suppress side reactions such as self-aldolisation and oxazolidinone formation, it does not 
prevent the formation of the elimination byproduct. Formation of significant quantities of 
dehydrated 101 poses a serious limitation to this method.141,145 Repeating the reaction using 
unnatural R-proline we obtained almost exclusive formation of isomer 82 (ratio 95:5) in a 
yield of 33%. The pleasing diastereoselectivity is attributed to the si facial bias exerted to the 
aldehyde by the amino acid which matches the Felkin-Anh selectivity of the aldehyde. 
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 Finally with PMB ether 82 in hand, formation of the PMB acetal 57 was expected to 
proceed smoothly under oxidative anhydrous conditions (Scheme 13). Thus treatment of 82 
with DDQ in dichloromethane in the presence of activated 4Å powdered molecular sieves 
resulted in the oxidative cyclisation of the C14 hydroxy group onto the benzylic carbon via a 
benzyl cation intermediate 105146 in a yield of 88%. There are two possible isomers with 
respect to the benzylic position, so it was pleasing that only one isomer was obtained. The cis 
stereochemistry around the acetal ring was established by the observance of strong Nuclear 
Overhauser Enhancements (nOe) between the three ring protons. Based on the known 
absolute configuration at C15, the absolute stereochemistry of the C14 hydroxy was 
established as S. A byproduct identified as aryl ester 106 was isolated in only trace quantity. 
Formation of the monobenzoate byproduct 106 was significant when molecular sieves were 
not used in the reaction. It is believed to arise by the further oxidation of 57 with DDQ in the 
presence of contamination by trace water.146,147 For comparative reasons, the oxidative 
cyclisation of the unrequired isomer 89 was achieved under identical conditions to afford 
107 (Scheme 14). Once again only one of two possible isomers was formed. Irradiation of 
Ar-CH in a 1D nOe experiment showed enhancements to C15-H and C13-Ha, suggesting that 
the C14 and C15 ring substituents were trans related. The absence of an nOe to C14-H upon 
irradiation of C15-H was also consistent with this analysis. Thus the absolute configuration at 
the C14-hydroxy centre of isomer 89 was determined as R based on the known absolute 
stereochemistry at C15. The formation of 107 was observed to proceed more sluggishly than 
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for 57. This observation can be rationalised by the presence of destabilising steric 
interactions in the intermediate oxonium 108. 
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Hydrolysis of PMB acetal 57 under acidic conditions posed a problem and was 
evidenced by the presence of p-anisaldehyde. The instability of PMB acetal to even traces of 
acid was more accentuated than initially expected and would make the handling and 
purification of compounds bearing this protecting group difficult. The problem was 
minimised by the basic treatment of flash silica prior to purification using 0.1% triethylamine 
and filtration of NMR solvents through a column of K2CO3. Attempts to remove 
contaminating p-anisaldehyde via its bisulphate derivative148 was met with difficulty. Thus it 
was abandoned in favour of a preventative approach.  
Attempted protection of the hydroxy group at C14 as the PMB ether 110 using PMB 
trichloroacetimidate 111 (Scheme 15) was met with poor conversions and low yields. PMB 
trichloroacetimidate 111 was prepared from p-methoxybenzyl alcohol and 
trichloroacetonitrile following the procedure of Bundle149 and was used without purification. 
Following literature precedent, the attempted purification by distillation150 under reduced 
pressure resulted in the darkening and eventual decomposition of the reagent. Following 
Bundle conditions149,151 alcohol 82 was treated with PMB trichloroacetimidate 111 and acid 
at 0oC then the reaction pursued at room temperature (Table 3). The poor conversion of 
starting material was attributed to the decomposition of the acid sensitive acetimidate 
reagent. In light of the difficulties experienced and the inefficiency of the approach, it was 
abandoned in favour of PMB acetal protection described above. 
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Entry 111 (equiv) acid (mol%) solvent time/h recovery  82 yield 110
1 3.4 TfOH (20) Et2O 20.5 51% 36%
2 1.7 BF3.OEt2 (13) hexane:CH2Cl2
        (2 : 1)
20.5 54% 18%
 
Table 3. 
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 In conclusion, the left hand segment C11-C20 57 of the fumonisin backbone was 
expeditiously synthesised in approximately 93% ee and with good diastereoselectivity using 
acyclic stereocontrol. PMB acetal 57 was obtained in a linear reaction sequence consisting of 
9 steps in 18% overall yield. Next we undertake the synthesis of aminoaldehyde fragment 58 
of FB3 (Chapter 1, Scheme 6) required for the impending key boron aldol coupling that will 
install the C10 hydroxy within the backbone 60. 
 
20 
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3            Synthesis of the                  C1-C10 Fragment 
 
 
The synthesis of the left hand C11-C20 fragment 57, common to both fumonisins B1 
and B3 has been achieved in an expeditious and highly stereoselective approach as described 
in Chapter 2. Attention then turned to the synthesis of the aminoaldehyde fragment 58 that 
will constitute the right hand portion of the FB3 backbone (Scheme 1). It was envisaged that 
aldehyde 58 will arise from alkene 62 by sequential hydrogenation and oxidation reactions. 
Disconnection at the trans double bond of 63 provides the C1-C4 65 and C5-C10 67 
synthons illustrated. The 2,3-syn-aminohydroxy functionality in 65 will be installed 
simultaneously by employing the Sharpless asymmetric aminohydroxylation reaction.  
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Scheme 1. 
 
The strategy employed in the synthesis of 58 could also allow entry to the 
aminoaldehyde fragment 64 of FB1 bearing an additional stereogenic hydroxy centre at C5 
via E-alkene 63 as shown in Scheme 2. The C5 alkoxy will arise from diastereomeric 
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epoxide 68 that in turn will arise from trans alkene 63, common to the C1-C10 retrosynthetic 
strategy of FB3.  
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Scheme 2. 
 
In the following discussion, the construction and assembly of the C1-C10 fragment 
58 of FB3 will be presented.  
 
3.1 Synthesis of the C1-C4 Aldehyde Fragment. 
 
Synthesis of the C1-C4 fragment 65 began with the installation of the syn-amino and 
hydroxy groups at C2 and C3 respectively using the carbamate-based Sharpless 
aminohydroxylation (AA)152,153 reaction on a suitable crotonate. The AA reaction, a close 
cousin of the asymmetric dihydroxylation (AD) reaction, employs a catalyst consisting of 
Cinchona alkaloid derived ligands, an osmium species, and a nitrogen source that also 
functions as the oxidant.154 Three different types of nitrogen sources exist, namely 
sulfonamides, carbamates and amides, with the carbamates widely accepted as the most 
viable in terms of synthetic utility. The alkali metal salt of the N-chlorocarbamate is actually 
required in the reaction and is formed in situ from the carbamate in the presence of NaOH 
and a chlorine source such as tert-butylhypochlorite or more recently 1,3-dichloro-5,5-
dimethyl hydantoin or dichloroisocyanuric acid sodium salt155 which are more readily 
available. 
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The proposed catalytic cycle for the AA is shown in Figure 1. The reaction proceeds 
through imidoosmium(VIII) species 112 which adds with syn-stereospecificity to the alkene 
to give azaglycolate 113. Oxidation of 113 by the nitrogen source gives complex 114 which 
undergoes hydrolysis to give the amino alcohol product and regenerate catalyst 112. 
Oxidised 114 may also enter the inimical secondary cycle and add to a second alkene to give 
bis(azaglycolate)osmium species 115 which undergoes hydrolysis to give 113 and liberates 
product. Since the addition step in the secondary cycle is not ligand mediated, product with 
lower enantio- and regio-selectivity is produced.154 
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Figure 1. 
 
As the majority of AA literature coverage deals with regioselectivity and 
enantioselectivity issues of substrates containing an aromatic group (e.g. cinnamates, 
styrenes, and vinyl arenes), a brief investigation into the steric effect of substituents in 
carbamates and crotonates on regioselectivity was conducted in the quest for optimal 
conditions. We began with the most favourable conditions reported for carbamate-based 
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aminohydroxylation of α,β-unsaturated esters, namely ethyl carbamate with phthalazine 
(PHAL) ligands in n-PrOH/water solvent system using tert-butylhypochlorite as the co-
oxidant (Scheme 3).156  
Use of the 1,4-bis(9-O-dihydroquininyl)-phthalazine [(DHQ)2PHAL] (vs 1,4-bis(9-O-
dihydroquinidinyl)-phthalazine [(DHQD)2PHAL]) ligand was dictated by the adapted AD 
mnemonic for required α-face attack to a prochiral alkene (Figure 2). Furthermore, the 
choice of phthalazine derived ligands was made based on favoured formation of the β-amino 
product in related systems.154 
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O
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Figure 2. 
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Scheme 3. 
 
Preliminary results suggested that as the steric demands of the ester group increased 
in the series R = Me>Et>iPr, better regioselectivity for the β-amino product was obtained. 
This is supported by the Janda model for ligand-substrate interactions which positions the 
bulky ester group outside the binding cleft of the active RN=OsO3-ligand complex to favour 
mode B interactions (Figure 3).154,157 
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Proposed binding modes of crotonate with the RO2CN=OsO3-(DHQ)2PHAL catalyst. 
Figure 3. 
 
The reactions also appeared to suffer from lower yields and increased diol formation 
as the steric bulk of the crotonate increased. It is proposed that the rate of 
aminohydroxylation may be slower than the hydrolysis of imidoosmium species 112 or 114 
in the AA catalytic cycle (Figure 1), due to steric effects that retard substrate-catalyst 
interactions. The liberated osmium(VIII) tetroxide consequently undergoes a ligand-
mediated AD reaction to give the diol byproduct.154 Formation of the diol byproduct can 
potentially be alleviated by reducing the water content in the solvent system thereby slowing 
the offending hydrolysis side reaction.154 Isolation of the major β-amino products from the 
regioisomers, diol and from the excess carbamate was achieved by careful flash 
chromatography. 
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 The effect of different carbamates on the AA reaction was next investigated (Scheme 
4). Thus, the AA reaction was conducted using the conditions above with tert-butyl 
carbamate and 1,3-dichloro-5,5-dimethyl hydantoin155 in n-PrOH/water (1:1). The 
regioselectivity obtained was moderately reduced compared to the preliminary analogous 
reaction in the ethyl carbamate series, lending support to the observation made by Sharpless 
and coworkers152 that smaller substituents on the nitrogen source allows for a better substrate 
fit in the ligand binding pocket of the catalyst to enhance regioselectivity and yield. 
Formation of diol158,159 116 remained problematic. Interestingly, use of the alternate chlorine 
source provided for a cleaner reaction, possibly due to the absence of impurities formed in 
the preparation of tert-butylhypochlorite. 
 
EtO
O
EtO
O
OH
NHBoc
EtO
O
NHBoc
OH
+
tert-butyl carbamate, NaOH, 
1,3-dichloro-5,5-dimethyl hydantoin,
(DHQ)2PHAL (5 mol%),
117 118
EtO
O
OH
OH
116
+
K2OsO4.2H20 (4 mol%),
n-PrOH/H2O (1:1)
60:40* 22%
* ratio obtained after flash chromatography  
Scheme 4. 
 
A brief investigation on the effect of the acetonitrile/water solvent system, reported to 
influence the regiochemical outcome of the AA reaction of styrenes,160 was applied to ethyl 
crotonate. The tert-butyl carbamate AA reaction in this solvent system proceeded with 
comparable regioselectivity (Scheme 5, Table 1, entry 1). Attempts to minimise diol 
formation by reducing the water content in the solvent system from acetonitrile/water (1:1) 
to (2:1) and by conducting the reaction at 0oC unexpectedly failed to provide an 
improvement. Reduction in the amounts of (DHQ)2PHAL ligand 2.5 mol% and potassium 
osmate(VI) 2.0 mol% from that previously used161 allowed the more economical scale up 
without any deleterious effects on regioselectivity (Table 1, entry 2).  
Purification of the tert-butyl carbamate AA mixture proved cumbersome by simple 
flash chromatography owing to the fact that the excess carbamate (3.08 equivalents used in 
reaction) closely trailed with the amino alcohol products. A purification system that isolated 
the β-amino alcohol 117 free from contaminants was devised. The three step process 
involved (a) suspending the excess carbamate in the crude AA mixture in a minimum 
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volume of chilled hexane followed by filtration, washing the residue with further chilled 
hexane and concentrating the filtrate for chromatography. (b) Flash chromatographic 
purification using 40% ethyl acetate : hexane to remove the lower running diol 116. (c) 
Careful flash chromatography using dichloromethane as eluent to remove trace carbamate 
and regioisomer 118. The excess carbamate and diol also made obtaining accurate 
regiochemical ratios from crude mixtures by 1H NMR difficult. Thus, where indicated with 
an asterisk, regiochemical ratios were determined by 1H NMR integration of the N-H or O-H 
protons following flash chromatography to remove diol and carbamate byproducts. Hence it 
is important to bear in mind that these product distributions may have been distorted by the 
purification. 
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O
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O
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NHR
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O
NHR
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+
RNH2, NaOH, 
1,3-dichloro-5,5-dimethyl hydantoin,
(DHQ)2PHAL, K2OsO4.2H2O,
117   R = Boc
EtO
O
OH
OH
116
+
CH3CN/H2O (1:1)
119   R = Cbz
118    R = Boc
120    R = Cbz  
Scheme 5. 
 
(DHQ)2PHAL mol%Carbamate K2OsO4.2H2O mol% Ratio
Combined
 yield Yield 116
1. Determined using Mosher's derivatisation or Daicel Chiralcel OD-H on the major isomer.
2. N-H signal of 117 obscured by tBu carbamate in the crude mixture.
3. tBuOCl used as the chlorine source.
ee1
tert-butyl 5.0 4.0 117:118
 68:322
78:22*
64 (Mosher) - 21
tert-butyl 2.5 2.0 117:118
 72:28*
82 (Chiralcel) 40 21
benzyl 5.0 4.0 119:120
78:22
- - -
Entry
1
2
3
43 benzyl 5.0 4.0 119:120
85:15 87 (Mosher) 12 -
Table 1. 
 
An investigation into the AA reaction giving rise to Cbz protected nitrogen products 
was conducted and the result of this work is summarised in Table 1, entries 3 and 4. The 
regiochemical and enantiomeric outcome of these reactions were comparable to those of the 
tert-butyl carbamate AA. An 87% ee was determined by derivatisation as the Mosher ester 
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using excess MTPA and DCC/DMAP to aid conversion.162 The purification issue was further 
complicated by the presence of diol 116 and efforts to remove the benzyl carbamate by 
sublimation were met with failure.  
In summary, ethyl crotonate was the starting substrate of choice based on availability 
as well as regiocontrol. Although ethyl carbamate has been demonstrated to give better 
results, the difficulty of deprotecting an ethyl carbamate makes it synthetically unviable. The 
choice of tert-butyl carbamate over benzyl carbamate was made on the grounds of ease of 
purification. Notably, the low isolated yields reported are not indicative of reaction progress 
but rather of the difficulty of purification. 
The stereochemical configurations of the newly created C2,3 centres were 2S, 3R as 
predicted by the AD mnemonic (Figure 2). The absolute configuration at the C3 secondary 
hydroxy was confirmed using the modified Mosher’s method.162-164 The proposed 
conformation of the (R)- and (S)-Mosher esters in solution, shown in Figure 4, disposes the 
carbinyl proton, ester carbonyl and trifluoromethyl groups of the MTPA moiety in the same 
plane. 
O
F3C O
H
NHCbz
MeO O
O
(S)-MTPA ester
O
F3C O
H
NHCbz
OMe
O
O
(R)-MTPA ester
1
3
1
3
 
Figure 4. 
 
proton δ (R)-MTPA ester δ (S)-MTPA ester ∆δ (δR-δS)
C1-H 1.09 1.25 -0.16
C2-H 4.53-4.40 4.55-4.42 -0.02
*
N-H 4.85 4.93 -0.08
OCH2CH3 4.22 4.20 +0.02
OCH2CH3 1.26 1.24 +0.02
* ∆δ calculated from the midpoints of the multiplets  
Table 2. 
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For the (S)-Mosher derivative in the conformation depicted the proton signals of the 
ethyl ester region are shielded and appear upfield relative to the (R)-Mosher ester. Thus by 
assigning the proton signals of the (R)- and (S)-Mosher ester derivatives, the ∆δ (δS-δR) 
(ppm) values could be obtained (Table 2). The arrangement of positive and negative ∆δ’s 
confirmed the R configuration at C3 needed for the natural product. Since installation of the 
amino and hydroxy groups in the AA occurs via a concerted syn mechanism, the relative 
configuration at C2 can thus be designated S. 
Simultaneous protection of the secondary β-amino and hydroxy groups in 117 was 
accomplished with p-TSA-catalysed acetal exchange using 2,2-dimethoxypropane (2,2-
DMP) in toluene in the presence of a Dean-Stark trap to afford oxazolidine 121 in a 
maximum yield of 74% (Scheme 6, Table 3, entry 1). The equilibrium in the 
thermodynamically-driven isopropylidene acetal formation (Scheme 6) appeared 
unfavourable since exchange was not going to completion. The isolation of uncyclised 
intermediate 122 suggests the low nucleophilicity of the amide nitrogen is responsible for the 
slow cyclisation toward 121. Since 2,2-DMP liberates two molecules of MeOH, it was 
expected that the introduction of 5Å molecular sieves and the use of 2-methoxypropene, 
would push the equilibrium forward according to Le Chatelier’s principle. Although 2-
methoxypropene proceeded to give better average yields (Table 3, entries 4, 5 and 6), the 
process produced an unidentified isomer, a possible epimer, with Rf 0.68 in 20% ethyl 
acetate : hexane that was difficult to isolate from 121 by flash chromatography, along with 
high running contaminants by t.l.c. Interestingly, the absence of intermediate 122 by t.l.c. 
under 2-methoxypropene conditions suggests the product is favoured since loss of only one 
molecule of MeOH is possible. Notably, the direct introduction of molecular sieves into a 
reaction proved detrimental when a vast quantity of them was used. For good conversion of 
117, additional 2-methoxypropene and 2,2-DMP reagents were best added in portions as can 
be seen from Table 3, as loss of reagent from the reaction mixture to the Dean-Stark during 
reflux and to the molecular sieves may have been occurring. 
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Scheme 6. 
 
 
 
Entry 
 
Reagent (no. portions) 
(total equivalents) 
 
Conditions 
5Å 
molecular 
sieves 
(Y/N) 
 
Solvent 
 
Catalyst 
(mol%) 
 
Time/h 
 
Yield 
121 
 
Recovered 
117 
 
1 
 
2,2-DMP (2) 
(3.7) 
 
Dean-
Stark 
reflux 
 
Y 
 
benzene 
 
p-TSA 
(1.2) 
 
2 
 
74 
 
- 
 
2 
 
2,2-DMP (3) 
(8.5) 
 
Dean-
Stark 
reflux 
 
Y 
 
toluene 
 
p-TSA 
(50) 
 
6 
 
54 
 
4 
 
3 
 
2,2-DMP (2) 
(6.0) 
 
90oC 
 
Y 
 
toluene 
 
PPTS 
(20) 
 
21 
 
16 
 
61 
 
4 
 
2-methoxypropene (3) 
(4.0) 
 
0oC-RT 
 
Y 
 
benzene 
 
p-TSA 
(4.9) 
 
4 
 
85 
 
- 
 
5 
 
2-methoxypropene (1) 
(4.0) 
 
0oC-RT 
 
Y 
 
 
benzene 
 
p-TSA 
(15) 
 
4 
 
67 
 
29 
 
6 
 
2-methoxypropene (2) 
(3.5) 
 
0oC-RT 
 
N 
 
CH2Cl2 
 
10-CSA 
(10) 
 
3 
 
60 
 
21 
 
Table 3. 
 
Efforts to directly reduce ester 121 to aldehyde 65 using DIBALH afforded an 
inseparable mixture of aldehyde165 65 and alcohol165 123 in a ratio of 76:24 respectively by 
1H NMR integration (Scheme 7, Table 4). Attempts to minimise over-reduction to 123 by 
decreasing both the amount of reducing agent and reaction time, resulted in the formation of 
65 in 22% yield and a recovery of 55% of ester 121. Competing aluminium coordination by 
ester 121 may account for the slow and incomplete consumption of starting material in the 
presence of only 2.0 equivalents of DIBALH. Given these difficulties we sought the 
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preparation of aldehyde 65 over two steps through stable alcohol 123 as demonstrated in 
Scheme 8.  
 
O NBoc
EtO
O
121
O NBoc
H
O
65
O NBoc
HO
123
+
see Table 4
below
 
Scheme 7. 
 
Reductant 
(equivalents) 
Solvent 
 
Time/h 
 
65:123 
 
Yield 65 
 
 
DIBALH 
(3.0) 
 
THF 
 
3 
 
76:24 
 
48 
 
DIBALH 
(2.0) 
 
CH2Cl2 
 
1 
 
- 
 
22 
 
Table 4. 
 
Reduction of ester 121 to alcohol 123 using LiBH4 in THF (Table 5, entries 1 and 2) 
was accomplished, albeit in reduced yield. By comparison, reduction of 121 in diethyl ether 
using LiAlH4 was effected in 30 min in 93% isolated yield of alcohol 123 as a white solid 
(Table 5, entry 3). The poor yields and slower reactions of LiBH4 are attributed to its low 
reactivity. 
 
O NBoc
EtO
O
121
O NBoc
H
O
65
O NBoc
HO
123
see Table 5
left
DMSO, (COCl)2,
Et3N, CH2Cl2,
-78oC
 
Scheme 8. 
 
A water quench of the reduction reaction and flash chromatography gave 
contaminating O,O-acetonide 124 byproduct which was isolated by HPLC as a colourless 
oil. An aqueous basic workup and chromatographic purification of 123 using deactivated 
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flash silica was needed to eliminate the acid induced rearrangement of oxazolidine 123 to 
O,O-acetonide 124 (Scheme 9).  
 
124
O NBoc
HO
123
O
O
NHBoc
H+
 
Scheme 9. 
 
Finally, aldehyde 65 was successfully obtained after Swern oxidation of alcohol 123 
followed by immediate filtration of the reaction mixture to remove the triethylammonium 
chloride salt (Scheme 8). The crude aldehyde, of sufficient purity and dryness, was 
immediately used in the subsequent coupling step to the C5-C10 sulfone and Wittig 
fragments.  
Characterisation of aldehyde 65 revealed an unstable compound 125 that possessed a 
carbonyl stretch in the complex 1738-1652 cm-1 region by IR, as well as an unexpected 
strong OH stretch at 3444 cm-1. The presence of this OH stretch was attributed to hydration 
of the aldehyde as depicted in Scheme 10. 
 
O NBoc
65
O
O NBoc
HO
125
OH
H2O
 
Scheme 10. 
 
3.2 Synthesis of the C5-C10 Sulfone Fragment. 
 
The synthetic plan for the preparation of the C5-C10 sulfone fragment 67 required for 
the impending modified Julia olefination coupling to C1-C4 aldehyde fragment 65 (see 
Scheme 1) began with the monosilylation of commercially available 1,6-hexanediol through 
McDougal’s sodium alkoxide method.166 Thus 1,6-hexanediol was treated with 
stoichiometric NaH and the monosodium alkoxide was formed at room temperature over 1 h 
prior to the addition of tert-butyldimethylsilyl chloride. Monosilylated adduct 126 was 
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isolated in 19% yield along with unreacted diol (Scheme 11, Equation 1). Owing to the low 
yields obtained, possibly due to poor NaH quality, the transformation was effected under 
alternate conditions using imidazole and DMF, and employing a large excess of the diol 
relative to the tert-butyldimethylsilyl chloride reagent (Scheme 11, Equation 2).166 A 
statistical mixture of monosilylated 126 and disilylated 127 products was obtained in yields 
of 66% and 28% respectively, and the excess diol was recycled via flash chromatography. 
 
HO
OH
TBSO
OH
HO
OH
TBSO
OH
TBSO
OTBS
NaH, THF, RT, 2 h,
TBSCl, 19%
126
+
DMF, imidazole,
TBSCl, RT, 3 h
126 127
66% 28%
(1)
(2)
 
Scheme 11. 
 
Silyl derivative 126 was transformed cleanly under Mitsunobu conditions with 2-
mercaptobenzothiazole (BTSH) to give the thioether 128 in good yield (Scheme 12). 
Oxidation of the thioether 128 to the corresponding sulfone 67 by ammonium molybdate(VI) 
tetrahydrate [(NH4)6Mo7O24.4H2O] catalysis under buffered conditions over 19 h was 
obtained in 94% yield in the absence of the intermediate sulfoxide 129 (Table 6, entry 3). 
Previously attempted oxidations leading up to the optimal conditions are also reported. It is 
noteworthy that the absence of buffer gave silyl deprotected 130 (Table 6, entry 1) and use of 
potassium hydrogen persulfate (KHSO5), commercially sold as oxone® (contains 2 mol 
KHSO5, 1 mol KHSO4, 1 mol K2SO4) in water with acetone as catalyst and cosolvent 
produced low yields of sulfone 67 and substantial amounts of the sulfoxide intermediate 129 
(Table 6, entry 4).167,168  
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Scheme 12. 
 
 
Entry 
 
 
Oxidant 
(equiv.) 
 
Solvent 
 
 
Condition 
 
 
Buffer 
(equiv.) 
 
Time/h 
 
 
 67  
 
 
130 
 
 
129 
 
 
1 
Mo(VI) 
H2O2 (10) 
EtOH/H2O 
15:2 
 
RT 
 
- 
 
20 
 
- 
Sole product 
(not quantified) 
 
- 
 
2 
Mo(VI) 
H2O2 (12) 
EtOH/H2O 
13:2 
 
RT 
 
KH2PO4 
(3.0) 
 
19 
 
58 
 
38 
 
- 
 
3 
Mo(VI) 
H2O2 (10) 
EtOH/H2O 
15:2 
 
RT 
 
KH2PO4 
(4.0) 
 
19 
 
94 
 
- 
 
- 
 
4 
KHSO5 
(3.0) 
acetone:H2O 
1:3 
 
RT 
 
NaHCO3 
(9.0) 
 
18 
 
29 
 
- 
 
70 
 
5 
KHSO5 
(6.0) 
acetone:H2O 
1:3 
 
reflux 
 
NaHCO3 
(12.0) 
 
14 
 
- 
 
73 
 
- 
 
Table 6. 
 
3.3 Synthesis of the C1-C10 Fragment via Coupling of Fragments C1-C4 
and C5-C10 by the Modified Julia Olefination Method.  
 
 With syntheses of the two fragments 65 and 67 available, attention was directed 
toward the coupling of these fragments to assemble the right half of FB3 (Scheme 1). A 
connective olefination reaction that is both compatible with many functional groups as well 
as highly trans selective was sought. Access to the right half of FB1 could also be realised 
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via an asymmetric epoxidation of the resulting trans alkene 63 (Scheme 2). An approach 
based on the modified (or one-pot) Julia olefination was selected among several alternatives 
as it both satisfies the requisites and delivers the alkene directly and economically. 
 The modified Julia olefination was reported in 1991 by Sylvestre Julia and 
coworkers169 and involves the reaction of metallated heteroarylalkylsulfones with carbonyl 
compounds. The two most commonly used heterocyclic activators of the modified Julia 
olefination are benzothiazol-2-yl (BT)169,170 and 1-phenyl-1H-tetrazol-5-yl (PT) sulfones 
(Figure 5).170,171  
Mechanistically, the modified Julia olefination of benzothiazol-2-yl-sulfone (BT-
sulfone) and an aldehyde proceeds with the addition of metallated BT-sulfone 131 to a 
carbonyl compound to give β-alkoxysulfone 132 which undergoes a facile rearrangement via 
the spirocyclic intermediate 133 to yield sulfinate salt 134 (Scheme 13). This sequence 
results in the transfer of the BT group from sulfur to oxygen in 134. Spontaneous elimination 
of sulfur dioxide and lithium benzothiazolone from the sulfinate yields the alkene products 
directly.170 
 
S
N
SO2R
BT-sulfone
N
NN
N
SO2R
PT-sulfone  
Figure 5. 
 
The origin of E/Z stereoselectivity is complex and depends strongly on the substrates 
and reaction conditions. For simple saturated aldehydes and sulfones, E selectivity is thought 
to arise from the initial kinetically-controlled nucleophilic addition of metallated sulfone to 
the aldehyde. Stereospecific elimination of the antiperiplanar oriented OBT and SO2Li 
groups in the sulfinate 134 arising from anti-β-alkoxy-BT-sulfone 132 yields an E-alkene, 
while elimination of the sulfinate arising from syn-β-alkoxy-BT-sulfone leads to the Z-
alkene.170 
 
Chapter 3 
 54 
S
N
S
O2
R1
Li
S
N
S
O2
OLiR2
R1 S
Li
N
S
O2
O R
2
R1 S
R2
R1
LiO
O
O
S
N
R1
R2
S
N
S
O2
OLiR2
R1 S
Li
N
S
O2
O R
2
R1 S
R2
R1
LiO
O
O
S
N
R2
R1
R2
O
H
+
anti-132
syn-132
trans
syn
S
N
OLi+SO2
+
+
134133
131
Scheme 13. 
 
A model study of the Julia olefination of BT-sulfone 67 with isobutyraldehyde 
(Scheme 14), namely by addition of isobutyraldehyde to the prelithiated BT-sulfone 135 
gave only unreacted sulfone and other UV active byproducts.  
 
TBSO
S
135
S
N
O O
Li
O
TBSO+
139
THF, -78oC-RT,
3 h
 
Scheme 14. 
 
1H NMR data on one such byproduct suggested the formation of 136 (Scheme 15) 
and is thought to arise from the self-condensation of the BT-sulfone via ipso substitution. 
Nucleophilic attack of carbanion 135 to the electrophilic imine-like moiety within the 
sulfone heterocycle gives an intermediate 137 which undergoes elimination to afford 
compound 136.169 This byproduct characteristically possesses aromatic resonance signals in 
the region δ 8.21-7.38 ppm, which collectively integrate to 8 protons, as well as a doublet of 
doublets at δ 5.22 ppm which corresponds to the methine proton. The chemical shift of the 
methine is lower field than expected. The propensity for a sterically unencumbered sulfone 
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to self-condense has been reported and is linked to the combined electrophilic and 
nucleophilic character of metallated BT-sulfones.169,170  
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Scheme 15. 
 
Since the competing self-condensation side reaction was preventing product 
formation, the adoption of Barbier-type conditions was investigated. Under the Barbier 
protocol the base is added to a mixture of sulfone and aldehyde. The in situ metallation of the 
sulfone and its subsequent addition to the aldehyde compete against the self condensation 
mechanism.169,170 Use of the Barbier method afforded alkenes Z-138 and E-139, which are 
consistent with 1H and 13C NMR data, in low yield and in a ratio of 62:38 respectively as 
determined by 13C NMR (Scheme 16). The moderate preponderance for the Z-alkene 138 
was somewhat surprising and suggests formation of the syn-β-hydroxysulfone intermediate 
syn-132 (Scheme 13) is kinetically favoured. 
 
TBSO
S
67
S
N
O O
O
TBSO+
Z-138:E-139
Barbier method
THF, LDA, -78oC-RT,
23 h, 36%
62:38  
Scheme 16. 
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 Adoption of the Barbier method in the construction of alkene 63 afforded an 
inseparable mixture of E- and Z-alkenes 63 and 140 in a ratio of 50:50 as determined by 13C 
NMR, and in a combined yield of 22% after chromatographic purification (Scheme 17). 
Reports for the low yield and selectivity of simple unbranched BT-sulfones have been made 
by others.171-174 
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S
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S
N
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+
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Barbier method
THF, LDA, -78oC-RT,
42 h, 22%
Z-140:E-63 
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TBSO
141
O NBoc
Pt/C (5 mol%),
MeOH, H2 (15 psi),
100%
O
FB3  fragment 58
O NBoc
110
1. TBAF
2. [O]
 
Scheme 17. 
 
 Kocienski and coworkers171 reported the preferential use of the PT heterocycle for 
unbranched alkyl groups. They afford better trans stereoselectivity than their BT 
counterparts and are less prone to self-condensation owing to the enhanced stability of their 
anion (PT has a greater electron withdrawing ability than BT).  
Thus in hindsight, the PT heterocycle would have been a better choice coupled with 
an appropriate base and solvent. However, since the aims of this work were target oriented 
toward the construction of the FB3 backbone, the poor trans-selectivity in the olefination 
reaction was not problematic as the subsequent hydrogenation of the alkenes would afford a 
single product. Indeed hydrogenation of the mixture of Z-140 and E-63 under atmospheric 
H2 using platinum-on-carbon in methanol over 3 h afforded alkane 141 in 100% yield 
(Scheme 17). Only two steps to the FB3 fragment 58 remained, namely TBAF deprotection 
followed by oxidation of the primary alcohol. 
 With hopes of improving on the yield of the olefinic coupling, the Wittig reaction 
was next investigated.  
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3.4 Synthesis of the C5-C10 Phosphonium Salt Fragments. 
 
Attention was directed toward the formation of the Wittig iodide salt 142, which was 
achieved in two steps following the sequence of reactions outlined in Scheme 18. Monosilyl 
adduct 126 was converted to iodide 143 via a Mitsunobu-like process (I2, PPh3, imidazole) in 
94% yield. Conversion of 143 to the iodide salt 142 was effected in 90% yield following 
flash chromatographic purification using 10% ethyl acetate : hexane then 10% MeOH : 
CH2Cl2. It will be seen later that chromatographic purification of the Wittig salt 142 was to 
the detriment of the subsequent Wittig reaction.  
 
TBSO
OH
TBSO
I
TBSO
PPh3I
I2, PPh3,
Et2O/CH3CN
RT, 2 h, 94%
PPh3, CH3CN,
∆, 25 h, 90%
143 142126
 
Scheme 18. 
 
Attempted formation of the TBS protected phosphonium bromide salt by an 
analogous route to the one shown in Scheme 18 was complicated by the formation of 1,6-
dibromohexane during the bromide substitution reaction of 126 with N-bromosuccinimide. 
This byproduct is formed as a result of TBS deprotection by traces of acid in the reaction 
medium. This approach was abandoned in favour of the more expeditious one outlined below 
(Scheme 19).  
The phosphonium bromide salt 66 required for the Wittig linkage to aldehyde 65 was 
prepared cleanly and simply by a two step sequence in an overall yield of 69% (Scheme 19) 
and obviated the protection/deprotection cycle prescribed by the Julia coupling partner 67 
and the phosphonium iodide 142. The reaction sequence commenced with the 
monobromination175 of symmetrical 1,6-hexanediol with a slight excess of aqueous HBr in 
toluene at reflux, to afford exclusively monobromide 144 in 81%. Chong et al.175 speculate 
that the dibromide byproduct is not formed because the hydroxy in the bromoalcohol is 
shielded from further reaction with the HBr by its involvement in aggregate formation. 
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Scheme 19. 
 
Treatment of the bromide 144 with triphenylphosphine in acetonitrile at reflux 
provided phosphonium bromide salt 66 as a white, amorphous, and extremely hygroscopic 
solid in 85% yield after purification by precipitation and washing with anhydrous 
acetone/Et2O. 
 The Wittig coupling of the C1-C4 fragment 65 with both C5-C10 142 and 66 was 
next investigated.  
 
3.5 Synthesis of the C1-C10 Fragment via Coupling of Fragments C1-C4 
and C5-C10 by the Wittig Olefination Method. 
 
The Wittig olefination entails the condensation of a phosphorous ylide with a 
carbonyl compound to yield an alkene and a phosphine oxide. The unstabilised phosphine 
ylide is prepared in situ from a phosphonium salt by treatment with a base (Scheme 20).176 
Mechanistically, the initial step involves nucleophilic addition of the polarised ylide 
to the carbonyl to form betaines 145 and/or 146 which cyclise to form the intermediate cis- 
and trans-oxaphosphetanes 147 and 148. It has also been argued that the oxaphosphetanes 
are formed directly from the ylide carbonyl via a concerted addition through a four-centred 
transition state.176,177 Subsequent elimination of 147 and 148 yields triphenylphosphine oxide 
and the cis- and trans-alkenes respectively with retention of configuration (Scheme 20).176 
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Scheme 20. 
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A model Wittig reaction between 66 and isobutyraldehyde was conducted at -78oC to 
provide 149 smoothly in 100% yield in a Z:E ratio of 92:8 respectively based on 13C NMR 
data (Scheme 21). This model study essentially established that the Wittig salt 66 was of 
sufficient purity and dryness for the Wittig reaction. The stereochemical outcome was as 
normally observed for unstabilised ylides.176  
 
HO
PPh3Br
66
LiO
PPh3
HO
149
THF, n-BuLi
-78oC, 30 min O
-78oC-RT, 
5 h, 100%
Z:E = 92:8
Scheme 21. 
 
Reaction of nonstabilised phosphonium ylides 66 and 142 with α-alkoxy aldehyde 65 
was next undertaken (Scheme 22). The procedure of Merrer and coworkers178 was followed. 
They successfully effected a Wittig olefination with coupling partners bearing similar 
structural features in high yield and with Z-selectivity.  
Thus, Swern oxidation of the alcohol 123 led to crude aldehyde 65 which was 
immediately condensed at -78oC with the required ylide, obtained by treating Wittig salt 66 
with n-BuLi at -78oC in THF over 30 min under an Ar atmosphere, to afford 150 in >95:5 
Z:E ratio and in a combined yield of 45% over 2 steps.  
 
R
PPh3X
66     R = OH, X = Br
R
PPh3 O NBoc
R
142   R = OTBS, X = I
   R = OH
   R = OTBS
150   R = OH     Z:E = >95:5     45%
140   R = OTBS  Z:E = >95:5     5%
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THF
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O
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Scheme 22. 
 
Wittig olefination of aldehyde 65 with the ylide obtained from phosphonium iodide 
142 (n-BuLi, -78oC-0oC, 8 min, Et2O, N2) led to isolation of only 5% 140 and the starting 
aldehyde 65 (Scheme 22). The failure of phosphonium iodide 142 to provide sufficient 
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olefination product may be attributed to the insufficient dryness of the hygroscopic salt 
acquired during flash chromatography.  
With Z-olefin 150 in hand, a direct route to right fragment 58 was realised in 2 steps 
involving hydrogenation of the double bond followed by Swern oxidation in good yield 
(Scheme 23).  
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Scheme 23. 
 
 In summary, the FB3 fragment 58 was synthesised in 9 steps via the Wittig 
olefination approach. The low yielding coupling of 65 with sulfone 67 via the Julia 
olefination approach was resolved by the Wittig olefination of 65 and 66 and concurrently 
reduced the number of steps in the synthesis by eliminating a protection/deprotection 
strategy. Although the stereochemical outcome of both the modified Julia and Wittig 
reactions were not as required, it was envisaged that entry to E-olefin 63 (Scheme 2) required 
for the FB1 fragment 64 could be brought about by double bond isomerisation by irradiation 
of Z-140 from a mercury lamp.178 Alternatively, access to E-alkene 63 can be achieved by 
further probing the modified Julia olefination reaction. 
 With both the C1-C10 right fragment 58 and C11-C20 left fragment 57 (Chapter 2) 
available, the boron aldol coupling of the two subunits that will secure the C10 stereocentre 
was undertaken. The following chapter describes model studies conducted toward the 
stereoselective installation of the C10 hydroxy and subsequent elaborations to the C12 
methyl centre. Finally a complete synthesis of the protected FB3 backbone C1-C20 structure 
59 will be reported.  
39 
 
61 
                 Synthesis of the  
                  C1-C20 Fumonisin B3 
                  Backbone 
 
 
The plan for the synthesis of the fumonisin B3 backbone is outlined in Scheme 1. 
Retrosynthetically, the final C12-methyl stereogenic centre is established via a 1,3-hydroxy-
directed hydrogenation of the 1,1-disubstituted alkene functionality at C12, itself arising 
from methylenation of the carbonyl group within ketone 60. Assembly of the C1-C20 
backbone 60 from fragments C11-C20 57 and C1-C10 58 with concomitant installation of 
the C10-hydroxy is achieved in a stereocontrolled manner using a 1,5-anti selective boron 
aldol reaction.  
 
NBoc
OO
OH
1012
15
O
NBoc
O
O
10
5 1
57 58
1. methylenation
2. 1,3-hydroxy-directed hydrogenation
1,5-anti aldol
PMP
NBoc
OO
OH
10
O
PMP
O
11
O
O
PMP
O
11
20
59
60
20
1
 
Scheme 1. 
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The key steps of the synthetic plan outlined above, namely the boron aldol coupling 
of 57 and 58, and the hydroxy-directed hydrogenation were based on precedented 
methodologies described below. 
Evans90 and Paterson91,179 have demonstrated that excellent 1,5-anti stereoinduction 
in the boron-mediated aldol reaction of β-oxygenated methyl ketones may be realised with 
the correct selection of the protective group on the β-oxygen. As illustrated by representative 
examples in Scheme 2, they have concluded that a benzylic protected β-oxygen leads to high 
selectivity, while silicon protecting groups in methyl ketone-derived boron enolates revoke 
the 1,5-induction element, leading to diminished selectivity (Scheme 2, Equations 1 vs 2). It 
is also evident from the reactions (Scheme 2, Equation 3) carried out that having the β-
oxygen substituent constrained in a ring does not alter the diastereoselectivity of the reaction. 
Thus, to ensure a useful level of 1,5-stereoinduction, the PMB acetal protecting group was 
incorporated into the methyl ketone 57 (Chapter 2). It was anticipated that the late stage 
deprotection of the labile PMB acetal group would proceed selectively under mild conditions 
to allow for the esterification of the C14 and C15 hydroxy groups with 42 (Chapter 1, 
Scheme 6). 
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OO O
TrO
Ph
OO O
TrO
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OH
15
c-hexyl2BCl, Et3N
O
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O
Bu2BOTf, i-Pr2NEt
O
Ph
1,5-anti : 1,5-syn = 97 : 3
1,5-anti : 1,5-syn = 42 : 58
1,5-anti : 1,5-syn = >95 : 5
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(2)
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Scheme 2. 
 
Selected examples77-79 of hydroxy-directed hydrogenations of homoallylic alcohols 
(Scheme 3) provided a good paradigm for the diastereoselective formation of methyl-bearing 
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59 from the preceding olefin. As can be seen from Equation 6, the presence of an electron 
withdrawing group adjacent to the hydroxy group decreases the oxygen’s basicity which 
leads to poor diastereoselection in the case of the Rh catalyst. 
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Scheme 3. 
 
4.1 Model Study: Construction of the C4-C20 Unit via Aldol Coupling of  
   the C11-C20 Fragment with Heptaldehyde. 
 
 Remote induction from a cyclohexylboron enolate such as 152 can be used to achieve 
high levels of 1,5-stereocontrol in the boron-mediated aldol reaction of β-oxygenated chiral 
methyl ketone 57 with an achiral aldehyde. Evans et al.90 demonstrated that the polar effect 
of the β-heteroatom substituent on enolate facial bias is a key stereocontrolling factor. 
 Indeed, this pivotal 1,5-anti boron-mediated aldol reaction was used for the coupling 
of fragments 57 and 58 in the construction of the fumonisin backbone 59 (Scheme 1). 
Due to the remoteness of the stereogenic centres within the C1-C10 fragment 58 from 
the reactive aldehyde site, it was anticipated that they would not influence the stereochemical 
outcome of the aldol reaction of 58 with the boron enolate of methyl ketone 57. Thus, achiral 
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heptaldehyde was deemed a suitable model system for analysing the level of 1,5-anti 
stereocontrol in the aldol reaction of β-oxygenated methyl ketone 57 for the stereoselective 
establishment of the C10-hydroxy centre. Any steric influence91 from heptaldehyde on the 
aldol reaction was expected to be comparable with the side chain of 58. 
 Upon treatment of methyl ketone 57 with 5.9 equivalents of c-hexyl2BCl followed by 
Et3N at 0oC then heptaldehyde at -78oC, a single product of the expected molecular weight 
was obtained as determined by mass spectrometry, 1H and 13C NMR (Scheme 4). 
Comparison of the 1H NMR of the (R)- and (S)–MTPA ester derivatives of the product 
disappointingly showed S absolute configuration, assuming the formation of the desired aldol 
adduct 153. This suggested 10,14-syn selectivity in the boron-mediated aldol reaction. Closer 
inspection of the COSY spectrum surprisingly revealed coupling between C11-H and the 
benzylic hydrogen, suggestive of a rearrangement to form a cyclic system. This led to the 
postulation of 7-membered adduct 154 (Figure 1).  
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The cyclic compound 154 was thought to arise via a Lewis acid induced 
rearrangement under the reaction conditions used. In order to determine the timing of this 
rearrangement a simple experiment was conducted (Scheme 5); the boron enolate of 57 
formed under similar enolisation conditions was oxidatively quenched (pH 7.0 buffer, 
MeOH, H2O2) to afford rearranged ketone 155. Thus it became evident that boron enolate 
152 was undergoing a rearrangement in the presence of excess c-hexyl2BCl and Et3N prior to 
the aldol coupling with heptaldehyde. The mechanism for this rearrangement is proposed to 
occur via the Lewis acid induced opening of the acetal to give oxonium intermediate 156 
followed by an intramolecular aldol annulation to give intermediate 157 (Scheme 6). 
Deprotonation of 157 gives enolate 158 which undergoes an aldol addition to heptaldehyde.  
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Scheme 5. 
 
The absolute configuration determined by the Mosher method is in accord with 
derivatisation at the C14 hydroxy (Figure 2, Table 1). The steric environment around the C10 
hydroxy may have prevented derivatisation at this site. As a consequence, the relative 
stereochemistry of the three new stereogenic centres within 154 have not been fully 
elucidated. 
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Figure 2. 
 
Proton δ (S)-MTPA ester δ (R)-MTPA ester ∆δ (δS-δR) 
 
C15-H 
 
C16-CH3 
 
C16-H 
 
Ar-CH 
 
 
3.77 
 
1.04 
 
1.91-1.83 
 
4.99 
 
3.59 
 
1.00 
 
1.87-1.77 
 
4.81 
 
 
+0.18 
 
+0.04 
 
+0.05* 
 
+0.18 
 
C13-Ha 
 
 
3.30 
 
3.33 
 
-0.03 
                     ∗ ∆δ calculated from the midpoints of the multiplets. 
 
Table 1. 
 
 The rearrangement was somewhat unexpected since the use of up to 11.6 equivalents 
of c-hexyl2BCl in the aldol reaction of acetone with aldehyde 75 (Chapter 2) had no effect on 
the reaction. It did, however, reinforce the fact that the PMB acetal group is labile enough to 
cause side reactions and extra care needed to be taken. 
 The unwanted rearrangement was prevented by reducing the amount of c-hexyl2BCl 
used and varying its order of addition. Thus enolisation of methyl ketone 57 with Et3N and 
then 2.2 equivalents c-hexyl2BCl at -78oC, followed by addition of heptaldehyde cleanly 
furnished 159 in 64% yield as a 62:38 mixture of R:S diastereomers as determined by 
13C NMR (Scheme 7, Table 2). The major isomer was identified as having the R 
configuration at C10 by comparison of the (S)- and (R)-MTPA esters 161 and 162 within the 
mixture (Figure 3, Table 3). Verification of the R configuration was achieved using 
diastereomerically pure 163 (see page 77).  
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L 10,14-anti 159 : 10,14-syn 160 yield 
 
c-hexyl 
 
 
62:38 
 
64 
                                                                      
(+)-Ipc 
 
76:24 
 
36 
 
(-)-Ipc 
 
 
67:33 
 
48 
 
Table 2. 
 
The reduced level of 1,5-stereoinduction from the ketone component may be a 
consequence of steric congestion arising from the bulky PMB acetal since it has been 
observed that a large steric influence from the ketone has a deleterious effect on reaction 
stereoselectivity.180 As a corollary, it has been observed that an increase in 1,5-induction 
roughly correlates with an increase in the steric encumbrance of the aldehyde.91 
 Since substrate control was moderate, it was anticipated that asymmetric induction 
from Ipc ligands on boron would enhance selectivity for 10,14-anti 159. Using (+)-Ipc2BCl 
and Et3N137,179 in the matched reaction (i.e. where the influence of the β-stereocentre from 
the ketone and boron reagent are matched), the aldol addition of methyl ketone 57 to 
heptaldehyde proceeded in 36% isolated yield to afford 10,14-anti adduct 159 with 76:24 
diastereoselectivity by 13C NMR (Scheme 7, Table 2), and 31% recovery of starting material. 
In the mismatched case using (-)-Ipc2BCl and Et3N, the aldol addition of methyl ketone 57 to 
heptaldehyde proceeded in 48% isolated yield to afford 10,14-anti adduct 159 with 67:33 
diastereoselectivity by 13C NMR. The stereoselectivity of this reaction gave comparable 
results to the c-hexyl ligands. It is evident from the results obtained that stereoinduction from 
B
Cl
(+)-Ipc2BCl
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the Ipc ligands was not strong enough to substantially increase 1,5-stereoinduction in the 
matched reaction nor decrease selectivity in the mismatched case.  
 Purification of the mixture by flash chromatography failed to separate the two 
diastereomers. Furthermore, the observation of additional benzylic hydrogen signals in the 
1H NMR spectrum also suggested acid-catalysed epimerisation of the protecting group. 
Attempted isolation of (10R)-159 and (10S)-160 by HPLC using base-deactivated silica 
resulted in a retroaldol reaction. The product was therefore taken onto the next step as a 
diastereomeric mixture. 
 
4.2 Model Study: Chemical Elaboration of the C4-C20 Fragment.  
 
4.2.1 Carbonyl Methylenation and Directed Hydrogenation Reactions on a Simple 
Model System. 
 
Only two steps to the construction of the C4-C20 fragment remained; methylenation 
of the carbonyl to a 1,1-disubstituted alkene followed by 1,3-hydroxy-directed 
hydrogenation. In order to conserve methyl ketone 57, the development of suitable 
conditions for the methylenation and hydrogenation reactions were conducted on a simple 
ketone 164 synthesised by the aldol addition of the c-hexylboron enolate derived from 2-
hexanone with heptaldehyde to give racemic 165 in 73% yield (Scheme 8). The hydroxy 
group was then protected as the TBS ether 164 in 100% yield. 
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2.
-78oC, 1.5 h
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O OTBS
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100%
165
 
Scheme 8. 
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Use of the Peterson olefination protocol would, in principle, spontaneously furnish 
the 1,1-disubstituted alkene 166 as illustrated in Scheme 9. Under this protocol, Grignard 
addition of (trimethylsilylmethyl)magnesium chloride to ketone 164 is expected to give 
alcohol intermediate 167 which undergoes an elimination to give 166. In light of the 
complex mixtures obtained by the in situ addition of (trimethylsilylmethyl)magnesium 
chloride to the boron aldolate of 165, the aldol-Grignard sequence was conducted over 2 
steps. The addition of (trimethylsilylmethyl)magnesium chloride to 164 was achieved in 20% 
yield with only trace amount of the elimination product 166 detected. Efforts to induce the 
elimination of the trimethylsilyl group from 167 using KH were met with failure. 
 
O OTBS
164
OTBS
167
OTBS
166
Grignard
TMSCH2MgCl
KH
Me3Si
HO
 
Scheme 9. 
 
Attempted Wittig olefination of 164 with the ylide derived from 
methyltriphenylphosphonium bromide afforded byproduct 168 arising from the elimination 
of the OTBS group (Scheme 10). This side reaction is believed to be caused by the basic 
nature of the Wittig reagent. 
 
O OTBS
 164
O
168
CH3PPh3Br, n-BuLi,
THF, -78oC to 50oC
 
Scheme 10. 
 
Application of Takai181-183 methodology (Zn-CH2I2-TiCl4) to β-hydroxy ketone 164 
was also troubled by β-elimination of the OTBS group to afford olefin 168 once again, along 
with other unidentified low running byproducts by t.l.c. Use of Lombardo’s 
modification182,184,185 of the Takai methylenation reaction did not furnish the desired olefin 
166 either.  
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Recent reports of the ability of dimethyl titanocene to methylenate carbonyl 
compounds upon thermolysis at 60-75oC prompted its use in the methylenation of 164. 
Dimethyl titanocene was prepared from titanocene dichloride by treatment with 
methylmagnesium chloride in toluene and could be stored in solution for several months.186 
Petasis olefination of 164 (THF, Cp2TiMe2, 65oC) cleanly gave 1,1-disubstituted alkene 166 
in 69% yield (Scheme 11). The methylenation process is postulated to proceed via the 
titanocene methylidene intermediate generated during the thermolysis of Cp2TiMe2. The 
formation of titanocene oxide is the driving force for the reaction.187,188 Silyl protected 166 
was converted to the corresponding homoallylic alcohol 169 using TBAF in 92% yield.  
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Scheme 11. 
 
With homoallylic alcohol 169 in hand, an investigation into the directed 
hydrogenation for the stereoselective construction of the 1,3-methyl-secondary alcohol was 
initiated. Directed homogeneous hydrogenation189-192 of allylic and homoallylic alcohols 
have been carried out using a variety of rhodium and iridium catalysts the most common of 
which include Wilkinson’s catalyst 170, and the cationic catalysts [Rh(NBD)(diphos-4)]BF4 
171193 and [Ir(COD)py(PChx3)]PF6 (Crabtree’s catalyst)194 172 (Figure 4).  
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Figure 4. 
Chapter 4 
 71 
The reaction takes place by reduction of the diene ligands to give an active 12-
electron transition metal complex (Scheme 12). Two-point binding of the active metal with 
the hydroxy group and proximal alkene of the reactant gives metal complex 173 which 
undergoes oxidative addition to H2 to give the dihydride complex 174. Transfer of the 
diastereotopic hydride parallel to the alkene from the metal to the olefin (migratory insertion) 
gives the primary alkyl metal 175 which is thermodynamically more stable than the 
secondary alkyl metal 176. Finally reductive elimination of the alkyl metal complex 175 
liberates the alkane product and regenerates the active hydrogenation catalyst.191 
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Scheme 12. 
 
1,3-Asymmetric induction in the hydrogenation reaction of homoallylic alcohols 
arises as a consequence of diastereofacial selectivity brought about by the minimisation of 
nonbonded interactions in complexes 177 and 178 (Figure 5). Delivery of hydrogen from the 
metal to the alkene in these complexes gives rise to the 1,3-anti and 1,3-syn isomers 
respectively. The homoallylic group of 1,1-disubstituted olefins preferentially adopts the 
pseudoequatorial position, such as in complex 177, and although stereoinduction is not 
expected to be as high as for homoallylic alcohols possessing an allylic substituent in the 
appropriate configuration,78 good levels of asymmetric induction are reported (see Scheme 
3). 
 The hydroxy-directed hydrogenation of racemic homoallylic alcohol 169 with 
Wilkinson’s catalyst 170 at 300 psi H2 pressure afforded a virtually even distribution of 
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1,3-anti 179 and 1,3-syn 180 isomers (52:48) as determined by gas chromatography (Scheme 
13, Table 4, entry 1). The reduction of 169 under atmospheric H2 pressure was extremely 
slow with only trace quantity of product in a 47:53 ratio of anti:syn isomers isolated after 4 
days. The low level of stereodifferentiation was attributed to poor substrate binding to the 
transition metal. 
OH
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13
13
1,3-anti  179
1,3-syn  180
see Table 4
below +
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Scheme 13. 
 
Entry 
 
Catalyst (mol%) 
 
Solvent 
 
H2/psi 
 
t/h 
 
179:180 
 
yield 
 
 
1 
 
 
(PPh3)3RhCl                   170 (10) 
 
C6H6 
 
300 
 
48 
 
52:48 
 
82 
 
2 
 
 
(PPh3)3RhCl                   170 (10) 
 
C6H6 
 
15 
 
96 
 
47:53 
 
trace 
 
3 
 
 
[Rh(NBD)(dppb)]+        171 (17.5) 
 
CH2Cl2 
 
640 
 
18 
 
61:39 
 
76 
 
4 
 
 
[Rh(NBD)(dppb)]+        171 (9.9) 
 
CH2Cl2 
 
340 
 
22 
 
61:39 
 
85 
 
5 
 
 
[Ir(COD)py(PChx3)]+    172 (2.5) 
 
CH2Cl2 
 
15 
 
18 
 
39:61 
 
97 
 
6 
 
 
[Ir(COD)py(PChx3)]+      172 (2.5) 
 
CH2Cl2 
 
640 
 
18 
 
32:68 
 
94 
 
Table 4. 
 
 Attempts at further enhancement of substrate binding and thus reaction 
diastereoselectivity by employing a more highly π-acidic cationic rhodium(I) catalyst proved 
moderately successful (Table 4, entries 3 and 4). Reaction through coordination complex 
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177, in which the bulky butyl group is oriented pseudoequatorial, rationalises the preferential 
formation of the 1,3-anti isomer. Reduction was extremely slow at atmospheric H2 pressure 
and stereoinduction was observed to be independent of catalyst loading.  
Investigation of Crabtree’s cationic iridium complex 172 under atmospheric H2 
pressure unexpectedly afforded preponderance for the 1,3-syn isomer. Diastereomeric 
complementarity between the cationic rhodium and iridium complexes (Table 4, entries 3 
and 6) was observed. As expected olefin isomerisation within the iridium system is 
insignificant since similar levels of stereoinduction were obtained at higher H2 
pressure191,195,196 (Table 4, entries 5 and 6). A plausible explanation for the reversal in 
selectivity may lie in the nature of the ligands attached to the transition metals. Enhancement 
for 1,3-anti diastereoselectivity may have been brought about by the bidentate 1,4-
bis(diphenylphosphino)butane (dppb).197 Also numerous reports for the superiority of 
rhodium vs iridium catalysts in acyclic substrates have been documented.195,197  
Moderate selectivities were obtained even in the best cases possibly due to steric and 
electronic factors within the substrate. Separation of the hydrogenation mixture by HPLC 
(2.5% ethyl acetate : hexane) afforded 1,3-anti 179 followed by 1,3-syn 180 in pure form. 
 The relative stereochemistry of the newly created γ-methyl substituent in 179 was 
accomplished using the recently reported method of Takahashi et al.198 which is based on the 
Mosher’s method and relies on the strong, long-range anisotropic effects caused by the 2-
naphthylmethoxyacetic (2-NMA) derived esters.198-200 It has been shown from X-ray 
crystallography that the conformation of a 2-NMA ester is as demonstrated by Trost163 in 
that the carbinyl proton, carbonyl oxygen and methoxy group lie in the same plane. For the 
case of enantiomerically pure 2-NMA esters, the difference in the chemical shifts (∆δ) of the 
γ-, δ-, ε- and ζ-positions within the diastereomeric esters is compared to threshold values 
which discriminate between the α,γ-syn and anti isomers. Thus a larger |∆δ| than the 
threshold values indicate an anti isomer and vice versa. The method can also be used to 
elucidate the absolute configuration of secondary alcohols within long-chain acyclic systems 
where the Mosher method becomes unreliable due to the smaller upfield shifts caused by the 
benzene moiety. Thus the absolute configuration of the carbon bearing the methyl group can 
also be determined. 
 2-NMA was provided in racemic form, and had been prepared following the 
depiction in Scheme 14. The hydroxy acid 181 was obtained from the cyanohydrin of the 
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corresponding 2-naphthaldehyde followed by acid hydrolysis. The hydroxy acid was 
globally methylated to afford the methyl α-methoxy-naphthylacetate 182 which was 
hydrolysed under basic conditions to give racemic 2-methoxynaphthylacetic acid 183. 
Resolution of the enantiomeric forms can easily be achieved by chiral derivatisation.199,200 
Recently a chemo-enzymatic synthesis of enantiomerically pure (R)-2-
methoxynaphthylacetic acid from 2-naphthaldehyde was reported.201 
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Scheme 14. 
 
 Racemic 179 was stirred with racemic 2-NMA (DCC/DMAP, CH2Cl2) to afford a 
diastereomeric mixture of racemic 2’S*,10R* and 2’R*,10R* NMA esters (Figure 6) which 
were separated by HPLC. For the sake of simplicity only the one enantiomer is depicted.  
For the (2’S*,10R*)-NMA esters in the conformation depicted, the proton signals of 
the C11-C16 chain appear significantly downfield relative to the (2’R*,10R*)-NMA esters 
due to the strong anisotropic effect of the naphthyl group (Table 5). The chemical shift of 
signals marked with an asterisk were estimated from the centre of COSY cross peaks. The 
|∆δ| for the γ- and ζ-positions were found to be larger than the threshold values of 0.41 and 
0.15 respectively, showing 1,3-anti stereochemistry. The 1,3-syn stereochemistry of 180 was 
attained by an identical analysis of the corresponding 2-NMA esters (Table 6). The |∆δ| 
value obtained for the γ hydrogen was less than the threshold as expected. Although |∆δ| of 
the ζ hydrogen did not fit the rule, its value was considerably smaller than in the anti-isomer. 
This suggests caution when using this technique to assign relative stereochemistry in 
complex environments. The |∆δ| values for the δ- and ε-hydrogens could not be obtained due 
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to the inability to resolve the complex overlapping pattern of methylene signals by 400 MHz 
NMR. 
O
MeO
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O
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O
H
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(2'S*,10R*)-NMA ester
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ε
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Figure 6.  
 
Proton 
 
δ (2’S*,10R*)-NMA δ (2’R*,10R*)-NMA ∆δ (δS*,R*-δR*,R*) |∆δ| (> threshold) 
 
α  C10-H 
 
 
5.10-5.00 
 
5.08-5.00 
 
+0.01 
 
- 
 
γ  C12-H* 
 
 
1.38 
 
0.73 
 
+0.65 
 
0.65 (> 0.41) 
 
ζ  C15-H* 
 
 
1.22 
 
0.92 
 
+0.30 
 
0.30 (> 0.15) 
 
C12-CH3 
 
 
0.82 
 
0.58 
 
+0.24 
 
- 
 
C16-H 
 
 
0.86* 
 
0.68 
 
+0.18 
 
- 
 
Table 5-NMA esters of 179 
 
Proton 
 
δ (2’S*,10R*)-NMA δ (2’R*,10R*)-NMA ∆δ (δS*,R*-δR*,R*) |∆δ| (< threshold) 
 
α  C10-H 
 
 
5.05-4.93 
 
5.03-4.95 
 
- 
 
- 
 
γ  C12-H* 
 
 
1.36 
 
1.00 
 
+0.36 
 
0.36 (< 0.41) 
 
ζ  C15-H* 
 
 
1.21 
 
1.03 
 
+0.18 
 
0.18 (not < 0.15) 
 
C12-CH3 
 
 
0.84* 
 
0.59 
 
+0.25 
 
- 
                                                                  
Table 6-NMA esters of 180 
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4.2.2 Carbonyl Methylenation and Directed Hydrogenation Reactions on Fragment 
C4-C20. 
 
With the availability of ketone 159, Petasis olefination of the corresponding silyl 
protected adduct 184 was conducted. TES ethers 184 and 185 were obtained in 100% yield 
from a diastereomeric mixture of alcohols 159 and 160 (Scheme 15). Subsequent Petasis 
olefination of 184 and 185 in the absence of light afforded alkenes 186 and 187 in 66% yield. 
Despite the mildness of the Petasis olefination, the substrate remained prone to acid-
catalysed epimerisation at the acetal centre as evidenced by the isolation of 188 by flash 
chromatography possessing a benzylic proton resonance downfield of the desired product.  
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RT, 3.5 h, 100%
OO
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OTES
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oC,
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159 184
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+ 10,14-syn 160
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+
+ 10,14-syn 185
+ 10,14-syn 187
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OCH3
OTES
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+
 
Scheme 15. 
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Removal of the silyl protecting group with TBAF gave a mixture of 
chromatographically resolvable alcohols 163 and 189 in 92% yield. Diastereomerically pure 
163 was the first fraction to be obtained by HPLC purification, and possessed the same 
optical rotatory sense as 189. The homoallylic moiety in 163 was thus set up for the 
subsequent directed hydrogenation reaction. 
The C10 configuration in 163 was confirmed as R by 1H NMR spectrometry on the 
corresponding (R)- and (S)-MTPA esters using the modified Mosher’s method (Figure 7, 
Table 7).164 
Based on the modelling studies conducted above, it was anticipated that moderate 
levels of stereoinduction would be achieved in the reduction of homoallylic alcohol 163 to 
hydrogenated 190 using cationic Rh(I) catalysts (Scheme 16). 
 As a control experiment, the heterogeneous reduction of 163 using platinum on 
carbon in methanol under an atmosphere of H2 cleanly afforded an even distribution of the 
10,12-anti and syn isomers 190 and 191 (Scheme 16, Table 8, entry 1). This suggests that 
both diastereotopic faces of the alkene are sterically hindered to a similar extent and in this 
way, any stereoselectivity observed is solely attributable to alternate directing effects. The 
presence of a bulky TES protecting group on oxygen shielded the face of the alkene syn to 
the heteroatom from addition to H2, thus affording a predominance of the syn isomer 191 
(Scheme 17, Table 8, entry 2). Ratios were obtained by analytical HPLC using silica 
deactivated with triethylamine. Separation of isomers 190 and 191 by HPLC gave pure 
10,12-syn 191 followed by 10,12-anti 190. 
 The results from the homogeneous hydroxy-directed hydrogenation of homoallylic 
alcohol 163 (Scheme 16) are summarised in Table 8. Side reactions involving the acetal 
protecting group were common due to the Lewis acidic nature of the catalysts. The presence 
of p-anisaldehyde resulting from the destruction of the PMB acetal group, constituted a large 
portion of the crude reaction mixtures by 1H NMR integration. Likewise the presence of 
additional benzylic signals identified by 1H NMR suggested acid-catalysed epimerisation of 
the protecting group was also common. This made obtaining diastereomeric product ratios 
by HPLC integration extremely difficult and it must be emphasised that the reported ratios 
may not reflect the directivity of the reduction because of the prolific side reactions. The 
ratio in Table 8, entry 7 is an exception to the aforementioned statement as the reaction was 
observed to proceed cleanly. 
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Scheme 17. 
 
Due to the lability of the PMB acetal group, attention was directed toward alkoxide-
directed hydrogenations. The first known report of alkoxide-directed hydrogenations was 
made by Thompson and McPherson202 who demonstrated that the alkoxide displaces 
chloride from the rhodium centre of Wilkinson’s catalyst thereby improving the 
stereoselectivity of the directed hydrogenation. Paquette et al.203 extended this notion further 
to ionic complexation between sodium alkoxide salts and the cationic catalyst 
[Rh(NBD)(diphos-4)]BF4 171. They found that the mildly basic conditions employed 
averted side reactions caused by the otherwise Lewis-acidic rhodium.  
Adoption of Paquette’s optimised conditions (NaH, THF, catalyst 20 mol%, H2/300 
psi) to homoallylic 163 (Scheme 16) gave no reduction. This is attributed to the poor 
solubility of the catalyst in the THF solvent. Pleasingly, recourse to the dichloromethane 
solvent (Table 8, entry 8) cleanly afforded products 190 and 191 without contamination from 
significant byproducts, albeit with no stereoselectivity despite the precedent set by the model 
work (see above). Clearly, the reaction is expected to proceed through complexed 
intermediate 177 (Figure 5), however the hexyl group is not large enough to direct the 
reaction efficiently through its pseudoequatorial orientation, and the involvement of a 178-
type intermediate becomes substantial. A second possibility is that directing effects from the 
acetal oxygens at C14 and C15 may contribute to the reduction in selectivity. 
Attempts to improve the diastereoselectivity of the reaction by employing cationic 
rhodium catalysts that utilise chiral 1,2-bis(phospholano)benzene (DuPHOS) ligands204 192 
(Figure 8) in a double stereodifferentiating reaction proved only moderately successful. 
Commercially available C2-symmetric 1,2-bisphospholano catalysts204,205 (-)-[Rh((R,R)-Me-
DuPHOS)(COD)]BF4 193 (Figure 8) and (+)-[Rh((S,S)-Me-DuPHOS)(COD)]BF4 194 in 
both enantiomeric forms were employed. The five-membered chelate ring is 
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conformationally rigid by virtue of the 1,2-phenylene backbone. This conformational rigidity 
efficiently transfers chirality from the phospholane rings to the bound substrate.206 
 
P
P
Rh BF4
(-)-[Rh((R,R)-Me-DuPHOS)(COD)]BF4  193
P P
(R,R)-Me-DuPHOS  192  
 
Figure 8. 
 
Surprisingly, there was no evidence of double stereodifferentiation as both 
enantiomeric forms of the rhodium catalyst 193 and 194 afforded similar selectivities for the 
10,12-anti product 190 (Table 8, entries 9 and 10). It was also observed that selectivity in the 
hydroxy- and alkoxide-directed hydrogenations were comparable (entries 7 and 10). The 
small increase in selectivity (compare entries 8, 9, 10) suggests that stereodifferentiation 
imparted by the chiral DuPHOS ligands is subordinate to polar group directivity in the 
substrate.  
 
4.3 Work Towards the Stereochemical Elucidation of the C12-Methyl  
            Centre within Fragment C4-C20. 
 
 With the availability of acyclic C4-C20 fragment 190, the next objective became the 
confirmation of the absolute stereochemistry at the C12 methyl, disposed γ to the C10-
hydroxy. This was accomplished using the recently reported method of Takahashi et al.198 
described in section 4.2.1. Independent validation of this method was accomplished by 
chemical elaborations of 190 and 191 following the protocol of Hoye et al.60 
 
4.3.1 NMA Method. 
 
Treatment of 10,12-syn 191 with racemic 2-naphthylmethoxyacetic acid (CH2Cl2, 
DCC/DMAP) gave a mixture of (R)- and (S)-NMA ester derivatives which were separated 
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by HPLC (Figure 9). The 1H NMR shifts associated with significant resonances were 
identified by 2D-NMR experiments. The |∆δ| for the γ-, δ-, ε- and ζ-positions were found to 
be smaller than the threshold values of 0.41, 0.23, 0.28 and 0.15 respectively, implying α,γ-
syn stereochemistry (Table 9). The consistent pattern of 1H NMR shifts in the depicted 
conformation suggested that the first peak to be isolated was the (R)-NMA derivative and the 
second was the (S)-NMA ester. 
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O
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Figure 9.  
 
Proton 
 
δ (R)-NMA δ (S)-NMA ∆δ (δR-δS) |∆δ| (< threshold) 
 
α  C10-H 
 
    
5.03-4.96 
 
 
5.04-4.95 
 
0 
 
- 
 
γ  C12-H* 
 
 
1.65 
 
1.78 
 
-0.13 
 
0.13 (< 0.41) 
 
δ  C13-Ha* 
 
 
1.55 
 
1.66 
 
-0.11 
 
0.11 (< 0.23) 
 
δ  C13-Hb* 
 
 
1.05 
 
1.16 
 
-0.11 
 
0.11 (< 0.23) 
 
ε  C14-H 
  
 
4.13 
 
4.21 
 
-0.08 
 
0.08 (< 0.28) 
 
ζ  C15-H 
 
 
3.73 
 
3.79-3.76 
 
-0.05 
 
0.05 (< 0.15) 
                      * Estimated from centre of COSY cross peak 
 
Table 9-NMA esters of 191 
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By a similar analysis of the second fraction 190 isolated by HPLC, the α,γ-anti 
configuration was postulated based on comparison of 1H NMR shifts of the (R)- and (S)-
NMA esters (Table 10). The |∆δ| of 0.29 ppm for the ε-position was found to be slightly 
larger than the threshold value of 0.28 while |∆δ| for the ζ-protons was identical to the 
threshold value. Although |∆δ| for the γ-, δ-protons were both smaller than the threshold 
values, they remained considerably larger than the corresponding values obtained for the syn 
diastereomer, thus lending support to the anti relative configuration. Once again this 
technique for assigning relative stereochemistry needs to be used cautiously. Confirmation 
for the α,γ-anti configuration was derived from an independent chemical synthesis as 
discussed below. 
 
Proton 
 
δ (R)-NMA δ (S)-NMA ∆δ (δR-δS) |∆δ| (> threshold) 
 
α  C10-H 
 
    
5.06-4.98 
 
 
5.11-5.03 
 
-0.05 
 
- 
 
γ  C12-H* 
 
 
1.44 
 
1.78 
 
-0.34 
 
0.34 (not > 0.41) 
 
δ  C13-Ha* 
 
 
1.32 
 
1.53 
 
-0.21 
 
0.21 (not > 0.23) 
 
ε  C14-H 
  
 
3.89 
 
4.18 
 
-0.29 
 
0.29 (> 0.28) 
 
ζ  C15-H 
 
 
3.62 
 
3.77 
 
-0.15 
 
0.15 (= 0.15) 
                     * Estimated from centre of COSY cross peak 
                         
Table 10-NMA esters of 190 
 
4.3.2 Chemical Method. 
 
Confirmation of the stereochemical assignment of C12 obtained by the NMA 
Takahashi method was made by elaboration of the C4-C20 units 190 and 191 to pyrans using 
a sequence of reported reactions.60 
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Synthesis of pyran 195 was initiated by mesylation of 10,12-syn 191 (CH2Cl2, 
DMAP, MsCl) to 196 in 70% yield (Scheme 18). Due to the instability of 196, the PMB 
acetal group was immediately removed with Dowex® 50W resin in methanol to give 
intermediate 197 which underwent a facile cyclisation to give hydroxy pyran 195 in 100% 
yield. The facility of the cyclisation is attributed to the positioning of all substituents within 
the chair-like transition state leading to 195 in equatorial orientation. Finally the acetyl 
derivative 198 was made in 70% yield (pyridine, Ac2O, DMAP) from secondary alcohol 195. 
The use of DMAP was necessitated by the slow acylation rate of the secondary hindered 
alcohol.207 
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OCH3
OH
4
20
191
OO
OCH3
OMs
4
20 196
OH
OH OMs
O
HO
H H
4
12
12
20O
O
H H
4
12
20
O
198 195
197
DMAP, CH2Cl2, MsCl,
Et3N, 0
oC-RT, 12 h, 70%
Dowex 50W, MeOH/H2O,
RT, 1 h, 100%
via
py, Ac2O, DMAP,
RT, 6 h, 70%
 
 
Scheme 18. 
 
Following identical conditions, 10,12-anti 190 was converted to the unstable C10 
mesylate 199 which was afforded as a mixture with epimer-200, postulated  to have formed 
by acid-catalysed epimerisation at the benzylic position (Scheme 19). This was confirmed by 
the disappearance of the minor isomer in the subsequent acetal deprotection reaction. 
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Removal of the acetal group using Dowex® 50W resin in methanol afforded a mixture of 
intermediate diol 201 and hydroxy pyran 202 which were readily separated by 
chromatography. The reluctance of 201 to cyclise as readily as the syn isomer 197 above, 
may be due to the axial orientation of the C12 methyl in the chair-like transition state leading 
to ring formation. Acetylation of 202 under the conditions previously used cleanly afforded 
acetyl derivative 203 in 100% yield. 
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Scheme 19. 
 
The stereochemistry of the methyl-bearing stereocentre in diastereomeric pyrans 198 
and 203 was determined using a combination of spectral properties and 2D NOESY analysis 
(Figure 10). NOESY cross peaks between the C12-CH3, C10 and C14 protons in 203 
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indicates they are oriented cis to one another while the absence of NOESY cross peaks 
between C12-CH3 and the C10 and C14 protons in pyran 198 suggests C12-CH3 is disposed 
trans to the C10-H and C14-H. The C14 proton was established as a ddd in pyrans 203 and 
198 with coupling constants J14,15 8.1 Hz, J14,13ax 11.2 Hz , J14,13eq 2.0 Hz and J14,15 8.2 Hz, 
J14,13ax 10.4 Hz, J14,13eq 1.9 Hz respectively. The coupling constants of 11.2 and 10.4 Hz show 
C14-H to be axially oriented in a chair conformation in both pyrans 203 and 198. Also, the 
C12 proton in 203 comes into resonance at δ 2.16-2.07 ppm, downfield of the corresponding 
signal in 198 (δ 1.56-1.08 ppm) indicating that the C12-H in 203 is disposed equatorially. 
Further support for this comes from the upfield resonance of the C12-CH3 in 203 (δ 18.3 
ppm) relative to the C12-CH3 in 198 (δ 22.3 ppm) again consistent with an axially disposed 
methyl group in 203.208  
As the absolute configuration at the C10 stereocentre of 190 was previously 
determined as R by Mosher’s method and the ring closure occurs by nucleophilic 
displacement of the mesylate with inversion, then based on the collection of analyses above, 
the absolute configurations at C14 and C12 in 190 can both be assigned S. Furthermore, the 
configuration at C14 of 190 had also previously been assigned as S based on the known 
absolute configuration at C15 using nOe enhancements in acetal 57 (Chapter 2).  
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Figure 10. 
 
4.4 Synthesis of the C1-C20 Fumonisin B3 Backbone. 
 
The optimised reactions used in the synthesis of the model C4-C20 unit 190 were 
followed in the construction of the FB3 backbone. The configuration at any newly created 
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carbon centre was henceforth assigned by analogy to the intermediates modelled in the 
synthesis of the C4-C20 unit. One is justified in assigning the diastereomers by analogy on 
the basis that the stereogenic centres at the amino terminus of the backbone are too remote to 
interfere with the chiral centres at the other end of the chain.  
The synthesis began with the generation of the C10 hydroxy bearing stereocentre by 
reaction of the c-hexylboron enolate derived from methyl ketone 57 (Et2O, Et3N, c-
hexyl2BCl, -78oC) with amino aldehyde 58 to provide the 10,14-anti aldol product 60 in 65% 
yield as a 69:31 diastereomeric mixture on the basis of 13C NMR (Scheme 20). The major 
diastereomer was designated the R configuration at C10 by analogy to the C4-C20 model 
system based on the fact that the stereochemical outcome of the aldol reaction depicted in 
Scheme 20 was of similar magnitude to the modelled aldol which was shown to produce the 
(10R)-isomer 159 as the major adduct. Separation of the diastereomers was not attempted 
due to the proven instability of the model compounds 159 and 160 to HPLC separation.  
Protection of the hydroxy groups in aldol adducts 60 and 204 as TES ethers (pyridine, 
DMAP, TESCl) provided (10R)-205 in 90% yield as a mixture with (10S)-206. Petasis 
olefination of the diastereomeric mixture, 205 and 206 afforded 207 and 208 in 74% yield 
with no scrambling at the benzylic protecting group detected. Removal of the silyl group 
from 207 and 208 afforded a chromatographically resolvable mixture of 209 and 210 in a 
ratio of 72:28, suggesting that flash chromatographic purification did not distort the ratio of 
the two diastereomers. The major isomer was the first fraction to elute and was thus 
designated as (10R)-209 based on its analogous mobility and matched ratio to the model C4-
C20 compound 163.  
Hydrogenation of 209 using Pt/C cleanly gave a 50:50 ratio of 10,12-anti 59 and 
10,12-syn products 211 by 1H NMR of the crude mixture (see appended spectrum) in 84% 
yield (Scheme 21). The diastereomers were isolated pure under HPLC separation. The 
identity of the second eluting fraction was proposed as 10,12-anti 59 based on the 
assumption that its order of mobility relative to the other diastereomer matches that of the 
model system. Poor stereoselectivity for the tentatively assigned anti isomer was obtained 
(36:64 and 46:54 by HPLC and 1H NMR integration respectively) in the alkoxide-directed 
hydrogenation of 209 with (-)-[Rh((R,R)-Me-DuPHOS)(COD)]BF4 193 . However the 
reaction was observed not to proceed as cleanly as was the case in the model system. 
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Scheme 21. 
 
 Side reactions involving the PMB acetal group in methyl-substituted 59 and 211, 
namely hydrolysis and epimerisation, made obtaining complete characterisation data 
virtually impossible. It is anticipated that removal of the PMB acetal protecting group will 
clean up these side products. A lack of available starting intermediates meant the 
hydrogenation reaction could not be repeated and the stereochemistry at C10 and C12 in 
alcohol 59 could not be rigorously proven. These problems do not pose a serious limitation 
since hydrolysed FB3 19, obtained by a global deprotection of 59, may be correlated with the 
natural product by HPLC. However since authentic samples of either FB3 or HFB3 could not 
be sourced, despite an international search, the global deprotection of 59 was not effected.  
 
4.5 Conclusions and Future Work.  
 
Synthesis of the C1-C10 fragment 58 of FB3 (Chapter 3) was realised in 9 steps in 
82% ee and the C11-C20 fragment 57 (Chapter 2) was obtained in 9 steps in 93% ee. Five of 
the total seven stereogenic centres within the FB3 backbone are contained in these fragments 
and were installed by catalytic asymmetric transformation or acyclic stereocontrol with good 
levels of selectivity. As entry to the FB1 natural product via fragment 64 is also desirable, the 
E-selective Julia olefination of 65 and 67 (Chapter 3) needs to be addressed. 
A modelled synthesis of the FB3 C4-C20 fragment 190 (Chapter 4) was achieved by a 
boron aldol coupling of fragment 57 with heptaldehyde and later a hydroxide directed 
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hydrogenation reaction. The morass of diastereomers obtained was a consequence of the 
moderate stereoselectivity that was inherent to the reaction system. 
 Adoption of the modelled reaction conditions towards the coupling of fragments 57 
and 58 en route to C1-C20 59, afforded moderate levels of 1,5-stereoinduction in the 
installation of the C10 hydroxy group. One expects the boron aldol coupling of the two 
fragments would effectively increase the overall ee of the major diastereomer to >95%. 
Installation of the final methyl stereocentre at C12 was realised using an alkoxide-directed 
hydrogenation reaction, albeit with poor stereoselectivity.  
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 The absolute configuration of all seven chiral centres within the FB3 backbone has 
also been determined from each of the individual fragments and by correlation to the C4-C20 
model system 190 using a combination of chemical derivatisations and NMR methods. 
 Although the stereochemistry at C10 and C12 in C1-C20 59 was not rigorously 
proven due to a lack of available starting material, we plan to correlate globally deprotected 
59 with an authentic sample of hydrolysed FB3 by HPLC in order to verify the identity of the 
synthesised diastereomer. A completion of the synthesis of FB3 will be achieved by selective 
deprotection of the PMB acetal group, followed by esterification of the C14 and C15 
hydroxy groups with 42 (Chapter 1, Scheme 6). 
Although the present methods have provided a new synthetic route to the FB3 
backbone, an alternate fragment coupling strategy (Scheme 22) is also available to overcome 
shortcomings in the asymmetric aldol coupling and directed reduction chemistry described. 
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Installation of the C10 hydroxy centre will use Brown’s allylboration chemistry. The 10,14-
anti stereochemistry in 212 is installed using a boron aldol reaction in which Felkin control 
from the aldehyde fragment and 1,5-anti stereoinduction are matched. The C12-methyl 
group is realised by cuprate substitution to the tosyl-bearing carbon with inversion. 
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Scheme 22.
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    5 Experimental 
 
 
General Details 
1. Melting points were determined using a Reichert heating stage with microscope and 
are uncorrected. 
2. Infra-red absorption spectra were recorded using a Perkin Elmer 1600 Fourier 
Transform infrared spectrometer. Compounds were prepared as either Nujol mulls or thin 
films between sodium chloride plates. Absorption maxima are expressed in wavenumbers 
(cm-1) and the appearance of bands are expressed as sh = shoulder and br = broad. 
3. 1H NMR spectra were recorded on a Bruker AC200 (200.1 MHz), Bruker AVANCE 
DPX200 (200 MHz), Bruker AVANCE DPX300 (300.1 MHz), Bruker AMX400 (400.1 
MHz) or Bruker DPX400 (400.2 MHz) spectrometer at 300K. Spectra were recorded in 
deuteriochloroform unless otherwise stated. Data is expressed in parts per million downfield 
shift from tetramethylsilane with either tetramethylsilane or chloroform as an internal 
standard and is reported as chemical shift, relative integral, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet or m = multiplet with descriptors ob = obscure, distort = 
distorted, br = broad), coupling constant (J Hz) and assignment. All multiplicities and 
coupling constants are apparent. The # denotes resonance disappears following D2O 
exchange and the ♦ denotes resonances from the minor diastereomer that differ from the 
major diastereomer in an inseparable mixture.  
4. 13C NMR spectra were obtained on a Bruker AC200 (50.3 MHz), Bruker AVANCE 
DPX200 (50 MHz), Bruker AVANCE DPX300 (75.5 MHz), Bruker AMX400 (100.4 MHz) 
or Bruker DPX400 (100.6 MHz) spectrometer with complete proton decoupling at 300K 
unless otherwise specified. Spectra were recorded in deuteriochloroform unless otherwise 
stated. The chemical shifts are reported relative to chloroform (δ 77.0) , benzene (δ 128.62) 
or acetonitrile (δ 118.26) and are expressed as position δ.  (δ position) denotes the 
resonances from the minor isomer in an inseparable mixture and br denotes a broad signal. 
Diastereomeric ratios are calculated based on the peak heights of signals corresponding to a 
common carbon. 
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5. Elemental analyses were carried out by the Microanalytical Unit, Research School of 
Chemistry, Australian National University. 
6. High and Low resolution mass spectra were recorded using positive-ion chemical 
ionization (CI+) with CH4 as reagent gas or electron impact (EI+) [run on a Finnigan Polaris 
Q ion trap at 70eV, Kratos MS 25 RFA used with an ion source at 70eV with PKF as 
standard and operated in magnetic scan, or VG Autospec (EBE) Sector mass spectrometer at 
70eV with PKF as standard], positive electrospray ionization (ESI+) [run on a 4.7T Bruker 
FT-ICR/MS, Finnigan LCQ or Finnigan MAT 900 XL], positive fast atom bombardment 
(FAB+) [run on ZAB-SEQ4F with magnetic scan], or liquid secondary ion mass 
spectrometry (LSIMS) obtained with m-nitrobenzylalcohol. The parent ion (M) or ion of 
highest mass is quoted first followed by ion fragments. Ion fragments are given as 
percentages relative to the base peak and assigned where possible. 
7. Gas chromatography (GC) was carried out on a Hewlett Packard 5890 series II Gas 
Chromatograph equipped with a split/splitless capillary injector, flame ionization detector 
(FID) and either capillary column SGE BPX70 (25 m x 0.22 mm ID, 0.25 µm) or HP-5 TA 
(30 m x 0.25 mm ID, 0.25 µm). He was used as carrier gas and data was acquired and 
processed using ChemStation software. 
8. Analytical High Performance Liquid Chromatography (HPLC) was carried out on a 
Waters Gradient system consisting of, two 510 pumps, a Millipore U6K injector, a model 
490E multiwavelength ultra-violet detector at 254 nm and a 410 differential refractometer. 
Data was acquired and processed using Millenium software. Separation was carried out 
using the indicated solvents on a Partisil 5 analytical column with a length of 250 mm, an 
internal diameter of 4.6 mm and particle size 5.0 µm. 
9. Semipreparative High Performance Liquid Chromatography (HPLC) was carried out 
on a Waters Associates system consisting of, an M-6000 pump, a Millipore U6K injector, a 
model 440 ultra-violet detector at 254 nm and a R401 differential refractometer. Separation 
was carried out using the indicated solvents on a Whatman Partisil 10 M9 semipreparative 
column with a length of 500 mm, an internal diameter of 9.4 mm and particle size 10.0 µm. 
10. Preparative High Performance Liquid Chromatography (HPLC) was carried out on a 
Waters Associates system consisting of, a 510EF pump, a Millipore U6K injector, a model 
ISCO 226 ultra-violet detector at 254 nm and a Waters R403 differential refractometer. 
Separation was carried out using the indicated solvents on a Whatman Partisil 10 M20 
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preparative column with a length of 500 mm, an internal diameter of 22 mm and particle size 
10.0 µm. 
11. Optical rotations α were measured on an Optical Activity POLAAR 2001 Automatic 
polarimeter with the sodium D line (589 nm) at ambient temperature. Optical rotations were 
recorded in chloroform unless otherwise stated and run in 0.5 dm or 0.25 dm length cells. 
Specific rotations [α]D, are expressed in units of dm-1 g-1 cm3 and concentrations are reported 
as c g solute/ 100 cm3 solution.  
12. Thin layer chromatography (t.l.c) was performed using 0.2 mm thick precoated 
aluminium backed silica gel plates (Merck Kieselgel 60 F254). Compounds were visualised 
by ultra-violet fluorescence or by staining with vanillin in ethanolic sulfuric acid or 
phosphomolybdic acid and ceric sulfate in sulfuric acid.  
13. Flash chromatography was performed using Merck Kieselgel 60 (230-400 Mesh) 
with the specified solvents, and was deactivated with 0.1% v/v triethylamine as indicated for 
acid-sensitive compounds. 
14. Concentration “in vacuo” or under “reduced pressure” refers to concentration using a 
rotary evaporator connected to a water aspirator. Removal of residual solvent was achieved 
by evacuation (0.7-0.01mmHg) with a high stage oil sealed pump. 
15. Solvents and reagents were dried and purified according to literature methods.148,209 
Methanesulfonyl chloride was distilled over CaH2 prior to use. Stock solutions of anhydrous 
tert-butylhydroperoxide in isooctane were prepared from aqueous 70% wt. tert-
butylhydroperoxide and assayed by iodometric titration.210 Commercial n-butyllithium in 
hexanes was titrated against 1,3-diphenyl-2-propanone p-toluenesulphonyl hydrazone,209 2,5-
dimethoxybenzyl alcohol in tetrahydrofuran, or s-butyl alcohol in toluene with either 2,2’-
bipyridyl or 1,10-phenanthroline as indicator. 
16. Hexane refers to n-hexane (b.p. 65-69oC) and brine refers to saturated aqueous 
sodium chloride solution. 
17. All non-aqueous reactions were performed under an atmosphere of N2 or Ar using 
oven dried glassware and vacuum dried syringes. 
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EXPERIMENTAL FOR CHAPTER 2 
 
5.1 Synthesis of the Methyl Ketone Fragment C11-C20. 
 
Hept-2-yn-1-ol82,211,212 
 
OH
14
20
 
 
Anhydrous liquid ammonia (approx. 750 ml) was distilled into a 1 L three-necked flask 
equipped with a dry ice-acetone condenser and mechanical stirrer. Lithium metal (3.70 g, 
0.533 mol, 2.1 eq) was prepared in small chunks. To the stirring ammonia under an 
atmosphere of N2 was added a small washed chunk of lithium metal (resulted in a deep blue 
solution) followed by ferric nitrate (100 mg). The remaining lithium metal was added 
chunkwise with stirring over 15 min. After 1.25 h, the initially blue solution gave way to a 
milky white suspension of lithium amide. Propargyl alcohol (14.4 g, 0.257 mol, 1.0 eq) was 
added dropwise over 15 min then n-butyl bromide (35.0 g, 0.255 mol, 1.0 eq) was added to 
the resulting grey solution dropwise over 45 min. An exothermic reaction ensued and the 
colourless mixture was stirred at -78oC for 1 h. The ammonia was allowed to evaporate at 
room temperature overnight then the solid residue was dissolved in water (500 ml). The 
aqueous solution was extracted with diethyl ether (5 x 100 ml) and the combined organic 
extract was dried (MgSO4), filtered and concentrated under reduced pressure. Fractional 
distillation (89-90oC/15mmHg; lit.82 83oC/12mmHg) of the crude product gave pure hept-2-
yn-1-ol as a colourless liquid (21.4 g, 74%); Rf (50% ethyl acetate : hexane) 0.41; IR (thin 
film) 3331 (OH), 2933 (CH), 2224 (C≡  C) cm-1; 1H NMR (200 MHz, CDCl3) δ 4.23 (2H, br 
s, C14-H), 2.25-2.16 (2H, m, C17-H), 1.82 (1H, br s, OH), 1.52-1.30 (4H, m, C18-H, C19-H), 
0.90 (3H, t, J = 7.0 Hz, C20-H); 13C NMR (50.3 Hz, CDCl3) δ 86.3, 78.7, 51.3, 30.6, 21.9, 
18.4, 13.5; m/z (EI+) 112 (M, 88), 97 (M-CH3, 14), 83 (M-C2H5, 100), 70 (70). 
 
 
 
 
Chapter 5 
 93 
(E)-Hept-2-en-1-ol213 77 
 
OH
14
20
77  
 
To a 0oC stirred suspension of lithium aluminium hydride (3.66 g, 0.0964 mol, 2.7 eq) in 
anhydrous diethyl ether (74 ml) was added hept-2-yn-1-ol (4.00 g, 0.0357 mol, 1.0 eq) in 
diethyl ether (40 ml) dropwise via cannula under an atmosphere of argon. The mixture was 
heated to reflux for 20 h then cooled to room temperature and diluted with diethyl ether. The 
reaction was quenched with water and then cold 2 M hydrochloric acid was added to 
facilitate layer separation. The layers were separated and the aqueous layer extracted with 
ether (3 x 50 ml). The combined organic extract was dried (MgSO4), filtered and 
concentrated under reduced pressure. The crude product was purified by fractional 
distillation (54-56oC/3mmHg; lit.213 78-80oC/16mmHg) to afford pure (E)-hept-2-en-1-ol 77 
as a colourless oil having the aroma of cooked asparagus (3.25 g, 80%); Rf (40% ethyl 
acetate : hexane) 0.43; IR (thin film) 3331 (OH), 3030 sh on 2957 (C=C-H), 2957, 2927, 
2860 (C-H), 1670 (C=C), 970 (C=C-H out-of-plane deformation) cm-1; 1H NMR (200 MHz, 
CDCl3) δ 5.77-5.57 (2H, m, C15-H, C16-H), 4.08 (2H, dd, J = 4.9, 0.9 Hz, C14-H), 2.09-1.99 
(2H, m, C17-H), 1.56 (1H, br s, OH), 1.43-1.26 (4H, m, C18-H, C19-H), 0.88 (3H, t, J = 6.9 
Hz, C20-H); 13C NMR (50.3 MHz, CDCl3) δ 133.1, 128.8, 63.4, 31.8, 31.2, 22.1, 13.8; m/z 
(CI+) 115 (M+H, 22), 97 (M-OH, 100). 
 
(2S, 3S)-(3-Butyl-oxiran-2-yl)-methanol86 61 
 
OH
14
20
O
61  
 
A three-necked 100 ml round-bottomed flask equipped with a thermometer, nitrogen inlet, 
magnetic stirrer bar and septum was charged with powdered, activated 4Å molecular sieves 
(200 mg) and dry dichloromethane (27 ml). The flask was cooled to -20oC then (R,R)-(+)-
diisopropyl tartrate (246 mg, 1.05 mmol, 12 mol%) and Ti(O-iPr)4 (249 mg, 0.876 mmol, 10 
mol%) were added sequentially with stirring. The reaction mixture was stirred at -20oC as 
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anhydrous tert-butylhydroperoxide86 (5.5 M in isooctane, 3.20 ml, 17.5 mmol, 2.0 eq) was 
added at a moderate rate. The resulting complex was matured at -20oC for 30 min before (E)-
hept-2-en-1-ol 77 (1.00 g, 8.76 mmol, 1.0 eq) in dichloromethane (3.8 ml) was added 
dropwise via cannula taking care to maintain the temperature at -20oC. The reaction mixture 
was stirred at -20oC for another 2 h and then warmed to 0oC. The mixture was poured into 
8.80 ml of a precooled, freshly prepared solution of ferrous sulfate heptahydrate (2.90 g, 10.4 
mmol) and tartaric acid (0.790 g, 5.28 mmol) in deionised water with stirring. The two-phase 
mixture was stirred for 10 min then the biphasic mixture was separated and the aqueous layer 
extracted with diethyl ether (2 x 20 ml). The combined organic extract was treated with a 
precooled solution of 4 M sodium hydroxide in saturated brine (1.65 ml). The mixture was 
stirred vigorously for 1 h at 0oC then diluted with water. The layers were separated and the 
aqueous layer extracted with diethyl ether (2 x 30 ml). The combined organic extract was 
dried (Na2SO4), filtered and concentrated under reduced pressure. Flash chromatographic 
purification (40% ethyl acetate : hexane) of the crude product afforded the epoxide 61 as a 
colourless liquid that solidified in the freezer (0.98 g, 86%); Rf (40% ethyl acetate : hexane) 
0.52; [α]D -29.2 (c 0.40, CHCl3) [lit.86 -29.7 (c 2.0, CHCl3), 95% ee]; IR (thin film) 3417 
(OH), 2958, 2931, 2862 (C-H) cm-1; 1H NMR (200 MHz, CDCl3) δ 3.90 (1H, dd, J = 12.6, 
2.4 Hz, C14-Ha), 3.60 (1H, dd, J = 12.5, 4.2 Hz, C14-Hb), 2.98-2.89 (2H, m, C15-H, C16-H), 
2.58 (1H, br s, OH), 1.60-1.31 (6H, m, CH2), 0.90 (3H, t, J = 7.0 Hz, C20-H); 13C NMR (50.3 
MHz, CDCl3) δ 61.7, 58.4, 56.0, 31.2, 28.0, 22.4, 13.9; m/z (EI+) 131 (M+H, 8), 113 
(M-OH, 23), 95 (113-H2O, 18), 87 (25), 69 (100), 57 (26); HRMS (EI+) calc. 131.1072 for 
C7H15O2, found 131.1072.  
 
(2R, 3R)-3-Methyl-heptane-1,2-diol 76 
 
OH
14
20
OH
76  
 
To a 0oC solution of epoxide 61 (1.96 g, 15.1 mmol, 1.0 eq) in dichloromethane (30 ml) 
under an atmosphere of N2 was added trimethylaluminium in hexane (2 M, 22.6 ml, 3.0 eq) 
dropwise. The reaction mixture was stirred at room temperature overnight and then cooled to 
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0oC and quenched with 2 M HCl dropwise. The mixture was extracted with ethyl acetate (3 x 
50 ml). The combined organic extract was washed with water (50 ml) and brine (50 ml), 
dried (MgSO4), filtered and concentrated under reduced pressure. The crude product was 
purified by flash chromatography using 40% ethyl acetate : hexane to afford pure diol 76 as a 
colourless oil (1.57 g, 71%); Rf (40% ethyl acetate : hexane) 0.36; [α]D +11.0 (c 0.69, 
CHCl3); IR (thin film) 3417 (OH), 2921 (C-H) cm-1; 1H NMR (200 MHz, CDCl3) δ 3.69-
3.35 (3H, m, C14-H, C15-H), 3.21# (2H, br s, OH), 1.64-1.04 (7H, m, C16-H, CH2), 0.88 (3H, 
ob t, C20-H), 0.86 (3H, d, J = 6.8 Hz, C16-CH3); 13C NMR (100.6 MHz, CDCl3) 76.3, 64.6, 
36.1, 32.1, 29.2, 22.9, 15.2, 14.0; m/z (EI+) 147 (M+H, 44), 146 (M, 5), 145 (M-H, 7), 131 
(M-CH3, 23), 129 (M-OH, 8), 119 (72), 105 (100), 91 (32), 61 (24); HRMS (EI+) calc. 
145.1229 for C8H17O2, found 145.1224. 
 
OH
1
OH
80
7
OH
 
 
A second fraction isolated in trace quantity as a white solid was assigned as heptan-tri-1,2,3-
ol87 80. The stereochemistry of the 2 chiral centres were not elucidated; Rf (40% ethyl 
acetate : hexane) 0.42; IR (thin film) 3435-3194 (OH), 2955 (C-H) cm-1; 1H NMR (400.2 
MHz, CDCl3) δ 3.95 (1H, ddd, J = 9.3, 5.7, 3.2 Hz, C2-H), 3.87-3.73 (3H, m, C1-H, C3-H), 
2.84 (1H, br s, OH), 2.33 (1H, br s, OH), 1.94-1.84 (2H, m, C4-Ha, OH), 1.73-1.54 (2H, m, 
CH2), 1.44-1.29 (3H, m, CH2, C4-Hb), 0.92 (3H, t, J = 7.2 Hz, C7-H); 13C NMR (100.6 MHz, 
CDCl3) δ 74.6, 63.9, 63.4, 33.4, 28.5, 22.2, 13.9; m/z (CI+) 149 (M+H, 20), 131 (M-OH, 
38), 113 (M-OH-H2O, 100). 
 
4-Methoxybenzaldehyde dimethyl acetal93 83 
 
H3CO
OCH3
OCH3
83  
 
To a mixture of p-anisaldehyde (67.1 g, 0.493 mol, 1.0 eq) and trimethyl orthoformate (62.8 
g, 0.591 mol, 1.2 eq) in dry methanol cooled to 0oC was added a catalytic amount of p-
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toluenesulfonic acid. After stirring for 2.5 h at room temperature the initially clear yellow 
reaction had turned red in colour. The mixture was evaporated at 40oC to dryness then dried 
under high vacuum for 1 h. The crude red syrup was purified by distillation (82oC/0.7mmHg; 
lit.93 102-104oC/4mmHg) to yield a colourless liquid of 4-methoxybenzaldehyde dimethyl 
acetal 83 (89 g, 99%); Rf (30% ethyl acetate : hexane) 0.55; IR (thin film) 1614, 1586, 1512 
(C=C), 824 (C-H, p-disubstituted benzene) cm-1; 1H NMR (200 MHz, CDCl3) δ 7.32 (2H, d, 
J = 8.8 Hz, Ar-H), 6.84 (2H, d, J = 8.8 Hz, Ar-H), 5.30 (1H, s, Ar-CH), 3.76 (3H, s, Ar-
OCH3), 3.27 (6H, s, CH-OCH3); 13C NMR (50.3 MHz, CDCl3) δ 159.6, 130.3, 127.8, 113.4, 
103.0, 55.1, 52.5; m/z (EI+) 182 (M, 2), 151 (M-OCH3, 100), 149 (11), 135 (27), 77 (7), 91 
(6).  
 
(2R, 4R, 1’R)-2-(p-Methoxy-phenyl)-4-(1’-methyl-pentyl)-[1,3]dioxolane 84 and  
(2S, 4R, 1’R)-2-(p-methoxy-phenyl)-4-(1’-methyl-pentyl)-[1,3]dioxolane 85 
 
14
20 O
O
OCH3
85
14
20 O
O
OCH3
84  
 
To a solution of diol 76 (1.00 g, 6.85 mmol, 1.0 eq) in dry DMF (3.4 ml) was added 4-
methoxybenzaldehyde dimethyl acetal 83 (1.87 g, 10.3 mmol, 1.5 eq) followed by a catalytic 
amount of p-toluenesulfonic acid at room temperature. The reaction mixture was stirred on a 
rotary evaporator at 76oC under reduced pressure (20mmHg) for 1 h 15 min. Aqueous 
NaHCO3 (5 ml, 10% w/v) was added to the reaction mixture and the solution diluted with 
water. The product was extracted into ether (5 x 20 ml) and the combined organic layer was 
washed with water (3 x 10ml) and brine (20 ml), dried (Na2SO4) and concentrated in vacuo. 
Purification and separation of the diastereomers 84 and 85 (38:62, 1.66 g, 92%) for the 
purpose of characterisation was achieved by flash chromatography (10% ethyl acetate : 
hexane). The first fraction contained the minor diastereomer 84 or 85; Rf (5% ethyl acetate : 
hexane) 0.38; [α]D -22.1 (c 0.84, CHCl3); IR (thin film) 2956, 2930, 2872 (C-H), 1614, 1515 
(C=C), 828 (C-H, p-disubstituted benzene) cm-1; 1H NMR (200 MHz, CDCl3) δ 7.40 (2H, d, 
Chapter 5 
 97 
J = 8.6 Hz, Ar-H), 6.90 (2H, d, J = 8.7 Hz, Ar-H), 5.86 (1H, s, Ar-CH), 4.21 (1H, dd, J = 
8.0, 6.1 Hz, C14-Ha), 3.95 (1H, dt, J = 7.8, 6.4 Hz, C15-H), 3.81 (3H, s, OCH3), 3.68 (1H, t, J 
= 7.8 Hz, C14-Hb), 1.60-1.80 (1H, m, C16-H), 1.08-1.47 (6H, m, C17-H, C18-H, C19-H), 0.91 
(3H, t, J = 6.5 Hz, C20-H), 0.87 (3H, d, J = 6.8 Hz, C16-CH3); 13C NMR (50.3 MHz, CDCl3) 
δ 160.2, 130.8, 127.8, 113.7, 103.3, 80.7, 69.1, 55.2, 36.4, 33.0, 28.9, 22.9, 14.6, 14.1. 
 
The second fraction afforded the major diastereomer; Rf (5% ethyl acetate : hexane) 0.32; 
[α]D +11.3 (c 0.34, CHCl3); IR (thin film) 2956, 2930, 2872 (C-H), 1615, 1516 (C=C), 829 
(C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.42 (2H, d, J = 8.7 
Hz, Ar-H), 6.90 (2H, d, J = 8.8 Hz, Ar-H), 5.75 (1H, s, Ar-CH), 4.04-3.95 (2H, m, C14-Ha, 
C15-H), 3.81 (3H, s, OCH3), 3.76 (1H, t, J = 6.4 Hz, C14-Hb), 1.81-1.74 (1H, m, C16-H), 1.68-
1.58 (1H, m, C17-Ha), 1.44-1.12 (5H, m, C17-Hb, C18-H, C19-H), 0.92 (3H, d, J = 6.8 Hz, C16-
CH3), 0.91 (3H, ob t, C20-H); 13C NMR (100.6 MHz, CDCl3) δ 160.4, 130.1, 128.1, 113.7, 
103.8, 81.4, 68.0, 55.3, 36.2, 32.8, 29.0, 22.9, 14.9, 14.1. Mass spectral data was obtained on 
a sample of the diastereomeric mixture; m/z (EI+) 264 (M, 13), 263 (M-H, 38), 179 (44), 
135 (60), 108 (67), 44 (100), 30 (73); HRMS (EI+) calc. 263.1647 for C16H23O3, found 
263.1658.  
 
(2R, 3R)-2-(p-Methoxy-benzyloxy)-3-methyl-heptan-1-ol 86 
 
OH
14
20
O
86
OCH3
 
 
To a 0oC cooled solution of PMB acetals 84 and 85 (84.0 mg, 0.318 mmol, 1.0 eq) in 
dichloromethane (1.5 ml) was added diisobutylaluminium hydride (1.5 M in toluene, 1.00 
ml, 1.50 mmol, 4.7 eq) dropwise. The reaction was stirred at 0oC for 1 h then warmed to 
room temperature and carefully quenched with aqueous tartaric acid solution (1 M, 10 ml). 
The biphasic mixture was vigorously stirred for 15 min then the layers were separated. The 
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aqueous layer was extracted with dichloromethane (2 x 50 ml) and the combined organic 
extract washed with brine (100 ml), dried (MgSO4), filtered and concentrated in vacuo. The 
crude product was purified by flash chromatography (20% ethyl acetate : hexane) to give 
alcohol 86 as a colourless liquid (70 mg, 83%); Rf (20% ethyl acetate : hexane) 0.37; [α]D 
-13.6 (c 0.66, CHCl3); IR (thin film) 3439 (OH), 2956, 2930, 2871 (C-H), 1613, 1514 
(C=C), 822 (C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.28 (2H, 
d, J = 8.5 Hz, Ar-H), 6.89 (2H, d, J = 8.5 Hz, Ar-H), 4.57 (1H, d, J = 11.0 Hz, Ar-CHa), 4.44 
(1H, d, J = 11.0 Hz, Ar-CHb), 3.81 (3H, s, OCH3), 3.70-3.56 (2H, m, C14-H), 3.34 (1H, dt, 
J = 6.2, 3.6 Hz, C15-H), 1.94-1.80 (2H, m, OH, C16-H), 1.50-1.13 (6H, m, C17-H, C18-H, 
C19-H), 0.90 (3H, t, J = 6.8 Hz, C20-H), 0.89 (3H, d, J = 6.9 Hz, C16-CH3); 13C NMR 
(100.6 MHz, CDCl3) δ 159.3, 130.7, 129.4, 113.9, 83.5, 71.6, 61.5, 55.3, 33.7, 32.6, 29.5, 
22.9, 14.8, 14.1; m/z (EI+) 266 (M, 14), 152 (19), 121 (C8H9O, 100), 78 (47), 43 (60), 28 
(68); HRMS (EI+) calc. 266.1882 for C16H26O3, found 266.1887. 
 
O
14
20
OH
88
OCH3
 
 
Regioisomer 88 was also isolated (3 mg); Rf (20% ethyl acetate : hexane) 0.46; IR (thin 
film) 3462 (OH), 2956, 2929, 2856 (C-H), 1613, 1514 (C=C), 821 (C-H, p-disubstituted 
benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.26 (2H, d, J = 8.6 Hz, Ar-H), 6.89 (2H, d, 
J = 8.6 Hz, Ar-H), 4.48 (2H, s, Ar-CH2), 3.81 (3H, s, OCH3), 3.66-3.57 (1H, m, C15-H), 3.54 
(1H, dd, J = 9.4, 2.8 Hz, C14-Ha), 3.37 (1H, dd, J = 9.3, 8.3 Hz, C14-Hb), 2.38 (1H, br s, OH), 
1.63-1.10 (7H, m, CH2, C16-H), 0.91-0.85 (6H, m, C16-CH3, C20-H); 13C NMR (100.6 MHz, 
CDCl3) δ 159.3, 130.1, 129.3, 113.8, 74.2, 73.0, 72.2, 55.3, 36.0, 32.1, 29.4, 23.0, 15.2, 14.1. 
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(2R, 3R)-2-(p-Methoxy-benzyloxy)-3-methyl-heptanal 75 
 
20
O
75
OCH3
O
14
 
 
To a solution of oxalyl chloride (73.3 µl, 0.840 mmol, 1.5 eq) in dichloromethane (3.5 ml) 
cooled to -78oC was added dry DMSO (0.120 ml, 1.69 mmol, 3.0 eq) as a solution in 
dichloromethane (0.54 ml) dropwise under an atmosphere of N2. After 20 min of stirring at -
78oC, a solution of alcohol 86 (150 mg, 0.564 mmol, 1.0 eq) in dichloromethane (0.54 ml) 
was added dropwise via cannula followed by triethylamine (0.530 ml, 3.80 mmol, 6.7 eq) to 
maintain the temperature at -78oC. The reaction mixture was stirred for 15 min then warmed 
to 0oC. Water (10 ml) was added then the layers were separated and the aqueous phase 
extracted with dichloromethane (2 x 10 ml). The combined organic extract was washed with 
brine (10 ml) and then dried over MgSO4. After filtration of the mixture and evaporation of 
the solvent, the crude product was purified by flash chromatography using 10% ethyl acetate 
: hexane to afford pure aldehyde 75 as a colourless liquid (134 mg, 91%); Rf (30% ethyl 
acetate : hexane) 0.60; [α]D +65.7 (c 1.1, CHCl3); IR (thin film) 2957, 2931, 2859 (C-H), 
1731 (C=O), 1613, 1586, 1514 (C=C), 821 (C-H, p-disubstituted benzene) cm-1; 1H NMR 
(400.2 MHz, CDCl3) δ 9.64 (1H, d, J = 2.7 Hz, CHO), 7.27 (2H, d, J = 8.8 Hz, Ar-H), 6.89 
(2H, d, J = 8.7 Hz, Ar-H), 4.59 (1H, d, J = 11.5 Hz, Ar-CHa), 4.44 (1H, d, J = 11.5 Hz, Ar-
CHb), 3.80 (3H, s, OCH3), 3.51 (1H, dd, J = 5.6, 2.7 Hz, C15-H), 1.98-1.90 (1H, m, C16-H), 
1.59-1.44 (1H, m, C17-Ha), 1.30-1.18 (5H, m, C17-Hb, C18-H, C19-H), 0.94 (3H, d, J = 6.9 Hz, 
C16-CH3), 0.88 (3H, t, J = 6.9 Hz, C20-H); 13C NMR (100.6 MHz, CHCl3) δ 204.6, 159.4, 
129.6, 113.8, 87.1, 72.4, 55.2, 34.9, 31.4, 29.1, 22.7, 15.5, 14.0, 1C overlapping; m/z (EI+) 
264 (M, 11), 137 (C8H9O2, 18), 121 (C8H9O, 100), 107 (6), 91 (10), 78 (17); HRMS (EI+) 
calc. 264.1725 for C16H24O3, found 264.1720. 
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5.1.1 Boron-Mediated Aldol Reaction. 
A. Asymmetric Induction From a Chiral Aldehyde. 
 
Dicyclohexylboron chloride 127,128 
 
B
Cl
 
 
A dry round-bottomed flask connected to a distillation head was charged with dried 
cyclohexene (10.6 ml, 0.105 mol, 2.1 eq) and anhydrous diethyl ether (40.0 ml) under an 
atmosphere of Ar. Monochloroborane·dimethyl sulfide (5.21 ml, 0.050 mol, 1.0 eq) was 
slowly added at room temperature with stirring. The exothermic reaction spontaneously 
distilled ether (~ 7 ml) out of the mixture. The solution was stirred at room temperature for 
1.5 h and then the solvent was removed by distillation. The resulting crude product was 
distilled under reduced pressure (90-95oC/0.3mmHg; lit.127 95-96oC/0.35mmHg) to afford 
the title compound (6.99 g, 66%) as a colourless oil.  
 
(4S, 5R, 6R)-4-Hydroxy-5-(p-methoxy-benzyloxy)-6-methyl-decan-2-one 82 and  
(4R, 5R, 6R)-4-hydroxy-5-(p-methoxy-benzyloxy)-6-methyl-decan-2-one 89 
 
20
O
82
OCH3
20
O
89
OCH3
O OOHOH
11 11
 
 
METHOD A: In situ formation of dicyclohexylboron enolate followed by addition of 
aldehyde. 
To a solution of dicyclohexylboron chloride (0.537 ml, 2.45 mmol, 2.2 eq ) in anhydrous 
diethyl ether (23 ml) at -78oC was added freshly distilled triethylamine (0.389 ml, 2.79 
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mmol, 2.5 eq) dropwise followed by freshly distilled acetone (0.205 ml, 2.79 mmol, 2.5 eq). 
The initially clear solution formed a white precipitate of triethylammonium chloride upon 
addition of the acetone. The reaction mixture was stirred at -78oC for 2 h then aldehyde 75 
(295 mg, 1.12 mmol, 1.0 eq) in diethyl ether (3.0 ml) was added dropwise via cannula and 
stirring continued for 1.5 h at this temperature. The reaction was warmed to 0oC and 
quenched with pH 7.0 buffer (0.6 ml), methanol (0.6 ml) and 30% H2O2 (0.6 ml) 
sequentially. After vigorously stirring for 15 min, the layers were separated and the aqueous 
phase extracted with ether (3 x 5 ml). The combined extracts were washed with brine (15 
ml), then dried (MgSO4), filtered and concentrated in vacuo. Removal of cyclohexanol from 
the crude mixture was achieved using Kugelrohr distillation. Diastereomer analysis by 1H 
NMR gave an 88:12 ratio of anti-82 and syn-89 products respectively. The diastereomers 
were purified (276 mg, 77%) and isolated by flash chromatography (20% ethyl acetate : 
hexane) to give:  
(4S, 5R, 6R)-4-Hydroxy-5-(p-methoxy-benzyloxy)-6-methyl-decan-2-one 82 as a colourless 
oil; Rf (20% ethyl acetate : hexane) 0.21; [α]D -20.6 (c 2.1, CHCl3); IR (thin film) 3463 
(OH), 1700 (C=O), 1613, 1513 (C=C), 829 (C-H, p-disubstituted benzene) cm-1; 1H NMR 
(400.2 MHz, CDCl3) δ 7.27 (2H, d, J = 8.6 Hz, Ar-H), 6.88 (2H, d, J = 8.7 Hz, Ar-H), 4.59 
(1H, distort d, J = 11.0 Hz, Ar-CHa), 4.55 (1H, distort d, J = 10.9 Hz, Ar-CHb), 4.19 (1H, m, 
C14-H), 3.80 (3H, s, OCH3), 3.28 (1H, dd, J = 6.0, 4.8 Hz, C15-H), 3.16 (1H, d, J = 4.7 Hz, 
OH), 2.69 (2H, d, J = 5.8 Hz, C13-H), 2.15 (3H, s, C11-H), 1.74-1.55 (2H, m, C16-H, C17-Ha), 
1.40-1.15 (5H, m, C17-Hb, C18-H, C19-H), 0.93 (3H, d, J = 6.9 Hz, C16-CH3), 0.89 (3H, t, J = 
7.0 Hz, C20-H); 13C NMR (100.6 MHz, CDCl3) δ 210.7, 159.2, 130.9, 129.5, 113.8, 85.8, 
74.1, 69.0, 55.3, 45.2, 34.9, 31.9, 30.9, 29.4, 23.0, 16.2, 14.1; m/z (EI+) 322 (M, 13), 305 
(M-OH, 4), 201 (18), 190 (47), 168 (44), 150 (35), 137 (C8H9O2, 14), 121 (C8H9O, 100), 87 
(13), 77 (7); HRMS (EI+) calc. 322.2144 for C19H30O4, found 322.2147.  
(Spectra appended) 
 
(4R, 5R, 6R)-4-Hydroxy-5-(p-methoxy-benzyloxy)-6-methyl-decan-2-one 89 as a colourless 
oil; Rf (20% ethyl acetate : hexane) 0.16; [α]D +6.9 (c 0.52, CHCl3); IR (thin film) 3463 
(OH), 2956-2870 (C-H), 1706 (C=O), 1606, 1513 (C=C), 831 (C-H, p-disubstituted benzene) 
cm-1; 1H NMR (200 MHz, CDCl3) δ 7.27 (2H, d, J = 8.6 Hz, Ar-H), 6.89 (2H, d, J = 8.7 Hz, 
Ar-H), 4.63 (1H, d, J = 11.0 Hz, Ar-CHa), 4.44 (1H, d, J = 11.0 Hz, Ar-CHb), 4.23-4.12 (1H, 
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m, C14-H), 3.81 (3H, s, OCH3), 3.10 (1H, dd, J = 6.0, 3.2 Hz, C15-H), 2.69 (1H, dd, J = 16.2, 
8.4 Hz, C13-Ha), 2.60 (1H, d, J = 6.8 Hz, OH), 2.47 (1H, dd, J = 16.3, 4.5 Hz, C13-Hb), 2.14 
(3H, s, C11-H), 1.92-1.75 (1H, m, C16-H), 1.64-1.17 (6H, m, C17-H, C18-H, C19-H), 1.00 (3H, 
d, J = 6.8 Hz, C16-CH3), 0.90 (3H, t, J = 7.0 Hz, C20-H); 13C NMR (100.6 MHz, CDCl3) δ 
208.4, 159.3, 130.5, 129.5, 114.0, 84.5, 73.4, 67.7, 55.3, 48.5, 34.6, 32.0, 30.8, 29.6, 23.0, 
16.0, 14.1; m/z (EI+) 322 (M, 15), 304 (M-H2O, 1), 236 (8), 201 (26), 190 (53), 168 (42), 
150 (43), 137 (C8H9O2, 15), 121 (C8H9O, 100), 77 (8), 43 (15); HRMS (EI+) calc. 322.2144 
for C19H30O4, found 322.2145. 
 
METHOD B: Addition of a stock solution of dicyclohexylboron enolate to an aldehyde. 
 
O
B
91  
 
A centrifuge tube equipped with a septum and magnetic stirrer bar was charged sequentially 
with anhydrous diethyl ether (30.8 ml), dicyclohexylboron chloride (3.76 ml, 17.2 mmol, 1.5 
eq) and triethylamine (2.88 ml, 20.7 ml, 1.8 eq) at 0oC. After the addition of dry acetone 
(0.840 ml, 11.4 mmol, 1.0 eq), the initially clear solution turned cloudy white. The reaction 
mixture was stirred at 0oC under an atmosphere of N2 for 2 h then centrifuged for 7 min. The 
supernatant solution of acetone dicyclohexylboron enolate 91 (0.370 M, 30.8 ml) could be 
used immediately or stored in the freezer for up to 2 weeks. 
To a solution of aldehyde 75 (393 mg, 1.49 mmol, 1.0 eq) in diethyl ether (4.8 ml) cooled to 
-78oC was added a solution of acetone dicyclohexylboron enolate 91 in diethyl ether (0.370 
M, 30.8 ml, 7.7 eq) under an atmosphere of N2. The aldol mixture was stirred at -78oC for 45 
min then left in the freezer at -20oC overnight. The reaction was warmed to 0oC and then 
quenched sequentially with pH 7.0 buffer (4.0 ml), methanol (4.0 ml) and 30% H2O2 (4.0 
ml). After stirring vigorously for 15 min, the layers were separated and the aqueous phase 
extracted with ether (3 x 15 ml). The combined extracts were washed with brine (40 ml), 
then dried (MgSO4), filtered and concentrated in vacuo. Removal of cyclohexanol from the 
residue was achieved using Kugelrohr distillation. The crude diastereomeric mixture was 
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purified by flash chromatography (20% ethyl acetate : hexane) to afford pure anti-82 (134 
mg, 28%) and syn-89 (49 mg, 10%) along with a mixture of the diastereomers. 
 
METHOD C: In situ formation of excess dicyclohexylboron enolate followed by addition of 
an aldehyde. 
To a solution of dicyclohexylboron chloride (2.90 ml, 13.3 mmol, 11.6 eq) in dry diethyl 
ether (23.7 ml) cooled to -78oC was added triethylamine (2.20 ml, 15.8 ml, 13.7 eq) and 
acetone (0.650 ml, 8.85 mmol, 7.7 eq) sequentially with stirring. The resulting cloudy white 
mixture was stirred at -78oC under an atmosphere of N2 for 2 h 20 min then aldehyde 75 (304 
mg, 1.15 mmol, 1.0 eq) in diethyl ether (3.7 ml) was added via cannula over 15 min, and 
stirring continued at this temperature for 1 h. The reaction mixture was warmed to 0oC then 
quenched with pH 7.0 buffer (3 ml), methanol (3 ml) and 30% H2O2 (3 ml). After stirring for 
20 min, the biphasic mixture was separated and the aqueous layer extracted into ether (2 x 10 
ml). The combined organic extract was washed with brine (20 ml), dried (MgSO4) and 
concentrated under reduced pressure. Cyclohexanol was removed from the crude mixture 
using a Kugelrohr apparatus then purification of the residue by flash chromatography (20% 
ethyl acetate : hexane) afforded methyl ketones 82 and 89 (84:16, 274 mg, 74%) as 
colourless oils.  
 
B. Matched Double Asymmetric Induction using (+)-Ipc2BCl. 
 
B
O
 
 
METHOD B: A centrifuge tube equipped with a septum and magnetic stirrer bar was 
charged sequentially with anhydrous diethyl ether (4.8 ml), (+)-diisopinocampheylboron 
chloride (900 mg, 2.81 mmol, 1.5 eq), triethylamine (0.457 ml, 3.28 mmol, 1.8 eq) and 
acetone (0.134 ml, 1.82 mmol, 1.0 eq) at 0oC. The resulting cloudy white reaction mixture 
was stirred at 0oC under an atmosphere of N2 for 2 h then centrifuged for 4 min. The 
supernatant solution of acetone (+)-diisopinocampheylboron enolate was used immediately. 
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To a solution of aldehyde 75 (57.0 mg, 0.216 mmol, 1.0 eq) in diethyl ether (0.7 ml) cooled 
to -78oC was added a solution of acetone (+)-diisopinocampheylboron enolate in diethyl 
ether (0.379 M, 1.52 mmol, 7.0 eq) under an atmosphere of N2. The aldol mixture was stirred 
at -78oC for 1 h then warmed to 0oC and sequentially quenched with pH 7.0 buffer (1.0 ml), 
methanol (1.0 ml) and 30% H2O2 (1.0 ml). After stirring vigorously for 15 min, the layers 
were separated and the aqueous phase extracted with ether (3 x 5 ml). The combined extract 
was washed with brine (10 ml), dried (MgSO4), filtered and concentrated in vacuo. The 
crude mixture was purified by flash chromatography (20% ethyl acetate : hexane) to afford 
anti alcohol 82 (7 mg, 11%) as a colourless oil. 
 
C. Mismatched Double Asymmetric Induction using (-)-Ipc2BCl. 
 
B
O
 
 
METHOD B: A centrifuge tube equipped with a septum and magnetic stirrer bar was 
charged sequentially with anhydrous diethyl ether (4.8 ml), (-)-diisopinocampheylboron 
chloride (883 mg, 2.75 mmol, 1.5 eq), triethylamine (0.457 ml, 3.28 mmol, 1.8 eq) and 
acetone (0.134 ml, 1.82 mmol, 1.0 eq) at 0oC. The resulting cloudy white reaction mixture 
was stirred at 0oC under an atmosphere of N2 for 2 h then centrifuged for 4 min. The 
supernatant solution of acetone (-)-diisopinocampheylboron enolate was used immediately. 
To a solution of aldehyde 75 (50.0 mg, 0.189 mmol, 1.0 eq) in diethyl ether (0.6 ml) cooled 
to -78oC was added a solution of acetone (-)-diisopinocampheylboron enolate in diethyl ether 
(0.379 M, 0.758 mmol, 4.0 eq) under an atmosphere of N2. The aldol mixture was stirred at -
78oC for 1 h then warmed to 0oC and quenched with pH 7.0 buffer (1.0 ml), methanol (1.0 
ml) and 30% H2O2 (1.0 ml). After stirring vigorously for 15 min, the layers were separated 
and the aqueous phase extracted with ether (3 x 5 ml). The combined extracts were washed 
with brine (10 ml), then dried (MgSO4), filtered and concentrated in vacuo. The crude 
mixture was purified by flash chromatography (20% ethyl acetate : hexane) to afford anti 
alcohol 82 and syn alcohol 89 (58 mg, 74%) in a ratio of 63:37, respectively by 1H NMR. 
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5.1.2 Mukaiyama Aldol Reaction. 
 
Isopropenyloxy-trimethyl-silane109,214 90 
 
OSiMe3
90  
 
A four-necked flask equipped with a mechanical stirrer, reflux condenser with nitrogen inlet, 
thermometer and pressure-equalizing dropping funnel was charged with dry, distilled AR 
acetone (75.0 g, 1.29 mol, 1.4 eq) and triethylamine (96.0 g, 0.949 mol, 1.03 eq). The 
mixture was stirred at room temperature under N2, while chlorotrimethylsilane (100 g, 0.920 
mol, 1.0 eq) was added via the dropping funnel over 10 min. White fumes were generated 
and a turbid solution was obtained. The mixture was warmed to 35oC in a water bath which 
was then removed. A solution of dry sodium iodide (143 g, 0.954 mol, 1.04 eq) in 
acetonitrile (1.07 L) was introduced through the dropping funnel over 1 h so as to maintain 
the temperature of the reaction at 35-40oC. A copious white precipitate was formed. The 
reaction mixture was stirred for 2 h at room temperature then poured onto ice water (2 L). 
The aqueous layer was extracted with pentane (2 x 1 L) and the combined organic phase was 
dried over anhydrous potassium carbonate. After filtering the mixture, the pentane was 
distilled off at atmospheric pressure. The crude residue was transferred to a smaller flask 
equipped with a vigreux column and distilled (94-96oC/760mmHg; lit.214 94-
96oC/760mmHg) to give acetone trimethyl enolsilane 90 (57 g, 48%) as a colourless liquid; 
IR (thin film) 3114 (C=C-H), 1653 or 1636 (C=C) cm-1; 1H NMR (200 MHz, CDCl3) δ 4.05 
(2H, s, C=CH2), 1.77 (3H, s, CH3), 0.20 (9H, s, Si-CH3); 13C NMR (50 MHz, CDCl3) δ 
155.9, 91.2, 22.8, 0.1. 
 
 
 
 
 
 
 
Chapter 5 
 106 
tert-Butyl-isopropenyloxy-dimethyl-silane116  
 
OSiMe2
tBu
 
 
To a solution of tert-butyldimethylsilyl trifluoromethanesulfonate (4.9 g, 18.5 mmol, 1.2 eq) 
and triethylamine (1.6 g, 15.8 mmol, 1.0 eq) in dichloromethane (15.5 ml) was added 
acetone (0.9 g, 15.8 mmol, 1.0 eq) at 0oC. After stirring for 1 h, the reaction mixture was 
poured into a solution of hexane (40 ml) and water (20 ml). The organic layer was washed 
with brine (30 ml), dried over MgSO4 and concentrated under reduced pressure. The residue 
was distilled (lit.116 70oC/30mmHg) to give acetone tert-butyldimethyl enolsilane (0.91 g, 
33%) as a colourless liquid; IR (thin film) 3114 (C=C-H), 1660 or 1639 (C=C) cm-1; 
1H NMR (200 MHz, CDCl3) δ 4.04 (2H, s, C=CH2), 1.77 (3H, s, CH3), 0.91 (9H, s, tBu-
CH3), 0.15 (6H, s, Si-CH3); 13C NMR (50 MHz, CDCl3) δ 156.2, 91.2, 25.6, 22.7, 18.7, -4.7. 
 
METHOD A: BF3.OEt2-mediated Mukaiyama aldol reaction. 
Boron trifluoride etherate (25.3 µl, 0.200 mmol, 1.0 eq) was added dropwise to a solution of 
acetone trimethyl enolsilane 90 (52.0 mg, 0.399 mmol, 2.0 eq) and aldehyde 75 (53.2 mg, 
0.202 mmol, 1.0 eq) in dichloromethane (4.1 ml) at -78oC. The reaction mixture was stirred 
at this temperature for 20 min then quenched with saturated aqueous NaHCO3 (~2 ml) at 
-78oC. The solution was warmed to room temperature then diluted with dichloromethane (3 
ml). The layers were separated and the aqueous phase extracted with dichloromethane (2 x 5 
ml). The combined organic layers were dried (Na2SO4), filtered and concentrated in vacuo to 
give a crude yellow residue consisting of anti-82 and syn-89 in a ratio of 72:28 by 1H NMR. 
Flash chromatographic purification (20% ethyl acetate : hexane) afforded pure anti-82 and 
syn-89 as colourless oils (53 mg, 82%). 
 
METHOD B: BF3.OEt2-mediated Mukaiyama aldol reaction in the presence of calcium 
hydride. 
To a flask containing a few grains of CaH2 was added a solution of aldehyde 75 (38 mg, 
0.144 mmol, 1.0 eq) in dichloromethane (3.6 ml). To the stirred mixture at -78oC was added 
acetone tert-butyldimethyl enolsilane (37 mg, 0.214 mmol, 1.5 eq) followed by BF3.OEt2 
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(18.2 µl + 7.00 µl, total 0.199 mmol, 1.4 eq). After stirring for 15 min, the mixture was 
quenched with saturated aqueous NaHCO3 (~1 ml) at -78oC. The solution was allowed to 
warm to room temperature and then the layers were separated. The aqueous layer was 
extracted with dichloromethane (2 x 2 ml) and the combined organic extracts dried over 
MgSO4, filtered and concentrated under reduced pressure. Flash chromatographic 
purification (20% ethyl acetate : hexane) of the crude mixture afforded unreacted aldehyde 
75 (24.5 mg) along with anti-product 82 (3.6 mg) and syn-product 89 (4.4 mg) in a combined 
yield of 17% and in a ratio of 45:55 respectively by mass.  
 
5.1.3 Proline-Catalysed Asymmetric Aldol Reaction. 
 
(4R)-4-Hydroxy-5-methyl-hexan-2-one180 
 
O OH
1
6
 
 
METHOD A-1: S-Proline catalysed aldol reaction.  
To a solution of 4:1 anhydrous DMSO (55.2 ml) and acetone (13.8 ml) was added S-proline 
(318 mg, 2.76 mmol, 40 mol%) and then the mixture was stirred at room temperature under 
an atmosphere of N2 for 15 min. S-Proline was only slightly soluble in the reaction mixture. 
Neat, freshly dried and distilled isobutyraldehyde (500 mg, 6.93 mmol, 1.0 eq) was added 
and the resulting homogeneous reaction mixture was stirred for 5 h then treated with 
saturated aqueous ammonium chloride solution (69 ml). The solution was extracted with 
ethyl acetate (4 x 80 ml) and the combined organic layers were washed with water (150 ml) 
and brine (150 ml), and dried over MgSO4. After filtration and concentration of the filtrate in 
vacuo, flash chromatographic purification (30% ethyl acetate : hexane) of the residue 
afforded the title compound (103 mg, 11%) as a colourless, volatile liquid; Rf (30% ethyl 
acetate : hexane) 0.32; [α]D +70.9 (c 0.92, CHCl3) [lit.180,215 43.4 (c 1.4, CHCl3), 61% ee and 
-55.0 (c 1.4, CHCl3) for (S)-isomer]; IR (thin film) 3446 (OH), 2961 (C-H), 1706 (C=O); 1H 
NMR (200 MHz, CDCl3) δ 3.89-3.74 (1H, m, C4-H), 2.93 (1H, br d, J = 2.7 Hz, OH), 2.65-
2.43 (2H, m, C3-H), 2.17 (3H, s, C1-H), 1.78-1.55 (1H, m, C5-H), 0.92 (3H, d, J = 6.4 Hz, 
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C6-H or C5-CH3), 0.89 (3H, d, J = 6.7 Hz, C6-H or C5-CH3); 13C NMR (50 MHz, CDCl3) δ 
210.0, 72.2, 46.9, 32.9, 30.6, 18.1, 17.5. 
 
(5R, 6R)-5-(p-Methoxy-benzyloxy)-6-methyl-dec-3-en-2-one 101, 82 and 89 
 
O
O
OCH3
11
20
101  
To a solution of 4:1 anhydrous DMSO (0.904 ml) and acetone (0.226 ml) was added S-
proline (5.2 mg, 0.0452 mmol, 40 mol%) and then the mixture was stirred at room 
temperature under an atmosphere of N2 for 15 min. S-Proline was only partially soluble in 
the mixture. A solution of aldehyde 75 (29.7 mg, 0.113 mmol, 1.0 eq) in a minimum volume 
of DMSO (~0.2 ml) was added via cannula and the resulting homogeneous reaction mixture 
was stirred for 28 h. After t.l.c. analysis confirmed the absence of starting material, the 
reaction mixture was treated with saturated aqueous ammonium chloride solution (1.5 ml) 
and the products extracted into ethyl acetate (4 x 5 ml). The combined organic layers were 
washed with water (10 ml) and brine (10 ml) then dried (MgSO4), filtered and concentrated 
in vacuo. Flash chromatographic purification (20% ethyl acetate : hexane) of the crude 
residue afforded three fractions. The first fraction consisted of the elimination byproduct 101 
(10 mg, 29%) as a colourless oil; Rf (20% ethyl acetate : hexane) 0.56; [α]D -10.0 (c 0.08, 
CHCl3); IR (thin film) 3053 (C=C-H), 1677 (C=O α,β-unsaturated), 1613, 1514 (C=C), 823 
(C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.24 (2H, d, J = 8.6 
Hz, Ar-H), 6.87 (2H, d, J = 8.6 Hz, Ar-H), 6.65 (1H, dd, J = 16.2, 6.8 Hz, C14-H), 6.21 (1H, 
d, J = 16.1 Hz, C13-H), 4.49 (1H, d, J = 11.5 Hz, Ar-CHa), 4.31 (1H, d, J = 11.4 Hz, Ar-
CHb), 3.81 (3H, s, OCH3), 3.76 (1H, t, J = 6.9 Hz, C15-H), 2.28 (3H, s, C11-H), 1.80-1.70 
(1H, m, C16-H), 1.52-1.42 (1H, m, C17-Ha), 1.37-1.08 (5H, m, C17-Hb, C18-H, C19-H), 0.88 
(3H, ob t, C20-H), 0.86 (3H, d, J = 6.9 Hz, C16-CH3); 13C NMR (100.6 MHz, CDCl3) 
δ 198.3, 159.2, 146.0, 132.2, 131.3, 129.3, 113.8, 82.2, 71.6, 55.3, 37.5, 32.2, 29.2, 27.2, 
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22.9, 15.2, 14.1; m/z (EI+) 304 (M, 13), 271 (8), 231 (4), 206 (31), 192 (18), 183 (M-C8H9O, 
13), 168 (19), 152 (7), 135 (14), 121 (C8H9O, 100), 77 (13); HRMS (EI+) calc. 304.2038 for 
C19H28O3, found 304.2036.  
Integration of the combined second and third fractions by 1H NMR gave a 25:75 ratio of 
anti-alcohol 82 and syn-alcohol 89 (combined 6.5 mg, 18%) respectively. 
 
METHOD A-2: R-Proline catalysed aldol reaction. 
To a solution of 4:1 anhydrous DMSO (1.30 ml) and acetone (0.330 ml) was added R-proline 
(7.5 mg, 0.0651 mmol, 40 mol%) and then the mixture was stirred at room temperature 
under an atmosphere of N2 for 15 min. R-Proline was only partially soluble in the reaction 
mixture. A solution of aldehyde 75 (42.8 mg, 0.162 mmol, 1.0 eq) in a minimum volume of 
DMSO (~0.2 ml) was added via cannula and the resulting homogeneous reaction mixture 
was stirred for 24.5 h, after which time t.l.c. analysis showed incomplete consumption of the 
starting material. Despite this, the solution was treated with saturated aqueous ammonium 
chloride solution (1.5 ml) and the products were extracted into ethyl acetate (4 x 5 ml). The 
combined organic layers were washed with water (10 ml) and brine (10 ml) then dried 
(MgSO4), filtered and concentrated in vacuo to give a crude mixture containing the 
elimination byproduct 101, aldehyde 75 and aldol products 82 and 89. Flash 
chromatographic purification (20% ethyl acetate : hexane) of the crude mixture afforded a 
mixed fraction of anti-82 and syn-89 (12.9 mg, 33%) in a ratio of 95:5 respectively as 
determined by 200 MHz 1H NMR. 
 
(1’R, 2S, 4S, 5R)-1”-[2-(p-Methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-
propan-2”-one 57 
 
15
14
20
11
O
O
H
H H
O OCH3
57
OOO
OCH3
=
1120
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To a solution of alcohol 82 (224 mg, 0.696 mmol, 1.0 eq) in dry dichloromethane (11.6 ml) 
was added activated, powdered 4Å molecular sieves (269 mg). The suspension was stirred 
for a few minutes under an atmosphere of N2 then DDQ (182 mg, 0.800 mmol, 1.15 eq) was 
added. The reaction mixture was stirred at 0oC for 30 min after which time the initial green 
colour was replaced with brown. The mixture was diluted with aqueous saturated NaHCO3 
(10 ml) then the layers were separated. The aqueous phase was extracted with 
dichloromethane (3 x 10 ml), taking care not to produce an emulsion. The combined organic 
extract was washed with aqueous saturated NaHCO3 (3 x 20 ml), water (3 x 20 ml) and brine 
(2 x 20 ml), and then dried over Na2SO4. After filtration and concentration of the filtrate in 
vacuo, the crude residue was immediately purified by flash chromatography on silica 
deactivated with 0.1% triethylamine and eluted with 20% ethyl acetate : hexane. Two 
fractions were obtained, the first was isolated pure as a colourless syrup and identified as 
acetal 57 (196 mg, 88%); Rf (20% ethyl acetate : hexane) 0.45; [α]D -59.5 (c 0.82, CHCl3); 
IR (thin film) 1731 (C=O), 1605, 1512 (C=C), 833 (C-H, p-disubstituted benzene) cm-1; 1H 
NMR (400.2 MHz, CDCl3) δ 7.39 (2H, d, J = 8.7 Hz, Ar-H), 6.90 (2H, d, J = 8.7 Hz, Ar-H), 
5.75 (1H, s, Ar-CH), 4.65 (1H, ddd, J = 10.1, 5.8, 3.0 Hz, C14-H), 3.84 (1H, dd, J = 9.8, 5.8 
Hz, C15-H), 3.81 (3H, s, OCH3), 2.75 (1H, dd, J = 15.2, 10.2 Hz, C13-Ha), 2.48 (1H, dd, J = 
15.2, 3.0 Hz, C13-Hb), 2.16 (3H, s, C11-H), 1.82-1.71 (1H, m, C17-Ha or C16-H), 1.71-1.59 
(1H, m, C17-Ha or C16-H), 1.43-1.18 (5H, m, C17-Hb, C18-H, C19-H), 0.90 (3H, d, J = 6.6 Hz, 
C16-CH3), 0.90 (3H, t, J = 6.9 Hz, C20-H); 13C NMR (50 MHz, CDCl3) δ 207.0, 160.2, 130.0, 
127.9, 113.6, 103.2, 84.3, 74.1, 55.2, 44.8, 33.3, 32.3, 31.1, 28.4, 22.4, 14.0, 13.3; m/z (EI+) 
320 (M, 32), 235 (18), 167 (100), 152 (28), 135 (58), 121 (15), 108 (35); HRMS (EI+) calc. 
320.1988 for C19H28O4, found 320.1990.  
1D nOe (400.2 MHz, CDCl3). Irradiation of Ar-CH (δ 5.75) showed nOe’s to Ar-H (δ 7.39), 
C14-H (δ 4.65), and C15-H (δ 3.84).  
(Spectra appended) 
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The second fraction was identified as the aryl ester byproduct 106 (trace); Rf (30% ethyl 
acetate : hexane) 0.31; 1H NMR (400.2 MHz, CDCl3) δ 7.99 (2H, d, J = 8.9 Hz, Ar-H), 6.94 
(2H, d, J = 9.0 Hz, Ar-H), 5.05 (1H, dd, J = 7.1, 4.7 Hz, C15-H), 4.34-4.28 (1H, m, C14-H), 
3.87 (3H, s, OCH3), 3.31 (1H, br s, OH), 2.66-2.64 (2H, m, C13-H), 2.15 (3H, s, C11-H), 
2.08-1.98 (1H, m, C16-H), 1.68-1.20 (6H, m, C17-H, C18-H, C19-H), 0.95 (3H, d, J = 6.9 Hz, 
C16-CH3), 0.89 (3H, t, J = 6.8 Hz, C20-H). 
 
(1’R, 2S, 4R, 5R)-1”-[2-(p-Methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-
propan-2”-one 107 
 
OOO
OCH3
107
15
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To a solution of alcohol 89 (172 mg, 0.534 mmol, 1.0 eq) in dry dichloromethane (9.0 ml) 
was added activated, powdered 4Å molecular sieves (206 mg). The suspension was stirred 
for a few minutes under an atmosphere of N2 then DDQ (139 mg, 0.614 mmol, 1.15 eq) was 
added at 0oC. After stirring at 0oC for 30 min, the initial green colour was replaced by brown. 
The mixture was diluted with aqueous saturated NaHCO3 (5 ml) and then the layers were 
separated. The aqueous phase was extracted with dichloromethane (3 x 5 ml). The combined 
organic extract was washed with aqueous saturated NaHCO3 (3 x 10 ml), water (3 x 10 ml) 
and brine (2 x 10 ml), then dried (Na2SO4), filtered and concentrated in vacuo. The crude 
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residue was immediately purified by flash chromatography on silica deactivated with 0.1% 
triethylamine and eluted with 20% ethyl acetate : hexane. The first fraction identified as 
acetal 107 was isolated pure as a colourless syrup; Rf (20% ethyl acetate : hexane) 0.43; [α]D 
+29.0 (c 1.2, CHCl3); IR (thin film) 2957-2871 (C-H), 1717 (C=O), 1615, 1518 (C=C), 831 
(C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.40 (2H, d, J = 8.7 
Hz, Ar-H), 6.89 (2H, d, J = 8.7 Hz, Ar-H), 5.80 (1H, s, Ar-CH), 4.42 (1H, ddd, J = 9.1, 6.1, 
3.5 Hz, C14-H), 3.80 (3H, s, OCH3), 3.66 (1H, t, J = 6.2 Hz, C15-H), 2.88 (1H, dd, J = 15.9, 
8.8 Hz, C13-Ha), 2.57 (1H, dd, J = 15.9, 3.5 Hz, C13-Hb), 2.24 (3H, s, C11-H), 1.85-1.78 (1H, 
m, C16-H), 1.66-1.50 (1H, m, C17-Ha), 1.43-1.12 (5H, m, C17-Hb, C18-H, C19-H), 0.97 (3H, d, 
J = 6.8 Hz, C16-CH3), 0.89 (3H, t, J = 6.9 Hz, C20-H); 13C NMR (50 MHz, CDCl3) δ 206.1, 
160.4, 129.4, 128.2, 113.6, 102.3, 86.2, 74.7, 55.2, 47.8, 35.8, 32.0, 30.8, 29.0, 22.7, 15.4, 
14.2; m/z (EI+) 320 (M, 10), 152 (100), 135 (99), 167 (23), 235 (6), 108 (15); HRMS (EI+) 
calc. 320.1988 for C19H28O4, found 320.1991. 
1D nOe (400.2 MHz, CDCl3). Irradiation of Ar-CH (δ 5.80) showed nOe’s to Ar-H (δ 7.40), 
C15-H (δ 3.66), and C13-Ha (δ 2.88). Irradiation of C15-H (δ 3.66) showed nOe’s to Ar-CH (δ 
5.80), C13-Ha (δ 2.88), C13-Hb (δ 2.57), C16-H (δ 1.85-1.78), and C17-Ha (δ 1.66-1.50).  
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The second fraction was identified as the aryl ester byproduct 109; Rf (30% ethyl acetate : 
hexane) 0.27; 1H NMR (400.2 MHz, CDCl3) δ 8.05 (2H, d, J = 8.9 Hz, Ar-H), 6.94 (2H, d, J 
= 8.9 Hz, Ar-H), 4.84 (1H, dd, J = 8.8, 2.5 Hz, C15-H), 1.44-1.39 (1H, m, C14-H), 3.87 (3H, 
s, OCH3), 2.94 (1H, br s, OH), 2.63-2.60 (2H, m, C13-H), 2.14 (3H, s, C11-H), 2.17-2.09 (1H, 
m, C16-H), 1.10-1.50 (6H, m, C17-H, C18-H, C19-H), 1.03 (3H, d, J = 6.8 Hz, C16-CH3), 0.82 
(3H, t, J = 6.9 Hz, C20-H). 
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p-Methoxybenzyl trichloroacetimidate150,216 111 
 
O
NH
CCl3
H3CO
111  
 
The procedure of Bundle and colleagues149 was followed. 
To a suspension of 60% sodium hydride (0.42 g, 0.0104 mol, 0.1 eq) in dry diethyl ether (10 
ml) was added a solution of p-methoxybenzyl alcohol (13.1 ml, 0.105 mol, 1.05 eq) in 
diethyl ether (15 ml) dropwise with stirring under a N2 atmosphere. The resulting mixture 
was stirred at room temperature for 20 min then cooled to 0oC. Trichloroacetonitrile (10 ml, 
0.0997 mol, 1.0 eq) was added dropwise over 15 min and then the reaction was slowly 
allowed to warm to room temperature over 1 h. The solution was concentrated to an orange 
syrup then pentane (10 ml) containing anhydrous methanol (0.4 ml) was added. After 
vigorous shaking and filtration through celite, the filtrate was concentrated under reduced 
pressure to give the crude imidate as a clear yellow-orange syrup (27.9 g, 99%). Attempted 
purification of the imidate by distillation (lit.150 b.p. 135-137oC/0.7mmHg) resulted in 
decomposition. 
Crude p-methoxybenzyl trichloroacetimidate 111 was of sufficient purity; IR (thin film) 
3337 (=N-H), 1663 (C=N), 1613, 1515 (C=C) cm-1; 1H NMR (200 MHz, CDCl3) δ 8.36 
(1H, br s, NH), 7.38 (2H, d, J = 8.6 Hz, Ar-H), 6.91 (2H, d, J = 8.7 Hz, Ar-H), 5.28 (2H, s, 
CH2), 3.82 (3H, s, OCH3). 
 
(4S, 5R, 6R)-Bis-(p-methoxy-benzyloxy)-6-methyl-decan-2-one 110 
 
O
O
11
20
110
O
OCH3
H3CO
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(1.) To a solution of alcohol 82 (56 mg, 0.174 mmol, 1.0 eq) in diethyl ether (2.7 ml) at room 
temperature was added crude p-methoxybenzyl trichloroacetimidate 111 (168 mg, 0.595 
mmol, 3.4 eq) under a N2 atmosphere. The mixture was cooled to 0oC then treated with 
trifluoromethanesulfonic acid (3.08 µl, 0.0348 mmol, 0.2 eq). The solution was stirred at 0oC 
for 30 min then at room temperature for 20 h. T.l.c analysis showed incomplete consumption 
of the starting material. Despite this, the mixture was washed with saturated aqueous 
NaHCO3 solution (3 ml) and water (3 ml), then dried (Na2SO4), filtered and concentrated 
under reduced pressure. Purification of the crude mixture by flash chromatography (20% 
ethyl acetate : hexane) afforded the starting alcohol 82 (28.5 mg) and the title compound 110 
(27.4 mg, 36%) as a clear yellow oil; Rf (20% ethyl acetate : hexane) 0.33; [α]D -8.4 (c 1.7, 
CHCl3); IR (thin film) 2955, 2858 (C-H), 1715 (C=O), 1613, 1514 (C=C), 821 (C-H, p-
disubstituted benzene) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 7.27-7.22 (4H, ob d, Ar-H), 
6.86 (4H, d, J = 8.6 Hz, Ar-H), 4.72 (1H, d, J = 10.9 Hz, Ar-CHa), 4.55-4.42 (3H, m, Ar-
CHb, Ar-CH2), 4.15 (1H, dt, J = 8.4, 3.0 Hz, C14-H), 3.80 (6H, s, OCH3), 3.37 (1H, dd, J = 
7.2, 2.9 Hz, C15-H), 2.87 (1H, dd, J = 16.8, 8.5 Hz, C13-Ha), 2.58 (1H, dd, J = 16.8, 3.1 Hz, 
C13-Hb), 2.13 (3H, s, C11-H), 1.65-1.48 (2H, m, C16-H, C17-Ha), 1.37-1.07 (5H, m, C17-Hb, 
C18-H, C19-H), 0.88 (3H, t, J = 6.9 Hz, C20-H), 0.88 (3H, d, J = 6.8 Hz, C16-CH3); 13C NMR 
(75.5 MHz, CDCl3) δ 207.8, 159.2, 159.1, 131.7, 131.1, 129.5, 113.8, 83.7, 77.1, 73.8, 71.7, 
55.3, 44.6, 35.2, 32.3, 31.1, 29.1, 23.0, 16.3, 14.1, 3C overlapping; m/z (EI+) 442 (M, 1), 
441 (M-H, 4), 378 (24), 321 (M-C8H9O, 20), 242 (9), 185 (16), 167 (6), 137 (20), 121 
(C8H9O, 100), 91 (5), 78 (10); HRMS (EI+) calc. 441.2641 for C27H37O5, found 441.2648. 
 
(2.) To a solution of alcohol 82 (29.0 mg, 0.0901 mmol, 1.0 eq) in 2:1 hexane : 
dichloromethane (0.33 ml) was added crude p-methoxybenzyl trichloroacetimidate 111 (43 
mg, 0.152 mmol, 1.7 eq) under a N2 atmosphere at room temperature. The mixture 
immediately developed a white precipitate which intensified after it was treated with boron 
trifluoride etherate (~1.5 µl, 0.0118 mmol, 0.13 eq) at 0oC. After stirring at room temperature 
for 20 h 20 min, t.l.c analysis showed incomplete consumption of the starting material. 
Despite this, the reaction was diluted with dichloromethane (2 ml) then washed with 
saturated aqueous NaHCO3 solution (3 ml) and water (3 ml). The organic phase was dried 
(Na2SO4), filtered and concentrated under reduced pressure. Purification of the crude mixture 
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by flash chromatography (20% ethyl acetate : hexane) afforded the starting alcohol 82 (15.6 
mg) and the title compound 110 (7.3 mg, 18%) as a clear yellow oil. 
 
 
EXPERIMENTAL FOR CHAPTER 3 
 
5.2 Synthesis of the Aminoaldehyde Fragment C1-C4. 
 
tert-Butylhypochlorite217  
 
A 2-necked 1-l round-bottomed flask equipped with a large magnetic stirrer bar and 
thermometer was charged with commercial household bleach☼
O
O
OH
HN
O
O
1
4
119
 solution (4.5% sodium 
hypochlorite, 500 ml, 0.303 mol, 1.0 eq) and then cooled to below 10oC in an ice bath. The 
lights in the vicinity of the reaction were turned off then a solution mixture of tert-butyl 
alcohol (31.8 ml, 0.333 mol, 1.1 eq) and glacial acetic acid (19.1 ml, 0.333 mol, 1.1 eq) was 
added dropwise to the rapidly stirring solution. After stirring for 15 min, the layers were 
separated. The lower aqueous layer was discarded and the oily yellow organic layer was 
washed first with 10% aqueous sodium carbonate solution (50 ml) then water (50 ml). The 
product was dried over CaCl2 then filtered. The photosensitive oily yellow tert-
butylhypochlorite (13.85 g, 61%) of sufficient purity was stored in the freezer over CaCl2 in 
a glass flask wrapped in aluminium foil. 
 
(2R, 3S)-3-Benzyloxycarbonylamino-2-hydroxy-butyric acid ethyl ester 119 
 
 
 
 
                                                   
☼ The commercial household bleach Zixo was used. The solution was stated to be 4.5% sodium hypochlorite 
(NaOCl). The household bleach solution White King, lead to the formation of a precipitate and decomposition 
of the reaction mixture.  
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METHOD A: Aminohydroxylation with tert-butylhypochlorite. 
Sodium hydroxide (214 mg, 5.35 mmol, 3.06 eq) was dissolved in water (13.1 ml) then 12.1 
ml of this solution was added to a solution of benzyl carbamate (821 mg, 5.43 mmol, 3.1 eq) 
in acetonitrile (7 ml). The reaction mixture was stirred in a room temperature water bath then 
tert-butylhypochlorite (580 mg, ~0.61 ml, 5.34 mmol, 3.05 eq) was added dropwise with 
stirring. A mixture of the ligand (DHQ)2PHAL (68 mg, 0.0876 mmol, 5 mol%) and ethyl 
crotonate (200 mg, 1.75 mmol, 1.0 eq) in acetonitrile (6.1 ml) was next added via a Pasteur 
pipette. Potassium osmate dihydrate (25.8 mg, 0.0701 mmol, 4 mol%) was solubilised in 1 
ml of the aqueous sodium hydroxide solution and then added to the reaction flask. The 
homogeneous reaction was stirred at room temperature for 3 h, by which time the initial 
brilliant green colour gave way to light yellow. Saturated aqueous sodium sulfite solution (15 
ml) was added slowly and the mixture stirred for 10 min. The organic layer was separated 
and then the aqueous layer extracted with ethyl acetate (3 x 10 ml). The combined organic 
layers were washed with water and brine, then dried over Na2SO4, filtered and concentrated 
to dryness to afford the crude product mixture containing excess benzyl carbamate. The ratio 
of the β-amino product 119 to regioisomer was 85:15 by 1H NMR integration of the crude 
product mixture. Purification by flash chromatography (30% ethyl acetate : hexane) afforded 
the desired product 119 contaminated with benzyl carbamate. Suspension of the benzyl 
carbamate in a minimum volume of chilled hexane, followed by repeated filtration, afforded 
pure 119 (59 mg, 12%) as a colourless liquid. The enantiomeric excess of 119 was 
determined as 87% by Mosher’s ester; Rf (30% ethyl acetate : hexane) 0.32; [α]D -10.0 (c 
3.0, CHCl3); IR (thin film) 3360 with sh (OH, N-H), 3033 (aryl C-H), 2980, 2936 (C-H), 
1724 br (C=O), 1605 (C=C), 1530 (C=C, C-N-H), 698 (C-H, monosubstituted benzene) 
cm-1; 1H NMR (200.1 MHz, CDCl3) δ 7.43-7.23 (5H, m, Ar-H), 5.24 (1H, d, J = 9.4 Hz, 
N-H), 5.07 (2H, s, Ar-CH2), 4.30-4.04 (4H, m, C2-H, C3-H, OCH2CH3), 3.57 (1H, d, J = 3.7 
Hz, OH), 1.26-1.20 (6H, m, C1-H, OCH2CH3); 13C NMR (75.5 MHz, CDCl3) δ 173.3, 155.6, 
136.4, 128.5, 128.1, 127.9, 73.1, 66.6, 62.2, 49.1, 18.0, 14.0; m/z (EI+) 281 (M, 10), 238 (7), 
208 (9), 178 (26), 134 (27), 108 (C7H8O, 11), 91 (C7H7, 100), 77 (C6H5, 10), 65 (21), 57 (7); 
HRMS (EI+) calc. 281.1263 for C14H19NO5, found 281.1262. 
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METHOD B: Aminohydroxylation with 1,3-dichloro-5,5-dimethyl hydantoin.155  
Sodium hydroxide (85.5 mg, 2.14 mmol, 3.05 eq) was dissolved in water (5.2 ml) then 4.2 
ml of this solution was added to a solution of benzyl carbamate (326 mg, 2.16 mmol, 3.08 
eq) in acetonitrile (2.8 ml). The reaction mixture was stirred in a room temperature water 
bath then 1,3-dichloro-5,5-dimethyl hydantoin (211 mg, 1.07 mmol, 1.53 eq) was added with 
stirring. A mixture of the ligand (DHQ)2PHAL (27 mg, 0.0346 mmol, 5 mol%) and ethyl 
crotonate (80 mg, 0.701 mmol, 1.0 eq) in acetonitrile (2.4 ml) was next added via a Pasteur 
pipette. Potassium osmate dihydrate (10.3 mg, 0.0280 mmol, 4 mol%) was dissolved in 1 ml 
of the aqueous sodium hydroxide solution, then the resulting pink solution was added to the 
reaction flask. The homogeneous mixture was stirred at room temperature for 3 h 20 min, 
after which time the green colour gave way to light yellow. Saturated aqueous sodium sulfite 
(6 ml) was added slowly then the mixture was stirred for 10 min. The organic layer was 
separated and the aqueous phase extracted with ethyl acetate (3 x 6 ml). The combined 
organic layers were washed with water and brine, then dried over Na2SO4, filtered and 
concentrated in vacuo to afford a crude mixture containing product, benzyl carbamate and 
diol 116. The ratio of β-amino 119 to regioisomer was determined as 78:22 by 1H NMR of 
the crude mixture. Purification by flash chromatography (40% ethyl acetate : hexane) 
afforded the desired product 119 contaminated with benzyl carbamate (390 mg, 119 
constituted ~46% of the mixture by 1H NMR).  
 
(R)-MTPA-ester derivative of 119 
 
O
O
O(R)-MTPA
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To a solution of alcohol 119 (28 mg, 0.0996 mmol, 1.0 eq) in dry dichloromethane (4.5 ml) 
at room temperature was added a solution of 1,3-dicyclohexylcarbodiimide (79.6 mg, 0.386 
mmol, 3.9 eq) and 4-N,N-dimethylaminopyridine (5.3 mg, 0.0434 mmol, 0.4 eq) in 
dichloromethane (205 µl) followed by (R)-MTPA acid (89 mg, 0.380 mmol, 3.8 eq) under an 
atmosphere of N2. The initially clear reaction mixture turned cloudy white in colour. After 
stirring at room temperature for 5 h, t.l.c analysis confirmed the absence of starting material. 
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The mixture was filtered through a pad of celite and washed with dichloromethane. Removal 
of the solvent under reduced pressure afforded crude product which was purified by flash 
chromatography (30% ethyl acetate : hexane) to give the (R)-Mosher’s ester of 119 (44.3 mg, 
90%) as a colourless liquid; Rf (30% ethyl acetate : hexane) 0.68; 1H NMR (300.1 MHz, 
CDCl3) δ 7.71-7.62 (2H, m, Ar-H), 7.48-7.25 (8H, m, Ar-H), 5.13 (1H, d, J = 2.2 Hz, C3-H), 
5.06 (2H, s, ArCH2O), 4.85 (1H, d, J = 9.7 Hz, N-H), 4.53-4.40 (1H, m, C2-H), 4.22 (2H, q, 
J = 7.1 Hz, CH3CH2O), 3.64 (3H, s, OCH3), 1.26 (3H, t, J = 7.2 Hz, CH3CH2O), 1.09 (3H, d, 
J = 6.9 Hz, C1-H). 
 
(S)-MTPA-ester derivative of 119 
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To a solution of alcohol 119 (23.4 mg, 0.0832 mmol, 1.0 eq) in dry dichloromethane (3.7 ml) 
at room temperature was added a solution of 1,3-dicyclohexylcarbodiimide (78.9 mg, 0.382 
mmol, 4.6 eq) and 4-N,N-dimethylaminopyridine (4.7 mg, 0.0385 mmol, 0.5 eq) in 
dichloromethane (185 µl) followed by (S)-MTPA acid (66 mg, 0.282 mmol, 3.4 eq) under an 
atmosphere of N2. The initially clear reaction mixture turned cloudy white in colour. After 
stirring at room temperature for 5 h, t.l.c analysis confirmed the absence of starting material. 
The mixture was filtered through a pad of celite and the filter cake washed with 
dichloromethane. Removal of the solvent under reduced pressure afforded a crude mixture 
which was purified by flash chromatography (30% ethyl acetate : hexane) to give (S)-
Mosher’s ester of 119 (36.2 mg, 88%) as a colourless liquid; Rf (30% ethyl acetate : hexane) 
0.68; 1H NMR (300.1 MHz, CDCl3) δ 7.63-7.53 (2H, m, Ar-H), 7.46-7.26 (8H, m, Ar-H), 
5.16 (1H, d, J = 2.4 Hz, C3-H), 5.07 (2H, s, ArCH2O), 4.93 (1H, d, J = 9.5 Hz, N-H), 4.55-
4.42 (1H, m, C2-H), 4.20 (2H, q, J = 7.1 Hz, CH3CH2O), 3.55 (3H, s, OCH3), 1.25 (3H, d, J 
= 7.0 Hz, C1-H), 1.24 (3H, t, J = 7.0 Hz, CH3CH2O). 
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(2R, 3S)-3-tert-Butoxycarbonylamino-2-hydroxy-butyric acid ethyl ester 117 
 
O
O
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HN
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Sodium hydroxide (1.46 g, 36.5 mmol, 3.07 eq) was dissolved in water (68.5 ml) then 58.5 
ml of this solution was added to a solution of tert-butyl carbamate (4.31 g, 36.8 mmol, 3.09 
eq) in acetonitrile (48 ml). The reaction mixture was stirred in a room temperature water bath 
and then 1,3-dichloro-5,5-dimethyl hydantoin (3.60 g, 18.3 mmol, 1.54 eq) was added, 
followed by a mixture of the ligand (DHQ)2PHAL (232.5 mg, 0.298 mmol, 2.5 mol%)218 and 
ethyl crotonate (1.36 g, 11.9 mmol, 1.0 eq) in acetonitrile (20.5 ml). Potassium osmate 
dihydrate (88 mg, 0.239 mmol, 2.0 mol%) was solubilised in 10 ml of the aqueous sodium 
hydroxide solution, then the resulting pink solution was added to the reaction flask. After 
stirring the homogeneous mixture at room temperature for 4 h, the pale orange-pink colour 
had given way to light yellow. The reaction mixture was diluted with ethyl acetate then the 
organic layer was separated. The aqueous phase was extracted with ethyl acetate (3 x 20 ml) 
and then the combined organic layers were washed with water and brine, dried over Na2SO4, 
filtered and concentrated to dryness to afford a crude mixture. The residue was suspended in 
a minimum volume of chilled hexane then filtered to remove the bulk of the tert-butyl 
carbamate. The carbamate was washed with a copious quantity of chilled hexane and then 
the filtrate was concentrated to dryness. Purification of the residue by flash chromatography 
(40% ethyl acetate : hexane) removed the lower running diol 116 (0.37 g, 21 %). A ratio of 
72:28 of β-amino product 117 to regioisomer was determined by 1H NMR integration of the 
combined upper spots. Further flash chromatographic purification (100% dichloromethane 
then 50% ethyl acetate : hexane) through a short column removed the last traces of tert-butyl 
carbamate to give the desired product 117 (1.17 g, 40%) in pure form as a thick colourless 
liquid. The enantiomeric excess was determined as 82% by chiral HPLC (Daicel Chiralcel 
OD-H, 10% isopropyl alcohol : hexane, tR [117] 11.720 min, tR [enantiomer-117] 8.561 
min); Rf (30% ethyl acetate : hexane) 0.47; [α]D +14.4 (c 0.5, CHCl3); IR (thin film) 3450 sh 
(H-N-C=O secondary amide), 3378 (OH), 2978, 2934 (C-H), 1717 (H-N-C=O amide I, C=O 
ester), 1508 (C-N-H amide II) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 4.74 (1H, d, J = 8.6 
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Hz, N-H), 4.30-4.12 (3H, m, C2-H, CH3CH2O), 4.07 (1H, dd, J = 4.7, 2.1 Hz, C3-H), 3.12 
(1H, d, J = 4.8 Hz, OH), 1.40 (9H, s, tBu-CH3), 1.31 (3H, t, J = 7.0 Hz, CH3CH2O), 1.24 
(3H, d, J = 6.9 Hz, C1-H); 13C NMR (75.5 MHz, CDCl3) δ 173.5, 155.0, 79.3, 73.3, 62.1, 
48.5, 28.2, 18.1, 14.0; m/z (ESI+) 270 (M+Na, 35); HRMS (ESI+) calc. 270.1311 for 
C11H21NNaO5, found 270.1298. 
O
O
OH
OH
1
4
116  
 
Ethyl dihydroxybutanoate158,159 116; Rf (30% ethyl acetate : hexane) 0.09; 1H NMR (200.1 
MHz, CDCl3) δ 4.28 (2H, q, J = 7.1 Hz, OCH2CH3), 4.14-3.96 (2H, m, C2-H, C3-H), 3.21 
(1H, br s, OH), 2.28 (1H, br s, OH), 1.31 (3H, t, J = 7.1 Hz, OCH2CH3), 1.30 (3H, d, J = 6.4 
Hz, C1-H). 
O
O
HN
OH
14
118
O
O
 
 
A third fraction, proposed as the regioisomer 118, runs beneath the tert-butyl carbamate spot 
by t.l.c and was isolated as a mixture with the carbamate; Rf (30% ethyl acetate : hexane) 
0.42; 1H NMR (300.1 MHz, CDCl3) δ 4.99 (1H, br d, J = 9.4 Hz, N-H), 4.22-4.07 (3H, m, 
CH3CH2O, C2-H), 4.04 (1H, dd, J = 6.0, 2.2 Hz, C3-H), 3.81 (1H, d, J = 5.9 Hz, OH), 1.35 
(9H, s, tBu-CH3), 1.24 (3H, t, J = 7.2 Hz, CH3CH2O), 1.19 (3H, d, J = 6.9 Hz, C1-H); 
13C NMR (75.5 MHz, CDCl3) δ 173.5, 155.1, 79.1, 73.4, 61.7, 48.6, 28.1, 17.9, 13.9.  
 
Note: The resonance corresponding to the N-H signal of the regioisomer is found at δ 4.99-
5.32 ppm and is at lower field than the N-H signal of the major product. Also the signal 
corresponding to CH3CH2O is at higher field in the regioisomer than in the product. 
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(R)-MTPA-ester derivative of 117 
 
O
O
O(R)-MTPA
HN
O
O
14
 
 
To a solution of alcohol 117 (27.1 mg, 0.110 mmol, 1.0 eq) in dry dichloromethane (4.4 ml) 
at room temperature was added a solution of 1,3-dicyclohexylcarbodiimide (90.6 mg, 0.439 
mmol, 4.0 eq) and 4-N,N-dimethylaminopyridine (6.2 mg, 0.0507 mmol, 0.5 eq) in 
dichloromethane (206 µl) followed by (R)-MTPA acid (77 mg, 0.329 mmol, 3.0 eq) under an 
atmosphere of N2. The initially clear reaction mixture turned cloudy white in colour. After 
stirring at room temperature for 5 h, t.l.c analysis confirmed the absence of starting material. 
The mixture was filtered through a pad of celite and the filter cake was washed with 
dichloromethane. Removal of the solvent under reduced pressure afforded a crude mixture 
which was purified by flash chromatography (30% ethyl acetate : hexane) to afford the (R)-
Mosher’s ester of 117 (50 mg, 98%) as a colourless liquid as well as traces of the minor 
diastereomer; Rf (30% ethyl acetate : hexane) 0.76; 1H NMR (300.1 MHz, CDCl3) δ 7.73-
7.64 (1H, m, Ar-H), 7.46-7.32 (4H, m, Ar-H), 5.12 (1H, d, J = 2.3 Hz, C3-H), 4.60 (1H, d, J 
= 9.7 Hz, N-H), 4.48-4.34 (1H, m, C2-H), 4.31-4.18 (2H, m, CH3CH2O), 3.65 (3H, s, OCH3), 
1.41 (9H, s, tBu-CH3), 1.30 (3H, t, J = 7.2 Hz, CH3CH2O), 1.07 (3H, d, J = 6.9 Hz, C1-H); 
Peaks were also observed for the minor diastereomer, 1H NMR♦ (300.1 MHz, CDCl3) δ 
7.62-7.54 (2H, m, Ar-H), 5.15 (1H, d, J = 2.7 Hz, C3-H), 4.67 (1H, d, J = 9.6 Hz, N-H), 3.57 
(3H, s, OCH3), 1.23 (3H, t, J = 6.8 Hz, CH3CH2O). 
 
(4S, 5R)-2,2,4-Trimethyl-oxazolidine-3,5-dicarboxylic acid 3-tert-butyl ester 5-ethyl ester 
121 
 
N
O
O
O
O
O
4
1
121  
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METHOD A: Isopropylidene protection using 2,2-dimethoxypropane. 
To a solution of aminoalcohol 117 (1.39 g, 5.62 mmol, 1.0 eq) in anhydrous toluene (14 ml) 
was added 2,2-dimethoxypropane (2.07 ml, 16.8 mmol, 3.0 eq) followed by p-
toluenesulfonic acid (214 mg, 1.13 mmol, 0.2 eq). The reaction vessel was equipped with a 
Dean-Stark apparatus containing activated 5Å molecular sieves and toluene. The solution 
mixture was brought to reflux for 2 h 30 min ensuring the toluene-methanol azeotrope was 
condensing onto the molecular sieves. T.l.c analysis showed about 50% conversion of the 
starting material, and so further 2,2-dimethoxypropane (3.0 eq) and p-toluenesulfonic acid 
(0.2 eq) were added. After refluxing for another 2 h 30 min, final aliquots of 2,2-
dimethoxypropane (1.73 ml, 14.1 mmol, 2.5 eq) and catalyst (107 mg, 0.563 mmol, 0.1 eq) 
were added and reflux continued for 1h 30 min. After t.l.c analysis confirmed reaction 
completion, the mixture was poured into saturated aqueous NaHCO3 solution (30 ml). The 
layers were separated then the aqueous phase was extracted into diethyl ether (3 x 20 ml). 
The combined organic extracts were dried over Na2SO4, filtered and concentrated under 
reduced pressure. Flash chromatographic purification (20% ethyl acetate : hexane) afforded 
the pure oxazolidine 121 (875 mg, 54%) as a clear liquid; Rf (20% ethyl acetate : hexane) 
0.65; [α]D -5.0 (c 3.7, CHCl3); IR (thin film) 2979, 2937 (C-H), 1759, 1732 (O-C=O), 1694 
(N-C=O), 1385 (C(CH3)2) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 4.33-4.17 (4H, m, 
CH3CH2O, C2-H, C3-H), 1.62 (3H, s, CH3), 1.58 (3H, s, CH3), 1.48 (9H, s, tBu-CH3), 1.43 
(3H, d, J = 6.2 Hz, C1-H), 1.31 (3H, t, J = 7.1 Hz, CH3CH2O); 13C NMR (75.5 MHz, CDCl3) 
δ 170.8, 151.4, 95.8 br, 80.0, 79.7, 61.3, 55.9 br, 28.3, 27.5 br, 26.6 br, 20.1 br, 14.0; m/z 
(ESI+) 326 (M+K, 25), 310 (M+Na, 100); HRMS (ESI+) calc. 310.1624 for C14H25NNaO5, 
found 310.1608. 
(Spectra appended) 
O
O
O
HN
O
O
1
4
122
OCH3
 
 
Isolation of intermediate 122 was achieved after the premature workup of the reaction 
mixture; Rf (20% ethyl acetate : hexane) 0.48; 1H NMR (200.1 MHz, CDCl3) δ 4.84 (1H, br 
d, J = 6.9 Hz, N-H), 4.22 (1H, d, J = 3.2 Hz, C3-H), 4.16 (2H, q, J = 7.1 Hz, CH3CH2O), 
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4.11-3.92 (1H, m, C2-H), 3.23 (3H, s, OCH3), 1.41 (9H, s, tBu-CH3), 1.38 (3H, s, OCH3), 
1.31 (3H, s, CH3), 1.26 (3H, t, J = 7.2 Hz, CH3CH2O), 1.18 (3H, d, J = 6.8 Hz, C1-H). 
 
METHOD B: Isopropylidene protection using 2-methoxypropene 
To a 0oC solution of aminoalcohol 117 (122.7 mg, 0.497 mmol, 1.0 eq) in dry benzene (1.2 
ml) was added activated 5Å molecular sieves followed by 2-methoxypropene (119 µl, 1.24 
mmol, 2.5 eq) and p-toluenesulfonic acid (9.4 mg, 0.0494 mmol, 0.1 eq). The resulting deep 
red-brown reaction mixture was stirred at 0oC for 45 min. T.l.c analysis confirmed the 
presence of starting material. Further 2-methoxypropene (47.5 µl, 0.496 mmol, 1.0 eq) was 
added and the reaction stirred at room temperature for 50 min. T.l.c analysis revealed about 
90% conversion of starting material, and so a final aliquot of 2-methoxypropene (24 µl, 
0.251 mmol, 0.5 eq) was added and stirring continued at room temperature for 1 h. The 
reaction mixture was poured into saturated aqueous NaHCO3 solution (6 ml). The layers 
were separated and then the aqueous phase extracted into diethyl ether (3 x 10 ml). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated under reduced 
pressure. Flash chromatographic purification (20% ethyl acetate : hexane) afforded the pure 
oxazolidine 121 (121 mg, 85%) as a clear yellow liquid. 
 
Note: Method A for the protection of an aminoalcohol produces product free of 
contaminants, albeit in reduced yield. A maximum yield of 74% was obtained when the 
reaction was conducted on a smaller scale. 
 
 
(4S, 5R)-5-Hydroxymethyl-2,2,4-trimethyl-oxazolidine-3-carboxylic acid tert-butyl ester165 
123 
 
N
O
HO
O
O
4
1
123  
 
To a suspension of lithium aluminium hydride (312 mg, 8.22 mmol, 2.1 eq) in diethyl ether 
(52.9 ml) cooled to 0oC was added a solution of ester 121 (1.12 g, 3.90 mmol, 1.0 eq) in 
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diethyl ether (17.8 ml) via cannula under an atmosphere of N2. The reaction mixture was 
stirred at 0oC for 30 min then quenched dropwise with 14% sodium hydroxide (25 ml) 
solution. The layers were separated and then the aqueous phase was extracted into diethyl 
ether (3 x 15 ml). The combined organic extracts were washed with water and brine, dried 
(Na2SO4), filtered and concentrated under reduced pressure. Purification by flash 
chromatography (30% ethyl acetate : hexane) using silica treated with 0.1% TEA afforded 
the title compound 123 (0.889 g, 93%) as a white solid; Rf (30% ethyl acetate : hexane) 0.33; 
[α]D +10.2 (c 2.1, CHCl3); IR (Nujol mull) 3461 (OH), 1682 (N-C=O), 1376 (C(CH3)2) 
cm-1; m.p. 75-78oC; 1H NMR (400.2 MHz, CDCl3) δ 3.84-3.68 (3H, m, C2-H, C3-H, C4-Ha), 
3.62 (1H, dt, J = 11.7, 5.7 Hz, C4-Hb), 1.90 (1H, br t, J = 5.8 Hz, OH), 1.59 (3H, s, CH3), 
1.52 (3H, s, CH3), 1.47 (9H, s, tBu-CH3), 1.33 (3H, d, J = 6.0 Hz, C1-H); 13C NMR (100.6 
MHz, CD3CN, 345 K) δ 153.4, 95.4, 83.7, 80.6, 63.9, 55.9, 29.1, 28.4, 27.5, 20.0; m/z 
(ESI+) 268 (M+Na, 10), 246 (M+H, 19); HRMS (ESI+) calc. 268.1520 for C12H23NNaO4, 
found 268.1497. 
Note: Numerous attempts at obtaining a HRMS within the 5 ppm error limit were 
unsuccessful.  
(Spectra appended) 
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The use of a water quench and flash chromatography on untreated silica gave rise to the 
formation of O,O-acetonide 124 which was isolated by HPLC (Zorbax Sil, 30% ethyl acetate 
: hexane) as a colourless oil; Rf (30% ethyl acetate : hexane) 0.33; 1H NMR (400.2 MHz, 
CDCl3) δ 5.48 (1H, br s, N-H), 3.87 (1H, dt, J = 6.1, 3.8 Hz, C3-H), 3.80-3.58 (3H, m, C2-H, 
C4-H), 1.75 (3H, s, CH3), 1.71 (3H, s, CH3), 1.43 (9H, s, tBu-CH3), 1.32 (3H, d, J = 6.0 Hz, 
C1-H).  
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(4S, 5R)-5-Formyl-2,2,4-trimethyl-oxazolidine-3-carboxylic acid tert-butyl ester165 65 
 
N
O
O
O
O
4
165  
 
To a solution of oxalyl chloride (333.5 µl, 3.82 mmol, 1.5 eq) in dichloromethane (15.8 ml) 
cooled to -78oC was added dry DMSO (0.543 ml, 7.65 mmol, 3.0 eq) in dichloromethane 
(0.54 ml) dropwise under an atmosphere of N2. The mixture was stirred at -78oC for 20 min 
and then a solution of alcohol 123 (678 mg, 2.55 mmol, 1.0 eq) in dichloromethane (2.4 ml) 
was added dropwise via cannula, followed by triethylamine (2.42 ml, 17.4 mmol, 6.8 eq). 
After stirring for 1 h, the mixture was warmed to 0oC and quenched with saturated NaHCO3 
solution. The layers were separated and the aqueous phase extracted with dichloromethane (2 
x 10 ml). The combined organic extract was washed with brine (10 ml) then dried (MgSO4), 
filtered and evaporated to dryness. The crude mixture was purified by flash chromatography 
using 10% ethyl acetate : hexane to afford pure aldehyde 65 as an unstable colourless syrup 
for characterisation; Rf (30% ethyl acetate : hexane) 0.33; [α]D +27.7 (c 1.4, CHCl3); IR 
(thin film) 3444 (OH), 2977, 2936 (C-H), 1738-1652 (C=O) cm-1; 1H NMR (300.1 MHz, 
CDCl3) δ 9.76 (1H, s, CHO), 4.22-4.11 (1H, m, C2-H), 4.03 (1H, dd, J = 3.7, 1.0 Hz, C3-H), 
1.59 (3H, s, CH3), 1.56 (3H, s, CH3), 1.45 (9H, s, tBu-CH3), 1.38 (3H, d, J = 6.3 Hz, C1-H); 
13C NMR (50.3 MHz, CDCl3) δ 201.2, 151.6, 95.0, 85.5, 80.1 br, 54.5 br, 28.4, 27.4 br, 19.8 
br, 1C overlapping; m/z (EI+) 243 (M, 50), 228 (M-CH3, 48), 214 (M-CHO, 11), 172 (54), 
170 (M-C4H9O, 28), 158 (3), 128 (M-C5H9NO2, 16), 114 (14), 84 (8), 57 (C4H9, 100), 41 
(18); HRMS (EI+) calc. 243.1470 for C12H21NO4, found 243.1477. 
 
Alternative workup: Anhydrous diethyl ether (15 ml) was added to the reaction mixture and 
the triethylammmonium chloride salt removed by filtration. The filtrate was concentrated in 
vacuo to give a crude syrup which was used immediately in the next step without further 
purification. 
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5.3 Synthesis of the C5-C10 Sulfone Fragment. 
 
6-(tert-Butyl-dimethyl-silanyloxy)-hexan-1-ol166 126 
 
tBuMe2SiO
OH10
5
126  
 
METHOD A: To a solution of 1,6-hexanediol (4.0 g, 33.8 mmol, 2.0 eq) and imidazole 
(1.35 g, 19.8 mmol, 1.2 eq) in dry DMF (16.9 ml) at room temperature was added tert-
butyldimethylsilyl chloride (2.55 g, 16.9 mmol, 1.0 eq) under an atmosphere of N2. The 
exothermic reaction was stirred at room temperature for 3 h then quenched slowly with 
saturated aqueous NaHCO3 solution. The mixture was diluted with water (75 ml) and then 
extracted into diethyl ether (4 x 50 ml). The combined organic extracts were washed with 
water and brine, then dried over Na2SO4, filtered and concentrated in vacuo. Flash 
chromatographic purification (5% ethyl acetate : hexane then 30% ethyl acetate : hexane) 
afforded two fractions. 
 
tBuMe2SiO
OSiMe2
tBu10
5
127  
 
The first fraction identified as the disilylated adduct 127 (0.83 g, 28%) was isolated as a 
colourless liquid; Rf (5% ethyl acetate : hexane) 0.86; 1H NMR (200.1 MHz, CDCl3) δ 3.54 
(4H, t, J = 6.5 Hz, C5-H, C10-H), 1.60-1.38 (4H, m, C6-H, C9-H), 1.35-1.25 (4H, m, C7-H, 
C8-H), 0.83 (18H, s, tBu-CH3), -0.01 (12H, s, Si-CH3). 
 
The second fraction identified as monosilylated adduct 126 (2.6 g, 66%) was also obtained as 
a colourless liquid; Rf (30% ethyl acetate : hexane) 0.53; IR (thin film) 3345 (OH), 2930-
2857 (C-H) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 3.55 (2H, t, J = 6.5 Hz, C5-H), 3.58 (2H, 
t, J = 6.6 Hz, C10-H), 1.64-1.43 (4H, m, C6-H, C9-H), 1.38-1.30 (5H, m, C7-H, C8-H, OH), 
0.84 (9H, s, tBu-CH3), -0.01 (6H, s, Si-CH3); 13C NMR (75.5 MHz, CDCl3) δ 63.1, 62.9, 
32.8, 32.7, 25.9, 25.6, 25.5, 18.3, -5.3. 
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METHOD B:166 To a suspension of washed and dried sodium hydride (0.203 g, 8.46 mmol, 
1.0 eq) in tetrahydrofuran (16.6 ml) was added 1,6-hexanediol (1.0 g, 8.46 mmol, 1.0 eq) and 
then the mixture was stirred at room temperature for 1 h. tert-Butyldimethylsilyl chloride 
(1.28 g, 8.46 mmol, 1.0 eq) was added to the reaction and stirring was continued for 1 h. The 
mixture was poured into diethyl ether (100 ml), washed with aqueous 10% Na2CO3 solution 
(50 ml) and brine (50 ml), then dried over Na2SO4 and concentrated in vacuo. Purification by 
flash chromatography (30% ethyl acetate : hexane) afforded monosilylated product 126 
(0.376 g, 19%). 
 
2-[6-(tert-Butyl-dimethyl-silanyloxy)-hexylsulfanyl]-benzothiazole 128 
 
tBuMe2SiO
S10
5
S
N
128
 
 
To a solution of alcohol 126 (2.77 g, 11.9 mmol, 1.0 eq) in dry tetrahydrofuran (69.6 ml) at 
room temperature was added 2-mercaptobenzothiazole (2.39 g, 14.3 mmol, 1.2 eq) and 
triphenylphosphine (3.75 g, 14.3 mmol, 1.2 eq) under an atmosphere of N2. The resulting 
solution was cooled to 0oC then diisopropyl azodicarboxylate (3.1 ml, 15.5 mmol, 1.3 eq) 
was added dropwise. The cooling bath was removed and the mixture was stirred at room 
temperature for 2 h 35 min. Removal of the solvent under reduced pressure afforded a crude 
mixture which was purified by flash chromatography (4% ethyl acetate : hexane) to give 
pure sulfide 128 (4.09 g, 90%) as a colourless liquid; Rf (4% ethyl acetate : hexane) 0.38; IR 
(thin film) 3062 (aryl C-H), 2926-2855 (C-H), 1560 (C=N), 775 or 755 (C-H, o-disubstituted 
benzene) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 7.82 (1H, d, J = 8.0 Hz, Ar-H), 7.70 (1H, d, 
J = 8.0 Hz, Ar-H), 7.36 (1H, td, J = 8.2, 1.2 Hz, Ar-H), 7.23 (1H, td, J = 8.3, 1.2 Hz, Ar-H), 
3.56 (2H, t, J = 6.3 Hz, C10-H), 3.54 (2H, t, J = 7.3 Hz, C5-H), 1.79 (2H, quintet, J = 7.6 Hz, 
CH2), 1.57-1.29 (6H, m, CH2), 0.84 (9H, s, tBu-CH3), 0.00 (6H, s, Si-CH3); 13C NMR (75.5 
MHz, CDCl3) δ 167.3, 153.4, 135.1, 125.9, 124.1, 121.4, 120.9, 63.0, 33.5, 32.6, 29.2, 28.5, 
26.0, 25.3, 18.3, -5.3; m/z (EI+) 381 (M, 8), 366 (M-CH3, 7), 324 (M-C4H9, 100), 224 
(M-157, 53), 181 (4), 167 (16), 143 (3), 127 (5), 115 (C6H15Si, 8), 89 (8), 75 (51); HRMS 
(EI+) calc. 381.1616 for C19H31NOS2Si, found 381.1613. 
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2-[6-(tert-Butyl-dimethyl-silanyloxy)-hexane-1-sulfonyl]-benzothiazole 67 
 
tBuMe2SiO
S10
5
S
N
O O
67  
 
To a solution of sulfide 128 (1.68 g, 4.40 mmol, 1.0 eq) in absolute ethanol (38.4 ml) was 
added solid potassium dihydrogenphosphate (2.4 g, 17.6 mmol, 4.0 eq). A solution of 
ammonium molybdate(VI) tetrahydrate (544 mg, 0.440 mmol, 0.1 eq) in hydrogen peroxide 
(30% wt., 5.0 ml, 44.0 mmol, 10 eq) was added dropwise at room temperature, and the 
ensuing exothermic reaction changed from clear yellow to cloudy. After stirring at room 
temperature for 19 h, the mixture was diluted with water and ethyl acetate. The layers were 
separated and the aqueous phase was extracted into ethyl acetate (3 x 50 ml). The combined 
organic layers were washed with brine, dried (Na2SO4), filtered and concentrated in vacuo to 
give the crude product which was purified by flash chromatography (20% ethyl acetate : 
hexane) to give pure sulfone 67 (1.71 g, 94%) as a colourless liquid; Rf (20% ethyl acetate : 
hexane) 0.50; IR (thin film) 3062 (aryl C-H), 2930-2856 (C-H), 1555 (C=N), 1332, 1147 
(SO2), 774 or 730 (C-H, o-disubstituted benzene) cm-1; 1H NMR (300.1 MHz, CDCl3) 
δ 8.20 (1H, dd, J = 7.1, 1.4 Hz, Ar-H), 8.00 (1H, dd, J = 7.1, 1.5 Hz, Ar-H), 7.66-7.55 (2H, 
m, Ar-H), 3.58-3.47 (4H, m, C5-H, C10-H), 1.95-1.80 (2H, m, CH2), 1.55-1.33 (6H, m, CH2), 
0.86 (9H, s, tBu-CH3), 0.01 (6H, s, Si-CH3); 13C NMR (75.5 MHz, CDCl3) δ 165.9, 152.7, 
136.7, 127.9, 127.6, 125.4, 122.3, 62.8, 54.6, 32.3, 28.0, 25.9, 25.2, 22.2, 18.2, -5.4; m/z 
(EI+) 412 (M-H, 15), 398 (M-CH3, 6), 356 (M-C4H9, 100), 324 (3), 298 (4), 256 (M-157, 
70), 241 (2), 228 (3), 208 (24), 182 (50), 162 (4), 143 (12), 115 (C6H15Si, 12), 89 (8), 75 
(46); HRMS (EI+) calc. 412.1436 for C19H30NO3S2Si, found 412.1444. 
 
tBuMe2SiO
S10
5
S
N
129
O
 
 
The sulfoxide intermediate 129 was isolated under alternative sulfide oxidation conditions; 
Rf (20% ethyl acetate : hexane) 0.36; 1H NMR (200.1 MHz, CDCl3) δ 8.08-7.98 (2H, m, Ar-
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H), 7.61-7.44 (2H, m, Ar-H), 3.57 (2H, t, J = 6.2 Hz, C10-H), 3.23 (1H, ddd, J = 19.1, 13.3, 
5.8 Hz, C5-Ha), 3.19 (1H, ddd, J = 18.9, 13.2, 5.9 Hz, C5-Hb), 2.10-1.29 (8H, m, CH2), 0.87 
(9H, s, tBu-CH3), 0.02 (6H, s, Si-CH3). 
 
HO
S10
5
S
N
O O
130  
 
Under non buffered conditions, byproduct 130 was obtained; Rf (50% ethyl acetate : hexane) 
0.32; IR (thin film) 3382 (OH), 3064 (aryl C-H), 2937, 2861 (C-H), 1554 (C=N), 1325, 1148 
(SO2), 763 (C-H, o-disubstituted benzene); 1H NMR (200.1 MHz, CDCl3) δ 8.24-8.19 (1H, 
m, Ar-H), 8.04-7.99 (1H, m, Ar-H), 7.68-7.54 (2H, m, Ar-H), 3.64-3.47 (4H, m, C5-H, C10-
H), 1.97-1.82 (2H, m, CH2), 1.76-1.31 (7H, m, CH2, OH). 
 
 
5.4 Synthesis of the C5-C10 Phosphonium Salt Fragment. 
 
(6-Iodo-hexyloxy)-tert-butyl-dimethyl-silane219 143 
 
tBuMe2SiO
I10
5
143  
 
To a 0oC solution of alcohol 126 (2.60 g, 11.2 mmol, 1.0 eq) in diethyl ether (21.5 ml) and 
acetonitrile (6.5 ml) was added triphenylphosphine (3.08 g, 11.7 mmol, 1.04 eq), imidazole 
(800 mg, 11.8 mmol, 1.05 eq) and iodine (2.84 g, 11.2 mmol, 1.0 eq, added in 3 portions). 
The solution was stirred at room temperature for 2 h and then passed through a pad of silica 
(pentane : diethyl ether 5:1) and concentrated under reduced pressure at ambient 
temperature. Flash chromatographic purification (10% ethyl acetate : hexane) afforded 
iodide 143 (3.59 g, 94%); Rf (10% ethyl acetate : hexane) 0.91; IR (thin film) 2929, 2855 
(C-H), 1102 (Si-O, C-O) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 3.60 (2H, t, J = 6.4 Hz, 
C10-H), 3.19 (2H, t, J = 7.0 Hz, C5-H), 1.83 (2H, quintet, J = 6.9 Hz, C9-H), 1.52 (2H, 
quintet, J = 6.7 Hz, C6-H), 1.46-1.26 (4H, m, C7-H, C8-H), 0.89 (9H, s, tBu-CH3), 0.04 (6H, 
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s, Si-CH3); 13C NMR (75.5 MHz, CDCl3) δ 63.0, 33.5, 32.6, 30.3, 26.0, 24.8, 18.3, 7.0, -5.3; 
m/z (EI+) 341 (M-H, 5), 327 (M-CH3, 13), 317 (5), 301 (6), 285 (M-C4H9, 36), 215 (M-I, 
15), 185 (M-157, 11), 157 (6), 115 (C6H15Si, 4), 101 (6), 89 (4), 83 (100), 75 (30), 55 (71), 
41 (14); HRMS (EI+) calc. 327.0641 for C11H24IOSi, found 327.0636. 
 
[6-(tert-Butyl-dimethyl-silanyloxy)-hexyl]-triphenyl-phosphonium iodide220 142 
 
tBuMe2SiO
P10
5
142
I
 
 
To a solution of iodide 143 (3.54 g, 10.3 mmol, 1.0 eq) in acetonitrile (103 ml) was added 
triphenylphosphine (3.26 g, 12.4 mmol, 1.2 eq). After heating at reflux for 25 h, the mixture 
was cooled to room temperature and then concentrated in vacuo. Purification by flash 
chromatography (10% ethyl acetate : hexane then 10% methanol : dichloromethane) gave 
phosphonium iodide 142 (5.58 g, 90%) as a hygroscopic, white, amorphous solid which 
quickly turned yellow; Rf (10% methanol : dichloromethane) 0.34; IR (thin film) 3053 (aryl 
C-H), 1485, 1470, 1438 (P-Ph, P-C), 775, 690 (C-H, monosubstituted benzene) cm-1; 
1H NMR (300.1 MHz, CDCl3) δ 7.73-7.57 (15H, m, Ar-H), 3.50-3.39 (2H, m, C5-H), 3.42 
(2H, t, J = 6.4 Hz, C10-H), 1.59-1.49 (4H, m, CH2), 1.38-1.15 (4H, m, CH2), 0.72 (9H, s, 
tBu-CH3), -0.12 (6H, s, Si-CH3); 13C NMR (75.5 MHz, CDCl3) δ 134.8 (d, J = 2.8 Hz), 
133.2 (d, J = 10.0 Hz), 130.2 (d, J = 12.5 Hz), 117.6 (d, J = 86.1 Hz), 62.5, 31.8, 29.7 (d, J = 
15.6 Hz), 25.5, 24.9, 22.7 (d, J = 50.4 Hz), 22.1 (d, J = 4.3 Hz), 17.9, -5.7; m/z (ESI+) 477 
(M-I, 100); HRMS (ESI+) calc. 477.2742 for C30H42OPSi, found 477.2750. 
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(6-Bromo-hexyloxy)-tert-butyl-dimethyl-silane221 
 
tBuMe2SiO
Br
5
10
 
 
To a mixture of alcohol 126 (1.04 g, 4.48 mmol, 1.0 eq) and triphenylphosphine (1.64 g, 6.25 
mmol, 1.4 eq) in dichloromethane (17.8 ml) at 0oC was added pyridine (1.08 ml, 13.4 mmol, 
3.0 eq) followed by carbon tetrabromide (2.22g, 6.69 mmol, 1.5 eq) under an atmosphere of 
Ar. After stirring at 0oC for 2 h, the brown-yellow solution was diluted with ethyl acetate, 
washed with brine and dried over MgSO4. The mixture was filtered and then the filtrate was 
evaporated to dryness. The crude residue was purified by flash chromatography (2% ethyl 
acetate : hexane) to give the title compound (1.27 g, 97%); Rf (2% ethyl acetate : hexane) 
0.51; IR (thin film) 2930, 2856 (C-H), 1103 (Si-O, C-O) cm-1; 1H NMR (300.1 MHz, 
CDCl3) δ 3.61 (2H, t, J = 6.4 Hz, C10-H), 3.41 (2H, t, J = 6.8 Hz, C5-H), 1.87 (2H, quintet, J 
= 6.8 Hz, C9-H), 1.57-1.30 (6H, m, CH2), 0.89 (9H, s, tBu-CH3), 0.05 (6H, s, Si-CH3); 
13C NMR (75.5 MHz, CDCl3) δ 63.0, 33.8, 32.8, 32.6, 28.0, 26.0, 25.0, 18.3, -5.3; m/z (EI+) 
295 (M+H, 6), 293 (M-H, 2), 239 (16), 237 (M-C4H9, 16), 215 (M-Br, 3), 181 (2), 167 (28), 
157 (7), 139 (25), 101 (17), 83 (100); HRMS (EI+) calc. 293.0936 for C12H26BrOSi, found 
293.0938. 
 
6-Bromo-hexan-1-ol175,222 144 
 
HO
Br10
5
144  
 
Concentrated hydrobromic acid (48% wt., 4.55 ml, 40.2 mmol, 1.6 eq) was added to a 
stirring solution of 1,6-hexanediol (3.0 g, 25.4 mmol, 1.0 eq) in toluene (75 ml). The mixture 
was heated at reflux with stirring for 48 h and then cooled to room temperature. The layers 
were separated, then the organic phase was diluted with diethyl ether and washed 
sequentially with aqueous sodium hydroxide solution (1M, 50 ml), buffer solution (0.1 M, 
pH 7.0, 50 ml), and brine (50 ml). The organic layer was dried (Na2SO4), filtered and 
concentrated in vacuo to give the crude product which was purified by flash chromatography 
(30% ethyl acetate : hexane) to yield pure monobrominated 144 (3.73 g, 81%) as a colourless 
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liquid; Rf (30% ethyl acetate : hexane) 0.33; IR (thin film) 3332 (OH), 2934, 2859 (C-H), 
1053 (C-O), 728 or 643 (C-Br) cm-1; 1H NMR (200.1 MHz, CDCl3) δ 3.63 (2H, t, J = 6.7 
Hz, C10-H), 3.40 (2H, t, J = 6.7 Hz, C5-H), 1.87 (2H, quintet, J = 6.8 Hz, CH2), 1.68-1.30 
(7H, m, CH2, OH); 13C NMR (75.5 MHz, CDCl3) δ 62.5, 33.7, 32.6, 32.4, 27.8, 24.8. 
 
(6-Hydroxy-hexyl)-triphenyl-phosphonium bromide223 66 
 
HO
P10
5
66
Br
 
 
To a solution of bromide 144 (1.48 g, 8.22 mmol, 1.0 eq) in acetonitrile (10.3 ml) was added 
triphenylphosphine (5.39 g, 20.5 mmol, 2.5 eq). The mixture was heated at reflux under an 
atmosphere of Ar for 24 h and then cooled to room temperature. The resulting precipitate 
was allowed to settle to the bottom of the flask, and then the supernatant solution was 
transferred to a dry round-bottomed flask via cannula under an atmosphere of Ar. After 
evaporation of the solvent from the supernatant under reduced pressure, anhydrous acetone 
followed by diethyl ether was added to the residue. The solid was allowed to settle over ~2 h, 
and then the washings were removed via cannula. The solid residue was dried under high 
vacuum to give a white hygroscopic foam of phosphonium bromide 66 (3.09 g, 85%); IR 
(thin film) 3353 (OH), 3054 (aryl C-H), 2932, 2862 (C-H), 1438 (P-Ph), 1113 (C-O), 749, 
691 (C-H, monosubstituted benzene) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 7.90-7.63 (15H, 
m, Ar-H), 3.80-3.55 (4H, m, C5-H, C10-H), 2.54 (1H, s, OH), 1.75-1.43 (8H, m, CH2); 
13C NMR (75.5 MHz, CDCl3) δ 134.9 (d, J = 2.6 Hz), 133.4 (d, J = 9.9 Hz), 130.3 (d, J = 
12.5 Hz), 118.0 (d, J = 85.9 Hz), 61.1, 31.7, 29.3 (d, J = 15.9 Hz), 24.6, 22.2 (d, J = 50.4 
Hz), 22.1 (d, J = 4.3 Hz). 
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5.5 Synthesis of the C1-10 Aminoaldehyde Unit: Coupling of Fragments 
C1-C4 and C5-C10. 
 
Model Julia Olefination Reaction. 
 
(6Z)-tert-Butyl-dimethyl-(8-methyl-non-6-enyloxy)-silane 138 and (6E)-tert-butyl-dimethyl-
(8-methyl-non-6-enyloxy)-silane 139 
 
tBuMe2SiO
1 8
tBuMe2SiO
1 8
139138  
 
To a solution of sulfone 67 (322 mg, 0.779 mmol, 1.0 eq) and isobutyraldehyde (71 µl, 0.782 
mmol, 1.0 eq) in tetrahydrofuran (3.12 ml) cooled to -78oC was added LDA (0.524 M, 0.859 
mmol, 1.1 eq) dropwise. The resulting bright yellow mixture was stirred at -78oC for 1 h and 
then at room temperature for 64 h. The reaction was quenched with water and extracted with 
diethyl ether (2 x 4 ml). The combined organic extracts were washed with brine, dried over 
Na2SO4 and concentrated to dryness. Flash chromatographic purification (10% ethyl acetate : 
hexane) afforded a mixture of 138:139 in a ratio of 62:38 respectively as determined by 13C 
NMR; Rf (10% ethyl acetate : hexane) 0.97; IR (thin film) 2956, 2929, 2857 (C-H), 1104 (C-
O or Si-O) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 5.42-5.32 (1H, m, C=CH), 5.30-5.14 (1H, 
m, C=CH), 3.60 (2H, t, J = 6.5 Hz, C1-H), 2.65-2.53 (1H, m, C8-H), 2.07-1.95 (2H, m, C5-
H), 1.58-1.44 (2H, m, CH2), 1.44-1.26 (4H, m, CH2), 0.96 (3H, d, J = 6.2 Hz, C8-CH3), 0.94 
(3H, d, J = 6.4 Hz, C8-CH3), 0.90 (9H, s, tBu-CH3), 0.05 (6H, s, Si-CH3); 1H NMR♦ (300.1 
MHz, CDCl3) δ 2.30-2.15 (1H, m, C8-H); 13C NMR (75.5 MHz, CDCl3) δ 137.7 (137.6), 
127.3 (127.1), 63.3, 32.8 (32.5), (31.0), 29.7 (29.5), 27.3, 26.4, 26.0, 25.5 (25.3), 23.2, 22.7, 
18.4, -5.3. 
Note: Numerous efforts to obtain mass spectrometry data were unsuccessful. 
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Model Wittig Reaction 
 
(6Z)-8-Methyl-non-6-en-1-ol224 149 
 
HO
149
1
6
 
 
A stirring suspension of phosphonium bromide 66 (135 mg, 0.305 mmol, 1.3 eq) in 
anhydrous tetrahydrofuran (1.22 ml) cooled to -78oC was treated with n-butyllithium (1.6 M, 
0.608 mmol, 2.6 eq) dropwise under an atmosphere of Ar. The resulting orange ylide 
solution was stirred at -78oC for 30 min and then neat isobutyraldehyde (21.3 µl, 0.235 
mmol, 1.0 eq) was added. Stirring was continued at -78oC for 1 h and then at room 
temperature for 4 h, after which time the mixture had turned cloudy. The precipitate was 
dissolved in acetone (3 ml) and then diethyl ether (3 ml) was added. After washing the 
resulting solution with brine, the layers were separated and the organic phase was dried 
(MgSO4) and filtered. Removal of the solvent under reduced pressure gave a crude mixture 
which was purified by flash chromatography (20% ethyl acetate : hexane) to afford a 92:8 
ratio of Z:E olefins (33 mg, 100%) as determined by 13C NMR as a colourless and volatile 
sweet-smelling liquid. Data for the major isomer where appropriate, is as follows; Rf (20% 
ethyl acetate : hexane) 0.40; IR (thin film) 3330 (OH), 2997, 2931, 2864 (C-H), 1654 (C=C), 
742 (trans C=C-H out-of-plane deformation) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 5.26-
5.14 (2H, m, CH=CH), 3.63 (2H, t, J = 6.7 Hz, C1-H), 2.66-2.50 (1H, m, C8-H), 2.09-1.93 
(2H, m, CH2), 1.62-1.31 (7H, m, CH2, OH), 0.93 (6H, d, J = 6.6 Hz, C8-CH3); 13C NMR 
(75.5 MHz, CDCl3) δ 137.7, 127.1, 63.0, 32.7, 29.7, 27.2, 26.4, 25.4, 23.2, 1C overlapping. 
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(4S, 5S, 1’E)-5-[7’-(tert-Butyl-dimethyl-silanyloxy)-hept-1’enyl]-2,2,4-trimethyl-
oxazolidine-3-carboxylic acid tert-butyl ester 63 and (4S, 5S, 1’Z)-5-[7’-(tert-butyl-dimethyl-
silanyloxy)-hept-1’enyl]-2,2,4-trimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 140 
 
NO
O
O
14
NO
O
O
tBuMe2SiO
14
10
tBuMe2SiO
63 140
10
 
 
METHOD A: Modified Julia olefination reaction.  
To a solution mixture of sulfone 67 (473 mg, 1.14 mmol, 1.3 eq) and freshly prepared dry 
aldehyde 65 (212 mg, 0.872 mmol, 1.0 eq) in tetrahydrofuran (2.1 ml) at -78oC was added a 
cooled solution of LDA in tetrahydrofuran (0.543 M, 1.03 mmol, 1.2 eq) dropwise under an 
atmosphere of N2. The mixture was stirred at -78oC for 1 h and then at room temperature for 
41 h. The initially intense yellow colour gave way to pale yellow. The mixture was diluted 
with diethyl ether and quenched slowly with water. The layers were separated then the 
aqueous phase was extracted with diethyl ether (3 x 5 ml). The combined organic extracts 
were washed with brine, dried (Na2SO4), filtered and concentrated via rotary evaporation. 
The crude residue was purified by flash chromatography (5% ethyl acetate : hexane) to give 
a pure mixture of the E- and Z-olefins 63 and 140 (85 mg, 22%) in a ratio of 50:50 as 
determined by 13C NMR. The compounds were characterised as a mixture; Rf (10% ethyl 
acetate : hexane) 0.66; IR (thin film) 2930, 2856 (C-H), 1670 (C=O) cm-1; 1H NMR (300.1 
MHz, CDCl3) δ 5.80 (1H, dt, J = 15.2, 6.7 Hz, C5-H), 5.48-5.36 (1H, m, C4-H), 3.98 (1H, t, J 
= 7.7 Hz, C3-H), 3.58 (2H, t, J = 6.5 Hz, C10-H), 3.53-3.38 (1H, m, C2-H), 2.16-2.02 (2H, m, 
C6-H), 1.57 (3H, s, CH3), 1.50 (3H, s, CH3), 1.46 (9H, s, tBu-CH3), 1.55-1.30 (6H, m, CH2), 
1.27 or 1.26 (3H, d, J = 6.0 or 6.1 Hz, C1-H), 0.88 (9H, s, SitBu-CH3), 0.03 (6H, s, Si-CH3); 
1H NMR♦ of (Z)-isomer (300.1 MHz, CDCl3) δ 5.68 (1H, dt, J = 11.1, 7.8 Hz, C5-H), 4.41 
(1H, t, J = 7.8 Hz, C3-H), 3.58 (2H, t, J = 6.5 Hz, C10-H), 1.27 or 1.26 (3H, d, J = 6.0 or 6.1 
Hz, C1-H); 13C NMR (75.5 MHz, CDCl3) δ 152.2, 136.6, 136.2, 127.2, 127.0, 94.0, 82.8, 
79.6, 76.8, 63.1, 63.0, 58.4, 57.8, 32.6, 32.2, 29.4, 28.7, 28.5, 27.8, 27.8-26.3 br, 25.9, 25.4, 
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25.4, 18.3, 17.9 br, -5.3; m/z (ESI+) 480 (M+K, 9), 464 (M+Na, 100); HRMS (ESI+) calc. 
464.3166 for C24H47NNaO4Si, found 464.3163. 
 
Note: The presence of E- and Z-isomers in a ratio of 50:50 and overlapping signals made the 
accurate assignment of 13C NMR signals very difficult. Thus all peaks have been reported 
without assignment to an isomer. 
 
METHOD B: Wittig reaction. 
A -78oC suspension of phosphonium iodide 142 (614 mg, 1.02 mmol, 1.3 eq) in anhydrous 
diethyl ether (10.2 ml) was treated dropwise with n-butyllithium (1.2 M, 1.02 mmol, 1.3 eq) 
under an atmosphere of N2. The resulting orange ylide solution was stirred at 0oC for 8 min 
and then cooled to -78oC. A solution of aldehyde 65 (190 mg, 0.781 mmol, 1.0 eq) in diethyl 
ether (3 ml) was added via cannula. The mixture was stirred at -78oC for 1.5 h and then at 
room temperature for 17 h. T.l.c analysis confirmed the presence of starting material. Despite 
this, the reaction was quenched with saturated aqueous NaHCO3 and then after filtering the 
mixture, the layers were separated. The aqueous phase was extracted with diethyl ether (2 x 
5 ml) and the combined organic extracts were dried (Na2SO4), filtered and concentrated in 
vacuo. The crude mixture was purified by flash chromatography to give the Z-olefin 140 (17 
mg, 5%) in >95:5 isomer ratio by 13C NMR.  
 
(4S, 5S, 1’Z)-5-(7’-Hydroxy-hept-1’-enyl)-2,2,4-trimethyl-oxazolidine-3-carboxylic acid 
tert-butyl ester 150 
 
NO
O
O
14
HO
150  
 
A -78oC suspension of phosphonium bromide 66 (577 mg, 1.31 mmol, 1.3 eq) in anhydrous 
tetrahydrofuran (5.2 ml) was treated dropwise with n-butyllithium (1.6 M, 2.62 mmol, 2.6 
eq) under an atmosphere of Ar. The resulting orange ylide solution was stirred at -78oC for 
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35 min and then a solution of crude aldehyde 65 (258 mg, 1.06 mmol, 1.0 eq) in 
tetrahydrofuran (3.7 ml) was added via cannula. The reaction mixture was stirred at -78oC 
for 1 h and then at room temperature for 12 h. After the addition of acetone (10 ml), the 
resulting solution was dried over Na2SO4 and filtered. Removal of the solvent under reduced 
pressure gave a crude mixture which was purified by flash chromatography (30% ethyl 
acetate : hexane) to afford a yellow oil of olefin Z-150 (155 mg, 45%); Rf (30% ethyl acetate 
: hexane) 0.33; [α]D +33.7 (c 1.5, CHCl3); IR (thin film) 3458 (OH), 3077 (olefin C-H), 
2972, 2930, 2867 (C-H), 1694 (C=O), 1682 (olefin C=C) cm-1; 1H NMR (300.1 MHz, 
CDCl3) δ 5.68 (1H, dt, J = 10.3, 7.3 Hz, C5-H), 5.44-5.37 (1H, m, C4-H), 4.40 (1H, t, J = 8.0 
Hz, C3-H), 3.62 (2H, t, J = 6.6 Hz, C10-H), 3.53-3.39 (1H, m, C2-H), 2.25-2.04 (2H, m, C6-
H), 1.57 (3H, s, CH3), 1.50 (3H, s, CH3), 1.46 (9H, s, tBu-CH3), 1.55-1.34 (7H, m, OH, 
CH2), 1.26 (3H, d, J = 6.0 Hz, C1-H); 13C NMR (75.5 MHz, CDCl3) δ 152.2, 136.0, 127.1, 
94.1, 81.8, 79.7, 62.7, 58.3, 32.5, 29.3, 28.4, 27.7, 28.4-26.4 br, 25.3, 18.3, 1C overlapping; 
m/z (EI+) 327 (M, 5), 312 (M-CH3, 30), 286 (2), 256 (21), 240 (2), 226 (M-C5H9O2, 5), 212 
(M-C6H15Si, 34), 196 (3), 184 (23), 170 (45), 153 (20), 135 (13), 109 (12), 97 (33), 84 (31), 
69 (23), 57 (C4H9, 100); HRMS (EI+) calc. 327.2410 for C18H33NO4, found 327.2409. 
 
(4S, 5S)-5-[7’-(tert-Butyl-dimethyl-silanyloxy)-heptyl]-2,2,4-trimethyl-oxazolidine-3-
carboxylic acid tert-butyl ester 141 
 
NO
O
O
141
tBuMe2SiO
1
410
 
 
To a solution of olefins 63 and 140 (41 mg, 0.0929 mmol, 1.0 eq) in dry methanol (0.3 ml) 
was added platinum on carbon (10% wt., 9.1 mg, 0.00467 mmol, 5 mol%). A three way tap 
fitted with a H2 balloon was attached, then the reaction flask was evacuated using a water 
aspirator and purged with H2. The evacuation/purge cycle was repeated twice and then the 
reaction vessel was filled with H2 gas. The mixture was stirred under a H2 atmosphere for 3 h 
and then filtered through a celite pad. Removal of the solvent via rotary evaporation gave the 
crude product which was purified by flash chromatography (10% ethyl acetate : hexane) to 
afford pure oxazolidine 141 (41 mg, 100%) as a colourless oil; Rf (10% ethyl acetate : 
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hexane) 0.61; [α]D +5.0 (c 1.9, CHCl3); IR (thin film) 2928, 2857 (C-H), 1704 (C=O) cm-1; 
1H NMR (300.1 MHz, CDCl3) δ 3.64 (1H, q, J = 6.2 Hz, C3-H), 3.59 (2H, t, J = 6.6 Hz, 
C10-H), 3.56-3.37 (1H, m, C2-H), 1.58-1.41 (10H, m, CH2, CH3), 1.47 (9H, s, tBu-CH3), 
1.34-1.28 (8H, m, CH2), 1.27 (3H, d, J = 6.1 Hz, C1-H), 0.88 (9H, s, SitBu-CH3), 0.03 (6H, s, 
Si-CH3); 13C NMR (75.5 MHz, CDCl3) δ 152.2, 93.5, 81.5, 79.4, 63.2, 57.9, 33.7, 32.8, 
29.6, 29.3, 28.5, 27.6-26.0 br, 26.0, 25.7, 19.8-18.3 br, 18.3, -5.3, 2C overlapping; m/z 
(ESI+) 482 (M+K, 8), 466 (M+Na, 100); HRMS (ESI+) calc. 466.3328 for C24H49NNaO4Si, 
found 466.3333. 
 
(4S, 5S)-5-(7’-Hydroxy-heptyl)-2,2,4-trimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
151 
 
NO
O
O
151
HO
1
410
 
 
To a solution of olefin 150 (62 mg, 0.189 mmol, 1.0 eq) in dry methanol (1.9 ml) was added 
platinum on carbon (10% wt., 18.5 mg, 0.00949 mmol, 5 mol%). A three way tap fitted with 
a H2 balloon was attached and then the reaction flask was evacuated using a water aspirator 
and purged with H2. The evacuation/purge cycle was repeated twice, before the reaction 
vessel was filled with H2 for the final time. The mixture was stirred under a H2 atmosphere 
for 3 h and then filtered through a celite pad. Removal of the solvent via rotary evaporation 
gave the crude product which was purified by flash chromatography (30% ethyl acetate : 
hexane) to afford pure alcohol 151 (57 mg, 92%) as a colourless oil; Rf (30% ethyl acetate : 
hexane) 0.39; [α]D +3.2 (c 1.4, CHCl3); IR (thin film) 3455 (OH), 2974, 2932, 2857 (C-H), 
1697 (C=O) cm-1; 1H NMR (300.1 MHz, CD3CN) δ 3.42 (1H, ddd, J = 7.6, 6.5, 4.8 Hz, 
C3-H), 3.30-3.14 (3H, m, C2-H, C10-H), 3.28 (1H, t, J = 5.4 Hz, OH), 1.27 (3H, s, CH3), 1.20 
(9H, s, tBu-CH3), 1.19 (3H, s, CH3), 1.28-1.07 (12H, m, CH2), 1.00 (3H, d, J = 6.1 Hz, 
C1-H); 13C NMR (75.5 MHz, CD3CN, 345K) δ 153.6, 95.0, 83.0, 80.6, 63.3, 59.5, 35.0, 
34.1, 30.7, 30.5, 29.2, 28.6, 27.6, 27.0, 26.9, 19.8; m/z (ESI+) 368 (M+K, 14), 352 (M+Na, 
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40), 330 (M+H, 20); HRMS (ESI+) calc. 352.2463 for C18H35NNaO4, found 352.2458 and 
calc. 330.2644 for C18H36NO4, found 330.2651. 
 
(4S, 5S)-2,2,4-Trimethyl-5-(7’-oxo-heptyl)-oxazolidine-3-carboxylic acid tert-butyl ester 58 
 
NO
O
O
58
O
1
410
 
 
To a solution of oxalyl chloride (42 µl, 0.481 mmol, 1.5 eq) in dichloromethane (0.62 ml) 
cooled to -78oC was added dry DMSO (68 µl, 0.958 mmol, 3.0 eq) dropwise under an 
atmosphere of N2. After stirring at -78oC for 20 min, a solution of alcohol 151 (105 mg, 
0.319 mmol, 1.0 eq) in dichloromethane (1.61 ml) was added dropwise via cannula, followed 
by triethylamine (0.3 ml, 2.15 mmol, 6.7 eq). The reaction mixture was stirred at -78oC for a 
further 2 h and then warmed to 0oC and quenched with saturated NaHCO3 solution. The 
mixture was separated and then the aqueous layer was extracted with dichloromethane (2 x 5 
ml). The combined organic extracts were washed with brine (10 ml), dried (MgSO4), filtered 
and evaporated to dryness. The crude residue was purified by flash chromatography (30% 
ethyl acetate : hexane) to afford pure aldehyde 58 (84 mg, 81%) as a colourless oil for 
characterisation; Rf (30% ethyl acetate : hexane) 0.68; [α]D +5.1 (c 1.0, CHCl3); IR (thin 
film) 2968, 2927, 2855 (C-H), 2710 (aldehyde C-H), 1727 (HC=O), 1694 (C=O) cm-1; 1H 
NMR (300.1 MHz, CDCl3) δ 9.76 (1H, t, J = 1.8 Hz, CHO), 3.64 (1H, q, J = 6.2 Hz, C3-H), 
3.57-3.40 (1H, m, C2-H), 2.42 (2H, dt, J = 7.3, 1.8 Hz, C9-H), 1.66-1.47 (10H, m, CH2, CH3), 
1.47 (9H, s, tBu-CH3), 1.39-1.23 (6H, m, CH2), 1.27 (3H, d, J = 6.0 Hz, C1-H); 13C NMR 
(75.5 MHz, CDCl3) δ 202.7, 152.2, 93.6 br, 81.4, 79.6 br, 57.9, 43.8, 33.6, 29.3, 29.0, 28.5, 
27.4-26.2 br, 25.6, 22.0, 19.6 br, 18.3 br; m/z (ESI+) 328 (M+H, 88); m/z (EI+/CI+) 328 
(M+H, 17), 312 (M-CH3, 7), 272 (8), 254 (M-C4H9O, 2), 228 (100), 212 (M-C5H9NO2, 8), 
169 (10), 84 (8), 57 (C4H9, 38); HRMS (ESI+) calc. 328.2487 for C18H34NO4, found 
328.2492. 
(Spectrum appended) 
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EXPERIMENTAL FOR CHAPTER 4 
 
5.6 Model Studies Towards the Installation of the Methyl Substituent at 
 C12. 
 
(7R*)-7-Hydroxy-tridecan-5-one 165 
 
O OH
1012
4R
165  
 
To a solution of dicyclohexylboron chloride (328 µl, 1.50 mmol, 1.5 eq) in anhydrous 
diethyl ether (15 ml) cooled to -78oC was added freshly distilled triethylamine (250 µl, 1.79 
mmol, 1.8 eq) dropwise followed by freshly distilled 2-hexanone (123 µl, 0.997 mmol, 1.0 
eq). The initially clear solution was rapidly clouded with a white precipitate. The reaction 
mixture was stirred at -78oC for 2 h and then freshly distilled heptaldehyde (1.07 ml, 7.66 
mmol, 7.7 eq) in diethyl ether (13.5 ml) was added dropwise via cannula and stirring 
continued for 1.5 h at this temperature. The reaction was warmed to 0oC and then quenched 
sequentially with pH 7.0 buffer (0.4 ml), methanol (0.4 ml) and 30% H2O2 (0.4 ml). After 
stirring vigorously for 15 min, the layers were separated and the aqueous phase was 
extracted with ether (3 x 5 ml). The combined organic extracts were washed with brine (20 
ml), dried (MgSO4), filtered and concentrated in vacuo. Cyclohexanol was removed from the 
crude mixture under high vacuum prior to purification by flash chromatography (10% ethyl 
acetate : hexane) to give racemic alcohol 165 (156 mg, 73%); Rf (10% ethyl acetate : 
hexane) 0.27; IR (thin film) 3426 (OH), 2930 (C-H), 1708 (C=O) cm-1; 1H NMR (400.2 
MHz, CDCl3) δ 4.01-3.99 (1H, m, C10-H), 3.07 (1H, br s, OH), 2.58 (1H, dd, J = 17.4, 2.8 
Hz, C11-Ha), 2.48 (1H, dd, J = 17.4, 9.0 Hz, C11-Hb), 2.41 (2H, t, J = 7.4 Hz, C13-H), 1.55 
(2H, quintet, J = 7.5 Hz, C14-H), 1.51-1.21 (12H, m, CH2), 0.89 (3H, t, J = 7.3 Hz, C4-H or 
C16-H), 0.89-0.85 (3H, ob t, C4-H or C16-H); 13C NMR (100.6 MHz, CDCl3) δ 212.6, 67.6, 
48.9, 43.4, 36.5, 31.8, 29.2, 25.7, 25.4, 22.6, 22.2, 14.0, 13.8; m/z (LSIMS+) 215 (M+H, 49), 
197 (M-OH, 100), 139 (27); HRMS (LSIMS+) calc. 215.2011 for C13H27O2, found 
215.2007. 
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(7R*)-7-(tert-Butyl-dimethyl-silanyloxy)-tridecan-5-one 164 
 
O OSiMe2
tBu
1012
164
R 4
 
 
To a solution of racemic alcohol 165 (1.64 g, 7.66 mmol, 1.0 eq) in dry, distilled DMF (5.5 
ml) at room temperature was added imidazole (3.13 g, 46.0 mmol, 6.0 eq) followed by tert-
butyldimethylsilyl chloride (3.46 g, 23.0 mmol, 3.0 eq) under an atmosphere of N2. The 
slightly exothermic reaction mixture was stirred at room temperature for 18 h and then 
quenched slowly with saturated aqueous NaHCO3 solution until effervescence ceased. The 
mixture was diluted with water (15 ml) and then extracted into diethyl ether (4 x 20 ml). The 
combined organic extracts were washed with water (2 x 20 ml), dried (MgSO4), filtered and 
concentrated under reduced pressure. Purification of the crude residue by flash 
chromatography (2.5% ethyl acetate : hexane) afforded racemic product 164 (2.54 g, 100%); 
Rf (2.5% ethyl acetate : hexane) 0.50; IR (thin film) 2956, 2930, 2857 (C-H), 1716 (C=O) 
cm-1; 1H NMR (200 MHz, CDCl3) δ 4.15 (1H, m, C10-H), 2.58 (1H, dd, J = 15.1, 7.1 Hz, 
C11-Ha), 2.45-2.36 (3H, m, C11-Hb, C13-H), 1.61-1.16 (14H, m, CH2), 0.93-0.84 (6H, m, 
C4-H, C16-H), 0.85 (9H, s, tBu-CH3), 0.05 (6H, s, Si-CH3); 13C NMR (50 MHz, CDCl3) 
δ 198.5, 69.3, 50.0, 44.4, 37.8, 31.8, 29.4, 25.8, 25.6, 25.0, 22.6, 22.3, 18.8, 14.1, 13.8, -4.2; 
m/z (EI+) 327 (M-H, 7), 313 (M-CH3, 9), 271 (M-tBu, 100), 229 (12), 185 (21), 157 (58), 
115 (SiMe2tBu, 12), 75 (47); HRMS (EI+) calc. 327.2719 for C19H39O2Si, found 327.2721.  
 
Carbonyl Methylenation. 
 
Dimethyl titanocene186 
 
Ti
CH3
CH3
 
 
To a 3-necked round-bottomed flask equipped with a large stirrer bar, thermometer, 
pressure-equalizing addition funnel connected to a N2 line and septum with a N2 inlet, was 
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added titanocene dichloride (8.00 g, 32.1 mmol, 1.0 eq) and dry toluene (88.4 ml). The red 
slurry was cooled to an internal temperature of -5oC then methylmagnesium chloride (24.1 
ml, 3.0 M in tetrahydrofuran, 72.3 mmol, 2.25 eq) was added via the pressure-equalizing 
addition funnel with stirring over 20 min so as to maintain the temperature below 0oC. The 
reaction mixture was aged for 2 h 15 min between -10oC and -5oC, during which time the 
insoluble red titanocene dichloride had dissolved. A 1H NMR assay on a quenched sample 
was taken to confirm reaction completion (a 0.2 ml sample was quenched into 1 ml of water 
and 1 ml of CDCl3 and then the chloroform layer was analysed directly). Excess 
methylmagnesium chloride in the resulting orange viscous mixture was quenched by 
addition to a 0oC solution of 6% aqueous ammonium chloride (22 ml) via cannula. After 
separating the layers, the organic phase was washed with cold water (2 x 80 ml) and brine (2 
x 80 ml), then dried over Na2SO4. The organic phase was evaporated to approximately half 
the original volume at ambient temperature. Weight % assay by 1H NMR showed the 
solution to contain 2.90 g of product (43%, 9.96% wt. solution in toluene) and to be of high 
purity with no traces of the starting material or monomethyl intermediate.☺
OSiMe2
tBu
1012
166
4
 The product was 
stored as a solution in toluene at -20oC for up to several months. 1H NMR (200 MHz, 
CDCl3) Cp2TiMe2: δ 6.05 (10H, s, Cp), -0.13 (6H, s, CH3). Cp2TiClMe: δ 6.26 (10H, s, Cp), 
0.81 (3H, s, CH3).  
 
(1R*)-tert-Butyl-(3-butyl-1-hexyl-but-3-enyloxy)-dimethyl-silane 166 
 
 
 
METHOD A: Petasis olefination. 
To a solution of ketone 164 (1.28 g, 3.90 mmol, 1.0 eq) in tetrahydrofuran (39 ml) was added 
dimethyl titanocene (10.9 ml, 0.479 M in toluene, 5.22 mmol, 1.3 eq) under an atmosphere 
of N2. The reaction mixture was stirred at 65oC in the dark for 22 h after which time the 
initial orange colour had changed to dark brown. The solution was diluted with a copious 
quantity of hexane and then the resulting yellow precipitate was removed by filtration. The 
                                                   
☺ Cp2TiClMe was visible in an assay of the reaction mixture after aging for 1.5 h. 
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filtrate was concentrated under reduced pressure to give a crude residue which was purified 
by flash chromatography (100% hexane) to give olefin 166 (0.882 g, 69%) as a colourless 
liquid; Rf (100% hexane) 0.58; IR (thin film) 3087 (C=C-H), 1645 (C=C) cm-1; 1H NMR 
(200 MHz, CDCl3) δ 4.75 (1H, br s, C=CH2), 4.73 (1H, br s, C=CH2), 3.82-3.71 (1H, m, 
C10-H), 2.25-2.06 (2H, m, C11-H), 2.01 (2H, t, J = 7.6 Hz, C13-H), 1.56-1.18 (14H, m, CH2), 
0.95-0.85 (6H, m, C4-H, C16-H), 0.89 (9H, s, tBu-CH3), 0.04 (6H, s, Si-CH3); 13C NMR (50 
MHz, CDCl3) δ 147.1, 111.4, 71.2, 44.4, 37.0, 36.1, 32.0, 30.0, 29.5, 26.0, 25.3, 22.7, 22.5, 
18.1, 14.1, 14.0, -4.2; m/z (EI+) 325 (M-H, 9), 311 (M-CH3, 41), 269 (M-tBu, 100), 229 
(51), 185 (14), 115 (SiMe2tBu, 5), 73 (17); HRMS (EI+) calc. 325.2927 for C20H41OSi, 
found 325.2929 and calc. 311.2770 for C19H39OSi, found 311.2773. 
 
METHOD B-1: Takai olefination.181-183 
 
O
10
11
168
4
 
 
Diiodomethane (249 mg, 0.930 mmol, 5.0 eq) was added at room temperature to a 
suspension of activated209 zinc powder (110 mg, 1.68 mmol, 9.0 eq) in tetrahydrofuran (1.86 
ml) under an argon atmosphere. After stirring for 30 min, a dichloromethane solution of 
TiCl4 (1 M, 186 µl, 0.186 mmol, 1.0 eq) was added at 0oC and then the resulting black-grey 
viscous mixture was stirred at room temperature for another 30 min. A solution of ketone 
164 (61.2 mg, 0.187 mmol, 1.0 eq) in tetrahydrofuran (0.37 ml) was added dropwise via 
cannula at room temperature. After stirring for 40 min, the reaction mixture turned white-
grey in colour. T.l.c. analysis showed no consumption of starting material and so the reaction 
was left to stir overnight. T.l.c. analysis of the brown coloured mixture after this time 
showed complete consumption of substrate 164 and considerable baseline material. The 
mixture was diluted with diethyl ether (10 ml) and the organic layer was washed with 1 M 
hydrochloric acid solution (10 ml) and brine (10 ml). After drying over MgSO4, the mixture 
was filtered and concentrated in vacuo. Flash chromatographic purification (2.5% diethyl 
ether : hexane) of the crude yellow residue afforded a fraction identified as the eliminated 
byproduct 168 (11.7 mg, 31%); Rf (2.5% diethyl ether : hexane) 0.30; IR (thin film) 1698, 
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1675 (α,β-unsaturated C=O), 1630 (C=C of an α,β-unsaturated carbonyl), 977 (C=C-H, out-
of-plane deformation); 1H NMR (200 MHz, CDCl3) δ 6.82 (1H, dt, J = 15.9, 6.9 Hz, C10-H), 
6.08 (1H, d, J = 16.0 Hz, C11-H), 2.52 (2H, t, J = 7.2 Hz, C13-H), 2.28-2.14 (2H, m, C9-H), 
1.70-1.10 (12H, m, CH2), 1.02-0.80 (6H, m, C4-H, C16-H).  
 
METHOD B-2: Methylenation using the Lombardo modified Takai methylenation.182,184,185  
To a dry round-bottomed flask was added activated zinc powder209 (30.6 mg, 0.468 mmol, 
4.6 eq), dry tetrahydrofuran (0.7 ml) and dibromomethane (9.2 µl, 0.131 mmol, 1.3 eq). The 
mixture was cooled to -40oC (dry ice/acetone) with stirring, then a solution of TiCl4 in 
dichloromethane (1 M, 130 µl, 0.130 mmol, 1.3 eq) was added dropwise. The dry 
ice/acetone bath was removed and then the reaction was stirred between -7oC and 0oC 
(water/ethanol and cold finger) for 3 days under a N2 atmosphere. Dry dichloromethane (0.2 
ml) was added to the grey-brown slurry maintained at 0oC (ice/water bath). To the stirred 
mixture was added a solution of ketone 164 (33 mg, 0.101 mmol, 1.0 eq) in dichloromethane 
(0.2 ml+0.2 ml) dropwise and then stirring was continued at room temperature for 1.5 h. 
T.l.c analysis showed complete consumption of starting material and considerable formation 
of baseline material. The mixture was diluted with pentane (0.3 ml) and then a slurry of 
NaHCO3 (1.7 g) in water (0.9 ml) was added cautiously with stirring. The clear organic layer 
was pipetted off and the residue extracted with pentane (5 x 5 ml). The combined organic 
layers were dried over a mixture of Na2SO4 (1 g) and NaHCO3 (0.2 g) and then shaken for 
10 min to remove the last traces of titanium salts. Filtration of the mixture and removal of the 
solvent under reduced pressure afforded a crude yellow liquid (46 mg) which was purified by 
flash chromatography (2.5% diethyl ether : hexane) to give the eliminated byproduct 168 
(trace). 
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(7R*)-7-(tert-Butyl-dimethyl-silanyloxy)-5-trimethylsilanylmethyl-tridecan-5-ol 167 
 
OSiMe2
tBu
167
Me3Si
HO
412
 
 
To a solution of racemic ketone 164 (72 mg, 0.219 mmol, 1.0 eq) in diethyl ether (1 ml) 
cooled to 0oC was added (trimethylsilylmethyl)magnesium chloride (0.715 M, 1.08 ml, 3.5 
eq) dropwise with stirring under an atmosphere of N2. The reaction mixture was stirred at 
room temperature overnight and then poured onto crushed ice. The magnesium compounds 
were dissolved with 2 M HCl and then the product was extracted with ether (3 x 15 ml). The 
combined organic layers were washed with brine (20 ml) and dried over MgSO4. After 
filtering the mixture and concentrating the filtrate under reduced pressure, purification by 
flash chromatography (5% ethyl acetate : hexane) afforded the racemic Peterson olefination 
precursor 167 (18.2 mg, 20%); Rf (5% ethyl acetate : hexane) 0.77; IR (thin film) 3521 
(OH), 2930, 2858 (C-H) cm-1; 1H NMR (200 MHz, CDCl3) δ 4.24-4.03 (1H, m, C10-H), 
1.73-1.13 (19H, m, CH2, OH), 0.96-0.84 (17H, m, Si-CH2, tBu-CH3, C4-H, C16-H), 0.14 (3H, 
s, Si-CH3), 0.12 (3H, s, Si-CH3), 0.04 (9H, s, Si-CH3).  
 
(4R*)-2-Butyl-dec-1-en-4-ol 169  
 
OH
1012
169
4
 
 
To a stirring solution of the silyl ether 166 (0.882 g, 2.71 mmol, 1.0 eq) in dry 
tetrahydrofuran (39 ml) at room temperature was added a solution of tetrabutylammonium 
fluoride in tetrahydrofuran (1 M, 10.7 mmol, 3.9 eq) under a N2 atmosphere. The reaction 
mixture was stirred for 43 h and then poured into brine (150 ml). After separating the layers, 
the aqueous phase was extracted with diethyl ether (3 x 50 ml). The combined organic 
extracts were washed with brine (80 ml) and then dried (MgSO4), filtered and concentrated 
under reduced pressure to afford a crude liquid which was purified by flash chromatography 
(5% diethyl ether : hexane) to yield racemic alcohol 169 (522 mg, 92%) as a colourless 
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liquid; Rf (5% diethyl ether : hexane) 0.29; IR (thin film) 3355 (OH), 3072 (C=C-H), 2956-
2857 (C-H, 3 bands), 1644 (C=C), 890 (C=C-H out-of-plane deformation) cm-1; 1H NMR 
(200 MHz, CDCl3) δ 4.88 (1H, s, C=CH2), 4.83 (1H, s, C=CH2), 3.80-3.62 (1H, m, C10-H), 
2.25 (1H, dd, J = 13.7, 3.2 Hz, C11-Ha), 2.13-1.94 (3H, m, C11-Hb, C13-H), 1.72 (1H, d, J = 
2.4 Hz, OH), 1.58-1.13 (14H, m, CH2), 0.99-0.80 (6H, m, C4-H, C16-H); 13C NMR (50 MHz, 
CDCl3) δ 147.3, 112.1, 68.7, 44.5, 37.1, 35.5, 31.8, 29.9, 29.4, 25.2, 22.6, 22.4, 14.1, 14.0; 
m/z (EI+) 212 (M, 0.5), 194 (M-H2O, 6), 165 (2), 113 (2), 98 (18), 83 (53), 70 (100); HRMS 
(EI+) calc. 194.2035 for C14H26, found 194.2033. 
 
(5R*, 7R*)-5-Methyl-tridecan-7-ol 179 and (5S*, 7R*)-5-methyl-tridecan-7-ol 180 
 
OH
1012
179
OH
1012
180  
 
METHOD A: Hydrogenation using Wilkinson’s catalyst RhCl(PPh3)3 
A 10 ml round-bottomed flask containing olefin 169 (34.3 mg, 0.162 mmol, 1.0 eq) was 
charged with degassed dry benzene (3.2 ml) followed by Wilkinson’s catalyst 170 (15 mg, 
0.0162 mmol, 10 mol%). The reaction vessel was purged with Ar gas and then placed into a 
hydrogenation bomb apparatus. The bomb was purged with H2 and evacuated three times 
before being pressurised to 300 psi with H2 gas. The reaction was stirred at 300 psi for 48 h 
at room temperature after which time the reaction had changed in colour from clear yellow-
orange to brown. The mixture was filtered through florisil and the filter cake was washed 
with diethyl ether. The solvent was removed under reduced pressure to afford a crude residue 
which was purified by flash chromatography to give a mixture of anti-179 (GC tR 14.48 min) 
and syn-180 (GC tR 14.36 min) diastereomers in a ratio of 52:48 as determined by GC (SGE 
BPX70, 260oC, 110 kPa) and in a combined yield of 28.6 mg (82%). HPLC separation (2.5% 
ethyl acetate : hexane) of the diastereomers afforded racemic anti-179 (tR ~5.40 min) as a 
colourless oil; Rf (5% diethyl ether : hexane) 0.17; IR (thin film) 3346 (OH), 2956, 2926, 
2856 (C-H stretch) cm-1; 1H NMR (200 MHz, CDCl3) δ 3.74-3.56 (1H, m, C10-H), 1.72-1.50 
(1H, m, C12-H), 1.50-1.00 (19H, m, OH, CH2), 1.00-0.73 (9H, m, C4-H, C12-CH3, C16-H); 
13C NMR (50 MHz, CDCl3) δ 69.6, 45.0, 38.4, 37.6, 31.8, 29.4, 29.2, 25.6, 22.9, 22.6, 19.2, 
14.1, 14.0, 1C overlapping; m/z (EI+) 214 (M, 3), 213 (M-H, 18), 197 (M-OH, 7), 196 
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(M-H2O, 29), 168 (2), 154 (15), 140 (7), 139 (9), 129 (87), 115 (70), 111 (81), 97 (100), 85 
(70), 69 (88), 55 (100); HRMS (EI+) calc. 213.2218 for C14H29O, found 213.2219.  
 
The second fraction afforded racemic syn-180 (tR ~16.40 min); Rf (5% diethyl ether : 
hexane) 0.17; IR (thin film) 3332 (OH), 2956, 2923, 2856 (C-H stretch) cm-1; 1H NMR (200 
MHz, CDCl3) δ 3.81-3.61 (1H, m, C10-H), 1.73-1.04 (20H, m, C12-H, CH2, OH), 1.04-0.82 
(9H, m, C4-H, C12-CH3, C16-H); 13C NMR (50 MHz, CDCl3) δ 70.0, 45.3, 37.8, 36.3, 31.8, 
29.6, 29.4, 29.1, 25.5, 23.0, 22.6, 20.4, 14.1, 1C overlapping; m/z (EI+) 214 (M, 1), 213 
(M-H, 10), 197 (M-OH, 4), 196 (M-H2O, 22), 168 (1), 154 (10), 140 (4), 139 (5), 129 (78), 
115 (63), 111 (72), 97 (89), 85 (66), 69 (87), 55 (100); HRMS (EI+) calc. 213.2218 for 
C14H29O, found 213.2215. 
 
METHOD B: Hydrogenation using [Rh(NBD)(dppb)]+. 
A solution of racemic olefin 169 (69.8 mg, 0.329 mmol, 1.0 eq) and [1,4-
bis(diphenylphosphino)butane](norbornadiene)rhodium(I) tetrafluoroborate 171 (23 mg, 
0.0325mmol, 9.9 mol%) in dichloromethane (5.3 ml) was stirred under a H2 atmosphere of 
340 psi for 22 h at room temperature. The resulting brown solution was filtered through a 
short plug of silica gel (50% ethyl acetate : hexane) to remove the catalyst. The solvent was 
concentrated in vacuo to give a colourless oil (60 mg, 85%). Diastereomer analysis by GC 
(SGE BPX70, 220oC, 110 kPa) gave a ratio of 61:39 for anti-179 (tR 14.23 min) and syn-180 
(tR 14.13 min) respectively. The two diastereomers were separated by HPLC (2.5% ethyl 
acetate : hexane) to give pure racemic anti-179 (35.4 mg) and syn-180 (23.2 mg). 
 
METHOD C: Hydrogenation using Crabtree’s catalyst [Ir(COD)py(PChx3)]+. 
An orange coloured solution of olefin 169 (98.7 mg, 0.466 mmol, 1.0 eq) and Crabtree’s 
catalyst 172 (9.4 mg, 0.0117mmol, 2.5 mol%) in dichloromethane (18.6 ml) was stirred 
under a H2 gas balloon for 18 h at room temperature. The resulting pale yellow solution was 
filtered through a short plug of silica gel (10% ethyl acetate : hexane) to remove the catalyst. 
The solvent was concentrated in vacuo to give a colourless oil which was further purified by 
flash chromatography (5% ethyl acetate : hexane) to afford a mixture of anti-179 and syn-
180 diastereomers (96.9 mg, 97%) in a ratio of 39:61 respectively as determined by GC 
analysis (SGE BPX70, 220oC, 110 kPa).  
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(1R*, 2’’S*, 3R*)-2’’-Methoxy-naphthalen-2’-yl-acetic acid 1-hexyl -3-methyl-heptyl ester 
and (1R*, 2’’R*, 3R*)-2’’-methoxy-naphthalen-2’-yl-acetic acid 1-hexyl -3-methyl-heptyl 
ester 
 
(2'S*,10R*)-NMA ester of 179
O
1012
O
O
1012
O
OCH3OCH3
2' 2'
(2'R*,10R*)-NMA ester of 179  
 
To a solution of racemic anti-179 (23.9 mg, 0.112 mmol, 1.0 eq) and racemic 2-
naphthylmethoxyacetic acid☼
                                                   
☼ 2-Naphthylmethoxyacetic acid was kindly prepared by Dr. Malcolm D. McLeod in racemic form following Scheme 
14 outlined in Chapter 4. 
 (31.5 mg, 0.146 mmol, 1.3 eq) in dry dichloromethane (3.0 
ml) at room temperature was added a solution of 1,3-dicyclohexylcarbodiimide (45.8 mg, 
0.222mmol, 2.0 eq) and 4-N,N-dimethylaminopyridine (2.8 mg, 0.0229mmol, 0.2 eq) in 
dichloromethane (110 µl) under an atmosphere of N2. The initially clear reaction mixture 
turned cloudy white in colour. After stirring at room temperature for 3.5 h, t.l.c analysis 
confirmed the absence of starting material. The reaction mixture was filtered through celite 
and then the filter cake was washed with dichloromethane. Removal of the solvent under 
reduced pressure afforded a crude mixture which was purified by flash chromatography 
(20% diethyl ether : hexane) to give the title compounds as clear oils (40.7 mg, 88%). HPLC 
separation (0.75% ethyl acetate : hexane) of the mixture yielded two fractions. The first 
fraction was proposed as racemic diastereomer (2’S*,10R*)-NMA ester of 179 (15.9 mg, tR 
6.46 min [3% ethyl acetate : hexane]); Rf (20% diethyl ether : hexane) 0.75; IR (thin film) 
3057 (aryl C-H), 2922, 2856 (C-H), 1747 (C=O), 1602, 1508 (C=C) cm-1; 1H NMR (400.2 
MHz, CDCl3) δ 7.92 (1H, s, Ar-H), 7.85-7.81 (3H, m, Ar-H), 7.56 (1H, dd, J = 8.5, 1.4 Hz, 
Ar-H), 7.50-7.46 (2H, m, Ar-H), 5.10-5.00 (1H, m, C10-H), 4.90 (1H, s, CHOCH3), 3.46 (3H, 
s, OCH3), 1.64-1.58 (1H, m, C11-Ha), 1.40-0.84 (18H, m, CH2, C11-Hb, C12-H), 0.86 (3H, t, J 
= 7.2 Hz, C16-H), 0.82 (3H, d, J = 6.5 Hz, C12-CH3), 0.71 (3H, t, J = 7.2 Hz, C4-H); 13C 
NMR (100.6 MHz, CDCl3) δ 170.5, 134.0, 133.4, 133.2, 128.3, 128.1, 127.7, 126.6, 126.3, 
Chapter 5 
 149 
126.2, 124.5, 82.9, 73.6, 57.3, 41.7, 37.2, 34.9, 31.5, 29.2, 29.1, 29.0, 24.7, 22.9, 22.3, 19.4, 
14.1, 13.9; m/z (EI+) 412 (M, 7), 185 (3), 171 (C12H11O, 100), 155 (16), 141 (3), 128 (C10H8, 
10), 127 (10), 85 (6), 71 (8); HRMS (EI+) calc. 412.2977 for C27H40O3, found 412.2972. 
 
The second fraction was proposed as racemic diastereomer (2’R*,10R*)-NMA ester of 179 
(21.5 mg, tR 6.85 min [3% ethyl acetate : hexane]); Rf (20% diethyl ether : hexane) 0.75; IR 
(thin film) 3057 (aryl C-H), 2926 (C-H), 1745 (C=O), 1602, 1509 (C=C) cm-1; 1H NMR 
(400.2 MHz, CDCl3) δ 7.91 (1H, s, Ar-H), 7.84-7.80 (3H, m, Ar-H), 7.55 (1H, dd, J = 8.5, 
1.5 Hz, Ar-H), 7.51-7.46 (2H, m, Ar-H), 5.08-5.00 (1H, m, C10-H), 4.89 (1H, s, CHOCH3), 
3.46 (3H, s, OCH3), 1.58-1.41 (2H, m, C9-Ha, C11-Ha), 1.28-1.14 (9H, m, CH2, C9-Hb), 1.07-
0.99 (1H, m, C11-Hb), 0.99-0.71 (7H, m, C12-H, CH2), 0.84 (3H, t, J = 7.1 Hz, C4-H), 0.68 
(3H, t, J = 7.1 Hz, C16-H), 0.58 (3H, d, J = 6.2 Hz, C12-CH3); 13C NMR (100.6 MHz, CDCl3) 
δ 170.5, 134.0, 133.5, 133.1, 128.3, 128.1, 127.7, 126.8, 126.3, 126.2, 124.5, 82.8, 73.5, 
57.3, 41.8, 37.2, 35.2, 31.7, 29.1, 28.9, 28.7, 25.2, 22.7, 22.5, 18.9, 14.0, 14.0; m/z (EI+) 412 
(M, 13), 185 (3), 171 (C12H11O, 100), 155 (15), 141 (3), 127 (9), 85 (6), 71 (7); HRMS (EI+) 
calc. 412.2977 for C27H40O3, found 412.2973. 
 
(1R*, 2’’R*, 3S*)-2’’-Methoxy-naphthalen-2’-yl-acetic acid 1-hexyl -3-methyl-heptyl ester 
and (1R*, 2’’S*, 3S*)-2’’-methoxy-naphthalen-2’-yl-acetic acid 1-hexyl -3-methyl-heptyl 
ester 
 
O
1012
O
OCH3
(2'R*,10R*)-NMA ester of 180 (2'S*,10R*)-NMA ester of 180
O
1012
O
OCH3
2' 2'
 
 
To a solution of racemic syn-180 (23.7 mg, 0.111 mmol, 1.0 eq) and racemic 2-
naphthylmethoxyacetic acid (30.2 mg, 0.140 mmol, 1.3 eq) in dry dichloromethane (3.0 ml) 
at room temperature was added a solution of 1,3-dicyclohexylcarbodiimide (43.8 mg, 0.212 
mmol, 1.9 eq) and 4-N,N-dimethylaminopyridine (2.7 mg, 0.0221 mmol, 0.2 eq) in 
dichloromethane (105 µl) under an atmosphere of N2. The initially clear reaction mixture 
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turned cloudy white in colour. After stirring at room temperature for 3.5 h, t.l.c analysis 
showed complete consumption of the starting material. The reaction mixture was filtered 
through celite and then the filter cake was washed with dichloromethane. Removal of the 
solvent under reduced pressure afforded a crude mixture which was purified by flash 
chromatography (20% diethyl ether : hexane) to give the title compounds as a clear oil (38 
mg, 83%). HPLC separation (0.75% ethyl acetate : hexane) of the diastereomers yielded two 
fractions. The first fraction was proposed as racemic diastereomer (2’R*,10R*)-NMA ester of 
180 (17.1 mg, tR 6.37 min [3% ethyl acetate : hexane]); Rf (20% diethyl ether : hexane) 0.77; 
IR (thin film) 3057 (aryl C-H), 2926 (C-H), 1747 (C=O), 1602, 1509 (C=C) cm-1; 1H NMR 
(400.2 MHz, CDCl3) δ 7.92 (1H, s, Ar-H), 7.85-7.80 (3H, m, Ar-H), 7.56 (1H, dd, J = 8.5, 
1.7 Hz, Ar-H), 7.50-7.46 (2H, m, Ar-H), 5.03-4.95 (1H, m, C10-H), 4.90 (1H, s, CHOCH3), 
3.46 (3H, s, OCH3), 1.55-1.47 (1H, m, C9-Ha), 1.33-0.94 (16H, m, CH2, C9-Hb, C12-H), 0.92-
0.77 (2H, m, CH2), 0.84 (3H, t, J = 6.9 Hz, C4-H), 0.74 (3H, t, J = 6.8 Hz, C16-H), 0.59 (3H, 
d, J = 6.6 Hz, C12-CH3); 13C NMR (100.6 MHz, CDCl3) δ 170.4, 133.9, 133.4, 133.2, 128.3, 
128.1, 127.7, 126.6, 126.3, 126.2, 124.5, 83.0, 74.0, 57.3, 41.7, 35.7, 34.6, 31.7, 29.1, 29.0, 
28.8, 25.1, 22.7, 22.5, 19.8, 14.0, 14.0; m/z (EI+) 412 (M, 9), 185 (3), 171 (C12H11O, 100), 
155 (16), 141 (3), 127 (10), 85 (6), 71 (8); HRMS (EI+) calc. 412.2977 for C27H40O3, found 
412.2973. 
 
The second fraction was proposed as racemic diastereomer (2’S*,10R*)-NMA ester of 180 
(18.9 mg, tR 6.72 min [3% ethyl acetate : hexane]); Rf (20% diethyl ether : hexane) 0.77; IR 
(thin film) 3057 (aryl C-H), 2926 (C-H), 1748 (C=O), 1602, 1508 (C=C) cm-1; 1H NMR 
(400.2 MHz, CDCl3) δ 7.92 (1H, s, Ar-H), 7.86-7.80 (3H, m, Ar-H), 7.56 (1H, dd, J = 8.5, 
1.7 Hz, Ar-H), 7.50-7.46 (2H, m, Ar-H), 5.05-4.93 (1H, m, C10-H), 4.89 (1H, s, CHOCH3), 
3.46 (3H, s, OCH3), 1.48-0.76 (25H, m, CH2, C12-H, C12-CH3, C16-H), 0.70 (3H, t, J = 7.2 
Hz, C4-H); 13C NMR (100.6 MHz, CDCl3) δ 170.4, 134.0, 133.5, 133.2, 128.3, 128.1, 127.7, 
126.7, 126.3, 126.2, 124.5, 82.9, 73.9, 57.3, 41.6, 36.2, 34.3, 31.4, 29.5, 29.0, 29.0, 24.6, 
22.9, 22.3, 20.0, 14.1, 13.9; m/z (EI+) 412 (M, 9), 185 (3), 171 (C12H11O, 100), 155 (16), 
141 (3), 127 (10), 85 (6), 71 (8); HRMS (EI+) calc. 412.2977 for C27H40O3, found 412.2973. 
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5.7 Preparation of the C4-C20 Fragment of Fumonisin B3. 
 
(1”R, 2S, 4S, 4’R, 5R)-4’-Hydroxy-1’-[2-(p-methoxy-phenyl)-5-(1”-methyl-pentyl)-
[1,3]dioxolan-4-yl]-decan-2’-one 159 and (1”R, 2S, 4S, 4’S, 5R)-4’-hydroxy-1’-[2-(p-
methoxy-phenyl)-5-(1”-methyl-pentyl)-[1,3]dioxolan-4-yl]-decan-2’-one 160 
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METHOD A: Methyl ketone aldol reaction using c-hexyl2BCl. 
To a -78oC solution of methyl ketone 57 (364 mg, 1.14 mmol, 1.0 eq) in anhydrous diethyl 
ether (23.4 ml) was added dry, distilled triethylamine (396 µl, 2.84 mmol, 2.5 eq) followed 
by dicyclohexylboron chloride (547 µl, 2.50 mmol, 2.2 eq) with stirring under an atmosphere 
of N2. The resulting cloudy white mixture was stirred at -78oC for 3-4 h and then distilled 
neat heptaldehyde (794 µl, 5.69 mmol, 5.0 eq) was added via syringe. The reaction mixture 
was stirred for a further 1h 45 min at -78oC and then quenched at 0oC by the sequential 
addition of pH 7.0 buffer (0.6 ml), methanol (0.6 ml) and 30% H2O2 (0.6 ml). After stirring 
for 15 min at 0oC, the layers were separated and then the aqueous phase was extracted with 
diethyl ether (2 x 2 ml). The combined organic extracts were washed with brine (15 ml) and 
then dried (Na2SO4), filtered and concentrated under reduced pressure. The crude product 
was purified by flash chromatography (20% ethyl acetate : hexane) using silica gel 
deactivated with 0.1% triethylamine to give an inseparable mixture of aldol products 159 and 
160 (318 mg, 64%) in a diastereomeric ratio of 62:38 respectively as determined by 100.6 
MHz 13C NMR. Attempts to isolate the diastereomers by HPLC resulted in decomposition. 
The title compounds were characterised as a mixture; Rf (20% ethyl acetate : hexane) 0.39; 
[α]D -65.4 (c 0.84, CHCl3); IR (thin film) 3500 (OH), 1714 (C=O), 1614, 1517 (C=C), 830 
(C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.39 (2H, d, J = 8.6 
Hz, Ar-H), 6.89 (2H, d, J = 8.6 Hz, Ar-H), 5.74 (1H, s, Ar-CH), 4.65 (1H, ddd, J = 10.4, 5.7, 
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2.8 Hz, C14-H), 4.02-3.94 (1H, m, C10-H), 3.84 (1H, dd, J = 9.9, 5.8 Hz, C15-H), 3.81 (3H, s, 
OCH3), 2.74 (1H, dd, J = 14.7, 10.5 Hz, C13-Ha), 2.52-2.47 (2H, m, C11-H), 2.43 (1H, dd, J = 
14.8, 2.8 Hz, C13-Hb), 1.85-1.73 (1H, m, C9-Ha or C17-Ha), 1.70-1.60 (1H, m, C16-H), 1.48-
1.17 (16H, m, CH2, C9-Ha or C17-Ha, C9-Hb, C17-Hb, OH), 0.94-0.84 (6H, m, C4-H, C20-H), 
0.90 (3H, d, J = 6.5 Hz, C16-CH3); 13C NMR (100.6 MHz, CDCl3) δ 210.2, 160.3, 130.0, 
127.9, 113.7, 103.2, 84.4, 74.2 (74.0), (67.6) 67.3, 55.2, 50.8, 50.2, (44.8) 44.6, (36.4) 36.3, 
33.4, 32.4, 31.7, 29.1, 28.4, 25.3, 22.9, 22.5, 15.7, 14.0; m/z (EI+) 434 (M, 7), 433 (M-H, 
10), 349 (10), 319 (18), 281 (38), 263 (15), 235 (28), 206 (8), 167 (88), 135 (100), 108 (87), 
77 (25); HRMS (EI+) calc. 434.3032 for C26H42O5, found 434.3024. 
 
METHOD B-1: Methyl ketone aldol reaction using (+)-Ipc2BCl. 
To a -40oC solution of methyl ketone 57 (71 mg, 0.222 mmol, 1.0 eq) in anhydrous diethyl 
ether (4.6 ml) was added dry, distilled triethylamine (77.3 µl, 0.555 mmol, 2.5 eq) followed 
by (+)-diisopinocampheylboron chloride (163 mg, 0.508 mmol, 2.3 eq) with stirring under an 
atmosphere of N2. The resulting cloudy yellow mixture was stirred between -60oC and -25oC 
for 4 h and then neat distilled heptaldehyde (185 µl, 1.33 mmol, 6.0 eq) was added at -78oC 
via syringe. The reaction mixture was stirred for a further 1h 30 min at -78oC and then at 
-23oC for 17 h. The mixture was quenched at 0oC by the sequential addition of pH 7.0 buffer 
(0.2 ml), methanol (0.2 ml) and 30% H2O2 (0.2 ml). The solution was stirred for 20 min at 
0oC and then the layers were separated. The aqueous phase was extracted with diethyl ether 
(2 x 2 ml) and the combined organic extracts were washed with brine (5 ml), dried (Na2SO4), 
filtered and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (20% ethyl acetate : hexane) using silica deactivated with 0.1% 
triethylamine to give an inseparable mixture of aldol products 159 and 160 (35 mg, 36%) 
along with recovered starting material (22 mg). The diastereomer ratio of 159 and 160 was 
determined as 76:24 respectively by 100.6 MHz 13C NMR. 
 
METHOD B-2: Methyl ketone aldol reaction using (-)-Ipc2BCl. 
To a -40oC solution of methyl ketone 57 (61 mg, 0.191 mmol, 1.0 eq) in anhydrous diethyl 
ether (4.0 ml) was added dry, distilled triethylamine (66.4 µl, 0.476 mmol, 2.5 eq) followed 
by a solution of (-)-diisopinocampheylboron chloride (135 mg, 0.421 mmol, 2.2 eq) in a 
minimum volume of dichloromethane. The resulting cloudy white mixture was stirred at 
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-40oC under an atmosphere of N2 for 4 h and then neat distilled heptaldehyde (133 µl, 0.953 
mmol, 5.0 eq) was added at -78oC via syringe. The reaction mixture was stirred for a further 
2h 45 min between -78oC and -40oC and then quenched at 0oC by the sequential addition of 
pH 7.0 buffer (0.1 ml), methanol (0.1 ml) and 30% H2O2 (0.1 ml). After stirring the solution 
for 20 min at 0oC, the layers were separated. The aqueous phase was extracted with diethyl 
ether (2 x 1 ml) and the combined organic extracts were washed with brine (5 ml), dried 
(Na2SO4), filtered and concentrated under reduced pressure. The crude product was purified 
by flash chromatography (20% ethyl acetate : hexane) using silica deactivated with 0.1% 
triethylamine to give an inseparable mixture of aldol products 159 and 160 (40 mg, 48%) 
along with recovered starting material. The diastereomer ratio of anti-159 and syn-160 was 
determined as 67:33 respectively by 100.6 MHz 13C NMR. 
 
(R)-MTPA-ester derivatives 162 and (R)-MTPA of 160 
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To a solution of alcohols 159 and 160 (31.0 mg, 0.0714 mmol, 1.0 eq) in dry 
dichloromethane (3.2 ml) at room temperature was added a solution of 1,3-
dicyclohexylcarbodiimide (41.3mg, 0.200 mmol, 2.8 eq) and 4-N,N-dimethylaminopyridine 
(2.6 mg, 0.0214 mmol, 0.3 eq) in dichloromethane (100 µl) followed by (R)-MTPA acid (25 
mg, 0.107 mmol, 1.5 eq) under an atmosphere of N2. The initially clear reaction mixture 
turned cloudy white in colour. The mixture was stirred at room temperature for 2.5 h and 
then filtered through a pad of celite. Removal of the solvent under reduced pressure afforded 
a crude mixture which was purified by flash chromatography (20% ethyl acetate : hexane) 
using silica gel deactivated with 0.1% triethylamine. A clear oil of the (R)-MTPA-derivatives 
above was obtained as an inseparable mixture (40.6 mg, 97%). Data for the major isomer 
162 is as follows; Rf (20% ethyl acetate : hexane) 0.59; 1H NMR (400.2 MHz, CDCl3) δ 
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7.55-7.43 (2H, m, Ar-H), 7.43-7.33 (5H, m, Ar-H), 6.89 (2H, d, J = 8.6 Hz, Ar-H), 5.75 (1H, 
s, Ar-CH), 5.51-5.42 (1H, m, C10-H), 4.58 (1H, ddd, J = 10.5, 5.8, 2.7 Hz, C14-H), 3.82 (1H, 
dd, J = 9.9, 5.9 Hz, C15-H), 3.79 (3H, s, OCH3), 3.47 (3H, s, MTPA-OCH3), 2.78 (1H, dd, J 
= 17.6, 7.6 Hz, C11-Ha), 2.70 (1H, dd, J = 14.5, 10.6 Hz, C13-Ha), 2.56 (1H, dd, J = 17.7, 4.9 
Hz, C11-Hb), 2.36 (1H, dd, J = 14.6, 2.6 Hz, C13-Hb), 1.84-1.47 (5H, m, C9-H, C16-H, C17-H), 
1.45-1.00 (12H, m, CH2), 0.90-0.83 (9H, m, C4-H, C16-CH3, C20-H).  
 
(S)-MTPA-ester derivatives 161 and (S)-MTPA of 160 
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To a solution of alcohols 159 and 160 (119 mg, 0.274 mmol, 1.0 eq) in dry dichloromethane 
(12.2 ml) at room temperature was added a solution of 1,3-dicyclohexylcarbodiimide (108 
mg, 0.523 mmol, 1.9 eq) and 4-N,N-dimethylaminopyridine (6.7 mg, 0.0548 mmol, 0.2 eq) 
in dichloromethane (261 µl) followed by (S)-MTPA acid (80.3 mg, 0.343 mmol, 1.25 eq) 
under an atmosphere of N2. The initially clear reaction mixture turned cloudy white in 
colour. After stirring at room temperature for 2.5 h, the mixture was filtered through a pad of 
celite and then the filter cake was washed with dichloromethane. Removal of the solvent 
under reduced pressure afforded a crude mixture which was purified by flash 
chromatography (20% ethyl acetate : hexane) using silica gel deactivated with 0.1% 
triethylamine. A clear oil of the (S)-MTPA-derivatives above was obtained as an inseparable 
mixture (53 mg, 30%). Data for the major isomer 161 is as follows; Rf (20% ethyl acetate : 
hexane) 0.74; 1H NMR (400.2 MHz, CDCl3) δ 7.60-7.53 (1H, m, Ar-H), 7.53-7.45 (1H, m, 
Ar-H), 7.45-7.29 (5H, m, Ar-H), 6.88 (2H, d, J = 8.5 Hz, Ar-H), 5.74 (1H, s, Ar-CH), 5.53-
5.43 (1H, m, C10-H), 4.59-4.50 (1H, m, C14-H), 3.83-3.79 (1H, ob dd, J = obscure, 5.8 Hz, 
C15-H), 3.79 (3H, s, OCH3), 3.50 (3H, s, MTPA-OCH3), 2.74 (1H, dd, J = 17.6, 7.9 Hz, C11-
Ha), 2.65 (1H, dd, J = 14.8, 10.7 Hz, C13-Ha), 2.51 (1H, dd, J = 17.5, 4.9 Hz, C11-Hb), 2.27 
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(1H, dd, J = 14.7, 2.4 Hz, C13-Hb), 1.87-0.96 (17H, m, CH, CH2), 0.96-0.80 (9H, m, C4-H, 
C16-CH3, C20-H).  
 
METHOD C: Methyl ketone aldol reaction using excess c-hexyl2BCl. 
 
(1”R, 6S, 7R)-6-Hydroxy-3-(1’-hydroxy-heptyl)-2-(p-methoxy-phenyl)-7-(1”-methyl-
pentyl)-oxepan-4-one 154 
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To a solution of dicyclohexylboron chloride (206 µl, 0.943 mmol, 5.9 eq) in diethyl ether 
(2.0 ml) cooled to 0oC was added distilled triethylamine (158 µl, 1.13 mmol, 7.0 eq), 
followed by methyl ketone 57 (51.4 mg, 0.161 mmol, 1.0 eq) in diethyl ether (2 ml + 2 ml). 
The resulting cloudy yellow mixture was stirred for 2 h 30 min at 0oC under an atmosphere 
of N2. The reaction mixture was cooled to -78oC and then distilled heptaldehyde (173 µl, 
1.24 mmol, 7.7 eq) was added via syringe. After stirring at -78oC for a further 45 min, the 
mixture was warmed to 0oC and then quenched by the sequential addition of pH 7.0 buffer 
(0.2 ml), methanol (0.2 ml) and 30% H2O2 (0.2 ml). The solution was stirred for 15 min at 
0oC then the layers were separated. The aqueous phase was extracted with diethyl ether (2 x 
2 ml) and the combined organic extracts were washed with water (5 ml) and then dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude product was purified 
by flash chromatography (30% ethyl acetate : hexane) to give the title compound 154 (28.3 
mg, 41%) as a colourless oil which solidified in the freezer. The rearranged product 154 was 
shown to be a single diastereomer by 13C NMR; Rf (30% ethyl acetate : hexane) 0.30; [α]D 
+23.0 (c 0.31, CHCl3); IR (thin film) 3438 (OH), 2927 (C-H), 1694 (C=O), 1613, 1514 
(C=C), 833 (C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.23 (2H, 
d, J = 8.8 Hz, Ar-H), 6.90 (2H, d, J = 8.8 Hz, Ar-H), 5.22 (1H, d, J = 3.2 Hz, Ar-CH), 4.26-
4.21 (1H, m, C14-H), 3.81 (3H, s, OCH3), 3.70-3.63 (2H, m, C10-H, C15-H), 3.31 (1H, dd, J = 
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13.6, 2.0 Hz, C13-Ha), 2.86 (1H, dd, J = 13.6, 7.3 Hz, C13-Hb), 2.79 (1H, t, J = 3.2 Hz, 
C11-H), 1.87-1.79 (1H, m, C16-H), 1.60-1.50 (1H, m, C17-Ha), 1.44-1.07 (17H, m, C17-Hb, 
OH, CH2), 1.02 (3H, d, J = 6.8 Hz, C16-CH3), 0.89 (3H, t, J = 7.0 Hz, C4-H), 0.82 (3H, t, J = 
6.9 Hz, C20-H); 13C NMR (100.6 MHz, CDCl3) δ 210.4, 158.9, 131.2, 126.6, 113.9, 90.9, 
79.5, 69.6, 69.5, 62.4, 55.2, 50.7, 36.5, 34.9, 31.6, 31.1, 29.2, 29.0, 25.6, 22.9, 22.5, 16.4, 
14.1, 14.0; m/z (EI+) 434 (M, 0.2), 416 (M-H2O, 2), 349 (3), 319 (M-C7H15O, 13), 302 (8), 
231 (8), 227 (16), 206 (66), 161 (41), 134 (100), 115 (C7H15O, 10), 91 (31), 71 (54); HRMS 
(EI+) calc. 434.3032 for C26H42O5, found 434.3025. 
 
(R)-MTPA-ester derivative of 154  
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To a solution of alcohol 154 (8.2 mg, 0.0189 mmol, 1.0 eq) and (R)-MTPA acid (5.2 mg, 
0.0222 mmol, 1.17 eq) in dry dichloromethane (0.5 ml) at room temperature was added a 
solution of 1,3-dicyclohexylcarbodiimide (7.0 mg, 0.0340 mmol, 1.8 eq) and 4-N,N-
dimethylaminopyridine (0.48 mg, 0.00391 mmol, 0.2 eq) in dichloromethane (17 µl) under 
an atmosphere of N2. The resulting cloudy mixture was sonicated at room temperature for 2 
h, after which time t.l.c analysis showed approximately 50% conversion of the starting 
material. Despite this, the reaction mixture was filtered through a pad of celite and then the 
filter cake was washed with dichloromethane. Removal of the solvent under reduced 
pressure afforded a crude mixture of starting material and product which were isolated by 
flash chromatography (10% ethyl acetate : hexane then 30% ethyl acetate : hexane). The (R)-
MTPA-ester derivative of 154 was obtained as a clear colourless liquid; Rf (30% ethyl 
acetate : hexane) 0.77; 1H NMR (400.2 MHz, CDCl3) δ 7.53-7.51 (2H, m, Ar-H), 7.44-7.38 
(3H, m, Ar-H), 7.09 (2H, d, J = 8.6 Hz, Ar-H), 6.87 (2H, d, J = 8.7 Hz, Ar-H), 5.56-5.52 
(1H, m, C14-H), 4.81 (1H, d, J = 3.7 Hz, Ar-CH), 3.81 (3H, s, OCH3), 3.68-3.62 (1H, m, C10-
H), 3.59 (1H, dd, J = 5.8, 1.9 Hz, C15-H), 3.56 (3H, s, MTPA-OCH3), 3.33 (1H, dd, J = 14.7, 
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2.0 Hz, C13-Ha), 2.99 (1H, dd, J = 14.5, 6.5 Hz, C13-Hb), 2.77 (1H, t, J = 3.7 Hz, C11-H), 
1.87-1.77 (1H, m, C16-H), 1.40-1.06 (17H, m, CH2, OH), 1.00 (3H, d, J = 6.8 Hz, C16-CH3), 
0.89 (3H, t, J = 7.0 Hz, C4-H or C20-H), 0.82 (3H, t, J = 7.0 Hz, C4-H or C20-H).  
 
(S)-MTPA-ester derivative of 154  
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To a solution of alcohol 154 (12.6 mg, 0.0290 mmol, 1.0 eq) and (S)-MTPA acid (8.0 mg, 
0.0342 mmol, 1.18 eq) in dry dichloromethane (0.5 ml) at room temperature was added a 
solution of 1,3-dicyclohexylcarbodiimide (10.7 mg, 0.0520 mmol, 1.8 eq) and 4-N,N-
dimethylaminopyridine (0.73 mg, 0.00598 mmol, 0.2 eq) in dichloromethane (26 µl) under 
an atmosphere of N2. The resulting cloudy mixture was sonicated at room temperature for 
2 h and then t.l.c analysis showed approximately 50% conversion of the starting material. 
Despite this, the reaction mixture was filtered through a pad of celite and then the pad was 
washed with dichloromethane. Removal of the solvent under reduced pressure afforded a 
crude mixture of the starting material and product which were isolated by flash 
chromatography (10% ethyl acetate : hexane then 30% ethyl acetate : hexane). The (S)-
MTPA-ester derivative of 154 was obtained as a clear colourless liquid; Rf (30% ethyl 
acetate : hexane) 0.77; 1H NMR (400.2 MHz, CDCl3) δ 7.54-7.47 (2H, m, Ar-H), 7.47-7.37 
(3H, m, Ar-H), 7.15 (2H, d, J = 8.7 Hz, Ar-H), 6.89 (2H, d, J = 8.8 Hz, Ar-H), 5.53-5.47 
(1H, m, C14-H), 4.99 (1H, d, J = 3.7 Hz, Ar-CH), 3.81 (3H, s, OCH3), 3.77 (1H, dd, J = 5.7, 
2.0 Hz, C15-H), 3.69-3.61 (1H, m, C10-H), 3.51 (3H, s, MTPA-OCH3), 3.30 (1H, dd, J = 
14.5, 1.9 Hz, C13-Ha), 3.04 (1H, dd, J = 14.5, 6.6 Hz, C13-Hb), 2.76 (1H, t, J = 3.7 Hz, C11-
H), 1.91-1.83 (1H, m, C16-H), 1.43-1.07 (17H, m, CH2, OH), 1.04 (3H, d, J = 6.8 Hz, C16-
CH3), 0.90 (3H, t, J = 7.0 Hz, C4-H or C20-H), 0.82 (3H, t, J = 6.9 Hz, C4-H or C20-H).  
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(1’R, 6S, 7R)-6-Hydroxy-2-(p-methoxy-phenyl)-7-(1’-methyl-pentyl)-oxepan-4-one 155 
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To a -78oC solution of methyl ketone 57 (34.3 mg, 0.107 mmol, 1.0 eq) in anhydrous diethyl 
ether (1.4 ml) was added dicyclohexylboron chloride (136 µl, 0.622 mmol, 5.8 eq) dropwise 
followed by triethylamine (103 µl, 0.739 mmol, 6.9 eq). A white precipitate formed upon 
warming the reaction to 0oC. The mixture was stirred at 0oC for 2 h and then quenched with 
pH 7.0 buffer (0.2 ml), methanol (0.2 ml) and 30% H2O2 (0.2 ml). The solution was stirred at 
0oC for 15 min and then the layers were separated. The aqueous phase was extracted into 
diethyl ether (2 x 1 ml) and the combined organic extracts were dried (MgSO4), filtered and 
concentrated in vacuo. Flash chromatographic purification (20% ethyl acetate : hexane) of 
the crude residue afforded a pure colourless oil (solidified in the freezer) identified as the 
rearranged product 155; Rf (20% ethyl acetate : hexane) 0.088; [α]D +85.3 (c 0.23, CHCl3); 
IR (thin film) 3445 (OH), 2956, 2930, 2871 (C-H), 1698 (C=O), 1614, 1514 (C=C), 830 
(C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.25 (2H, d, J = 8.8 
Hz, Ar-H), 6.88 (2H, d, J = 8.7 Hz, Ar-H), 4.84 (1H, dd, J = 10.5, 3.9 Hz, Ar-CH), 4.00-3.96 
(1H, m, C14-H), 3.80 (3H, s, OCH3), 3.46 (1H, dd, J = 6.5, 3.8 Hz, C15-H), 3.00 (1H, dd, J = 
12.0, 3.2 Hz, C13-Ha), 2.93 (1H, dd, J = 11.9, 8.3 Hz, C13-Hb), 2.86 (1H, dd, J = 15.4, 3.9 Hz, 
C11-Ha), 2.77 (1H, dd, J = 15.5, 10.5 Hz, C11-Hb), 1.88-1.55 (2H, m, OH, C16-H), 1.55-1.13 
(6H, m, CH2), 0.98 (3H, d, J = 6.8 Hz, C16-CH3), 0.88 (3H, t, J = 7.1 Hz, C20-H); 13C NMR 
(100.6 MHz, CDCl3) δ 208.1, 158.9, 134.2, 126.5, 113.8, 91.6, 78.6, 69.1, 55.3, 53.3, 50.3, 
35.7, 30.2, 29.6, 23.0, 16.9, 14.1; m/z (EI+) 320 (M, 8), 302 (M-H2O, 2), 206 (77), 177 (3), 
163 (7), 134 (100), 121 (C8H9O, 34), 91 (12), 71 (8); HRMS (EI+) calc. 320.1988 for 
C19H28O4, found 320.1984. 
 
Chapter 5 
 159 
(1”R, 2S, 4S, 4’R, 5R)-1’-[2-(p-Methoxy-phenyl)-5-(1”-methyl-pentyl)-[1,3]dioxolan-4-yl]-
4’-triethylsilanyloxy-decan-2’-one 184 and (1”R, 2S, 4S, 4’S, 5R)-1’-[2-(p-methoxy-phenyl)-
5-(1”-methyl-pentyl)-[1,3]dioxolan-4-yl]-4’-triethylsilanyloxy-decan-2’-one 185 
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To a solution of alcohols 159 and 160 (368 mg, 0.848 mmol, 1.0 eq) and 4-N,N-
dimethylaminopyridine (21 mg, 0.172 mmol, 0.2 eq) in anhydrous pyridine (15.1 ml) was 
added neat chlorotriethylsilane (299 µl, 1.78 mmol, 2.1 eq) under an atmosphere of N2. The 
reaction mixture was stirred at room temperature for 3.5 h and then diluted with 
dichloromethane (20 ml). The solution was washed with 5% aqueous NaHCO3 (4 x 20 ml) 
and then the washings were extracted with dichloromethane (1 x 20 ml). The combined 
organic layers were washed with brine (20 ml), dried (Na2SO4) and concentrated under 
reduced pressure. Residual pyridine was coevaporated with heptane and then traces of 
pyridine were removed under high vacuum. Purification by flash chromatography (10% ethyl 
acetate : hexane) using silica treated with 0.1% triethylamine afforded a clear colourless 
liquid of the title compounds 184 and 185 (465 mg, 100%) in a ratio of 65:35 as determined 
by 13C NMR; Rf (10% ethyl acetate : hexane) 0.55; [α]D -49.2 (c 1.58, CHCl3); IR (thin 
film) 2955-2874 (C-H), 1714 (C=O), 1614, 1518 (C=C), 829 (C-H, p-disubstituted benzene) 
cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.38 (2H, d, J = 8.7 Hz, Ar-H), 6.88 (2H, d, J = 8.7 
Hz, Ar-H), 5.74 (1H, s, Ar-CH), 4.69-4.63 (1H, m, C14-H), 4.16 (1H, dq, J = 11.1, 5.6 Hz, 
C10-H), 3.83 (1H, dd, J = 9.7, 5.9 Hz, C15-H), 3.79 (3H, s, OCH3), 2.77 (1H, dd, J = 15.5, 
10.2 Hz, C13-Ha), 2.64-2.42 (3H, m, C13-Hb, C11-H), 1.82-1.73 (1H, m, C17-Ha), 1.70-1.59 
(1H, m, C16-H), 1.46-1.17 (15H, m, C17-Hb, CH2), 0.95-0.85 (18H, m, C20-H, C16-CH3, C4-H, 
Si-CH2CH3), 0.58 (6H, q, J = 7.9 Hz, Si-CH2CH3); 1H NMR♦ (400.2 MHz, CDCl3) δ 5.73 
(1H, s, Ar-CH), 3.84 (1H, dd, J = 9.6, 5.8 Hz, C15-H), 2.73 (1H, dd, J = 15.4, 9.9 Hz, 
C13-Ha); 13C NMR (100.6 MHz, CDCl3) δ 207.8 (207.6), 160.2, 130.2 (130.1), 128.0, 113.6, 
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103.2, (84.4) 84.3, 74.0, 68.5, 55.2, 51.7, 51.3, 45.3, 37.7, 33.4, 32.5, 31.7, 29.3, 28.5, (25.1) 
25.0, 22.9, 22.5, (15.8) 15.7, 14.0, 6.8, 4.9; m/z (FAB+) 572 (M+Na+H, 8), 549 (M+H, 21), 
519 (43), 395 (8), 263 (15), 229 (100), 171 (9), 137 (37); HRMS (FAB+) calc. 549.3990 for 
C32H57O5Si, found 549.3975. 
 
Acid-catalysed epimerisation of 159 or 160 about the benzylic carbon led to the formation of 
an epimer about the benzylic carbon; Rf (10% ethyl acetate : hexane) 0.15; [α]D -52.4 (c 
0.29, CHCl3); IR (thin film) 3483 (OH), 3015 (aryl C-H), 2927 (C-H), 1709 (C=O), 1614, 
1514 (C=C), 1086 (C-O) cm-1; 1H NMR (200 MHz, CDCl3) δ 7.33 (2H, d, J = 8.3 Hz, Ar-
H), 6.89 (2H, d, J = 8.3 Hz, Ar-H), 6.10 (1H, s, Ar-CH), 4.85-4.71 (1H, m, C14-H), 4.22-4.05 
(1H, m, C10-H), 3.81 (3H, s, OCH3), 3.81-3.74 (1H, ob dd, J = obscure, 4.8 Hz, C15-H), 2.94 
(1H, d, J = 2.9 Hz, OH), 2.82 (1H, dd, J = 15.3, 5.0 Hz, C13-Ha), 2.79-2.64 (2H, m, C11-H), 
2.44 (1H, dd, J = 15.4, 2.9 Hz, C13-Hb), 1.88-1.05 (17H, m, C16-H, CH2), 1.05-0.75 (9H, m, 
C4-H, C16-CH3, C20-H); 13C NMR (50MHz, CDCl3) δ 210.1, 160.0, 132.0, 127.3, 113.7, 
102.1, 82.2, 75.0, 67.5, 55.3, 50.8, 42.4, 36.4, 33.4, 32.8, 31.8, 29.7, 29.2, 28.6, 25.4, 23.0, 
22.6, 15.7, 14.1; m/z (EI+) 434 (M, 9), 433 (M-H, 14), 416 (M-H2O, 7), 349 (28), 319 (21), 
282 (M-152, 12), 235 (4), 207 (7), 185 (10), 167 (19), 152 (57), 135 (100), 121 (C8H9O, 19), 
108 (29), 83 (21), 69 (30); HRMS (EI+) calc. 434.3032 for C26H42O5, found 434.3020. 
 
(1’R, 1”R, 2S, 4S, 5R)-Triethyl-{1”-hexyl-3”-[2-(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-
[1,3]dioxolan-4-ylmethyl]-but-3”-enyloxy}-silane 186 and (1’R, 1”S, 2S, 4S, 5R)-triethyl-
{1”-hexyl-3”-[2-(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-ylmethyl]-but-
3”-enyloxy}-silane 187 
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To a solution of ketones 184 and 185 (1.17 g, 2.13 mmol, 1.0 eq) in tetrahydrofuran (21.4 
ml) was added dimethyl titanocene (11.7 ml, 0.548 M in toluene, 6.42 mmol, 3.0 eq) under 
an atmosphere of N2. The orange-coloured reaction mixture was heated at 60oC with stirring 
in the dark for 23 h 45 min. The dark brown solution was cooled to room temperature and 
then diluted with a copious quantity of hexane. After removal of the resulting yellow 
precipitate by filtration, the filtrate was concentrated under reduced pressure to give a crude 
residue which was purified by flash chromatography (4% ethyl acetate : hexane) to afford an 
inseparable mixture of olefins 186 and 187 (0.774 g, 66%) as a yellow oil; Rf (5% ethyl 
acetate : hexane) 0.63; [α]D -27.9 (c 0.56, CHCl3); IR (thin film) 3072 (C=C-H), 2954-2854 
(C-H), 1616, 1517 (C=C), 826 (C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, 
CDCl3) δ 7.43 (2H, d, J = 8.6 Hz, Ar-H), 6.88 (2H, d, J = 8.7 Hz, Ar-H), 5.74 (1H, s, 
Ar-CH), 4.91 (1H, s, C=CH2), 4.87 (1H, s, C=CH2), 4.36-4.29 (1H, m, C14-H), 3.80 (3H, s, 
OCH3), 3.88-3.75 (2H, m, C10-H, C15-H), 2.31-2.23 (4H, m, C11-H, C13-H), 1.84-1.74 (1H, 
m, C16-H), 1.50-1.05 (16H, m, CH2), 1.00-0.82 (18H, m, C4-H, C16-CH3, C20-H, 
Si-CH2CH3), 0.61-0.54 (6H, m, Si-CH2CH3); 1H NMR♦ (400.2 MHz, CDCl3) δ 7.42 (2H, d, 
J = 8.5 Hz, Ar-H), 5.75 (1H, s, Ar-CH), 4.88 (1H, s, C=CH2); 13C NMR (50 MHz, CDCl3) 
δ 160.2, 143.3, 130.4, 128.3 (128.2), 114.5, 113.6, 103.3, (84.9) 84.8, 71.5 (71.2), 55.2, 
(44.3) 44.0, 37.5, 37.0, 33.4, 32.3, 31.9, 29.7, 29.5, 28.7, 25.4 (25.2), 23.0, 22.6, 16.1, 14.1, 
6.9, 5.1, 1C overlapping; m/z (EI+) 546 (M, 12), 517 (M-CH2CH3, 13), 414 (12), 381 (6), 
283 (6), 263 (8), 229 (100), 201 (8), 135 (22), 115 (C6H15Si, 31), 103 (11), 87 (22), 75 (12); 
HRMS (EI+) calc. 546.4104 for C33H58O4Si, found 546.4099. 
 
OO
OCH3
20
188
OTES
4
10
 
 
When the Petasis methylenation reaction proceeded sluggishly, a second fraction identified 
as epimer 188 was isolated; Rf (5% ethyl acetate : hexane) 0.73; [α]D -20.3 (c 0.61, CHCl3); 
IR (thin film) 3072 (C=C-H), 2931 (C-H), 1615, 1514 (C=C), 826 (C-H, p-disubstituted 
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benzene) cm-1; 1H NMR (200 MHz, CDCl3) δ 7.36 (2H, d, J = 8.6 Hz, Ar-H), 6.88 (2H, d, J 
= 8.7 Hz, Ar-H), 6.04 (1H, s, Ar-CH), 4.96 (1H, s, C=CH2), 4.92 (1H, s, C=CH2), 4.41 (1H, 
ddd, J = 10.4, 4.8, 3.0 Hz, C14-H), 3.80 (3H, s, OCH3), 3.90-3.74 (2H, m, C15-H, C10-H), 
2.43-2.13 (4H, m, C11-H, C13-H), 1.86-1.10 (17H, m, C16-H, CH2), 1.09-0.79 (18H, m, C4-H, 
C16-CH3, C20-H, Si-CH2CH3), 0.74-0.53 (6H, m, Si-CH2CH3); 13C NMR (50.3 MHz, CDCl3) 
δ 160.0, 143.5, 132.5, 127.5, 114.5, 113.6, 101.8, 83.0, 71.4, 55.3, 44.2, 37.1, 34.3, 33.5, 
32.7, 31.9, 29.7, 29.5, 28.7, 25.3, 23.0, 22.6, 15.9, 14.2, 14.1, 7.0, 5.1; m/z (EI+) 546 (M, 
26), 517 (M-CH2CH3, 20), 414 (6), 381 (6), 283 (8), 263 (6), 229 (100), 201 (10), 135 (34), 
115 (C6H15Si, 35), 103 (12), 87 (26), 75 (12); HRMS (EI+) calc. 546.4104 for C33H58O4Si, 
found 546.4113.  
 
(1”R, 2S, 4S, 4’R, 5R)-2’-[2-(p-Methoxy-phenyl)-5-(1”-methyl-pentyl)-[1,3]dioxolan-4-
ylmethyl]-dec-1’-en-4’-ol 163 and (1”R, 2S, 4S, 4’S, 5R)-2’-[2-(p-methoxy-phenyl)-5-(1”-
methyl-pentyl)-[1,3]dioxolan-4-ylmethyl]-dec-1’-en-4’-ol 189 
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To a stirring solution of the silyl ethers 186 and 187 (0.637 g, 1.17 mmol, 1.0 eq) in dry 
tetrahydrofuran (27.3 ml) at room temperature was added a solution of tetrabutylammonium 
fluoride in tetrahydrofuran (1 M, 4.70 mmol, 4.0 eq ) under a N2 atmosphere. The reaction 
mixture was stirred at room temperature for 1 h 45 min and then poured into brine (30 ml). 
The layers were separated and the aqueous phase was extracted into diethyl ether (3 x 20 
ml). The combined organic extracts were washed with brine (50 ml) and then dried over 
Na2SO4, filtered and concentrated under reduced pressure. Purification of the crude liquid by 
flash chromatography (20% ethyl acetate : hexane) gave a diastereomeric mixture of the 
products 163 and 189 (0.449 g, 92%) in a ratio of 61:39 respectively by analytical HPLC 
(Whatman Partisil 5, 13% ethyl acetate : hexane, 0.1% TEA). HPLC separation of the 
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diastereomers afforded a pure colourless liquid of 163 (tR 13.923 min) as the major product; 
Rf (20% ethyl acetate : hexane) 0.41; [α]D -49.1 (c 1.2, CHCl3); IR (thin film) 3462 (OH), 
3076 (C=C-H), 2955, 2930, 2856 (C-H), 1648 (olefin C=C), 1615, 1517 (aryl C=C), 827 
(C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.42 (2H, d, J = 8.6 
Hz, Ar-H), 6.89 (2H, d, J = 8.8 Hz, Ar-H), 5.76 (1H, s, Ar-CH), 4.98 (1H, br s, C=CH2), 
4.97 (1H, br s, C=CH2), 4.35 (1H, ddd, J = 9.8, 5.9, 3.4 Hz, C14-H), 3.84 (1H, dd, J = 9.6, 5.9 
Hz, C15-H), 3.80 (3H, s, OCH3), 3.67-3.58 (1H, m, C10-H), 2.41-2.20 (3H, m, C11-Ha, C13-H), 
2.06 (1H, dd, J = 14.0, 9.8 Hz, C11-Hb), 1.86-1.72 (2H, m, C9-Ha, C16-H), 1.72-1.15 (16H, m, 
C9-Hb, CH2, OH), 0.93-0.87 (9H, m, C4-H, C16-CH3, C20-H); 13C NMR (50.3 MHz, CDCl3) 
δ 160.1, 143.1, 130.0, 128.0, 115.2, 113.4, 103.1, 84.7, 75.8, 68.8, 55.0, 44.3, 36.9, 36.6, 
33.4, 32.1, 31.7, 29.2, 28.4, 25.7, 22.8, 22.5, 15.8, 14.0, 14.0; m/z (FAB+) 433 (M+H, 100), 
318 (11), 263 (56); HRMS (FAB+) calc. 433.3318 for C27H45O4, found 433.3316; Anal. 
calc. for C27H44O4: C, 74.96; H, 10.25. Found: C, 74.82; H, 10.42. 
 
The minor product 189 (tR 18.050 min) was also isolated as a pure colourless liquid; Rf (20% 
ethyl acetate : hexane) 0.41; [α]D -47.5 (c 1.6, CHCl3); IR (thin film) 3444 (OH), 3076 
(C=C-H), 2926 (C-H), 1644 (olefin C=C), 1614, 1517 (aryl C=C), 825 (C-H, p-disubstituted 
benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.41 (2H, d, J = 8.7 Hz, Ar-H), 6.88 (2H, d, 
J = 8.7 Hz, Ar-H), 5.75 (1H, s, Ar-CH), 4.97 (1H, br s, C=CH2), 4.94 (1H, br s, C=CH2), 
4.31 (1H, dt, J = 8.6, 5.7 Hz, C14-H), 3.88-3.74 (1H, ob dd, C15-H), 3.80 (3H, s, OCH3), 
3.71-3.62 (1H, m, C10-H), 2.47-2.14 (3H, m, C11-Ha, C13-H), 2.08 (1H, dd, J = 13.9, 9.5 Hz, 
C11-Hb), 1.86-1.72 (2H, m, C9-Ha, C16-H), 1.54-1.13 (16H, m, OH, C9-Hb, CH2), 0.94-0.86 
(9H, m, C4-H, C16-CH3, C20-H); 13C NMR (50.3 MHz, CDCl3) δ 160.1, 144.0, 130.2, 128.0, 
115.0, 113.5, 103.1, 84.8, 77.0, 69.2, 55.1, 44.7, 37.2, 37.0, 33.4, 32.0, 31.7, 29.3, 28.4, 25.5, 
22.8, 22.5, 15.8, 14.0, 13.9; m/z (FAB+) 433 (M+H, 63), 307 (7), 263 (29), 181 (12); HRMS 
(FAB+) calc. 433.3318 for C27H45O4, found 433.3306; Anal. calc. for C27H44O4: C, 74.96; H, 
10.25. Found: C, 75.25; H, 10.52. 
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(R)-MTPA-ester derivative of 163 
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To a solution of alcohol 163 (12.2 mg, 0.0282 mmol, 1.0 eq) in dry dichloromethane (1.3 ml) 
was added a solution of 1,3-dicyclohexylcarbodiimide (16.3 mg, 0.0790 mmol, 2.8 eq) and 
4-N,N-dimethylaminopyridine (1.0 mg, 0.00819 mmol, 0.3 eq) in dichloromethane (39 µl) 
followed by (R)-MTPA acid (14.1 mg, 0.0602 mmol, 2.1 eq) under an atmosphere of N2. The 
resulting cloudy white mixture was stirred at room temperature for 2.5 h and then filtered 
through a pad of celite. The filter cake was washed with dichloromethane and then 
evaporation of the solvent from the filtrate under reduced pressure, afforded a crude mixture 
which was purified by flash chromatography (20% ethyl acetate : hexane) using silica gel 
deactivated with 0.1% triethylamine to give a clear oil of the (R)-MTPA-derivative of 163; 
Rf (20% ethyl acetate : hexane) 0.65; 1H NMR (400.2 MHz, CDCl3) δ 7.61-7.48 (2H, m, 
Ar-H), 7.48-7.31 (3H, m, Ar-H), 7.40 (2H, d, J = 8.7 Hz, Ar-H), 6.87 (2H, d, J = 8.8 Hz, 
Ar-H), 5.74 (1H, s, Ar-CH), 5.32-5.25 (1H, m, C10-H), 4.94 (1H, s, C=CH2), 4.91 (1H, s, 
C=CH2), 4.29 (1H, ddd, J = 9.4, 5.9, 3.3 Hz, C14-H), 3.82 (1H, dd, J = 9.5, 5.8 Hz, C15-H), 
3.79 (3H, s, OCH3), 3.51 (3H, s, MTPA-OCH3), 2.48-2.23 (4H, m, C11-H, C13-H), 1.85-1.09 
(17H, m, C16-H, CH2), 0.94-0.84 (9H, m, C4-H, C16-CH3, C20-H).  
 
(S)-MTPA-ester derivative of 163 
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To a solution of alcohol 163 (11.6 mg, 0.0269 mmol, 1.0 eq) in dry dichloromethane (1.2 ml) 
was added a solution of 1,3-dicyclohexylcarbodiimide (15.4 mg, 0.0746 mmol, 2.8 eq) and 
4-N,N-dimethylaminopyridine (0.95 mg, 0.00777 mmol, 0.3 eq) in dichloromethane (37 µl) 
followed by (S)-MTPA acid (10.2 mg, 0.0436 mmol, 1.6 eq) under an atmosphere of N2. The 
resulting cloudy white mixture was stirred at room temperature for 2.5 h and then filtered 
through a pad of celite, and the filter cake washed with dichloromethane. Removal of the 
solvent under reduced pressure afforded a crude mixture which was purified by flash 
chromatography (20% ethyl acetate : hexane) using silica deactivated with 0.1% 
triethylamine to give a clear oil of the (S)-MTPA-derivative of 163; Rf (20% ethyl acetate : 
hexane) 0.65; 1H NMR (400.2 MHz, CDCl3) δ 7.60-7.47 (2H, m, Ar-H), 7.47-7.31 (3H, m, 
Ar-H), 7.41 (2H, d, J = 8.6 Hz, Ar-H), 6.87 (2H, d, J = 8.8 Hz, Ar-H), 5.73 (1H, s, Ar-CH), 
5.31-5.22 (1H, m, C10-H), 4.82 (1H, s, C=CH2), 4.79 (1H, s, C=CH2), 4.25 (1H, ddd, J = 9.9, 
5.9, 3.4 Hz, C14-H), 3.80 (1H, dd, J = 9.7, 5.9 Hz, C15-H), 3.78 (3H, s, OCH3), 3.51 (3H, s, 
MTPA-OCH3), 2.46-2.17 (4H, m, C11-H, C13-H), 1.85-1.13 (17H, m, C16-H, CH2), 0.93-0.86 
(9H, m, C4-H, C16-CH3, C20-H).  
 
(1’R, 2S, 2”S, 4S, 4”R, 5R)-1”-[2-(p-Methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-
yl]-2”-methyl-decan-4”-ol 190 and (1’R, 2S, 2”R, 4S, 4”R, 5R)-1”-[2-(p-methoxy-phenyl)-5-
(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-decan-4”-ol 191 
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METHOD A: Hydrogenation using platinum on carbon. 
Platinum on carbon (10% wt., 6.8 mg, 0.00348 mmol, 2.2 mol%) was added to a solution of 
olefin 163 (68.3 mg, 0.158 mmol, 1.0 eq) in dry methanol (1.6 ml). The reaction vessel was 
evacuated then purged with H2 gas via a three-way tap. The evacuation/purge cycle was 
repeated twice before H2 was introduced for the final time. The reaction mixture was stirred 
Chapter 5 
 166 
under an atmosphere of H2 (H2 balloon) for 3.5 h at room temperature. The mixture was 
diluted with methanol and then filtered through a celite pad. The filtrate was concentrated in 
vacuo to afford a clean mixture of 2 isomeric products (96%). Separation of the 
diastereomers was achieved by preparative HPLC (Whatman Partisil 10, 13% ethyl acetate : 
hexane, 0.1% TEA) to give pure syn-alcohol 191 (33.3 mg, tR 11.200 min) as a colourless 
oil; Rf (20% ethyl acetate : hexane) 0.57; [α]D -24.5 (c 1.3, CHCl3); IR (thin film) 3446 
(OH), 2955, 2928, 2856 (C-H), 1615, 1517 (C=C), 829 (C-H, p-disubstituted benzene) cm-1; 
1H NMR (400.2 MHz, CDCl3) δ 7.42 (2H, d, J = 8.6 Hz, Ar-H), 6.89 (2H, d, J = 8.6 Hz, 
Ar-H), 5.77 (1H, s, Ar-CH), 4.23 (1H, ddd, J = 11.6, 5.8, 2.0 Hz, C14-H), 3.82-3.79 (1H, ob 
dd, C15-H), 3.80 (3H, s, OCH3), 3.59-3.50 (1H, m, C10-H), 2.07-1.56 (5H, m, C9-H, C12-H, 
C13-Ha, C16-H), 1.50-1.02 (18H, m, C13-Hb, OH, CH2), 0.96 (3H, d, J = 6.6 Hz, C12-CH3), 
0.91-0.84 (9H, m, C4-H, C16-CH3, C20-H); 13C NMR (75.5 MHz, CDCl3) δ 160.2, 130.8, 
128.0, 113.7, 103.1, 85.0, 75.5, 69.1, 55.2, 46.0, 37.7, 36.4, 33.5, 32.1, 31.9, 29.4, 28.6, 25.6, 
25.5, 23.0, 22.6, 20.0, 15.8, 14.1, 14.1; m/z (EI+) 434 (M, 47), 433 (M-H, 41), 349 (9), 281 
(18), 263 (11), 241 (2), 223 (8), 183 (12), 175 (33), 155 (15), 137 (100), 121 (C8H9O, 27), 
108 (37), 69 (29); HRMS (EI+) calc. 434.3396 for C27H46O4, found 434.3389. 
 
The second fraction of pure anti-alcohol 190 (32.4 mg, tR 18.776 min) was obtained as a 
colourless oil; Rf (20% ethyl acetate : hexane) 0.49; [α]D -48.5 (c 0.8, CHCl3); IR (thin film) 
3440 (OH), 2955, 2927, 2856 (C-H), 1615, 1517 (C=C), 830 (C-H, p-disubstituted benzene) 
cm-1; 1H NMR (300.1 MHz, CDCl3) δ 7.39 (2H, d, J = 8.8 Hz, Ar-H), 6.89 (2H, d, J = 8.7 
Hz, Ar-H), 5.74 (1H, s, Ar-CH), 4.26 (1H, ddd, J = 11.0, 6.0, 2.3 Hz, C14-H), 3.81 (3H, s, 
OCH3), 3.78 (1H, dd, J = 9.4, 5.9 Hz, C15-H), 3.75-3.62 (1H, m, C10-H), 2.05-1.87 (1H, m, 
C12-H), 1.84-1.50 (4H, m, C9-H, C13-Ha, C16-H), 1.50-1.00 (18H, m, C13-Hb, OH, CH2), 0.98 
(3H, d, J = 6.6 Hz, C12-CH3), 0.93-0.83 (9H, m, C4-H, C16-CH3, C20-H); 13C NMR (75.5 
MHz, CDCl3) δ 160.2, 130.5, 128.2, 113.7, 103.2, 84.9, 75.4, 69.8, 55.3, 43.4, 38.5, 38.1, 
33.4, 32.1, 31.8, 29.4, 28.6, 26.1, 25.7, 23.0, 22.6, 21.3, 16.0, 14.1, 14.1; m/z (EI+) 434 (M, 
62), 433 (M-H, 47), 349 (11), 281 (20), 263 (12), 241 (3), 223 (7), 183 (13), 155 (13), 137 
(100), 121 (C8H9O, 26), 108 (28), 95 (19), 69 (19); HRMS (EI+) calc. 434.3396 for 
C27H46O4, found 434.3397.  
(Spectrum appended) 
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(1’R, 1’’’R, 2S, 2”R, 4S, 5R)-Triethyl-(1’’’-{3”-[2-(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-
[1,3]dioxolan-4-yl]-2”-methyl-propyl}-heptyloxy)-silane 213 and (1’R, 1’’’R, 2S, 2”S, 4S, 
5R)-triethyl-(1’’’-{3”-[2-(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-
methyl-propyl}-heptyloxy)-silane 214 and (1’R, 1’’’S, 2S, 2”S, 4S, 5R)-triethyl-(1’’’-{3”-[2-
(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-propyl}-
heptyloxy)-silane 215 and (1’R, 1’’’S, 2S, 2”R, 4S, 5R)-triethyl-(1’’’-{3”-[2-(p-methoxy-
phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-propyl}-heptyloxy)-silane 216  
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Platinum on carbon (10% wt., 10.2 mg, 0.00523 mmol, 2.2 mol%) was introduced to a 
solution of olefins 186 and 187 (132 mg, 0.242 mmol, 1.0 eq) in dry methanol (0.81 ml). The 
reaction vessel was evacuated and then purged with H2 gas via a three-way tap. The 
evacuation/purge cycle was repeated twice before H2 was introduced for the final time. The 
reaction mixture was stirred under an atmosphere of H2 (H2 balloon) for 4 h at room 
temperature. The mixture was diluted with methanol and then filtered through a celite pad. 
The filtrate was concentrated in vacuo to afford a crude residue which was purified by flash 
chromatography (4% ethyl acetate : hexane) to give an inseparable mixture of 4 
diastereomers (tR 9.174, 9.750, 10.793, 11.211 min) in a combined yield of 0.103 g (78%), 
and in a ratio of 22:13:27:38 as determined by analytical HPLC (Zorbax Sil 5, 1% ethyl 
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acetate : hexane, 0.1% TEA). The mixture was taken onto the next step. Rf (4% ethyl acetate 
: hexane) 0.27; IR (thin film) 2955, 2932, 2874 (C-H), 1616, 1517 (C=C), 829 (C-H, p-
disubstituted benzene) cm-1; m/z (FAB+) 547 (M-H, 94), 417 (6), 383 (56), 327 (7), 281 
(51), 229 (55), 185 (18), base peak between 0-50 was not picked during processing; HRMS 
(FAB+) calc. 547.4183 for C33H59O4Si, found 547.4194. 
 
190, 191, (1’R, 2S, 2”R, 4S, 4”S, 5R)-1”-[2-(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-
[1,3]dioxolan-4-yl]-2”-methyl-decan-4”-ol 217 and (1’R, 2S, 2”S, 4S, 4”S, 5R)-1”-[2-(p-
methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-decan-4”-ol 218 
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To a stirring solution of silyl ethers 213, 214, 215 and 216 (18 mg, 0.0328 mmol, 1.0 eq) in 
dry tetrahydrofuran (130 µl) under a N2 atmosphere was added a solution of 
tetrabutylammonium fluoride in tetrahydrofuran (1 M, 0.131 mmol, 4.0 eq) at room 
temperature. After stirring the reaction mixture at this temperature for 1 h 45 min, the 
solution was pipetted into brine (1 ml). The layers were separated and then the aqueous 
phase was extracted into diethyl ether (2 x 1 ml). The combined organic extracts were 
washed with brine (1 ml) then dried (Na2SO4), filtered and concentrated under reduced 
pressure to afford a crude liquid. Purification by flash chromatography (20% ethyl acetate : 
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hexane) yielded an isomeric mixture of the products syn-191, 217, 218 and anti-190 (10 mg, 
71%, tR 11.200 min, tR 13.107 min, tR 15.646 min, tR 18.776 min) in a ratio of 40:29:12:19 as 
determined by analytical HPLC (Whatman Partisil 5, 13% ethyl acetate : hexane, 0.1% 
TEA). 
Note: The stereochemistry at C12 of isomers 190 and 191 was confirmed by comparison 
with other structures. 
 The stereochemistry at C10 of 217 and 218 was assigned as C10-(S) derived from 
C10-(S) of the starting olefin 189. The relative stereochemistry of C10/C12 was not 
determined. 
 
General Procedure: Hydrogenation of a homoallylic alcohol using a chiral rhodium 
catalyst. 
A 10 ml round-bottomed flask containing olefin 163 (14.7 mg, 0.0340 mmol, 1.0 eq) and 
(+)-1,2-bis((2S,5S)-2,5-dimethylphospholano)benzene(cyclooctadiene)rhodium(I) 
tetrafluoroborate (2.1 mg, 0.00348 mmol, 10 mol%) was charged with dry dichloromethane 
(0.67 ml) under an atmosphere of Ar. The reaction vessel was placed into a hydrogenation 
bomb apparatus and then evacuated and purged with H2 gas three times. The bomb was 
finally pressurised to 149 psi with H2 gas. The reaction mixture was stirred at this pressure 
for 11 h at room temperature after which time the reaction had changed in colour from clear 
yellow to murky yellow. The mixture was filtered through a short silica column (50% ethyl 
acetate : hexane) to remove the catalyst. The solvent was evaporated under reduced pressure 
to yield a crude mixture of 2 isomers identified as anti-190 and syn-191 (76%) in a ratio of 
60:40 respectively as determined by analytical HPLC (Whatman Partisil 5, 13% ethyl acetate 
: hexane). HPLC also revealed only traces of p-anisaldehyde and epimerisation or 
rearrangement of the benzylidene acetal.  
 
General Procedure: Hydrogenation of a homoallylic alkoxide using a chiral rhodium 
catalyst. 
To a slurry of washed and dried sodium hydride (2.0 mg, 0.0833 mmol, 1.09 eq) in degassed 
dichloromethane (0.4 ml) was added a solution of olefins 163 and 189 (33.1 mg, 0.0766 
mmol, 1.0 eq) in dichloromethane (0.4 ml) via cannula. The resulting mixture was stirred for 
10 min at room temperature under an atmosphere of Ar. A solution of catalyst (+)-1,2-
bis((2S,5S)-2,5-dimethylphospholano)benzene(cyclooctadiene)rhodium(I) tetrafluoroborate 
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(9.3 mg, 0.0154 mmol, 20 mol%) in dichloromethane (1.2 ml) was added via cannula and 
then the reaction mixture was quickly transferred to a hydrogenation bomb apparatus. The 
bomb was evacuated and purged with H2 three times, then pressurized to 300 psi with H2 
gas. The reaction mixture was stirred at this pressure for 16 h at room temperature and then 
filtered through a short silica column (50% ethyl acetate : hexane). The solvent was removed 
under reduced pressure to yield a clean mixture of syn-191, 217, 218 and anti-190 in a ratio 
of 23:28:12:43 by analytical HPLC (Whatman Partisil 5, 13% ethyl acetate : hexane). 
 
Determination of Stereochemistry at C12. 
 
NMA Method.198 
 
(1’R, 1”’R, 2S, 2”S, 2””R, 4S, 5R)-2””-Methoxy-naphthalen-2””’-yl-acetic acid 1”’-{3”-[2-
(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-propyl}-heptyl 
ester and (1’R, 1”’R, 2S, 2”S, 2””S, 4S, 5R)-2””-methoxy-naphthalen-2””’-yl-acetic acid 1”’-
{3”-[2-(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-propyl}-
heptyl ester 
 
 
 
 
 
 
 
 
 
 
To a solution of anti-190 (6.4 mg, 0.0147 mmol, 1.0 eq) and racemic 2-
naphthylmethoxyacetic acid (6.1 mg, 0.0282 mmol, 1.9 eq) in dry dichloromethane (0.7 ml) 
at room temperature was added a solution of 1,3-dicyclohexylcarbodiimide (8.8 mg, 
0.0427mmol, 2.9 eq) and 4-N,N-dimethylaminopyridine (0.670 mg, 0.00548 mmol, 0.4 eq) 
in dichloromethane (20.4 µl) under an atmosphere of N2. The initially clear reaction mixture 
turned cloudy white in colour. The mixture was stirred at room temperature for 3 h and then 
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filtered through celite. Removal of the solvent under reduced pressure afforded a crude 
mixture which was purified by flash chromatography (20% ethyl acetate : hexane) to give the 
title compounds 236 and 237 (7.8 mg, 84%) as a colourless oil. Semipreparative HPLC 
separation (5% ethyl acetate : hexane, 0.1% TEA) afforded diastereomerically pure (R)-
NMA ester of 190 (3.4 mg); Rf (20% ethyl acetate : hexane) 0.67; [α]D -29.1 (c 0.3, CHCl3); 
IR (thin film) 3050 (aryl C-H), 2955, 2928, 2856 (C-H), 1745 (C=O), 1615, 1517 (C=C), 
829 (C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.90 (1H, br s, 
Ar-H), 7.82-7.72 (2H, m, Ar-H), 7.69 (1H, d, J = 8.5 Hz, Ar-H), 7.52 (1H, dd, J = 8.5, 1.7 
Hz, Ar-H), 7.48-7.43 (2H, m, Ar-H), 7.33 (2H, d, J = 8.7 Hz, Ar-H), 6.87 (2H, d, J = 8.8 Hz, 
Ar-H), 5.62 (1H, s, Ar-CH), 5.06-4.98 (1H, m, C10-H), 4.87 (1H, s, CHOCH3), 3.89 (1H, 
ddd, J = 10.8, 6.1, 2.0 Hz, C14-H), 3.81 (3H, s, OCH3), 3.62 (1H, dd, J = 9.3, 6.0 Hz, C15-H), 
3.40 (3H, s, CHOCH3), 1.72-1.10 (22H, m, CH2, C12-H, C16-H), 0.88 (3H, t, J = 7.0 Hz, C4-
H), 0.81 (3H, t, J = 6.9 Hz, C20-H), 0.79 (3H, d, J = 6.7 Hz, C16-CH3), 0.71 (3H, d, J = 6.7 
Hz, C12-CH3); 13C NMR (100.6 MHz, CDCl3) δ 170.7, 160.2, 134.0, 133.4, 133.1, 130.7, 
128.3, 128.2, 128.1, 127.7, 126.4, 126.2, 126.1, 124.5, 113.6, 103.0, 84.7, 83.0, 75.8, 73.5, 
57.4, 55.3, 40.7, 37.9, 35.1, 33.3, 32.2, 31.6, 29.7, 29.1, 28.7, 26.2, 25.2, 23.0, 22.5, 20.3, 
16.0, 14.1, 14.0; m/z (EI+) 632 (M, 48), 601 (M-OCH3, 4), 547 (5), 302 (2), 281 (6), 263 
(12), 234 (5), 185 (C12H9O2, 9), 171 (C12H11O, 100), 156 (16), 135 (44), 109 (14), 97 (9), 83 
(13), 71 (7); HRMS (EI+) calc. 632.4077 for C40H56O6, found 632.4076. 
(Spectra appended) 
 
The second fraction proposed as (S)-NMA ester of 190 (4.4 mg) was also isolated pure; Rf 
(20% ethyl acetate : hexane) 0.67; [α]D -9.6 (c 0.3, CHCl3); IR (thin film) 3050 (aryl C-H), 
2955, 2928, 2856 (C-H), 1744 (C=O), 1614, 1517 (C=C), 830 (C-H, p-disubstituted 
benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.88 (1H, br s, Ar-H), 7.82-7.77 (2H, m, Ar-
H), 7.76 (1H, d, J = 8.7 Hz, Ar-H), 7.52 (1H, dd, J = 8.5, 1.3 Hz, Ar-H), 7.48-7.44 (2H, m, 
Ar-H), 7.39 (2H, d, J = 8.6 Hz, Ar-H), 6.89 (2H, d, J = 8.6 Hz, Ar-H), 5.75 (1H, s, Ar-CH), 
5.11-5.03 (1H, m, C10-H), 4.82 (1H, s, CHOCH3), 4.18 (1H, ddd, J = 10.9, 6.1, 1.9 Hz, C14-
H), 3.80 (3H, s, OCH3), 3.77 (1H, dd, J = 9.5, 6.1 Hz, C15-H), 3.30 (3H, s, CHOCH3), 1.84-
1.49 (4H, m, C11-Ha, C12-H, C13-Ha, C16-H), 1.44-1.10 (10H, m, CH2, C11-Hb, C13-Hb), 1.01-
0.76 (14H, m, CH2, C16-CH3, C20-H), 0.96 (3H, d, J = 6.6 Hz, C12-CH3), 0.69 (3H, t, J = 7.2 
Hz, C4-H); 13C NMR (100.6 MHz, CDCl3) δ 170.6, 160.3, 134.0, 133.4, 133.2, 130.7, 128.3, 
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128.2, 128.1, 127.7, 126.8, 126.2, 126.2, 124.6, 113.7, 103.3, 85.0, 82.7, 75.3, 73.2, 57.2, 
55.3, 40.4, 38.0, 35.0, 33.5, 32.2, 31.4, 29.7, 28.9, 28.7, 25.8, 24.8, 23.0, 22.3, 21.0, 16.0, 
14.2, 13.9; m/z (EI+) 632 (M, 56), 601 (M-OCH3, 12), 547 (7), 302 (2), 281 (7), 263 (12), 
234 (5), 185 (C12H9O2, 10), 171 (C12H11O, 100), 156 (15), 135 (44), 109 (13), 97 (9), 83 
(15); HRMS (EI+) calc. 632.4077 for C40H56O6, found 632.4084. 
(Spectra appended) 
 
(1’R, 1”’R, 2S, 2”R, 2””R, 4S, 5R)-2””-Methoxy-naphthalen-2””’-yl-acetic acid 1”’-{3”-[2-
(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-propyl}-heptyl 
ester and (1’R, 1”’R, 2S, 2”R, 2””S, 4S, 5R)-2””-methoxy-naphthalen-2””’-yl-acetic acid 1”’-
{3”-[2-(p-methoxy-phenyl)-5-(1’-methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-propyl}-
heptyl ester 
 
 
 
 
 
 
 
 
 
 
To a solution of syn-191 (13.5 mg, 0.0311 mmol, 1.0 eq) and racemic 2-
naphthylmethoxyacetic acid (14.0 mg, 0.0648 mmol, 2.1 eq) in dry dichloromethane (1.4 ml) 
at room temperature was added a solution of 1,3-dicyclohexylcarbodiimide (18.7 mg, 0.0906 
mmol, 2.9 eq) and 4-N,N-dimethylaminopyridine (1.4 mg, 0.0117mmol, 0.4 eq) in 
dichloromethane (43.2 µl) under an atmosphere of N2. The initially clear reaction mixture 
turned cloudy white after the formation of dicyclohexylurea. The mixture was stirred at room 
temperature for 3 h and then filtered through a celite pad. Removal of the solvent under 
reduced pressure afforded a crude mixture which was purified by flash chromatography 
(20% ethyl acetate : hexane) to give the title NMA esters (12.7 mg, 65%) as a colourless oil. 
Semipreparative HPLC separation (5% ethyl acetate : hexane, 0.1% TEA) afforded 
diastereomerically pure (R)-NMA ester of 191 (3.3 mg); Rf (20% ethyl acetate : hexane) 
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0.64; [α]D -29.1 (c 0.3, CHCl3); IR (thin film) 3057 (aromatic C-H), 2955, 2928, 2856 (C-
H), 1745 (C=O), 1615, 1516 (C=C), 829 (C-H, p-disubstituted benzene) cm-1; 1H NMR 
(400.2 MHz, CDCl3) δ 7.90 (1H, br s, Ar-H), 7.83-7.79 (3H, m, Ar-H), 7.52 (1H, dd, J = 8.5, 
1.7 Hz, Ar-H), 7.50-7.45 (2H, m, Ar-H), 7.36 (2H, d, J = 8.7 Hz, Ar-H), 6.88 (2H, d, J = 8.8 
Hz, Ar-H), 5.69 (1H, s, Ar-CH), 5.03-4.96 (1H, m, C10-H), 4.86 (1H, s, CHOCH3), 4.13 (1H, 
ddd, J = 11.4, 6.0, 2.0 Hz, C14-H), 3.79 (3H, s, OCH3), 3.73 (1H, dd, J = 9.7, 6.0 Hz, C15-H), 
3.41 (3H, s, CHOCH3), 1.00-0.79 (22H, m, CH2, C12-H, C16-H), 0.88 (3H, t, J = 7.0 Hz, 
C4-H), 0.85 (3H, d, J = 6.2 Hz, C16-CH3), 0.80 (3H, t, J = 6.9 Hz, C20-H), 0.80 (3H, d, J = 6.5 
Hz, C12-CH3); 13C NMR (100.6 MHz, CDCl3) δ 170.4, 160.2, 133.9, 133.4, 133.2, 130.5, 
128.3, 128.3, 128.1, 127.7, 126.5, 126.2, 126.1, 124.5, 113.7, 103.2, 84.9, 83.1, 75.0, 74.2, 
57.4, 55.2, 42.2, 37.6, 33.7, 33.5, 32.1, 31.6, 29.7, 29.1, 28.6, 26.0, 24.9, 23.0, 22.5, 18.6, 
15.9, 14.1, 14.0; m/z (EI+) 632 (M, 27), 601 (M-OCH3, 2), 406 (4), 281 (3), 216 (C13H12O3, 
2), 171 (C12H11O, 100), 135 (37), 105 (20), 77 (10); HRMS (EI+) calc. 632.4077 for 
C40H56O6, found 632.4068. 
(Spectra appended) 
 
A second fraction proposed as (S)-NMA ester of 191 (4.5 mg) was isolated pure; Rf (20% 
ethyl acetate : hexane) 0.64; [α]D +28.0 (c 0.4, CHCl3); IR (thin film) 3057 (aromatic C-H), 
2955, 2927, 2856 (C-H), 1746 (C=O), 1614, 1517 (C=C), 829 (C-H, p-disubstituted 
benzene) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 7.89 (1H, br s, Ar-H), 7.83-7.81 (3H, m, Ar-
H), 7.53 (1H, dd, J = 8.5, 1.6 Hz, Ar-H), 7.50-7.45 (2H, m, Ar-H), 7.36 (2H, d, J = 8.7 Hz, 
Ar-H), 6.86 (2H, d, J = 8.7 Hz, Ar-H), 5.72 (1H, s, Ar-CH), 5.04-4.95 (1H, m, C10-H), 4.84 
(1H, s, CHOCH3), 4.21 (1H, ddd, J = 11.3, 5.7, 1.8 Hz, C14-H), 3.79-3.76 (1H, ob dd, C15-
H), 3.77 (3H, s, OCH3), 3.40 (3H, s, CHOCH3), 1.86-1.08 (12H, m, CH2, C12-H, C16-H), 
1.02-0.73 (16H, m, CH2, C16-CH3, C20-H), 0.94 (3H, d, J = 6.6 Hz, C12-CH3), 0.69 (3H, t, J = 
7.2 Hz, C4-H); 13C NMR (100.6 MHz, CDCl3) δ 170.3, 160.3, 134.0, 133.5, 133.2, 130.5, 
128.4, 128.2, 128.1, 127.7, 126.9, 126.3, 126.2, 124.6, 113.7, 103.3, 84.9, 82.8, 75.0, 74.1, 
57.2, 55.2, 42.3, 37.7, 33.5, 32.2, 31.5, 29.7, 29.0, 28.6, 26.0, 24.5, 23.0, 22.3, 18.7, 15.9, 
14.2, 13.9; m/z (EI+) 632 (M, 54), 601 (M-OCH3, 10), 547 (6), 321 (14), 281 (6), 263 (7), 
242 (6), 216 (C13H12O3, 2), 185 (C12H9O2, 20), 171 (C12H11O, 94), 156 (9), 135 (55), 121 
(C8H9O, 100), 109 (14), 85 (12), 69 (16), 57 (28); HRMS (EI+) calc. 632.4077 for C40H56O6, 
found 632.4077. 
(Spectra appended) 
Chapter 5 
 174 
Chemical Method.60 
 
(1’R, 1’”R, 2S, 2”S, 4S, 5R)-Methanesulfonic acid 1’”-{3”-[2-(p-methoxy-phenyl)-5-(1’-
methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-propyl}heptyl ester 196 
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To a 0oC solution of syn-alcohol 191 (11.3 mg, 0.0260 mmol, 1.0 eq) and 4-N,N-
dimethylaminopyridine (0.32 mg, 0.00262 mmol, 0.1 eq) in dry dichloromethane (0.26 ml) 
was added a dichloromethane solution of freshly distilled methanesulfonyl chloride (1.61 M, 
24 µl, 0.0386 mmol, 1.5 eq). The mixture was stirred at 0oC for 10 min and then 
triethylamine (5 µl, 0.0359 mmol, 1.4 eq) was added and stirring continued for 12 h at room 
temperature. The reaction mixture was diluted with diethyl ether and filtered to remove the 
white solid of triethylammonium chloride. Removal of the solvent in vacuo gave the crude 
product which was purified by flash chromatography (20% ethyl acetate : hexane) on silica 
deactivated with 0.1% TEA. The unstable mesylate 196 (9.3 mg, 70%) was isolated pure as a 
colourless oil and used immediately in the next deprotection step; Rf (20% ethyl acetate : 
hexane) 0.57; 1H NMR (300.1 MHz, CDCl3) δ 7.39 (2H, d, J = 8.7 Hz, Ar-H), 6.90 (2H, d, J 
= 8.6 Hz, Ar-H), 5.72 (1H, s, Ar-CH), 4.76-4.68 (1H, m, C10-H), 4.28-4.19 (1H, m, C14-H), 
3.85-3.77 (1H, ob dd, C15-H), 3.81 (3H, s, OCH3), 2.80 (3H, s, SO2CH3), 1.89-1.50, 1.50-
1.10 (22H, m, CH2, C12-H, C16-H), 0.98 (3H, d, J = 6.4 Hz, C12-CH3), 0.95-0.83 (9H, m, 
C4-H, C16-CH3, C20-H). 
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(1’R, 2S, 2’R, 4R, 6S)-1’-(6-Hexyl-4-methyl-tetrahydro-pyran-2-yl)-2’-methyl-hexan-1’-ol 
195 
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To a solution of mesylate 196 (5.2 mg, 0.0102 mmol, 1.0 eq) in a mixture of methanol (170 
µl) and water (30 µl) was added Dowex® 50W resin beads (5.2 mg) at room temperature. 
After stirring at this temperature for 1 h 10 min, the heterogeneous mixture was diluted with 
methanol and filtered to remove the resin. Evaporation of the solvent under reduced pressure 
afforded a crude mixture which was purified by flash chromatography (20% ethyl acetate : 
hexane) to give pure pyran 195 (3.0 mg, 100%) as the sole product; Rf (20% ethyl acetate : 
hexane) 0.79; [α]D -6.7 (c 0.2, CH2Cl2); IR (thin film) 3472 (OH), 2954, 2927, 2858 (C-H), 
1089 (C-O) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 3.46-3.26 (3H, m, C10-H, C14-H, C15-H), 
2.10# (1H, d, J = 2.2 Hz, OH), 1.76-0.78 (28H, m, CH2, C4-H or C20-H, C12-H, C12-CH3 or 
C16-CH3, C16-H), 0.94 (3H, d, J = 6.1 Hz, C12-CH3 or C16-CH3), 0.90 (3H, t, J = 7.0 Hz, C4-H 
or C20-H); 13C NMR (75.5 MHz, CDCl3) δ 77.5, 40.4, 36.4, 34.1, 32.9, 31.9, 31.6, 29.9, 
29.4, 29.0, 25.5, 23.1, 22.6, 22.5, 15.5, 14.2, 14.1, 2C overlapping; m/z (ESI+) 321 (M+Na, 
100); m/z (EI+) 281 (M-OH, 15), 253 (16), 223 (24), 209 (36), 165 (30), 135 (41), 121 (26), 
109 (100), 95 (91), 81 (97), 67 (97), 55 (35); HRMS (ESI+) calc. 321.2769 for C19H38NaO2, 
found 321.2770. 
 
(1’R, 2S, 2’R, 4R, 6S)-Acetic acid 1’-(6-hexyl-4-methyl-tetrahydro-pyran-2-yl)-2’-methyl-
hexyl ester 198 
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To a solution of alcohol 195 (4.4 mg, 0.0148 mmol, 1.0 eq) in dry pyridine (0.3 ml) was 
added neat acetic anhydride (13.9 µl, 0.147 mmol, 10 eq). The reaction mixture was stirred 
at room temperature for 4 h after which time t.l.c analysis showed approximately 50% 
conversion of the starting material. Therefore, 4-N,N-dimethylaminopyridine (catalytic) was 
added to the mixture followed by a second aliquot of acetic anhydride (7 µl, 0.0742 mmol, 
5.0 eq) and stirring was continued at room temperature for 2 h 15 min. The reaction mixture 
was quenched with water (5 ml) and then the product was extracted into diethyl ether (3 x 5 
ml). The combined organic extracts were dried over MgSO4, filtered and concentrated in 
vacuo. Residual pyridine was removed under high vacuum. Flash chromatographic 
purification (5% ethyl acetate : hexane) of the crude mixture afforded acetate 198 (3.5 mg, 
70%) as a colourless oil; Rf (5% ethyl acetate : hexane) 0.70; [α]D -4.0 (c 0.3, CH2Cl2); IR 
(thin film) 2954, 2926, 2858 (C-H), 1741 (C=O) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 4.83 
(1H, dd, J = 8.2, 3.7 Hz, C15-H), 3.37 (1H, ddd, J = 10.4, 8.2, 1.9 Hz, C14-H), 3.29-3.17 (1H, 
m, C10-H), 2.05 (3H, s, COCH3), 2.00-1.86 (1H, m, C16-H), 1.56-1.08, 0.92-0.75 (33H, m, 
CH2, C4-H, C12-H, C12-CH3, C16-CH3, C20-H); 13C NMR (75.5 MHz, CDCl3) δ 170.7, 79.3, 
77.6, 75.5, 40.5, 36.6, 36.3, 33.3, 31.9, 30.1, 30.0, 29.6, 29.3, 25.7, 22.9, 22.6, 22.3, 21.0, 
16.1, 14.1, 1C overlapping; m/z (ESI+) 379 (M+K, 3), 363 (M+Na, 100), 341 (M+H, 59); 
m/z (EI+) 341 (M+H, 6), 297 (M-COCH3, 4), 281 (M-CO2CH3, 21), 211 (69), 209 (100); 
HRMS (ESI+) calc. 363.2875 for C21H40NaO3, found 363.2876. 
(Spectra appended) 
 
(1’R, 1’”R, 2S, 2”R, 4S, 5R)-Methanesulfonic acid 1’”-{3”-[2-(p-methoxy-phenyl)-5-(1’-
methyl-pentyl)-[1,3]dioxolan-4-yl]-2”-methyl-propyl}heptyl ester 199  
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To a stirring solution of anti-alcohol 190 (11.7 mg, 0.0315 mmol, 1.0 eq) and 4-N,N-
dimethylaminopyridine (0.40 mg, 0.00327 mmol, 0.1 eq) in dry dichloromethane (0.32 ml) at 
0oC was added triethylamine (8.8 µl, 0.0631 mmol, 2.0 eq) followed by a dichloromethane 
solution of freshly distilled methanesulfonyl chloride (1.61 M, 39 µl, 0.0628 mmol, 2.0 eq). 
The reaction mixture was stirred at room temperature for 3 h after which time t.l.c analysis 
showed complete consumption of the starting material. The reaction mixture was diluted 
with diethyl ether and filtered to remove the white solid of triethylammonium chloride. 
Evaporation of the solvent in vacuo gave the crude product which was purified by flash 
chromatography (20% ethyl acetate : hexane) on silica deactivated with 0.1% TEA. The 
unstable mesylate 199 (15 mg, 93%) containing the inseparable epimer 200 were isolated as 
a colourless oil and used immediately in the next deprotection step. 
Mesylate 199; Rf (20% ethyl acetate : hexane) 0.57; 1H NMR (300.1 MHz, CDCl3) δ 7.37 
(2H, d, J = 8.7 Hz, Ar-H), 6.89 (2H, d, J = 8.7 Hz, Ar-H), 5.73 (1H, s, Ar-CH), 4.90-4.76 
(1H, m, C10-H), 4.21 (1H, ddd, J = 11.2, 6.0, 2.4 Hz, C14-H), 3.81 (3H, s, OCH3), 3.78 (1H, 
dd, J = 9.6, 6.0 Hz, C15-H), 2.87 (3H, s, SO2CH3), 2.02-1.15 (22H, m, CH2, C12-H, C16-H), 
1.02 (3H, d, J = 6.7 Hz, C12-CH3), 0.93-0.82 (9H, m, C4-H, C16-CH3, C20-H). 
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Epimer 200; Rf (20% ethyl acetate : hexane) 0.57; 1H NMR♦ (300.1 MHz, CDCl3) δ 6.01 
(1H, s, Ar-CH), 4.32 (1H, ddd, J = 11.2, 5.0, 2.3 Hz, C14-H), 2.96 (3H, s, SO2CH3), 1.08 
(3H, d, J = 6.6 Hz, C12-CH3).  
The proposed stereochemistry of epimer 200 above has not been confirmed. 
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(1’R, 2S, 2’R, 4S, 6S)-1’-(6-Hexyl-4-methyl-tetrahydro-pyran-2-yl)-2’-methyl-hexan-1’-ol 
202 and (1R, 3R, 5S, 6R, 7R)-methanesulfonic acid 1-hexyl-5,6-dihydroxy-3,7-dimethyl-
undecyl ester 201 
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To a solution of mesylate 199 and 200 (6.9 mg, 0.0135 mmol, 1.0 eq) in a mixture of 
methanol (220 µl) and water (45 µl) was added Dowex® 50W resin beads (6.9 mg) at room 
temperature. After stirring at this temperature for 3 h, the heterogeneous mixture was diluted 
with methanol and then filtered to remove the resin. Evaporation of the solvent under 
reduced pressure afforded a crude mixture which was purified by flash chromatography 
(20% ethyl acetate : hexane) to give pure pyran 202 (2.9 mg, 72%); Rf (5% ethyl acetate : 
hexane) 0.34; [α]D +18.5 (c 0.1, CH2Cl2); IR (thin film) 3480 (OH), 2956, 2927, 2857 (C-
H), 1067 (C-O) cm-1; 1H NMR (400.2 MHz, CDCl3) δ 3.61 (1H, ddd, J = 12.0, 4.4, 2.1 Hz, 
C14-H), 3.58-3.53 (1H, m, C10-H), 3.43-3.37 (1H, m, C15-H), 2.21-2.12 (1H, m, C12-H), 2.10# 
(1H, d, J = 2.4 Hz, OH), 1.73-1.08 (21H, m, CH2, C16-H), 1.09 (3H, d, J = 7.3 Hz, C12-CH3), 
0.92-0.86 (6H, m, C4-H, C20-H), 0.83 (3H, d, J = 6.8 Hz, C16-CH3); 13C NMR (75.5 MHz, 
CDCl3) δ 77.7, 72.2, 72.1, 37.5, 36.7, 34.1, 31.9, 31.7, 29.9, 29.4, 29.0, 25.5, 25.2, 23.1, 
22.6, 18.2, 15.3, 14.2, 14.1; m/z (EI+) 298 (M, 23), 282 (35), 281 (M-OH, 83), 267 (42), 265 
(35), 208 (22), 183 (20), 165 (29), 149 (40), 109 (100), 95 (97), 81 (97), 79 (55), 67 (93), 55 
(49); HRMS (EI+) calc. 298.2872 for C19H38O2, found 298.2880. 
 
A second fraction identified as diol 201 (0.6 mg) was isolated pure by flash chromatography 
(50% ethyl acetate : hexane); Rf (20% ethyl acetate : hexane) 0.13; [α]D -12.9 (c 0.3, 
CH2Cl2); IR (thin film) 3523, 3448 (OH), 2956, 2927, 2858 (C-H), 1336, 1172 (SO2) cm-1; 
1H NMR (300.1 MHz, CDCl3) δ 4.88-4.76 (1H, m, C10-H), 3.81-3.75 (1H, m, C14-H), 3.38 
(1H, dd, J = 8.2, 3.8 Hz, C15-H), 3.02 (3H, s, SO2CH3), 2.00-1.05 (24H, m, CH2, OH, C12-H, 
C16-H), 1.04 (3H, d, J = 6.7 Hz, C12-CH3), 0.93-0.83 (9H, m, C4-H, C16-CH3, C20-H); 
13C NMR (75.5 MHz, CDCl3) δ 83.1, 79.2, 69.5, 40.9, 38.9, 37.3, 35.7, 35.0, 32.2, 31.6, 
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29.0, 28.9, 25.8, 25.1, 23.1, 22.5, 21.2, 15.4, 14.1, 14.0; m/z (ESI+) 417 (M+Na, 100); 
HRMS (ESI+) calc. 417.2650 for C20H42NaO5S, found 417.2655. 
 
(1’R, 2S, 2’R, 4S, 6S)- Acetic acid 1’-(6-hexyl-4-methyl-tetrahydro-pyran-2-yl)-2’-methyl-
hexyl ester 203 
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To a solution of alcohol 202 (3.1 mg, 0.0104 mmol, 1.0 eq) in dry pyridine (0.21 ml) at room 
temperature was added neat acetic anhydride (10 µl, 0.106 mmol, 10 eq) followed by 4-N,N-
dimethylaminopyridine (catalytic) under an atmosphere of N2. After stirring the reaction 
mixture at room temperature for 3 h, t.l.c analysis confirmed the absence of starting material. 
The solution was quenched with water (5 ml) and then extracted into diethyl ether (2 x 3 ml). 
Removal of the solvent by rotary evaporation gave a crude mixture which was subjected to 
high vacuum to remove residual pyridine. Flash chromatographic purification (5% ethyl 
acetate : hexane) of the crude product afforded pure acetate 203 (3.5 mg, 100%) as a 
colourless oil; Rf (5% ethyl acetate : hexane) 0.56; [α]D -3.3 (c 0.2, CH2Cl2); IR (thin film) 
2954, 2930, 2856 (C-H), 1740 (C=O), 1082 (C-O) cm-1; 1H NMR (400.2 MHz, CDCl3) 
δ 4.80 (1H, dd, J = 8.0, 3.7 Hz, C15-H), 3.61 (1H, ddd, J = 11.2, 8.1, 2.0 Hz, C14-H), 3.51-
3.41 (1H, m, C10-H), 2.16-2.07 (1H, m, C12-H), 2.04 (3H, s, COCH3), 1.98-1.88 (1H, m, 
C16-H), 1.56-1.09 (20H, m, CH2), 1.08 (3H, d, J = 7.3 Hz, C12-CH3), 0.90 (3H, t, J = 7.2 Hz, 
C4-H or C20-H), 0.88 (3H, t, J = 7.2 Hz, C4-H or C20-H), 0.86 (3H, d, J = 7.0 Hz, C16-CH3); 
13C NMR (75.5 MHz, CDCl3) δ 170.6, 79.5, 72.1, 70.4, 37.5, 36.5, 33.7, 33.3, 31.9, 30.1, 
29.6, 29.3, 25.7, 25.3, 22.9, 22.6, 21.0, 18.3, 16.1, 14.1, 14.1; m/z (ESI+) 363 (M+Na, 100); 
HRMS (ESI+) calc. 363.2875 for C21H40NaO3, found 363.2882. 
2D NOESY (400.2 MHz, CDCl3): Nuclear Overhauser Effect between C15-H (δ 4.80), C14-H 
(δ 3.61), C10-H (δ 3.51-3.41), C13-H (δ 1.56-1.09), and C12-CH3 (δ 1.08). 
(Spectra appended) 
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5.8 Synthesis of the C1-C20 Backbone of Fumonisin B3 
 
(1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”R)-5’-{7”-Hydroxy-10”-[2-(p-methoxy-phenyl)-5-(1’”-methyl-
pentyl)-[1,3]dioxolan-4-yl]-9”-oxo-decyl}-2’,2’,4’-trimethyl-oxazolidine-3’-carboxylic acid 
tert-butyl ester 60 and (1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”S)-{7”-hydroxy-10”-[2-(p-methoxy-
phenyl)-5-(1’”-methyl-pentyl)-[1,3]dioxolan-4-yl]-9”-oxo-decyl}-2’,2’,4’-trimethyl-
oxazolidine-3’-carboxylic acid tert-butyl ester 204 
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To a solution of methyl ketone 57 (90 mg, 0.281 mmol, 1.1 eq) in anhydrous diethyl ether (4 
ml) cooled to -78oC was added dry, distilled triethylamine (88.9 µl, 0.638 mmol, 2.5 eq) 
followed by dicyclohexylboron chloride (122.6 µl, 0.561 mmol, 2.2 eq) with stirring under 
an atmosphere of Ar. The resulting cloudy white mixture was stirred at -78oC for 3 h 25 min 
and then a solution of purified aldehyde 58 (84 mg, 0.257 mmol, 1.0 eq) in diethyl ether (6.4 
ml) was added via cannula. The reaction mixture was stirred for a further 2 h 10 min at -78oC 
and then quenched at 0oC by the sequential addition of pH 7.0 buffer (0.5 ml), methanol (0.5 
ml) and 30% H2O2 (0.5 ml). After stirring the solution for 15 min at 0oC, the layers were 
separated. The aqueous phase was extracted with diethyl ether (3 x 8 ml) and the combined 
organic extracts were washed with brine (20 ml), dried (Na2SO4), filtered and concentrated 
O
O
OCH3
204
N
O
O
O
O OH
1
20
Chapter 5 
 181 
under reduced pressure. The crude product was purified by flash chromatography (20% ethyl 
acetate : hexane) using silica gel deactivated with 0.1% triethylamine to give an inseparable 
mixture of aldol products 60 and 204 (107 mg, 65%) in a diastereomeric ratio of 69:31 as 
determined by 400 MHz 13C NMR and 300 MHz 1H NMR. The colourless pure liquid was 
characterised as a mixture; Rf (20% ethyl acetate : hexane) 0.15; [α]D -37.6 (c 1.7, CHCl3); 
IR (thin film) 3487 (OH), 2928, 2858 (C-H), complex 1698 (C=O), 1615, 1517 (C=C), 830 
(C-H, p-disubstituted benzene) cm-1; 1H NMR (300.1 MHz, CDCl3) δ 7.38 (2H, d, J = 8.6 
Hz, Ar-H), 6.89 (2H, d, J = 8.7 Hz, Ar-H), 5.74 (1H, s, Ar-CH), 4.64 (1H, ddd, J = 10.3, 5.9, 
2.9 Hz, C14-H), 4.03-3.91 (1H, m, C10-H), 3.84 (1H, dd, J = 9.9, 5.8 Hz, C15-H), 3.80 (3H, s, 
OCH3), 3.64 (1H, q, J = 6.1 Hz, C3-H), 3.56-3.38 (1H, m, C2-H), 2.74 (1H, dd, J = 14.6, 10.5 
Hz, C13-Ha), 2.60 (1H, dd, J = 17.5, 2.9 Hz, C11-Ha), 2.50-2.40 (2H, m, C11-Hb, C13-Hb), 
1.83-1.16 (29H, m, CH2, CH3, OH, C1-H, C16-H), 1.47 (9H, s, tBu-CH3), 0.91-0.87 (6H, m, 
C16-CH3, C20-H); 1H NMR♦ (400.2 MHz, C6D6) δ 7.50 (2H, d, J = 8.7 Hz, Ar-H), 5.76 (1H, 
s, Ar-CH), 4.59 (1H, ddd, J = 10.7, 5.9, 3.1 Hz, C14-H), 3.25 (3H, s, OCH3), 2.75 (1H, d, J = 
3.6 Hz, OH), 2.64 (1H, dd, J = 14.7, 10.4 Hz, C13-Ha), 2.17 (1H, dd, J = 14.8, 3.1 Hz, 
C13-Hb), 0.64 (3H, d, J = 6.6 Hz, C16-CH3); 13C NMR (100.6 MHz, C6D6) δ 210.2 (210.0), 
161.5, 152.8, 131.5, 129.1, 114.6, 104.3, 94.9-93.6 br, 85.2, 82.2 br, 79.7 br, 75.4 (75.2), 
68.0 br, 59.6-58.2 br, 55.4, 52.1 (51.4), (45.8) 45.5, (37.7) 37.6, 34.5, 33.2, 30.6, 30.5, 29.5, 
29.1, 28.8-26.4 br, 26.9, 26.4, 24.0, 21.2-19.7 br or (19.7-18.5 br), 16.3, 14.9, 2C 
overlapping; m/z (EI+) 647 (M, 4), 632 (M-CH3, 20), 614 (4), 588 (10), 574 (M-C4H9O, 2), 
562 (8), 532 (M-C5H9NO2, 15), 514 (2), 480 (3), 419 (M-228, 6), 396 (15), 378 (50), 344 (5), 
328 (9), 312 (15), 272 (50), 256 (18), 228 (40), 212 (70), 196 (6), 167 (32), 152 (20), 135 
(61), 121 (C8H9O, 13), 109 (47), 95 (11), 84 (33), 69 (23), 57 (C4H9, 100); HRMS (ESI+) 
calc. 670.4288 for C37H61NNaO8, found 670.4306. 
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(1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”R)-5’-{10”-[2-(p-Methoxy-phenyl)-5-(1’”-methyl-pentyl)-
[1,3]dioxolan-4-yl]-9”-oxo-7”-triethylsilanyloxy-decyl}-2’,2’,4’-trimethyl-oxazolidine-3’-
carboxylic acid tert-butyl ester 205 and (1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”S)-5’-{10”-[2-(p-
methoxy-phenyl)-5-(1’”-methyl-pentyl)-[1,3]dioxolan-4-yl]-9”-oxo-7”-triethylsilanyloxy-
decyl}-2’,2’,4’-trimethyl-oxazolidine-3’-carboxylic acid tert-butyl ester 206  
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To a solution of alcohols 60 and 204 (107 mg, 0.165 mmol, 1.0 eq) in freshly distilled dry 
pyridine (3.0 ml) was added 4-N,N-dimethylaminopyridine (4 mg, 0.0327 mmol, 0.2 eq) 
followed by neat chlorotriethylsilane (58.3 µl, 0.347 mmol, 2.1 eq) under an atmosphere of 
Ar. The reaction mixture was stirred at room temperature for 3 h and then diluted with 
dichloromethane (10 ml). After washing with 5% aqueous NaHCO3 solution (4 x 10 ml), the 
organic layer was washed with brine (10 ml), dried (Na2SO4) and concentrated under 
reduced pressure. Residual pyridine was removed under high vacuum. Purification by flash 
chromatography (10% ethyl acetate : hexane) using silica treated with 0.1% triethylamine 
afforded a thick colourless liquid of the title compounds 205 and 206 (113 mg, 90%) as an 
inseparable mixture; Rf (10% ethyl acetate : hexane) 0.26; [α]D -37.8 (c 0.9, CH2Cl2); IR 
(thin film) 2934, 2875 (C-H), 1698 (C=O), 1615, 1517 (C=C), 1387 (C(CH3)2) cm-1; 1H 
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NMR (400.2 MHz, C6D6) δ 7.49 (2H, d, J = 8.5 Hz, Ar-H), 6.80 (2H, d, J = 8.6 Hz, Ar-H), 
5.76 (1H, s, Ar-CH), 4.71 (1H, ddd, J = 9.7, 5.8, 2.8 Hz, C14-H), 4.39-4.32 (1H, m, C10-H), 
3.63-3.37 (2H, m, C2-H, C3-H), 3.59 (1H, dd, J = 9.6, 5.8 Hz, C15-H), 3.28 (3H, s, OCH3), 
2.74 (1H, dd, J = 14.8, 10.3 Hz, C13-Ha), 2.62 (1H, dd, J = 16.6, 6.8 Hz, C11-Ha), 2.43 (1H, 
dd, J = 16.6, 4.9 Hz, C11-Hb), 2.30 (1H, dd, J = 14.8, 2.8 Hz, C13-Hb), 1.89-0.53 (43H, m, 
CH2, CH3, CH3CH2Si, CH3CH2Si, C16-H), 1.44 (9H, s, tBu-CH3), 0.67 (3H, d, J = 6.5 Hz, 
C16-CH3), 0.89 (3H, m, C20-H); 1H NMR♦ (400.2 MHz, C6D6) δ 7.51 (2H, d, J = 8.4 Hz, Ar-
H), 6.81 (2H, d, J = 8.5 Hz, Ar-H), 4.68 (1H, ddd, J = 9.3, 5.8, 3.3 Hz, C14-H), 3.28 (3H, s, 
OCH3), 2.67 (1H, dd, J = 16.5, 6.3 Hz, C11-Ha), 2.50 (1H, dd, J = 16.4, 5.7 Hz, C11-Hb), 2.34 
(1H, dd, J = 14.8, 3.2 Hz, C13-Hb); 13C NMR (100.6 MHz, CDCl3) δ 207.1 (207.0), 161.4, 
152.8, 131.7 (131.6), 129.1, 114.6, (104.4) 104.3, 95.1-94.1 br, 85.2 (85.2), 82.3 br, 79.7 br, 
75.3, (69.3) 69.2, 59.2-58.7 br, 55.4, 52.8 (52.3), (46.4) 46.2, 38.8, 34.5, 33.4, 30.6, 30.6, 
29.5, 29.1, 28.3-26.9 br, 26.8, (26.1) 26.0, 24.0, 21.1-19.7 br or (19.7-18.5 br), 16.4, 14.9, 
7.9, 6.1, 2C overlapping; m/z (ESI+) 784.5 (M+Na, 100); HRMS (ESI+) calc. 784.5158 for 
C43H75NNaO8Si, found 784.5176. 
 
(1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”R)-5’-{9”-[2-(p-Methoxy-phenyl)-5-(1’”-methyl-pentyl)-
[1,3]dioxolan-4-ylmethyl]-7”-triethylsilanyloxy-dec-9”-enyl}-2’,2’,4’-trimethyl-oxazolidine-
3’-carboxylic acid tert-butyl ester 207 and (1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”S)-5’-{9”-[2-(p-
methoxy-phenyl)-5-(1’”-methyl-pentyl)-[1,3]dioxolan-4-ylmethyl]-7”-triethylsilanyloxy-
dec-9”-enyl}-2’,2’,4’-trimethyl-oxazolidine-3’-carboxylic acid tert-butyl ester 208 
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To a solution of ketones 205 and 206 (195 mg, 0.356 mmol, 1.0 eq) in tetrahydrofuran (2.8 
ml) was added dimethyl titanocene (2.7 ml, 0.398 M in toluene, 1.07 mmol, 3.0 eq) under an 
atmosphere of Ar. The reaction mixture was stirred at 70oC in the dark for 6 h 20 min, after 
which time the initial orange coloured solution had turned dark brown. The mixture was 
diluted with a copious quantity of hexane and the resulting yellow precipitate was removed 
by filtration. The filtrate was concentrated under reduced pressure to give a crude residue 
which was purified by flash chromatography (5% ethyl acetate : hexane) to furnish an 
inseparable mixture of olefins 207 and 208 (144 mg, 74%) as a colourless liquid; Rf (10% 
ethyl acetate : hexane) 0.39; IR (thin film) 3072 (C=C-H), 2932, 2924, 2897 (C-H), 1699 
(C=O), 1616, 1517 (C=C), 1387, 1365 (C(CH3)2) cm-1; 1H NMR (400.2 MHz, C6D6) δ 7.59 
(2H, d, J = 8.7 Hz, Ar-H), 6.82 (2H, d, J = 8.6 Hz, Ar-H), 5.87 (1H, s, Ar-CH), 5.14 (1H, s, 
C=CH2), 5.05 (1H, s, C=CH2), 4.37 (1H, ddd, J = 10.1, 6.1, 2.7 Hz, C14-H), 3.99 (1H, 
quintet, J = 6.8 Hz, C10-H), 3.72 (1H, dd, J = 9.3, 6.0 Hz, C15-H), 3.62-3.40 (2H, m, C2-H, 
C3-H), 3.27 (3H, s, OCH3), 2.56-2.36 (4H, m, C13-H, C11-H), 1.98-0.86 (28H, m, CH2, CH3, 
C16-H), 1.44 (9H, s, tBu-CH3), 1.05 (9H, t, J = 7.9 Hz, CH3CH2Si), 0.90 (3H, m, C20-H), 0.84 
(3H, d, J = 6.6 Hz, C16-CH3), 0.67 (6H, q, J = 7.8 Hz, CH3CH2Si); 1H NMR♦ (400.2 MHz, 
C6D6) δ 7.58 (2H, d, J = 8.6 Hz, Ar-H), 5.88 (1H, s, Ar-CH), 3.71 (1H, dd, J = 9.7, 5.9 Hz, 
C15-H), 3.28 (3H, s, OCH3), 1.06 (3H, t, J = 7.9 Hz, CH3CH2Si), 0.84 (3H, d, J = 6.6 Hz, 
C16-CH3), 0.68 (6H, q, J = 7.9 Hz, CH3CH2Si);  m/z (ESI+) 798.5 (M+K, 24), 782.7 (M+Na, 
100), 782.5 (M+Na, 98), 760.5 (M+H, 9); HRMS (ESI+) calc. 782.5366 for 
C44H77NNaO7Si, found 782.5379. 
Note: The 13C NMR spectrum was too complex to assign accurately. 
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(1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”R)-5’-{7”-Hydroxy-9”-[2-(p-methoxy-phenyl)-5-(1’”-methyl-
pentyl)-[1,3]dioxolan-4-ylmethyl]-dec-9”-enyl}-2’,2’,4’-trimethyl-oxazolidine-3’-carboxylic 
acid tert-butyl ester 209 and (1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”S)-5’-{7”-hydroxy-9”-[2-(p-
methoxy-phenyl)-5-(1’”-methyl-pentyl)-[1,3]dioxolan-4-ylmethyl]-dec-9”-enyl}-2’,2’,4’-
trimethyl-oxazolidine-3’-carboxylic acid tert-butyl ester 210 
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To a stirring solution of the silyl ethers 207 and 208 (43 mg, 0.0566 mmol, 1.0 eq) in dry 
tetrahydrofuran (1.3 ml) at room temperature was added a solution of tetrabutylammonium 
fluoride in tetrahydrofuran (1 M, 0.230 mmol, 4.1 eq ) under a N2 atmosphere. The reaction 
mixture was stirred for 1 h and then poured into brine (30 ml). The layers were separated and 
the aqueous phase was extracted into diethyl ether (3 x 20 ml). The combined organic 
extracts were washed with brine (50 ml) and then dried (Na2SO4), filtered and concentrated 
under reduced pressure to afford a crude liquid which was purified by flash chromatography 
(30% ethyl acetate : hexane) to give a diastereomeric mixture of alcohols 209 and 210 (24 
mg, 66%) in a ratio of 72:28 respectively by analytical HPLC (Whatman Partisil 5, 20% 
ethyl acetate : hexane, 0.1% TEA). Preparative HPLC separation of the mixture afforded a 
pure colourless liquid of 209 as the major product by analogy to the model compound 163; 
Rf (20% ethyl acetate : hexane) 0.28; [α]D -34.8 (c 1.5, CH2Cl2); IR (thin film) 3505 (OH), 
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3074 (C=C-H), 2932, 2857 (C-H), 1697 (C=O), 1615, 1517 (C=C), 1389, 1366 (C(CH3)2), 
827 (C-H, p-disubstituted benzene) cm-1; 1H NMR (300.1 MHz, C6D6) δ 7.54 (2H, d, J = 8.7 
Hz, Ar-H), 6.81 (2H, d, J = 8.7 Hz, Ar-H), 5.82 (1H, s, Ar-CH), 5.06 (1H, s, C=CH2), 5.01 
(1H, s, C=CH2), 4.30 (1H, ddd, J = 10.6, 5.9, 2.7 Hz, C14-H), 3.71-3.40 (3H, m, C2-H, C3-H, 
C10-H), 3.65 (1H, dd, J = 9.8, 5.9 Hz, C15-H), 3.28 (3H, s, OCH3), 2.37-2.19 (3H, m, C11-Ha, 
C13-H), 2.14 (1H, dd, J = 13.9, 9.3 Hz, C11-Hb), 1.98-1.13 (38H, m, CH2, CH3, OH, C1-H, 
C16-H), 0.90 (3H, t, J = 6.8 Hz, C20-H), 0.74 (3H, d, J = 6.6 Hz, C16-CH3); 13C NMR (75.5 
MHz, C6D6) δ 161.4, 152.8, 144.7, 131.8, 129.1, 115.7, 114.5, 104.3, 94.9-94.3 br, 85.6, 
82.3, 79.7, 77.1, 69.9, 59.0 br, 55.4, 45.9, 38.3, 37.9, 34.6, 33.2, 30.7, 30.7, 29.6, 29.1, 28.0-
27.1 br, 26.9, 24.0, 20.9-18.7 br, 16.7, 14.9, 3C overlapping; m/z (ESI+) 668.5 (M+Na, 100); 
HRMS (ESI+) calc. 668.4501 for C38H63NNaO7, found 668.4501. 
(Spectra appended) 
 
A second fraction proposed as 210 by analogy to model compound 189 based on mobility, 
was isolated as a colourless liquid; Rf (20% ethyl acetate : hexane) 0.28; [α]D -38.8 (c 0.7, 
CH2Cl2); IR (thin film) 3503 (OH), 3073 (C=C-H), 2932, 2857 (C-H), 1698 (C=O), 1616, 
1517 (C=C), 1388 (C(CH3)2), 827 (C-H, p-disubstituted benzene) cm-1; 1H NMR (300.1 
MHz, C6D6) δ 7.53 (2H, d, J = 8.7 Hz, Ar-H), 6.80 (2H, d, J = 8.8 Hz, Ar-H), 5.83 (1H, s, 
Ar-CH), 5.01 (1H, s, C=CH2), 4.96 (1H, s, C=CH2), 4.26 (1H, ddd, J = 10.6, 5.9, 2.6 Hz, 
C14-H), 3.74-3.40 (3H, m, C2-H, C3-H, C10-H), 3.64 (1H, dd, J = 9.7, 5.9 Hz, C15-H), 3.28 
(3H, s, OCH3), 2.42-2.20 (3H, m, C11-Ha, C13-H), 2.15 (1H, dd, J = 13.8, 9.3 Hz, C11-Hb), 
1.98-1.17 (38H, m, CH2, CH3, OH, C1-H, C16-H), 0.91 (3H, t, J = 6.9 Hz, C20-H), 0.76 (3H, 
d, J = 6.6 Hz, C16-CH3); 13C NMR (75.5 MHz, C6D6) δ 161.4, 152.8, 145.7, 131.9, 129.1, 
115.6, 114.5, 104.3, 95.7-94.3 br, 85.8, 82.3, 79.4, 78.2, 70.2, 59.4-58.2 br, 55.4, 46.2, 38.6, 
38.2, 34.6, 33.2, 30.7, 30.6, 29.6, 29.1, 29.1-26.7 br, 26.9, 26.8, 24.0, 20.6 br, 16.7, 14.9, 2C 
overlapping; m/z (ESI+) 668.5 (M+Na, 100); HRMS (ESI+) calc. 668.4501 for 
C38H63NNaO7, found 668.4497. 
(Spectrum appended) 
 
 
 
 
Chapter 5 
 187 
(1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”R, 9”S)-5’-{7”-Hydroxy-10”-[2-(p-methoxy-phenyl)-5-(1’”-
methyl-pentyl)-[1,3]dioxolan-4-yl]-9”-methyl-decyl}-2’,2’,4’-trimethyl-oxazolidine-3’-
carboxylic acid tert-butyl ester 59 and (1’”R, 2S, 4S, 4’S, 5R, 5’S, 7”R, 9”R)-5’-{7”-
hydroxy-10”-[2-(p-methoxy-phenyl)-5-(1’”-methyl-pentyl)-[1,3]dioxolan-4-yl]-9”-methyl-
decyl}-2’,2’,4’-trimethyl-oxazolidine-3’-carboxylic acid tert-butyl ester 211 
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METHOD A: Hydrogenation of a homoallylic alcohol using platinum on carbon. 
To a solution of olefin 209 (9.3 mg, 0.0144 mmol, 1.0 eq) in dry methanol (1.6 ml) was 
added platinum on carbon (10% wt., 0.62 mg, 0.000318 mmol, 2.2 mol%). The reaction 
vessel was fitted with a H2 balloon, and then evacuated and purged with H2 via a three-way 
tap. The evacuation/purge cycle was repeated twice then H2 was introduced for the final 
time. The reaction mixture was stirred under an atmosphere of H2 for 1.5 h at room 
temperature. After diluting with methanol, the mixture was filtered through a celite pad and 
the filter cake washed with methanol. The filtrate was concentrated in vacuo to afford a clean 
mixture of 2 isomeric products (84%) in a ratio of 50:50 as determined by 200 MHz 
1H NMR. Data for the mixture is as follows; 1H NMR (200.1 MHz, C6D6) δ 7.58 (d, J = 8.7 
Hz, Ar-H), 7.55 (d, J = 8.7 Hz, Ar-H), 6.85 (d, J = 8.8 Hz, Ar-H), 6.79 (d, J = 8.8 Hz, Ar-H), 
5.90 (s, Ar-CH), 5.87 (s, Ar-CH), 4.25 (ddd, J = 11.3, 5.5, 1.8 Hz, C14-H), 4.19 (ddd, J = 
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11.9, 5.8, 1.8 Hz, C14-H), 3.68 (dd, J = 9.5, 5.9 Hz, C15-H), 3.72-3.45 (m, C2-H, C3-H, 
C10-H), 3.30 (s, OCH3), 3.25 (s, OCH3), 2.29-1.04 (m, CH2, CH3, OH, C1-H, C12-H, C16-H), 
1.44 (s, tBu-CH3), 1.03 (d, J = 6.7 Hz, C12-CH3), 1.01 (d, J = 6.6 Hz, C12-CH3), 0.90 (t, J = 
6.9 Hz, C20-H), 0.78 (d, J = 6.5 Hz, C16-CH3), 0.76 (d, J = 6.5 Hz, C16-CH3). 
(Spectrum appended) 
 
Separation of the diastereomers was achieved by semipreparative HPLC (Whatman Partisil 
10, 20% ethyl acetate : hexane, 0.1% TEA) to give diastereomerically clean syn-alcohol 211 
(3.8 mg, tR 10.459 min [Whatman Partisil 5, 20% ethyl acetate : hexane, 0.1% TEA]), by 
analogy to the model compound 191 based on its mobility. Syn-alcohol 211 was obtained as 
a colourless oil for immediate characterisation. Acid-induced epimerisation and hydrolysis 
was evident by NMR, thus data for the major product is as follows; Rf (20% ethyl acetate : 
hexane) 0.36; IR (thin film) 3446 (OH), 2931, 2857 (C-H), 1699, 1684 (C=O), 1616, 1516 
(C=C), 830 (C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, CD2Cl2) δ 7.39 (2H, 
d, J = 8.1 Hz, Ar-H), 6.87 (2H, d, J = 7.5 Hz, Ar-H), 5.71 (1H, s, Ar-CH), 4.26-4.18 (1H, m, 
C14-H), 3.79 (3H, s, OCH3), 3.79-3.38 (4H, m, C2-H, C3-H, C10-H, C15-H), 2.05-0.83 (40H, 
m, CH2, CH3, OH, C1-H, C12-H, C16-H, C16-CH3, C20-H), 1.44 (9H, s, tBu-CH3), 0.95 (3H, d, 
J = 6.4 Hz, C12-CH3); m/z (ESI+) 670.6 (M+Na, 100); HRMS (ESI+) calc. 670.4658 for 
C38H65NNaO7, found 670.4646. 
 
A second fraction tentatively assigned as anti-alcohol 59 (4 mg, tR 16.960 min [Whatman 
Partisil 5, 20% ethyl acetate : hexane, 0.1% TEA]) by analogy to the model C4-C20 
fragment 190, was isolated as a colourless oil. Acid-induced epimerisation and hydrolysis 
was evident by NMR, thus data for the major product is as follows; Rf (20% ethyl acetate : 
hexane) 0.36; IR (thin film) 3448 (OH), 2931, 2857 (C-H), 1698 (C=O), 1613, 1515 (C=C), 
1390, 1368 (C(CH3)2), 830 (C-H, p-disubstituted benzene) cm-1; 1H NMR (400.2 MHz, 
CD2Cl2) δ 7.37 (2H, d, J = 8.7 Hz, Ar-H), 6.88 (2H, d, J = 8.7 Hz, Ar-H), 5.69 (1H, s, Ar-
CH), 4.23 (1H, ddd, J = 11.2, 6.0, 2.2 Hz, C14-H), 3.79 (3H, s, OCH3), 3.77 (1H, dd, J = 9.2, 
5.6 Hz, C15-H), 3.70-3.59 (2H, m, C3-H, C10-H), 3.52-3.37 (1H, m, C2-H), 2.04-0.83 (40H, 
m, CH2, CH3, OH, C1-H, C12-H, C16-H, C16-CH3, C20-H), 1.44 (9H, s, tBu-CH3), 0.96 (3H, d, 
J = 6.4 Hz, C12-CH3); m/z (ESI+) 670.5 (M+Na, 100); HRMS (ESI+) calc. 670.4658 for 
C38H65NNaO7, found 670.4654. 
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Note: Due to epimerisation and loss of the p-methoxybenzyl acetal group of compounds 59 
and 211 during characterisation, 13C NMR and optical rotation data could not be obtained. 
 
METHOD B: Hydrogenation of a homoallylic alkoxide using a chiral rhodium catalyst 
To a slurry of washed and dried sodium hydride (0.5 mg, 0.0208 mmol, 1.1 eq) in degassed 
dichloromethane (0.2 ml) was added a solution of olefin 209 (33.1 mg, 0.0766 mmol, 1.0 eq) 
in dichloromethane (0.2 ml) via cannula. The resulting mixture was stirred for 10 min at 
room temperature and then a solution of catalyst (-)-1,2-bis((2R,5R)-2,5-
dimethylphospholano)benzene(cyclooctadiene)rhodium(I) tetrafluoroborate (2.2 mg, 
0.00364 mmol, 20 mol%) in dichloromethane (0.3 ml + 0.1 ml) was added under an 
atmosphere of Ar. The reaction mixture was quickly transferred to a hydrogenation bomb 
apparatus which was then purged and evacuated with H2 three times. The reaction mixture 
was stirred under 300 psi H2 pressure for 16 h at room temperature. After t.l.c analysis 
confirmed the absence of starting material, the mixture was filtered through a short silica 
column (50% ethyl acetate : hexane) to remove both the catalyst and NaH. The solvent was 
evaporated under reduced pressure to yield a mixture of syn-211 and anti-59 in a ratio of 
54:46 as determined by 1H NMR, and 64:36 as determined by analytical HPLC (Whatman 
Partisil 5, 20% ethyl acetate : hexane, 0.1% TEA) of the crude mixture. 1H NMR of the 
crude also showed that the reaction had not proceeded cleanly. 
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5.9 Experimental Index of Compounds 
 
 
Compound Name        page 
 
Acetone (+)-diisopinocampheylboron enolate    103 
Acetone (-)-diisopinocampheylboron enolate    104 
(6-Bromo-hexyloxy)-tert-butyl-dimethyl-silane    131 
tert-Butylhypochlorite       115 
tert-Butyl-isopropenyloxy-dimethyl-silane     106 
Dicyclohexylboron chloride       100 
Dimethyl titanocene        141 
Hept-2-yn-1-ol        92 
(4R)-4-Hydroxy-5-methyl-hexan-2-one     107 
(R)-MTPA-ester derivative of 117      121 
(R)-MTPA-ester derivative of 119      117 
(S)-MTPA-ester derivative of 119      118 
(R)-MTPA-ester derivative of 154      156 
(S)-MTPA-ester derivative of 154      157 
(R)-MTPA-ester derivative of 163      164 
(S)-MTPA-ester derivative of 163      164 
NMA esters of 179        148 
NMA esters of 180        149 
NMA esters of 190        170 
NMA esters of 191        172 
 
 
Compound Number 
 
57          109 
58          139 
59          187,189 
60          180 
61          93 
63          135 
65          125 
66          132 
67          128 
75          99 
76          94 
77          93 
80          95 
82          100,102,103, 
104,106,108,109 
83          95 
84          96 
85          96 
86          97 
  
88          98 
89          100,102,104, 
106,108,109 
90          105 
91          102 
101          108 
106          111 
107          111 
109          112 
110          113,114 
111          113 
116          120 
117          119 
118          120 
119          115,117 
121          121,123 
122          122 
123          123 
124          124 
126          126,127 
127          126 
128          127 
129          128 
130          129 
138          133 
139          133 
140          135,136 
141          137 
142          130 
143          129 
144          131 
149          134 
150          136 
151          138 
154          155 
155          158 
159          151,152 
160          151,152 
161          154 
162          153 
163          162 
164          141 
165          140 
166          142 
167          145 
168          143,144 
169          145 
179          146,147 
180          146,147 
 191 
184          159 
185          159 
186          160 
187          160 
188          161 
189          162 
190          165,168,169 
191          165,168,169 
195          175 
196          174 
198          175 
199          176 
200          177 
201          178 
202          178 
203          179 
204          180 
205          182 
206          182 
207          183 
208          183 
209          185 
210          185 
211          187,189 
213,214,215,216        167 
217,218         168 
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